JADECARE Consortium Agreement - Final version , 2020-10-26
CONSORTIUM AGREEMENT
JOINT ACTION ON IMPLEMENTATION OF DIGITALLY
ENABLED INTEGRATED PERSON-CENTERED CARE
- JADECARE
Bilbao, Basque Country-Spain
October 26th 2020
1 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
Table of Content
CONSORTIUM AGREEMENT ................................................................................................................ 3
1 Section: Definitions ....................................................................................................................... 4
2 Section: Purpose ........................................................................................................................... 5
3 Section: Entry into force, duration and termination .................................................................. 5
4 Section: Responsibilities of Beneficiaries .................................................................................. 6
5 Section: Liability towards each other .......................................................................................... 8
6 Section: Governance structure .................................................................................................... 9
7 Section: Financial provisions..................................................................................................... 18
8 Section: Results........................................................................................................................... 19
9 Section: Access Rights ............................................................................................................... 22
10 Section: Non-disclosure of information .................................................................................... 24
11 Section: Miscellaneous ............................................................................................................... 26
12 Section Signatures ...................................................................................................................... 28
Attachment 1: Accession document ................................................................................................. 45
Attachment 2: List of Affiliated Entities ............................................................................................ 46
2 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
CONSORTIUM AGREEMENT
This Consortium Agreement is a private reciprocal agreement between the beneficiaries of
the Joint Action JADECARE, to set out the rights and obligations amongst themselves. (It
does not involve the European Commission nor CHAFEA). It complements the Grant
Agreement and does not contain any provision contrary to it. It must be signed by all
beneficiaries.
THIS CONSORTIUM AGREEMENT is based upon the Grant Agreement with the
Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) for the Joint Action
entitled “Joint Action on implementation of Digitally Enabled integrated person-centered
CARE – JADECARE” Grant Agreement number 951442, and is effective as of 01 October
2020, hereinafter referred to as “the starting date of the Joint Action” and “Effective Date”.
BETWEEN:
1. ASOCIACIÓN INSTITUTO DE INVESTIGACIÓN EN SERVICIOS DE SALUD- KRONIKGUNE
(KG), the coordinator,
2. MINISTRY OF CIVIL AFFAIRS (MCA), Bosnia and Herzegovina,
3. HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO (CIPH), Croatia,
4. MINISTERSTVO ZDRAVOTNICTVI CESKE REPUBLIKY (MZCR), Czech Republic,
5. REGION NORDJYLLAND (NORTH DENMARK REGION) (RND), Denmark,
6. SOTSIAALMINISTEERIUM (MSAE), Estonia,
7. EUROMETROPOLE DE STRASBOURG (EUSTRAS), France,
8. BEHOERDE FUER ARBEIT, GESUNDHEIT, SOZIALES, FAMILIE UND INTEGRATION HAMBURG
(BAGSFI), Germany,
9. 4I DIOIKISI YGEIONOMIKIS PERIFEREIAS MAKEDONIAS KAI THRAKIS (4THYPE), Greece,
10. ALLAMI EGESZSEGUGYI ELLATO KOZPONT (AEEK), Hungary,
11. AGENZIA NAZIONALE PER I SERVIZI SANITARI REGIONALI (AGENAS), Italy,
12. NACIONALAIS VESELIBAS DIENESTS (NVD), Latvia,
13. LIETUVOS RESPUBLIKOS SVEIKATOS APSAUGOS MINISTERIJA (LR SAM), Lithuania,
14. ADMINISTRACAO CENTRAL DO SISTEMA DESAUDE IP (ACSS), Portugal,
15. MINISTARSTVO ZDRAVLJA (MoHRS), Serbia,
16. NACIONALNI INSTITUT ZA JAVNO ZDRAVJE (NIJZ), Slovenia,
17. REGIONAL HEALTH AND SOCIAL CARE BOARD (HSCB), United Kingdom,
hereinafter, jointly or individually, referred to as “Beneficiaries” or “Beneficiary”
relating to the Joint Action entitled “JOINT ACTION ON IMPLEMENTATION OF DIGITALLY
ENABLED INTEGRATED PERSON-CENTERED CARE”
in short JADECARE
hereinafter referred to as “Joint Action (JA)”
3 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
WHEREAS:
The Beneficiaries, having considerable experience in the field concerned, have submitted a
proposal for the Joint Action to CHAFEA as part of the 3rd. EU Health Programme (2014-
2020).
The Competent Authorities wish to specify or supplement binding commitments among
themselves in addition to the provisions of the specific Grant Agreement to be signed by the
Competent Authorities and the Funding Authority (hereinafter “Grant Agreement”).
The Beneficiaries are aware that this Consortium Agreement is based upon the DESCA model
consortium agreement.
NOW, THEREFORE, IT IS HEREBY AGREED AS FOLLOWS:
1 Section: Definitions
1.1 Definitions
Words beginning with a capital letter shall have the meaning defined either herein or in the
Rules for Participation or in the Grant Agreement including its Annexes.
1.2 Additional Definitions
“Beneficiary or Beneficiaries” means a beneficiary or the beneficiaries to this Consortium
Agreement also identified as the beneficiaries to the Grant Agreement.
“Coordination Team”. The Coordination Team (CT) forms an integral part of the
Coordinator and both terms will be used interchangeably.
“Competent Authority” (CA) means the central authority of a Member State competent for
health/specific (public) health topic or any other authority to which that competence has
been conferred; it shall also include, where appropriate, the corresponding authority of a
third country. A Competent Authority can also be one at regional level, depending on the
governance structure of the Member State/third country.
“Affiliated Entity” (AE) - entities affiliated to the nominated Competent Authorities:
these are organizations that have a distinct legal personality but are linked to the
nominated Competent Authority.
“Consortium Body“ means any management body described in the Governance Structure
section of this Consortium Agreement.
“Consortium Plan” means the description of the action and the related agreed budget as
first defined in the Grant Agreement and which may be updated by the General Assembly.
"Funding Authority," means the body awarding the grant for the Joint Action.
4 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
“Force Majeure”
“Force Majeure” means any one or more events beyond the reasonable control of the
relevant Party which occur after the date of signing of this Consortium Agreement, were not
reasonably foreseeable at the time of signing of this Consortium Agreement, and the effects
of which are not capable of being overcome without unreasonable expense and/or
unreasonable loss of time to the Party concerned. Force Majeure events shall include
(without limitation) war, civil unrest, acts of government, natural disasters, exceptional
weather conditions, breakdown or general unavailability of transport facilities, accidents, fire,
explosions, and general shortages of energy.
“Defaulting Beneficiary” means a Beneficiary which the General Assembly has identified to
be in breach of this Consortium Agreement and/or the Grant Agreement as specified in
Section 4.2 of this Consortium Agreement.
“Needed” means:
For the implementation of the Joint Action:
Access Rights are Needed if, without the grant of such Access Rights, carrying out the tasks
assigned to the recipient Beneficiary would be technically or legally impossible, significantly
delayed, or require significant additional financial or human resources.
For Exploitation of own Results:
Access Rights are Needed if, without the grant of such Access Rights, the Exploitation of
own Results would be technically or legally impossible.
2 Section: Purpose
The purpose of this Consortium Agreement is to specify with respect to the Joint Action the
relationship among the Beneficiaries, in particular concerning the organisation of the work
between the Beneficiaries, the management of the Joint Action and the rights and
obligations of the Beneficiaries concerning inter alia liability, Access Rights and dispute
resolution.
3 Section: Entry into force, duration and termination
3.1 Entry into force
An entity becomes a Beneficiary to this Consortium Agreement upon signature of this
Consortium Agreement by a duly authorized representative.
This Consortium Agreement shall have effect from the Effective Date identified in the Grant
Agreement.
A new entity becomes a Beneficiary to the Consortium Agreement upon signature of the
accession document (Attachment 1) by the new Beneficiary and the Coordinator. Such
accession shall have effect from the date identified in the accession document.
3.2 Duration and termination
This Consortium Agreement shall continue in full force and effect until complete fulfilment of
all obligations undertaken by the Beneficiaries under the Grant Agreement and under this
Consortium Agreement.
5 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
However, this Consortium Agreement or the participation of one or more Beneficiaries may
be terminated in accordance with the terms of this Consortium Agreement.
If
- the Grant Agreement is not signed by the Funding Authority or a Beneficiary, or
- the Grant Agreement is terminated, or
- a Beneficiary's participation in the Grant Agreement is terminated,
this Consortium Agreement shall automatically terminate in respect of the affected
Beneficiary/ies, subject to the provisions surviving the expiration or termination under Section
3 of this Consortium Agreement.
3.3 Survival of rights and obligations
The provisions relating to Access Rights, Dissemination and Confidentiality, for the time
period mentioned therein, as well as for liability, applicable law and settlement of disputes
shall survive the expiration or termination of this Consortium Agreement.
Termination shall not affect any rights or obligations of a Beneficiary leaving the Consortium
incurred prior to the date of termination, unless otherwise agreed between the General
Assembly and the leaving Beneficiary. This includes the obligation to provide all input,
deliverables and documents for the period of its participation.
4 Section: Responsibilities of Beneficiaries
4.1 General principles
Each Beneficiary undertakes to take part in the efficient implementation of the Joint Action,
and to cooperate, perform and fulfil, promptly and on time, all of its obligations under the
Grant Agreement and this Consortium Agreement as may be reasonably required from it and
in a manner of good faith as prescribed by Belgian law.
Each Beneficiary undertakes to notify promptly, in accordance with the governance structure
of the Joint Action, any significant information, fact, problem or delay likely to affect the Joint
Action.
Each Beneficiary shall promptly provide all information reasonably required by a Consortium
Body or by the Coordinator to carry out its tasks.
Each Beneficiary shall take reasonable measures to ensure the accuracy of any information
or materials it supplies to the other Beneficiaries.
4.2 Breach
In the event that a responsible Consortium Body identifies a breach by a Beneficiary of its
obligations under this Consortium Agreement or the Grant Agreement (e.g. improper
implementation of the Joint Action), the Coordinator or, if the Coordinator is in breach of its
obligations, the Beneficiary appointed by the General Assembly, will give formal notice to
such Beneficiary requiring that such breach will be remedied within 30 calendar days from
the date of receipt of the written notice by the Beneficiary.
If such breach is substantial, as mention on the Grant Agreement Article 7, and is not
remedied within that period or is not capable of remedy, the General Assembly may decide
to declare the Beneficiary to be a Defaulting Beneficiary and to decide on the consequences
thereof that may include termination of its participation.
6 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
4.3 Involvement of third Beneficiaries
A Beneficiary that enters into a subcontract or otherwise involves third Beneficiaries
(including but not limited to Affiliated Entities) in the Joint Action remains responsible for
carrying out its relevant part of the Joint Action and for such Affiliated Entity’s compliance
with the provisions of this Consortium Agreement and of the Grant Agreement. It has to
ensure that the involvement of third Beneficiaries does not affect the rights and obligations of
the other Beneficiaries under this Consortium Agreement and the Grant Agreement.
4.4 Affiliated entities
With regards to affiliated entities, the following two options exist:
4.4.1 Affiliated entities to a beneficiary – legal or capital link
According to article 122 of the Financial Regulation an entity affiliated to a "single"
beneficiary (for Joint Actions - the competent authority) is an entity that fulfils the following
conditions:
It has a structural link with the "single" beneficiary, in particular a legal or capital link. In
general, the notion of legal and capital link encompasses mainly two notions - control and
membership. Control means that entities are directly or indirectly controlled by the
beneficiary, under the same control as the beneficiary - or controlling the beneficiary.
Membership, means that the beneficiary is defined as for example a network, federation,
association in which the affiliated entities also participate.
4.4.2 Affiliated entities forming one "Sole beneficiary" as a single entity
Article 122.1 of the Financial Regulation introduced the concept of "sole beneficiary": "Where
several entities satisfy the criteria for being awarded a grant and together form one entity,
that entity may be treated as the "sole beneficiary", including where the entity is specifically
established for the purpose of implementing the action to be financed by the grant".
The competent authority, acting as leader of or affiliated to the "sole beneficiary", must have
been nominated by the participating country. The "sole beneficiary" may be legally
established specifically for the purpose of the action. The "sole beneficiary" does not need to
have a distinct legal personality. The affiliated entities forming the "sole beneficiary" should
establish as appropriate internal arrangements setting out the functioning of the "sole
beneficiary" and the role of each one. This internal arrangement may take the form of
an internal co-operation agreement (national consortium agreement).
In both above cases, only the leader of the sole beneficiary will sign the Joint Action Grant
Agreement.
4.4.3 Legal commitment and responsibilities of the beneficiary and affiliated entities for both
options
a. The competent authority or beneficiary and its affiliated entities have to be identified in the
Grant Agreement.
b. The beneficiary is fully responsible for the implementation of the tasks assigned to its
affiliated entities, from the operational and financial point of view. Therefore: They must
inform of any change to the situation of their affiliates.
7 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
c. They are financially responsible for any amount that would have been paid as
reimbursement of costs unduly declared by its affiliated entities.
d. The beneficiary has obligations in connection to its affiliated entities, among
others: Ensuring that the eligibility criteria applying to its own costs apply also to the costs
incurred by its affiliated entities; Ensuring compliance of its affiliated entities with the rules
applying to them on nonliability of the Commission, absence of conflict of interest,
confidentiality, visibility of the Union and evaluation.
e. A beneficiary cannot subcontract tasks to its affiliated entities or to the entities affiliated to
another beneficiary in the same grant. This is considered like subcontracting activities
between different beneficiaries of a grant and is forbidden by the Financial Regulation.
5 Section: Liability towards each other
5.1 No warranties
In respect of any information or materials (incl. Results) supplied by one Beneficiary to
another under the Joint Action, no warranty or representation of any kind is made, given or
implied as to the sufficiency or fitness for purpose nor as to the absence of any infringement
of any proprietary rights of third Beneficiaries.
Therefore,
the recipient Beneficiary shall in all cases be entirely and solely liable for the use to which
it puts such information and materials, and
no Beneficiary granting Access Rights shall be liable in case of infringement of
proprietary rights of an Affiliated Entity resulting from any other Beneficiary (or its
Affiliated Entities) exercising its Access Rights.
5.2 Limitations of contractual liability
No Beneficiary shall be responsible to any other Beneficiary for any indirect or consequential
loss or similar damage such as, but not limited to, loss of profit, loss of revenue or loss of
contracts, provided such damage was not caused by a wilful act or by a breach of
confidentiality.
For any remaining contractual liability, a Beneficiary’s aggregate liability towards the other
Beneficiaries collectively shall be limited to the Beneficiary’s share of the total costs of the
Joint Action as identified in Annex 2 of the Grant Agreement provided such damage was not
caused by a wilful act or gross negligence.
The terms of this Consortium Agreement shall not be construed to amend or limit any
Beneficiary’s statutory liability.
5.3 Damage caused to third Beneficiaries
Each Beneficiary shall be solely liable for any loss, damage or injury to third Beneficiaries
resulting from the performance of the said Beneficiary’s obligations by it or on its behalf
under this Consortium Agreement or from its use of Results.
8 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
5.4 Force Majeure
No Beneficiary shall be considered to be in breach of this Consortium Agreement if it is
prevented from fulfilling its obligations under the Consortium Agreement by Force Majeure.
Each Beneficiary will notify the competent Consortium Bodies of any Force Majeure without
undue delay. If the consequences of Force Majeure for the Joint Action are not overcome
within 6 weeks after such notification, the transfer of tasks - if any - shall be decided by the
competent Consortium Bodies.
6 Section: Governance structure
6.1 General structure
The organisational structure of the Consortium shall comprise the following Consortium
Bodies:
“General Assembly (GA)” as the ultimate decision-making body of the Consortium.
“Steering Committee (SC)” as the supervisory body for the execution of the Joint Action
which shall report to and be accountable to the General Assembly.
The “Coordinator” is the legal entity acting as the intermediary between the Beneficiaries and
the Funding Authority. The Coordinator shall, in addition to its responsibilities as a
Beneficiary, perform the tasks assigned to it as described in the Grant Agreement and this
Consortium Agreement.
The “Coordination Team” is responsible for the achievement of the JA goals and the
contractual obligations towards the European Commission, and provides global scientific and
technical leadership, quality assurance policy and overall coordination of the joint action. The
Coordination Team is formed by the JA Coordinator supported by the Scientific Coordinator,
the Project Manager and the Financial Manager.
Coordination and implementation roles and activities in the Joint Action are performed by
CAs (as Leading Beneficiaries (LB)), and AEs. AEs can act as Leading Executive
Organisations (LEO) and Co-Leading Executive Organisations. CAs and AEs are responsible
for Work Packages and/or Tasks and contribute to the Deliverables and Milestones as
described in the JADECARE Joint Action.
The “Work Package lead (WPL)” is formed by the Lead Beneficiary (LB), the Leading
Executive Organization (LEO) and the co-Leading Executive Organisation. It is responsible
for the day-to-day management and coordination of the activities included in their respective
work packages as defined in the Grant Agreement, and will be able to raise proposals to the
SC regarding effort and budget redistribution, and re-assignment of roles and responsibilities
within their respective WPs.
“Next Adopters Working Groups (NAWG)” are in charge for the implementation of the Local
Good Practices, led by the representative of the corresponding Competent Authority or
Affiliated Entity.
“Policy Board (PB)” is responsible for giving input to sustainability plans from the focus of
policy, and the definition of core messages to support evidence-based policy making with
respect to sustainability of JADECARE results.
9 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
6.2 General operational procedures for all Consortium Bodies
6.2.1 Representation in meetings
Any Beneficiary which is a member of a Consortium Body (hereinafter referred to as
"Member"):
- should be present or represented at plenary meetings, GA meetings and Stakeholder
Forum.
- may appoint a substitute or a proxy to attend and vote at any meeting;
and shall participate in a cooperative manner in the meetings.
Work Package Leads should:
- be present or represented at plenary meetings and SC meetings.
- be present or represented at Work Package meetings in which they participate.
- may appoint a substitute or a proxy to attend a meeting;
and shall participate in a cooperative manner in the meetings.
CAs and AEs should:
- be present or represented at Work Package meetings in which they participate.
- may appoint a substitute or a proxy to attend a meeting;
and shall participate in a cooperative manner in the meetings.
6.2.2 Preparation and organisation of meetings
The Consortium Bodies will prepare and organize meetings according to the general rules
below. The General Assembly and the Steering Committee will comply with the specified
deadlines and rules.
6.2.2.1 Convening meetings
The chairperson of a Consortium Body shall convene meetings of that Consortium Body.
Ordinary Extraordinary meeting
meeting
General At least once At any time upon written request of the Coordinator,
Assembly a year Steering Committee or 1/3 of the Members of the General
Assembly
Steering At least once At any time upon written request of the Coordinator or any
Committee a month via 1/3 of the Members of the Steering Committee
tele or web-
conferencing
and at least
once a year
face to face.
10 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
6.2.2.2 Notice of a meeting
The chairperson of a Consortium Body shall give notice in writing of a meeting to each
Member of that Consortium Body as soon as possible and no later than the minimum number
of days preceding the meeting as indicated below.
Ordinary meeting Extraordinary meeting
General Assembly 45 calendar days 15 calendar days
Steering 14 calendar days 7 calendar days
Committee
6.2.2.3 Sending the agenda
The chairperson of a Consortium Body shall prepare and send each Member of that
Consortium Body a written (original) agenda no later than the minimum number of days
preceding the meeting as indicated below.
General Assembly 21 calendar days, 10 calendar days for an extraordinary meeting
Steering Committee 7 calendar days
6.2.2.4 Adding agenda items:
Any agenda item requiring a decision by the Members of a Consortium Body must be
identified as such on the agenda.
Any Member of a Consortium Body may add an item to the original agenda by written
notification to all of the other Members of that Consortium Body up to the minimum number
of days preceding the meeting as indicated below.
General Assembly 14 calendar days, 7 calendar days for an extraordinary meeting
Steering Committee 2 calendar days
6.2.2.5
During a meeting, the Members of a Consortium Body present or represented can
unanimously agree to add a new item to the original agenda.
6.2.2.6
Meetings of each Consortium Body may also be held by teleconference or other
telecommunication means.
6.2.2.7
Decisions will only be binding once the relevant part of the Minutes has been accepted
according to Section 6.2.5.
6.2.2.8
Any decision may also be taken without a meeting if the Coordinator circulates to all
Members of the Consortium Body a written document, which is then agreed by the defined
majority (see Section 6.2.3) of all Members of the Consortium Body. Such document shall
include the deadline for responses.
Decisions taken without a meeting shall be considered as accepted if, within the period set
out in article 6.2.4.4, no Member has sent an objection in writing to the chairperson. The
decisions will be binding after the chairperson sends to all Members of the Consortium Body
and to the Coordinator a written notification of this acceptance.
11 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
6.2.3 Voting rules and quorum
6.2.3.1
Each Consortium Body shall not deliberate and decide validly unless two-thirds (2/3) of its
Members are present or represented (quorum). If the quorum is not reached, the chairperson
of the Consortium Body shall convene another ordinary meeting within 15 calendar days. If in
this meeting the quorum is not reached once more, the chairperson shall convene an
extraordinary meeting, which shall be entitled to decide even if less than the quorum of
Members are present or represented.
6.2.3.2
Voting rules means one vote per Competent Authority (CA).
6.2.3.3
A Beneficiary which the General Assembly has declared according to Section 4.2 to be a
Defaulting Beneficiary may not vote.
6.2.3.4
Decisions shall be taken by a majority of two-thirds (2/3) of the votes cast.
6.2.4 Veto rights
6.2.4.1
A Member which can show that its own work, time for performance, costs, liabilities,
intellectual property rights or other legitimate interests would be severely affected by a
decision of a Consortium Body may exercise a veto with respect to the corresponding
decision or relevant part of the decision.
6.2.4.2
When the decision is foreseen on the original agenda, a Member may veto such a decision
during the meeting only.
6.2.4.3
When a decision has been taken on a new item added to the agenda before or during the
meeting, a Member may veto such decision during the meeting and within 15 calendar days
after the draft minutes of the meeting are sent.
6.2.4.4
When a decision has been taken without a meeting, a Member may veto such decision within
15 calendar days after written notification by the chairperson of the outcome of the vote.
6.2.4.5
In case of exercise of veto, the Members of the related Consortium Body shall make every
effort to resolve the matter, which occasioned the veto to the general satisfaction of all its
Members.
6.2.4.6
A Beneficiary may neither veto decisions relating to its identification to be in breach of its
obligations nor to its identification as a Defaulting Beneficiary. The Defaulting Beneficiary
may not veto decisions relating to its participation and termination in the consortium or the
consequences of them.
12 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
6.2.4.7
A Beneficiary requesting to leave the consortium may not veto decisions relating thereto.
6.2.5 Minutes of meetings
6.2.5.1
The chairperson of a Consortium Body shall produce written minutes of each meeting, which
shall be the formal record of all decisions taken. He/she shall send the draft minutes to all
Members within 10 calendar days of the meeting.
6.2.5.2
The minutes shall be considered as accepted if, within 15 calendar days from sending, no
Member has sent an objection in writing to the chairperson with respect to the accuracy of
the draft of the minutes.
6.2.5.3
The chairperson shall send the accepted minutes to all the Members of the Consortium Body
and to the Coordinator, who shall safeguard them. If requested the Coordinator shall provide
authenticated duplicates to Beneficiaries.
6.3 Specific operational procedures for the Consortium Bodies
6.3.1 General Assembly
In addition to the rules described in Section 6.2, the following rules apply:
6.3.1.1 Members
6.3.1.1.1
The General Assembly will be chaired by the Joint Action Coordinator and contain
representatives from each of the Competent Authorities and their Affiliated entities. This
plenary assembly will be the ultimate decision-making body in JADECARE.
A general assembly of all entities with decision-making responsibility in matters affecting the
overall project strategy, major work plan updates composition of the Consortium, effort and
budget re-assignment.
In the voting in the General Assembly, each Beneficiary/Competent Authority has one vote
(hereinafter General Assembly Member).
6.3.1.1.2
Each General Assembly Member shall be deemed to be duly authorised to deliberate,
negotiate and decide on all matters listed in Section 6.3.1.2. of this Consortium Agreement.
6.3.1.1.3
The Coordinator shall chair all meetings of the General Assembly, unless decided otherwise
in a meeting of the General Assembly.
6.3.1.1.4
The Beneficiaries agree to abide by all decisions of the General Assembly. This does not
prevent the Beneficiaries to submit a dispute to resolution in accordance with the provisions
of Settlement of disputes in Section 11.8.
13 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
6.3.1.2 Decisions
The General Assembly shall be free to act on its own initiative to formulate proposals and
take decisions in accordance with the procedures set out herein. In addition, all proposals
made by the Steering Committee shall also be considered and decided upon by the General
Assembly.
The following decisions shall be taken by the General Assembly:
As regards content, finances and intellectual property rights
Proposals for changes to Annexes 1 and 2 of the Grant Agreement to be agreed by the
Funding Authority
Changes to the Consortium Plan
Additions to Attachment 2 (Identified Affiliated Entities)
As regards evolution of the consortium
Entry of a new Beneficiary to the consortium and approval of the settlement on the
conditions of the accession of such a new Beneficiary
Withdrawal of a Beneficiary from the consortium and the approval of the settlement on
the conditions of the withdrawal
Identification of a breach by a Beneficiary of its obligations under this Consortium
Agreement or the Grant Agreement
Declaration of a Beneficiary to be a Defaulting Beneficiary
Remedies to be performed by a Defaulting Beneficiary
Termination of a Defaulting Beneficiary’s participation in the consortium and measures
relating thereto
Proposal to the Funding Authority for a change of the Coordinator
Proposal to the Funding Authority for suspension of all or part of the Joint Action
Proposal to the Funding Authority for termination of the Joint Action and the Consortium
Agreement
As regards appointments
On the basis of the Grant Agreement, the appointment if necessary of:
- Steering Committee Members
6.3.2 Steering Committee
In addition to the rules in Section 6.2, the following rules shall apply:
6.3.2.1 Members
The Steering Committee shall consist of an operational body comprising the Coordination
Team and the WP Leads (Lead Beneficiary, Leading and Co-Leading Executive
Organisations) as a decision making body on daily running of the project, with prerogatives
regarding minor updates, and effort/budget re-assignment as well as conflict resolution.
The Coordinator shall chair all meetings of the Steering Committee, unless decided
otherwise in a meeting of the Steering Committee.
14 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
6.3.2.2 Minutes of meetings
Minutes of Steering Committee meetings, once accepted, shall be sent by the Coordinator to
the General Assembly Members for information.
6.3.2.3 Tasks
6.3.2.3.1
The Steering Committee shall prepare the meetings, propose decisions and prepare the
agenda of the General Assembly according to Section 6.3.1.2.
6.3.2.3.2
The Steering Committee shall seek a consensus among the Beneficiaries.
6.3.2.3.3
The Steering Committee shall be responsible for the proper execution and implementation of
the decisions of the General Assembly.
6.3.2.3.4
The Steering Committee shall monitor the effective and efficient implementation of the Joint
Action.
6.3.2.3.5
In addition, the Steering Committee shall collect information at least every 6 months on the
progress of the Joint Action, examine that information to assess the compliance of the Joint
Action with the Consortium Plan and, if necessary, propose modifications of the Consortium
Plan to the General Assembly.
6.3.2.3.6
The Steering Committee shall be in charge of:
following up progress in each of the critical areas and the planning of tasks and activities;
monitoring the technical quality of the work and coordination between WP Leads;
conflict resolution;
establishment of mitigation plans to reduce the impact of potential risks;
effort/budget re-assignment;
constituting committees for matters that require specific attention (such as security, new
technological issues, gender equality, etc.) and establishing working procedures for such
committees;
supporting the Coordinator in preparing meetings with the Funding Authority and in
preparing related data and deliverables;
preparing the content and timing of press releases and joint publications by the
consortium or proposed by the Funding Authority in respect of the procedures of the
Grant Agreement Article 29.
6.3.2.3.7
In the case of abolished tasks as a result of a decision of the General Assembly, the Steering
Committee shall advise the General Assembly on ways to rearrange tasks and budgets of
the Beneficiaries concerned. Such rearrangement shall take into consideration the legitimate
commitments taken prior to the decisions, which cannot be cancelled.
15 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
6.4 Coordinator
6.4.1
The Coordinator shall be the intermediary between the Beneficiaries and the Funding
Authority and shall perform all tasks assigned to it as described in the Grant Agreement and
in this Consortium Agreement.
6.4.2
In particular, the Coordinator shall be responsible for:
monitoring compliance by the Beneficiaries with their obligations;
keeping the address list of Members and other contact persons updated and
available;
collecting, reviewing to verify consistency and submitting reports, other deliverables
(including financial statements and related certifications) and specific requested
documents to the Funding Authority;
transmitting documents and information connected with the Joint Action to any other
Beneficiaries concerned;
administering the financial contribution of the Funding Authority and fulfilling the
financial tasks described in Section 7.3;
providing, upon request, the Beneficiaries with official copies or originals of
documents that are in the sole possession of the Coordinator when such copies or
originals are necessary for the Beneficiaries to present claims.
Before sending any proposal for amendment to Grant Agreement to the EC on behalf of the
Beneficiaries, the Coordinator will inform all Beneficiaries in advance and present the
documents in question to those Beneficiaries that ask for it. The Coordinator will wait to
receive the explicit acceptance of the Beneficiaries which shall not be unreasonably withheld.
The terms and conditions of the signed documents are only binding for the Beneficiaries if
their explicit acceptance have been given prior to the time of the signature. If no answer is
received by the Coordinator from a Beneficiary before the deadline established in the
communication sent, it will be assumed that such silent Beneficiary accepts the content of
the amendment.
If one or more of the Beneficiaries is late in submission of any Joint Action deliverable, the
Coordinator may nevertheless submit the other ’Beneficiaries’ Joint Action deliverables and
all other documents required by the Grant Agreement to the Funding Authority in time.
6.4.3
If the Coordinator fails in its coordination tasks, the General Assembly may propose to the
Funding Authority to change the Coordinator.
6.4.4
The Coordinator shall not be entitled to act or to make legally binding declarations on behalf
of any other Beneficiary or of the consortium, unless explicitly stated otherwise in the Grant
Agreement or this Consortium Agreement.
6.4.5
The Coordinator shall not enlarge its role beyond the tasks specified in this Consortium
Agreement and in the Grant Agreement.
16 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
6.5 Coordination Team
KRONIKGUNE assumes the role of JA Coordinator, being the organization representing the
JADECARE Consortium. It is responsible for the achievement of the JA goals and the
contractual obligations towards the European Commission, and provides global scientific and
technical leadership, quality assurance policy and overall coordination of the joint action. The
Coordinator Team is formed by the JA Coordinator supported by the Scientific Coordinator,
the Project Manager and the Financial Manager.
6.6 Work Package Lead (WPL)
The WPL is performed by the Lead Beneficiary (LB), the Leading Executive Organization
(LEO) and the co-Leading Executive Organisation. LEO and co-Leading Executive
Organisation have the responsibility for day-to-day management and coordination of the
activities included in their respective work packages as defined in the work plan, implement
solutions for problems, supervise Task Leaders, produce the corresponding deliverables,
identify risks as early as possible and follow them up, and report to the PM about the
progress achieved against that planned. They are able to raise proposals to the SC
regarding effort and budget redistribution, and re-assignment of roles and responsibilities
within their respective WPs. WP participants meets at least once a month via tele- or web-
conferencing.
6.7 Next Adopters Working Groups (NAWG)
The NAWGs include local stakeholders in all the participating countries.
A Next Adopters Working Group (NAWG) is created in each of the next adopter sites for the
implementation of the Local Good Practices, led by the representative of the corresponding
Competent Authority or Affiliated Entity. NAWGs are supported by the responsible of the
original Good Practices as described in the transfer WPs (WP5-8). The NAWG includes a
representative of health systems, healthcare professionals, community members and third
sector. All members of each next adopter team shall meet regularly in order to share their
experiences and learn from them, suggest improvements, receive and provide support, plan
different measures, review objectives, and collect and deliver good practices. During these
meetings, the Competent Authority or affiliated Entity representative shall inform the
members of the team about the progress of the intervention in the other areas, highlighting
any problematic situation or any issues raised.
6.8 Policy Board (PB)
The PB is an external board composed by representatives of all Competent Authorities
involved in JADECARE that are MoHs, national focal points for Health Programme at the
European Commission (or other representatives of MSs identified by them) from other
Member States from EU and EEA, and all other policy-oriented stakeholders that
implementers will identify as important based on their sustainability-related analyses. The
role of the Policy Board shall be to give input to sustainability plans from the focus of policy,
and the definition of core messages to support evidence-based policy making with respect to
sustainability of JADECARE results. The PB has a key role in guaranteeing the sustainability
of the Joint Action and the impact after the end of the project. The Policy board shall be
established and coordinated by WP4 Lead with support of the Coordination Team.
17 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
7 Section: Financial provisions
7.1 General Principles
7.1.1 Distribution of Financial Contribution
The financial contribution of the Funding Authority to the Joint Action shall be distributed by
the Coordinator according to:
the Consortium Plan,
the approval of reports by the Funding Authority, and
the provisions of payment in Section 7.3.
A Beneficiary shall be funded only for its tasks carried out in accordance with the Consortium
Plan.
7.1.2 Justifying Costs
In accordance with its own usual accounting and management principles and practices, each
Beneficiary shall be solely responsible for justifying its costs with respect to the Joint Action
towards the Funding Authority. Neither the Coordinator nor any of the other Beneficiaries
shall be in any way liable or responsible for such justification of costs towards the Funding
Authority. Each Beneficiary will establish the necessary legal, administrative and/or
operational arrangements with their Affiliated Entities to ensure the correct justification of the
costs incurred.
7.1.3 Funding Principles
A Beneficiary that spends less than its allocated share of the budget as set out in the
Consortium Plan or implements less units than foreseen in the Consortium Plan will be
funded in accordance with its actual duly justified eligible costs only.
A Beneficiary that spends more than its allocated share of the budget as set out in the
Consortium Plan will be funded only in respect of duly justified eligible costs up to an amount
not exceeding that share.
7.1.4 Return of excess payments; receipts
In any case of a Beneficiary having received excess payments, the Beneficiary has to return
the relevant amount to the Coordinator without undue delay.
In case a Beneficiary earns any receipt that is deductible from the total funding as set out in
the Consortium Plan, the deduction is only directed toward the Beneficiary earning such
income. The other Beneficiaries’ financial share of the budget shall not be affected by one
Beneficiary’s receipt. In case the relevant receipt is more than the allocated share of the
Beneficiary as set out in the Consortium Plan, the Beneficiary shall reimburse the funding
reduction suffered by other Beneficiaries.
7.1.5 Financial Consequences of the termination of the participation of a Beneficiary
A Beneficiary leaving the consortium shall refund all payments it has received except the
amount of contribution accepted by the Funding Authority or another contributor.
Furthermore, a Defaulting Beneficiary shall, within the limits specified in Section 5.2 of this
Consortium Agreement, bear any reasonable and justifiable additional costs occurring to the
other Beneficiaries in order to perform its and their tasks.
18 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
7.2 Budgeting
The budget set out in the Consortium Plan shall be valued in accordance with the usual
accounting and management principles and practices of the respective Beneficiaries.
7.3 Payments
7.3.1 Payments to Beneficiaries are the exclusive tasks of the Coordinator.
In particular, the Coordinator shall:
Notify the Beneficiary concerned promptly of the date and composition of the amount
transferred to its bank account, giving the relevant references.
Perform diligently its tasks in the proper administration of any funds and in maintaining
financial accounts.
Undertake to keep the Funding Authority’s financial contribution to the Joint Action
separated from its normal business accounts, its own assets and property, except if the
Coordinator is a Public Body or is not entitled to do so due to statutory legislation.
With reference to Articles 16.2 and 16.3.2 of the Grant Agreement, no Beneficiary shall
before the end of the Joint Action receive more than its allocated share of the maximum
grant amount from which the amounts retained by the Funding Authority for the final
payment have been deducted.
7.3.2 Payment schedule
The payment schedule, which contains the transfer of pre-financing and interim payments to
Beneficiaries, will be handled after receipt from the Funding Authority according to the
following:
The Beneficiaries agree that the Funding Authority´s total pre-financing will be paid once the
Consortium Agreement has been signed by all beneficiaries.
Funding of costs included in the Consortium plan will be paid to Beneficiaries after receipt
from the Funding Authority without unjustified delay and in conformity with the provisions of
the Grant Agreement. Costs accepted by the Funding Authority will be paid to the Beneficiary
concerned.
The Coordinator is entitled to withhold any payments due to a Beneficiary identified by a
responsible Consortium Body to be in breach of its obligations under this Consortium
Agreement or the Grant Agreement or to a Beneficiary which has not yet signed this
Consortium Agreement.
The Coordinator is entitled to recover any payments already paid to a Defaulting Beneficiary.
The Coordinator is equally entitled to withhold payments to a Beneficiary when this is
suggested by or agreed with the Funding Authority.
8 Section: Results
8.1 Ownership of Results
Results are owned by the Beneficiary that generates them.
8.2 Joint ownership
Joint ownership is governed by Grant Agreement Article 19.2 with the following additions:
Unless otherwise agreed:
19 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
- each of the joint owners shall be entitled to use their jointly owned Results for non-
commercial research activities on a royalty-free basis, and without requiring the prior
consent of the other joint owner(s), and
- each of the joint owners shall be entitled to otherwise Exploit the jointly owned Results and
to grant non-exclusive licenses to third parties (without any right to sub-license), if the other
joint owners are given:
a) at least 45 calendar days advance notice with a right for the other joint owners to
object hereto at the latest 15 days after receipt of such notice, but only if the objecting
joint owner's legitimate academic or commercial interests are compromised; and
b) if no objection is made within the time limit stated above, the permission is given by
the other joint owners who each shall receive Fair and Reasonable compensation
taking into account each joint owner's relative contribution to the jointly owned
Results.
8.3 Transfer of Results
8.3.1
Each Beneficiary may transfer ownership of its own Results following the procedures of the
Grant Agreement Article n°19.
8.3.2
It may identify specific third Beneficiaries it intends to transfer the ownership of its Results to
in Attachment (2) to this Consortium Agreement. The other Beneficiaries hereby waive their
right to prior notice and their right to object to a transfer to listed third Beneficiaries according
to the Grant Agreement Article 19.
8.3.3
The transferring Beneficiary shall, however, at the time of the transfer, inform the other
Beneficiaries of such transfer and shall ensure that the rights of the other Beneficiaries will
not be affected by such transfer. Any addition to Attachment (2) after signature of this
Agreement requires a decision of the General Assembly.
8.3.4
The Beneficiaries recognize that in the framework of a merger or an acquisition of an
important part of its assets, it may be impossible under applicable EU and national laws on
mergers and acquisitions for a Beneficiary to give the full 45 calendar days prior notice for
the transfer as foreseen in the Grant Agreement.
8.3.5
The obligations above apply only for as long as other Beneficiaries still have - or still may
request - Access Rights to the Results.
8.4 Dissemination
8.4.1
For the avoidance of doubt, nothing in this Section 8.4 has impact on the confidentiality
obligations set out in Section 10.
20 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
8.4.2 Dissemination of own Results
8.4.2.1
During the Joint Action and for a period of 1 year after the end of the Joint Action, the
dissemination of own Results by one or several Beneficiaries including but not restricted to
publications and presentations, shall be governed by the procedure of Article 22 of the Grant
Agreement subject to the following provisions.
Prior notice of any planned publication shall be given to the other Beneficiaries at least 45
calendar days before the publication. Any objection to the planned publication shall be made
in accordance with the Grant Agreement in writing to the Coordinator and to the Beneficiary
or Beneficiaries proposing the dissemination within 30 calendar days after receipt of the
notice. If no objection is made within the time limit stated above, the publication is permitted.
8.4.2.2
An objection is justified if
(a) the protection of the objecting Beneficiary's Results would be adversely affected
(b) the objecting Beneficiary's legitimate interests in relation to the Results would be
significantly harmed.
The objection has to include a precise request for necessary modifications.
8.4.2.3
If an objection has been raised the involved Beneficiaries shall discuss how to overcome the
justified grounds for the objection on a timely basis (for example by amendment to the
planned publication and/or by protecting information before publication) and the objecting
Beneficiary shall not unreasonably continue the opposition if appropriate measures are taken
following the discussion.
8.5
The objecting Beneficiary can request a publication delay of not more than 90 calendar days
from the time it raises such an objection. After 90 calendar days, the publication is permitted,
provided that reasonable modifications of the objecting Party have been implemented in the
Publication as indicated by the objecting Party.
8.5.1 Dissemination of another Beneficiary’s unpublished Results
A Beneficiary shall not include in any dissemination activity another Beneficiary's Results
without obtaining the owning Beneficiary's prior written approval, unless they are already
published, in which case, in addition, the owning Beneficiary has to be informed. The mere
absence of an objection is not considered as an approval.
8.5.2 Cooperation obligations
The Beneficiaries undertake to cooperate to allow the timely submission, examination,
publication and defense of any dissertation or thesis for a degree that includes their Results
subject to the confidentiality and publication provisions agreed in this Consortium Agreement.
8.5.3 Use of names, logos or trademarks
Nothing in this Consortium Agreement shall be construed as conferring rights to use in
advertising, publicity or otherwise the name of the Beneficiaries or any of their logos or
trademarks without their prior written approval.
21 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
9 Section: Access Rights
9.1 General Principles
9.1.1
Each Beneficiary shall implement its tasks in accordance with the Consortium Plan and shall
bear sole responsibility for ensuring that its acts within the Joint Action do not knowingly
infringe Affiliated Entity property rights.
9.1.2
Any Access Rights granted expressly exclude any rights to sublicense unless expressly
stated otherwise.
9.1.3
Access Rights shall be free of any administrative transfer costs.
9.1.4
Access Rights are granted on a non-exclusive basis.
9.1.5
Results and Background shall be used only for the purposes for which Access Rights to it
have been granted.
9.1.6
All requests for Access Rights shall be made in writing. The granting of Access Rights may
be made conditional on the acceptance of specific conditions aimed at ensuring that these
rights will be used only for the intended purpose and that appropriate confidentiality
obligations are in place. For the avoidance of doubt, this means that the owning Beneficiary
may impose to the Beneficiary requesting an Access Right the execution of a separate
license agreement, this separate license agreement should be in line with the Consortium
Agreement.
9.1.7
The requesting Beneficiary must show that the Access Rights are needed.
9.2 Access Rights for implementation
Access Rights to Results needed for the performance of the own work of a Beneficiary under
the Joint Action shall be granted on a royalty-free basis.
9.3 Access Rights for Exploitation
9.3.1 Access Rights to Results
Access Rights to Results if Needed for Exploitation of a Beneficiary's own Results shall be
granted on a royalty-free basis.
9.3.2
Access Rights to Background if Needed for Exploitation of a Beneficiary’s own Results,
including for research on behalf of an Affiliated Entity, shall be granted on Fair and
Reasonable conditions.
22 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
9.3.3
A request for Access Rights may be made up to twelve months after the end of the Joint
Action or, in the case of Section 9.6.2.1.2, after the termination of the requesting
Beneficiary’s participation in the Joint Action.
9.4 Access Rights for Affiliated Entities
Affiliated Entities have Access Rights under the conditions of the Grant Agreement Article 19
if they are identified in [Attachment 2 (Identified Affiliated Entities) to this Consortium
Agreement].
Such Access Rights must be requested by the Affiliated Entity from the Beneficiary that holds
the Results. Alternatively, the Beneficiary granting the Access Rights may individually agree
with the Beneficiary requesting the Access Rights to have the Access Rights include the right
to sublicense to the latter's Affiliated Entities [listed in Attachment 2]. Access Rights to
Affiliated Entities shall be granted on Fair and Reasonable conditions and upon written
bilateral agreement.
Affiliated Entities which obtain Access Rights in return fulfil all confidentiality and other
obligations accepted by the Beneficiaries under the Grant Agreement or this Consortium
Agreement as if such Affiliated Entities were Beneficiaries.
Access Rights may be refused to Affiliated Entities if such granting is contrary to the
legitimate interests of the Beneficiary which owns the Results.
Access Rights granted to any Affiliated Entity are subject to the continuation of the Access
Rights of the Beneficiary to which it is affiliated, and shall automatically terminate upon
termination of the Access Rights granted to such Beneficiary.
Upon cessation of the status as an Affiliated Entity, any Access Rights granted to such
former Affiliated Entity shall lapse.
Further arrangements with Affiliated Entities may be negotiated in separate agreements.
9.5 Additional Access Rights
The Beneficiaries agree to negotiate in good faith any additional Access Rights to Results as
might be asked for by any Beneficiary, upon adequate financial conditions to be agreed.
9.6 Access Rights for Beneficiaries entering or leaving the consortium
9.6.1 New Beneficiaries entering the consortium
As regards Results developed before the accession of the new Beneficiary, the new
Beneficiary will be granted Access Rights on the conditions applying for Access Rights to
Background.
23 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
9.6.2 Beneficiaries leaving the consortium
9.6.2.1 Access Rights granted to a leaving Beneficiary
9.6.2.1.1 Defaulting Beneficiary
Access Rights granted to a Defaulting Beneficiary and such Beneficiary's right to request
Access Rights shall cease immediately upon receipt by the Defaulting Beneficiary of the
formal notice of the decision of the General Assembly to terminate its participation in the
consortium.
9.6.2.1.2 Non-defaulting Beneficiary
A non-defaulting Beneficiary leaving voluntarily and with the other Beneficiaries' consent
shall have Access Rights to the Results developed until the date of the termination of its
participation.
It may request Access Rights within the period specified in Section 9.3.3.
9.6.2.2 Access Rights to be granted by any leaving Beneficiary
Any Beneficiary leaving the Joint Action shall continue to grant Access Rights pursuant to the
Grant Agreement and this Consortium Agreement as if it had remained a Beneficiary for the
whole duration of the Joint Action.
9.7 Specific Provisions for Access Rights to Software
For the avoidance of doubt, the general provisions for Access Rights provided for in this
Section 9 are applicable also to Software.
Beneficiaries’ Access Rights to Software do not include any right to receive source code or
object code ported to a certain hardware platform or any right to receive respective Software
documentation in any particular form or detail, but only as available from the Beneficiary
granting the Access Rights.
10 Section: Non-disclosure of information
10.1
All information in whatever form or mode of communication, which is disclosed by a
Beneficiary (the “Disclosing Beneficiary”) to any other Beneficiary (the “Recipient”) in
connection with the Joint Action during its implementation and which has been explicitly
marked as “confidential” at the time of disclosure, or when disclosed orally has been
identified as confidential at the time of disclosure and has been confirmed and designated in
writing within 15 calendar days from oral disclosure at the latest as confidential information
by the Disclosing Beneficiary, is “Confidential Information”.
10.2
The Recipients hereby undertake in addition and without prejudice to any commitment on
non-disclosure under the Grand Agreement, for a period of 4 years after the end of the Joint
Action:
Not to use Confidential Information otherwise than for the purpose for which it was
disclosed;
not to disclose Confidential Information without the prior written consent by the Disclosing
Beneficiary;
24 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
to ensure that internal distribution of Confidential Information by a Recipient shall take
place on a strict need-to-know basis; and
to return to the Disclosing Beneficiary, or destroy, on request all Confidential Information
that has been disclosed to the Recipients including all copies thereof and to delete all
information stored in a machine-readable form to the extent practically possible. The
Recipients may keep a copy to the extent it is required to keep, archive or store such
Confidential Information because of compliance with applicable laws and regulations or
for the proof of on-going obligations provided that the Recipient comply with the
confidentiality obligations herein contained with respect to such copy for as long as the
copy is retained.
10.3
The recipients shall be responsible for the fulfilment of the above obligations on the part of
their employees or Affiliated Entities involved in the Joint Action and shall ensure that they
remain so obliged, as far as legally possible, during and after the end of the Joint Action
and/or after the termination of the contractual relationship with the employee or Affiliated
Entity.
10.4
The above shall not apply for disclosure or use of Confidential Information, if and in so far as
the Recipient can show that:
the Confidential Information has become or becomes publicly available by means other
than a breach of the Recipient’s confidentiality obligations;
the Disclosing Beneficiary subsequently informs the Recipient that the Confidential
Information is no longer confidential;
the Confidential Information is communicated to the Recipient without any obligation of
confidentiality by an Affiliated Entity who is to the best knowledge of the Recipient in
lawful possession thereof and under no obligation of confidentiality to the Disclosing
Beneficiary;
the disclosure or communication of the Confidential Information is foreseen by provisions
of the Grant Agreement;
the Confidential Information, at any time, was developed by the Recipient completely
independently of any such disclosure by the Disclosing Beneficiary;
the Confidential Information was already known to the Recipient prior to disclosure, or
the Recipient is required to disclose the Confidential Information in order to comply with
applicable laws or regulations or with a court or administrative order, subject to the
provision Section 10.7 hereunder.
10.5
The Recipient shall apply the same degree of care with regard to the Confidential Information
disclosed within the scope of the Joint Action as with its own confidential and/or proprietary
information, but in no case less than reasonable care.
10.6
Each Beneficiary shall promptly advise the other Beneficiary in writing of any unauthorised
disclosure, misappropriation or misuse of Confidential Information after it becomes aware of
such unauthorised disclosure, misappropriation or misuse.
25 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
10.7
If any Beneficiary becomes aware that it will be required, or is likely to be required, to
disclose Confidential Information in order to comply with applicable laws or regulations or
with a court or administrative order, it shall, to the extent it is lawfully able to do so, prior to
any such disclosure
notify the Disclosing Beneficiary, and
comply with the Disclosing Beneficiary’s reasonable instructions to protect the
confidentiality of the information.
11 Section: Miscellaneous
11.1 Attachments, inconsistencies and severability
This Consortium Agreement consists of this core text and
- Attachment 1 (Accession document).
- Attachment 2 (Identified Affiliated Entities).
In case the terms of this Consortium Agreement are in conflict with the terms of the Grant
Agreement, the terms of the latter shall prevail. In case of conflicts between the attachments
and the core text of this Consortium Agreement, the latter shall prevail.
Should any provision of this Consortium Agreement become invalid, illegal or unenforceable,
it shall not affect the validity of the remaining provisions of this Consortium Agreement. In
such a case, the Beneficiaries concerned shall be entitled to request that a valid and
practicable provision be negotiated that fulfils the purpose of the original provision.
11.2 No representation, partnership or agency
Except as otherwise provided in Section 6.4.4, no Beneficiary shall be entitled to act or to
make legally binding declarations on behalf of any other Beneficiary or of the consortium.
Nothing in this Consortium Agreement shall be deemed to constitute a joint venture, agency,
partnership, interest grouping or any other kind of formal business grouping or entity between
the Beneficiaries.
11.3 Notices and other communication
Any notice to be given under this Consortium Agreement shall be in writing to the addresses
and recipients as listed in the most current address list kept by the Coordinator.
Formal notices:
If it is required in this Consortium Agreement (Sections 4.2, 9.6, 9.7 and 11.4) that a formal
notice, consent or approval shall be given, such notice shall be signed by an authorised
representative of a Beneficiary and shall either be served personally or sent by mail with
recorded delivery.
Other communication:
Other communication between the Beneficiaries may also be affected by other means such
as e-mail with acknowledgement of receipt, which fulfils the conditions of written form.
26 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
Any change of persons or contact details shall be notified immediately by the respective
Beneficiary to the Coordinator. The address list shall be accessible to all Beneficiaries.
11.4 Assignment and amendments
Except as set out in Section 8.3, no rights or obligations of the Beneficiaries arising from this
Consortium Agreement may be assigned or transferred, in whole or in part, to any Affiliated
Entity without the other Beneficiaries’ prior formal approval. Amendments and modifications
to the text of this Consortium Agreement not explicitly listed in Section 6.3 require a separate
written agreement to be signed among all Beneficiaries.
11.5 Mandatory national law
Nothing in this Consortium Agreement shall be deemed to require a Beneficiary to breach
any mandatory statutory law under which the Beneficiary is operating.
11.6 Language
This Consortium Agreement is drawn up in English, which language shall govern all
documents, notices, meetings, arbitral proceedings and processes relative thereto.
11.7 Applicable law
This Consortium Agreement shall be construed in accordance with and governed by the laws
of Belgium excluding its conflict of law provisions.
11.8 Settlement of disputes
The Beneficiaries shall endeavor to settle their disputes amicably.
The Beneficiaries agree that any dispute, controversy or claim arising under, out of or
relating to this Consortium Agreement and any subsequent amendments of this Consortium
Agreement, including, without limitation, its formation, validity, binding effect, interpretation,
performance, breach or termination (a "Dispute") which cannot be solved amicably, shall first
be submitted by the Beneficiaries to the Work Package Leader concerned. The Coordination
Team may be involved in the conflict resolution if requested by the Work Package Leader. In
case the Work Package Leader fails to reach an amicable agreement within 15 days from the
date on which the Dispute was referred to it, the Dispute shall be submitted to the Steering
Committee that will try to reach a solution by consensus within (15 days) from the date on
which the Dispute was referred to it. Disputes which cannot be settled amicably shall be
subject to the jurisdiction of the competent court in Brussels.
27 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
LIETUVOS RESPUBLIKOS SVEIKATOS APSAUGOS MINISTERIJA (LR SAM),
Signature
Name: Gitana Ratkiene
Title: Ministry of Health of the Republic of Lithuania, Personal Health care Department,
Primary health care and nursing Division. Adviser
Date
40 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
Attachment 1: Accession document
ACCESSION
of a new Beneficiary to
[Acronym of the Joint Action] Consortium Agreement, version […, YYYY-MM-DD]
[OFFICIAL NAME OF THE NEW BENEFICIARY AS IDENTIFIED IN THE Grant Agreement]
hereby consents to become a Beneficiary to the Consortium Agreement identified above and
accepts all the rights and obligations of a Beneficiary starting [date].
[OFFICIAL NAME OF THE COORDINATOR AS IDENTIFIED IN THE Grant Agreement]
hereby certifies that the consortium has accepted in the meeting held on [date] the accession
of [the name of the new Beneficiary] to the consortium starting [date].
This Accession document has been done in 2 originals to be duly signed by the undersigned
authorised representatives.
[Date and Place]
[INSERT NAME OF THE NEW BENEFICIARY]
Signature(s)
Name(s)
Title(s)
[Date and Place]
[INSERT NAME OF THE COORDINATOR]
Signature(s)
Name(s)
Title(s)
45 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
Attachment 2: List of Affiliated Entities
FUNDACION PARA LA FORMACION E INVESTIGACION SANITARIAS DE LA
REGION DE MURCIA (FFIS), affiliated or linked to KG
FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD (FPS), affiliated or linked
to KG
Servicio Cántabro de Salud (SCS), affiliated or linked to KG
GERENCIA REGIONAL DE SALUD DE CASTILLA Y LEON (SACYL), affiliated or
linked to KG
CONSEJERIA DE SALUD y FAMILIAS DE LA JUNTA DE ANDALUCIA (CSFJA),
affiliated or linked to KG
FUNDACION INSTITUTO DE INVESTIGACION MARQUES DE VALDECILLA
(IDIVAL), affiliated or linked to KG
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER
(IDIBAPS), affiliated or linked to KG
AGENCIA DE QUALITAT I AVALUACIO SANITARIES DE CATALUNYA (AQUAS),
affiliated or linked to KG
SERVICIO MURCIANO DE SALUD (SMS), affiliated or linked to KG
ZAVOD ZA JAVNO ZDRAVSTVO FEDERACIJEBOSNE I HERCEGOVINE
(ZZJZFBIH), affiliated or linked to MCA
MINISTARSTVO ZDRAVLJA I SOCIJALNE ZASTITE REPUBLIKE SRPSKE (MHSw-
RS), affiliated or linked to MCA
HRVATSKI ZAVOD ZA ZDRAVSTVENO OSIGURANJE (CHIF), affiliated or linked to
CIPH
FAKULTNI NEMOCNICE OLOMOUC (UHO), affiliated or linked to MZCR
REGION SYDDANMARK (RSD), affiliated or linked to RND
SIHTASUTUS VILJANDI HAIGLA (VH), affiliated or linked to MSAE
BAYERISCHES LANDESAMT FUR GESUNDHEIT UND
LEBENSMITTELSICHERHEIT (LGL), affiliated or linked to BAGSFI
ZTG ZENTRUM FUR TELEMATIK IM GESUNDHEITSWESEN GMBH (ZTG-GmBH),
affiliated or linked to BAGSFI
ARISTOTELIO PANEPISTIMIO THESSALONIKIS (AUTH), affiliated or linked to
4THYPE
SEMMELWEIS EGYETEM (SU-HSMTC), affiliated or linked to AEEK
JAHN FERENC DEL-PESTI KORHAZ ES RENDELOINTEZET (JFDPK), affiliated or
linked to AEEK
46 / 47
JADECARE Consortium Agreement - Final version , 2020-10-26
AZIENDA ULSS 4 VENETO ORIENTALE (PROMIS), affiliated or linked to AGENAS
REGIONE LOMBARDIA (LOMBARDIA), affiliated or linked to AGENAS
AZIENDA UNITA SANITARIA LOCALE UMBRIA 1 (UMBRIA), affiliated or linked to
AGENAS
MINISTERO DELLA SALUTE (MhH), affiliated or linked to AGENAS
REGIONE MARCHE (MARCHE), affiliated or linked to AGENAS
AGENZIA REGIONALE DI SANITA (TOSCANA), affiliated or linked to AGENAS
AZIENDA SANITARIA LOCALE NA 2 NORD (ASL NA2), affiliated or linked to
AGENAS
BERNU KLINISKA UNIVERSITATES SLIMNICA VALSTS SIA (CCUH), affiliated or
linked to NVD
SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE (SPMS),
affiliated or linked to ACSS
UNIVERSIDADE NOVA DE LISBOA (ENSP/NOVA), affiliated or linked to ACSS
ZAVOD ZA ZDRAVSTVENO ZAVAROVANJE SLOVENIJE THE HEALTH
INSURANCE INSTITUTE OF SLOVENIA (ZZZS), affiliated or linked to NIJZ
47 / 47
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
EUROPEAN COMMISSION
Consumers, Health, Agriculture and Food Executive Agency
(CHAFEA)
The Director
GRANT AGREEMENT
NUMBER 951442 — JADECARE
This Agreement (‘the Agreement’) is between the following parties:
on the one part,
the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) ('the Agency'), under
the powers delegated by the European Commission ('the Commission'), represented for the purposes
of signature of this Agreement by Véronique WASBAUER, Director, or his/her duly authorised
representative,
and
on the other part,
1. ‘the coordinator’:
ASOCIACIÓN INSTITUTO DE INVESTIGACIÓN EN SERVICIOS DE SALUD-
KRONIKGUNE (KG), established in RONDA DE AZKUE 1 TORRE DEL BILBAO EXHIBITION
CENTRE, BARAKALDO 48902, Spain, VAT number: ESG95646014, represented for the purposes
of signing the Agreement by Director, Esteban DE MANUEL KEENOY
and the following other beneficiaries, if they sign their ‘Accession Form’ (see Annex 3 and Article 40):
2. MINISTRY OF CIVIL AFFAIRS (MCA), established in Trg Bosne i Hercegovine 1,
SARAJEVO 71000, Bosnia and Herzegovina,
3. HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO (CIPH), established in ROCKEFELLEROVA
7, ZAGREB 10000, Croatia, VAT number: HR75297532041,
4. MINISTERSTVO ZDRAVOTNICTVI CESKE REPUBLIKY (MZCR), established in
PALACKEHO NAMESTI 375/4, PRAHA 12801, Czech Republic,
5. REGION NORDJYLLAND (NORTH DENMARK REGION) (RND), established in Niels
Bohrs Vej 30, AALBORG 9220, Denmark, VAT number: DK29190941,
6. SOTSIAALMINISTEERIUM (MSAE), established in Suur-Ameerika 1, TALLINN 10122,
Estonia,
7. EUROMETROPOLE DE STRASBOURG (EUSTRAS), established in 1 PARC DE L'ETOILE,
STRASBOURG CEDEX 67076, France,
1
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
8. BEHOERDE FUER ARBEIT, GESUNDHEIT, SOZIALES, FAMILIE UND
INTEGRATION HAMBURG (BAGSFI), established in Billstrasse 80, Hamburg 20539, Germany,
VAT number: DE118509725,
9. 4I DIOIKISI YGEIONOMIKIS PERIFEREIAS MAKEDONIAS KAI THRAKIS
(4THYPE), established in 16 ARISTOTELOUS STR, THESSALONIKI 54623, Greece, VAT
number: EL999122126,
10. ALLAMI EGESZSEGUGYI ELLATO KOZPONT (AEEK), established in DIOS AROK 3,
BUDAPEST 1125, Hungary, VAT number: HU15324683,
11. AGENZIA NAZIONALE PER I SERVIZI SANITARI REGIONALI (AGENAS), established
in VIA PUGLIE 23, ROMA 00187, Italy,
12. NACIONALAIS VESELIBAS DIENESTS (NVD), established in 31 Cēsu str., k-3, 6.entrance,
Riga LV-1012, Latvia, VAT number: 90009649337,
13. LIETUVOS RESPUBLIKOS SVEIKATOS APSAUGOS MINISTERIJA (LR SAM),
established in VILNIAUS G 33, VILNIUS LT 01506, Lithuania,
14. ADMINISTRACAO CENTRAL DO SISTEMA DESAUDE IP (ACSS), established in
AVENIDA DO BRASIL 53, PARQUE DE SAUDE DE LISBOA EDIFICIO 16, Lisboa 1700-063,
Portugal, VAT number: PT508188423,
15. MINISTARSTVO ZDRAVLJE (MoHRS), established in NEMANJINA 22-26, BELGRADE
11000, Serbia,
16. NACIONALNI INSTITUT ZA JAVNO ZDRAVJE (NIJZ), established in TRUBARJEVA
CESTA 2, LJUBLJANA 1000, Slovenia, VAT number: SI44724535,
17. REGIONAL HEALTH AND SOCIAL CARE BOARD (HSCB), established in LINENHALL
STREET 12-22, BELFAST BT2 8BS, United Kingdom, VAT number: GB888808059,
Unless otherwise specified, references to ‘beneficiary’ or ‘beneficiaries’ include the coordinator.
The parties referred to above have agreed to enter into the Agreement under the terms and conditions
below.
By signing the Agreement or the Accession Form, the beneficiaries accept the grant and agree to
implement it under their own responsibility and in accordance with the Agreement, with all the
obligations and conditions it sets out.
2
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
The Agreement is composed of:
Terms and Conditions
Annex 1 Description of the action
Annex 2 Estimated budget for the action
Annex 2a Not applicable
Annex 3 Accession Forms
Annex 4 Model for the financial statements
Annex 5 Model for the certificate on the financial statements (CFS)
3
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
TERMS AND CONDITIONS
TABLE OF CONTENTS
CHAPTER 1 GENERAL................................................................................................................................................9
ARTICLE 1 — SUBJECT OF THE AGREEMENT.........................................................................................9
CHAPTER 2 ACTION................................................................................................................................................... 9
ARTICLE 2 — ACTION TO BE IMPLEMENTED.........................................................................................9
ARTICLE 3 — DURATION AND STARTING DATE OF THE ACTION......................................................9
ARTICLE 4 — ESTIMATED BUDGET AND BUDGET TRANSFERS........................................................ 9
4.1 Estimated budget.................................................................................................................................. 9
4.2 Budget transfers....................................................................................................................................9
CHAPTER 3 GRANT.....................................................................................................................................................9
ARTICLE 5 — GRANT AMOUNT, FORM OF GRANT, REIMBURSEMENT RATE AND FORMS OF
COSTS..............................................................................................................................................9
5.1 Maximum grant amount....................................................................................................................... 9
5.2 Form of grant, reimbursement rate and forms of costs....................................................................... 9
5.3 Final grant amount — Calculation.....................................................................................................10
5.4 Revised final grant amount — Calculation....................................................................................... 11
ARTICLE 6 — ELIGIBLE AND INELIGIBLE COSTS................................................................................12
6.1 General conditions for costs to be eligible........................................................................................ 12
6.2 Specific conditions for costs to be eligible........................................................................................12
6.3 Conditions for costs of affiliated entities to be eligible.....................................................................15
6.4 Ineligible costs....................................................................................................................................15
6.5 Consequences of declaration of ineligible costs................................................................................ 16
CHAPTER 4 RIGHTS AND OBLIGATIONS OF THE PARTIES........................................................................ 16
SECTION 1 RIGHTS AND OBLIGATIONS RELATED TO IMPLEMENTING THE ACTION................ 16
ARTICLE 7 — GENERAL OBLIGATION TO PROPERLY IMPLEMENT THE ACTION.........................16
7.1 General obligation to properly implement the action........................................................................ 16
7.2 Consequences of non-compliance...................................................................................................... 16
ARTICLE 8 — RESOURCES TO IMPLEMENT THE ACTION — THIRD PARTIES INVOLVED IN THE
ACTION.........................................................................................................................................17
ARTICLE 8a — IMPLEMENTATION OF ACTION TASKS BY BENEFICIARIES NOT RECEIVING EU
FUNDING...................................................................................................................................... 17
ARTICLE 9 — PURCHASE OF GOODS, WORKS OR SERVICES............................................................17
9.1 Rules for purchasing goods, works or services................................................................................. 17
4
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
9.2 Consequences of non-compliance...................................................................................................... 17
ARTICLE 10 — IMPLEMENTATION OF ACTION TASKS BY SUBCONTRACTORS............................18
10.1 Rules for subcontracting action tasks.............................................................................................. 18
10.2 Consequences of non-compliance.................................................................................................... 18
ARTICLE 11 — IMPLEMENTATION OF ACTION TASKS BY AFFILIATED ENTITIES........................18
11.1 Rules for calling upon affiliated entities to implement part of the action........................................19
11.2 Consequences of non-compliance.................................................................................................... 20
ARTICLE 11a — FINANCIAL SUPPORT TO THIRD PARTIES.................................................................21
SECTION 2 RIGHTS AND OBLIGATIONS RELATED TO THE GRANT ADMINISTRATION.............. 21
ARTICLE 12 — GENERAL OBLIGATION TO INFORM............................................................................21
12.1 General obligation to provide information upon request.................................................................21
12.2 Obligation to keep information up to date and to inform about events and circumstances likely to
affect the Agreement........................................................................................................................21
12.3 Consequences of non-compliance.................................................................................................... 21
ARTICLE 13 — KEEPING RECORDS — SUPPORTING DOCUMENTATION.........................................21
13.1 Obligation to keep records and other supporting documentation.................................................... 22
13.2 Consequences of non-compliance.................................................................................................... 23
ARTICLE 14 — SUBMISSION OF DELIVERABLES................................................................................. 23
14.1 Obligation to submit deliverables.................................................................................................... 23
14.2 Consequences of non-compliance.................................................................................................... 23
ARTICLE 15 — REPORTING — PAYMENT REQUESTS.......................................................................... 23
15.1 Obligation to submit reports............................................................................................................ 23
15.2 Reporting periods............................................................................................................................. 23
15.2a Request(s) for further pre-financing payment(s)............................................................................23
15.3 Periodic reports — Requests for interim payments.........................................................................23
15.4 Final report — Request for payment of the balance....................................................................... 25
15.5 Information on cumulative expenditure incurred.............................................................................25
15.6 Currency for financial statements and conversion into euro........................................................... 25
15.7 Language of reports..........................................................................................................................26
15.8 Consequences of non-compliance.................................................................................................... 26
ARTICLE 16 — PAYMENTS AND PAYMENT ARRANGEMENTS...........................................................26
16.1 Payments to be made....................................................................................................................... 26
16.2 Pre-financing payment — Amount .................................................................................................26
16.3 Interim payments — Amount — Calculation..................................................................................26
16.4 Payment of the balance — Amount — Calculation........................................................................ 27
5
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
16.5 Notification of amounts due.............................................................................................................28
16.6 Currency for payments..................................................................................................................... 28
16.7 Payments to the coordinator — Distribution to the beneficiaries....................................................28
16.8 Bank account for payments..............................................................................................................28
16.9 Costs of payment transfers...............................................................................................................28
16.10 Date of payment............................................................................................................................. 29
16.11 Consequences of non-compliance.................................................................................................. 29
ARTICLE 17 — CHECKS, REVIEWS, AUDITS AND INVESTIGATIONS — EXTENSION OF
FINDINGS..................................................................................................................................... 29
17.1 Checks, reviews and audits by the Agency and the Commission....................................................29
17.2 Investigations by the European Anti-Fraud Office (OLAF)............................................................31
17.3 Checks and audits by the European Court of Auditors (ECA)........................................................31
17.4 Checks, reviews, audits and investigations for international organisations..................................... 32
17.5 Consequences of findings in checks, reviews, audits and investigations — Extension of
findings............................................................................................................................................. 32
17.6 Consequences of non-compliance.................................................................................................... 33
ARTICLE 18 — EVALUATION OF THE IMPACT OF THE ACTION....................................................... 33
18.1 Right to evaluate the impact of the action.......................................................................................33
18.2 Consequences of non-compliance.................................................................................................... 34
SECTION 3 OTHER RIGHTS AND OBLIGATIONS.......................................................................................34
ARTICLE 19 — PRE-EXISTING RIGHTS AND OWNERSHIP OF THE RESULTS (INCLUDING
INTELLECTUAL AND INDUSTRIAL PROPERTY RIGHTS)................................................. 34
19.1 Pre-existing rights and access rights to pre-existing rights............................................................. 34
19.2 Ownership of results and rights of use............................................................................................ 34
19.3 Consequences of non-compliance.................................................................................................... 34
ARTICLE 20 — CONFLICT OF INTERESTS.............................................................................................. 34
20.1 Obligation to avoid a conflict of interests....................................................................................... 34
20.2 Consequences of non-compliance.................................................................................................... 35
ARTICLE 21 — CONFIDENTIALITY...........................................................................................................35
21.1 General obligation to maintain confidentiality................................................................................ 35
21.2 Consequences of non-compliance.................................................................................................... 35
ARTICLE 22 — PROMOTING THE ACTION — VISIBILITY OF EU FUNDING....................................35
22.1 Communication activities by the beneficiaries................................................................................ 35
22.2 Communication activities by the Agency and the Commission...................................................... 36
22.3 Consequences of non-compliance.................................................................................................... 37
ARTICLE 23 — PROCESSING OF PERSONAL DATA...............................................................................37
6
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
23.1 Processing of personal data by the Agency and the Commission................................................... 37
23.2 Processing of personal data by the beneficiaries............................................................................. 38
23.3 Consequences of non-compliance.................................................................................................... 38
ARTICLE 24 — ASSIGNMENTS OF CLAIMS FOR PAYMENT AGAINST THE AGENCY....................38
CHAPTER 5 DIVISION OF BENEFICIARIES’ ROLES AND RESPONSIBILITIES....................................... 38
ARTICLE 25 — DIVISION OF BENEFICIARIES’ ROLES AND RESPONSIBILITIES............................38
25.1 Roles and responsibilities towards the Agency............................................................................... 38
25.2 Internal division of roles and responsibilities.................................................................................. 39
25.3 Internal arrangements between beneficiaries — Consortium agreement.........................................39
CHAPTER 6 REJECTION OF COSTS — REDUCTION OF THE GRANT — RECOVERY — SANCTIONS
— DAMAGES — SUSPENSION — TERMINATION — FORCE MAJEURE................................ 40
SECTION 1 REJECTION OF COSTS — REDUCTION OF THE GRANT — RECOVERY —
SANCTIONS.............................................................................................................................................. 40
ARTICLE 26 — REJECTION OF INELIGIBLE COSTS.............................................................................. 40
26.1 Conditions......................................................................................................................................... 40
26.2 Ineligible costs to be rejected — Calculation — Procedure............................................................40
26.3 Effects............................................................................................................................................... 40
ARTICLE 27 — REDUCTION OF THE GRANT......................................................................................... 41
27.1 Conditions......................................................................................................................................... 41
27.2 Amount to be reduced — Calculation — Procedure.......................................................................41
27.3 Effects............................................................................................................................................... 41
ARTICLE 28 — RECOVERY OF UNDUE AMOUNTS............................................................................... 42
28.1 Amount to be recovered — Calculation — Procedure....................................................................42
ARTICLE 29 — ADMINISTRATIVE SANCTIONS..................................................................................... 44
SECTION 2 LIABILITY FOR DAMAGES.........................................................................................................44
ARTICLE 30 — LIABILITY FOR DAMAGES.............................................................................................44
30.1 Liability of the Agency.................................................................................................................... 44
30.2 Liability of the beneficiaries............................................................................................................ 44
SECTION 3 SUSPENSION AND TERMINATION............................................................................................44
ARTICLE 31 — SUSPENSION OF PAYMENT DEADLINE....................................................................... 44
31.1 Conditions......................................................................................................................................... 44
31.2 Procedure.......................................................................................................................................... 45
ARTICLE 32 — SUSPENSION OF PAYMENTS.......................................................................................... 45
32.1 Conditions......................................................................................................................................... 45
32.2 Procedure.......................................................................................................................................... 46
ARTICLE 33 — SUSPENSION OF THE ACTION IMPLEMENTATION................................................... 46
7
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
33.1 Suspension of the action implementation, by the beneficiaries.......................................................46
33.2 Suspension of the action implementation, by the Agency...............................................................47
ARTICLE 34 — TERMINATION OF THE AGREEMENT OR OF THE PARTICIPATION OF ONE OR
MORE BENEFICIARIES..............................................................................................................48
34.1 Termination of the Agreement, by the beneficiaries........................................................................48
34.2 Termination of the participation of one or more beneficiaries, by the beneficiaries........................48
34.3 Termination of the Agreement or of the participation of one or more beneficiaries, by the
Agency..............................................................................................................................................50
SECTION 4 FORCE MAJEURE.......................................................................................................................... 52
ARTICLE 35 — FORCE MAJEURE.............................................................................................................. 52
CHAPTER 7 FINAL PROVISIONS...........................................................................................................................53
ARTICLE 36 — COMMUNICATION BETWEEN THE PARTIES...............................................................53
36.1 Form and means of communication.................................................................................................53
36.2 Date of communication.................................................................................................................... 53
36.3 Addresses for communication.......................................................................................................... 54
ARTICLE 37 — INTERPRETATION OF THE AGREEMENT.....................................................................54
37.1 Precedence of the Terms and Conditions over the Annexes............................................................54
37.2 Privileges and immunities................................................................................................................ 54
ARTICLE 38 — CALCULATION OF PERIODS, DATES AND DEADLINES........................................... 54
ARTICLE 39 — AMENDMENTS TO THE AGREEMENT......................................................................... 55
39.1 Conditions......................................................................................................................................... 55
39.2 Procedure.......................................................................................................................................... 55
ARTICLE 40 — ACCESSION TO THE AGREEMENT............................................................................... 55
40.1 Accession of the beneficiaries mentioned in the preamble..............................................................55
40.2 Addition of new beneficiaries.......................................................................................................... 56
ARTICLE 41 — APPLICABLE LAW AND SETTLEMENT OF DISPUTES.............................................. 56
41.1 Applicable law..................................................................................................................................56
41.2 Dispute settlement............................................................................................................................ 56
ARTICLE 42 — ENTRY INTO FORCE OF THE AGREEMENT................................................................ 57
8
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
CHAPTER 1 GENERAL
ARTICLE 1 — SUBJECT OF THE AGREEMENT
This Agreement sets out the rights and obligations and the terms and conditions applicable to the grant
awarded to the beneficiaries for implementing the action set out in Chapter 2.
CHAPTER 2 ACTION
ARTICLE 2 — ACTION TO BE IMPLEMENTED
The grant is awarded for the action entitled ‘Joint Action on implementation of digitally enabled
integrated person-centred care — JADECARE’ (‘action’), as described in Annex 1.
ARTICLE 3 — DURATION AND STARTING DATE OF THE ACTION
The duration of the action will be 36 months as of 01/10/2020 (‘starting date of the action’).
ARTICLE 4 — ESTIMATED BUDGET AND BUDGET TRANSFERS
4.1 Estimated budget
The ‘estimated budget’ for the action is set out in Annex 2.
It contains the estimated eligible costs and the forms of costs, broken down by beneficiary (and
affiliated entity) and budget category (see Articles 5, 6 and 11).
4.2 Budget transfers
The estimated budget breakdown indicated in Annex 2 may be adjusted — without an amendment
(see Article 39) — by transfers of amounts between beneficiaries, budget categories and/or forms of
costs set out in Annex 2, if the action is implemented as described in Annex 1.
However, the beneficiaries may not add costs relating to subcontracts not provided for in Annex 1,
unless such additional subcontracts are approved by an amendment or in accordance with Article 10.
CHAPTER 3 GRANT
ARTICLE 5 — GRANT AMOUNT, FORM OF GRANT, REIMBURSEMENT RATE AND
FORMS OF COSTS
5.1 Maximum grant amount
The ‘maximum grant amount’ is EUR 3 999 226.00 (three million nine hundred and ninety nine
thousand two hundred and twenty six EURO).
5.2 Form of grant, reimbursement rate and forms of costs
9
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
The grant reimburses 80% of the action's eligible costs (see Article 6) (‘reimbursement of eligible
costs grant’) (see Annex 2).
The estimated eligible costs of the action are EUR 4 999 032.51 (four million nine hundred and ninety
nine thousand thirty two EURO and fifty one eurocents).
Eligible costs (see Article 6) must be declared under the following forms ('forms of costs' or 'costs
forms'):
(a) for direct personnel costs: as actually incurred costs (actual costs);
(b) for direct costs of subcontracting: as actually incurred costs (actual costs);
(c) for other direct costs: as actually incurred costs (actual costs);
(d) for indirect costs: on the basis of a flat-rate applied as set out in Article 6.2.D (‘flat-rate costs’);
5.3 Final grant amount — Calculation
The ‘final grant amount’ depends on the actual extent to which the action is implemented in
accordance with the Agreement’s terms and conditions.
This amount is calculated by the Agency — when the payment of the balance is made — in the
following steps:
Step 1 – Application of the reimbursement rate to the eligible costs
Step 2 – Limit to the maximum grant amount
Step 3 – Reduction due to the no-profit rule
Step 4 – Reduction due to substantial errors, irregularities or fraud or serious breach of obligations
5.3.1 Step 1 — Application of the reimbursement rate to the eligible costs
The reimbursement rate (see Article 5.2) is applied to the eligible costs (actual costs and flat-rate costs;
see Article 6) declared by the beneficiaries and affiliated entities (see Article 15) and approved by
the Agency (see Article 16).
5.3.2 Step 2 — Limit to the maximum grant amount
If the amount obtained following Step 1 is higher than the maximum grant amount set out in
Article 5.1, it will be limited to the latter.
5.3.3 Step 3 — Reduction due to the no-profit rule
The grant must not produce a profit.
‘Profit’ means the surplus of the amount obtained following Steps 1 and 2 plus the action’s total
receipts, over the action’s total eligible costs.
The ‘action’s total eligible costs’ are the consolidated total eligible costs approved by the Agency.
10
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
The ‘action’s total receipts’ are the consolidated total receipts generated during its duration (see
Article 3).
The following are considered receipts:
(a) income generated by the action;
(b) financial contributions given by third parties to the beneficiary or to an affiliated entity
specifically to be used for costs that are eligible under the action.
The following are however not considered receipts:
(a) financial contributions by third parties, if they may be used to cover costs other than the eligible
costs (see Article 6);
(b) financial contributions by third parties with no obligation to repay any amount unused at the
end of the period set out in Article 3.
If there is a profit, it will be deducted in proportion to the final rate of reimbursement of the eligible
actual costs approved by the Agency (as compared to the amount calculated following Steps 1 and 2).
5.3.4 Step 4 — Reduction due to substantial errors, irregularities or fraud or serious breach
of obligations
If the grant is reduced (see Article 27), the Agency will calculate the reduced grant amount by
deducting the amount of the reduction (calculated in proportion to the seriousness of the errors,
irregularities or fraud or breach of obligations, in accordance with Article 27.2) from the maximum
grant amount set out in Article 5.1.
The final grant amount will be the lower of the following two:
- the amount obtained following Steps 1 to 3 or
- the reduced grant amount following Step 4.
5.4 Revised final grant amount — Calculation
If — after the payment of the balance (in particular, after checks, reviews, audits or investigations;
see Article 17) — the Agency rejects costs (see Article 26) or reduces the grant (see Article 27), it
will calculate the ‘revised final grant amount’ for the action or for the beneficiary concerned.
This amount is calculated by the Agency on the basis of the findings, as follows:
- in case of rejection of costs: by applying the reimbursement rate to the revised eligible costs
approved by the Agency for the beneficiary concerned;
- in case of reduction of the grant: by deducting the amount of the reduction (calculated in
proportion to the seriousness of the errors, irregularities or fraud or breach of obligations, in
accordance with Article 27.2) from the maximum grant amount set out in Article 5.1 or from the
maximum EU contribution indicated for the beneficiary in the estimated budget (see Annex 2).
In case of rejection of costs and reduction of the grant, the revised final grant amount will be the
lower of the two amounts above.
11
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
ARTICLE 6 — ELIGIBLE AND INELIGIBLE COSTS
6.1 General conditions for costs to be eligible
‘Eligible costs’ are costs that meet the following criteria:
(a) for actual costs:
(i) they must be actually incurred by the beneficiary;
(ii) they must be incurred in the period set out in Article 3, with the exception of costs relating
to the submission of the periodic report for the last reporting period and the final report
(see Article 15);
(iii) they must be indicated in the estimated budget set out in Annex 2;
(iv) they must be incurred in connection with the action as described in Annex 1 and necessary
for its implementation;
(v) they must be identifiable and verifiable, in particular recorded in the beneficiary’s accounts
in accordance with the accounting standards applicable in the country where the beneficiary
is established and with the beneficiary’s usual cost accounting practices;
(vi) they must comply with the applicable national law on taxes, labour and social security, and
(vii) they must be reasonable, justified and must comply with the principle of sound financial
management, in particular regarding economy and efficiency;
(b) for unit costs: not applicable;
(c) for flat-rate costs:
(i) they must be calculated by applying the flat-rate set out in Annex 2, and
(ii) the costs (actual costs) to which the flat-rate is applied must comply with the conditions for
eligibility set out in this Article.
(d) for lump sum costs: not applicable;
6.2 Specific conditions for costs to be eligible
Costs are eligible if they comply with the general conditions (see above) and the specific conditions
set out below, for each of the following budget categories:
A. direct personnel costs;
B. direct costs of subcontracting;
C. other direct costs;
D. indirect costs;
‘Direct costs’ are costs that are directly linked to the action implementation and can therefore be
attributed to it directly. They must not include any indirect costs (see Point D below).
12
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
‘Indirect costs’ are costs that are not directly linked to the action implementation and therefore cannot
be attributed directly to it.
A. Direct personnel costs
Types of eligible personnel costs
A.1 Personnel costs are eligible if they are related to personnel working for the beneficiary under an
employment contract (or equivalent appointing act) and assigned to the action (‘costs for employees
(or equivalent)’). They must be limited to salaries, social security contributions, taxes and other
costs included in the remuneration, if they arise from national law or the employment contract (or
equivalent appointing act).
They may also include additional remuneration for personnel assigned to the action (including
payments on the basis of supplementary contracts regardless of their nature), if:
(a) it is part of the beneficiary’s usual remuneration practices and is paid in a consistent manner
whenever the same kind of work or expertise is required;
(b) the criteria used to calculate the supplementary payments are objective and generally applied
by the beneficiary, regardless of the source of funding used.
A.2 The costs for natural persons working under a direct contract with the beneficiary other than
an employment contract or seconded by a third party against payment are eligible personnel costs,
if:
(a) the person works under the beneficiary’s instructions and, unless otherwise agreed with the
beneficiary, on the beneficiary’s premises;
(b) the result of the work carried out belongs to the beneficiary, and
(c) the costs are not significantly different from those for personnel performing similar tasks under
an employment contract with the beneficiary.
Calculation
Personnel costs must be calculated by the beneficiaries as follows:
- for persons working exclusively on the action:
{monthly rate for the person
multiplied by
number of actual months worked on the action}.
The months declared for these persons may not be declared for any other EU or Euratom grant.
The ‘monthly rate’ is calculated as follows:
{annual personnel costs for the person
divided by
12}
13
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
using the personnel costs for each full financial year covered by the reporting period concerned.
If a financial year is not closed at the end of the reporting period, the beneficiaries must use the
monthly rate of the last closed financial year available.
- for all other persons:
{daily rate for the person
multiplied by
number of actual days worked on the action (rounded up or down to the nearest half-day)}.
The number of actual days declared for a person must be identifiable and verifiable (see
Article 13).
The total number of days declared in EU or Euratom grants, for a person for a year, cannot be
higher than the annual productive days used for the calculations of the daily rate. Therefore,
the maximum number of days that can be declared for the grant are:
{number of annual productive days for the year (see below)
minus
total number of days declared by the beneficiary, for that person for that year, for other EU or Euratom
grants}.
The ‘daily rate’ is calculated as follows:
{annual personnel costs for the person
divided by
number of individual annual productive days}
using the personnel costs and the number of annual productive days for each full financial
year covered by the reporting period concerned. If a financial year is not closed at the end of
the reporting period, the beneficiaries must use the daily rate of the last closed financial year
available.
The ‘number of individual annual productive days’ is the total actual days worked by the person
in the year. It may not include holidays and other absences (such as sick leave, maternity leave,
special leave, etc). However, it may include overtime and time spent in meetings, trainings and
other similar activities.
B. Direct costs of subcontracting (including related duties, taxes and charges, such as non-
deductible value added tax (VAT) paid by beneficiaries that are not public bodies acting as public
authority) are eligible if the conditions in Article 10.1.1 are met.
C. Other direct costs
C.1 Travel costs and related subsistence allowances (including related duties, taxes and charges,
such as non-deductible value added tax (VAT) paid by beneficiaries that are not public bodies acting
as public authority) are eligible if they are in line with the beneficiary’s usual practices on travel.
C.2 The depreciation costs of equipment, infrastructure or other assets (new or second-hand)
as recorded in the beneficiary’s accounts are eligible, if they were purchased in accordance
14
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
with Article 9.1.1 and written off in accordance with international accounting standards and the
beneficiary’s usual accounting practices.
The costs of renting or leasing equipment, infrastructure or other assets (including related duties,
taxes and charges, such as non-deductible value added tax (VAT) paid by beneficiaries that are not
public bodies acting as public authority) are also eligible, if they do not exceed the depreciation costs
of similar equipment, infrastructure or assets and do not include any financing fees.
The only portion of the costs that will be taken into account is that which corresponds to the duration
of the action and rate of actual use for the purposes of the action.
C.3 Costs of other goods and services (including related duties, taxes and charges, such as non-
deductible value added tax (VAT) paid by beneficiaries that are not public bodies acting as public
authority) are eligible, if they are purchased specifically for the action and in accordance with
Article 9.1.1.
Such goods and services include, for instance, consumables and supplies, dissemination, protection
of results, certificates on the financial statements (if they are required by the Agreement), translations
and publications.
D. Indirect costs
Indirect costs are eligible if they are declared on the basis of the flat-rate of 7% of the eligible direct
costs (see Article 5.2 and Points A to C above).
Beneficiaries receiving an operating grant1 financed by the EU or Euratom budget cannot declare
indirect costs for the period covered by the operating grant.
6.3 Conditions for costs of affiliated entities to be eligible
Costs incurred by affiliated entities are eligible if they fulfil — mutatis mutandis — the general and
specific conditions for eligibility set out in this Article (Article 6.1 and 6.2) and Article 11.1.1.
6.4 Ineligible costs
‘Ineligible costs’ are:
(a) costs that do not comply with the conditions set out above (Article 6.1 to 6.3), in particular:
(i) costs related to return on capital;
(ii) debt and debt service charges;
(iii) provisions for future losses or debts;
(iv) interest owed;
1 For the definition, see Article 121(1)(b) of Regulation (EU, Euratom) No 966/2012 of the European Parliament and
of the Council of 25 October 2012 on the financial rules applicable to the general budget of the Union and repealing
Council Regulation (EC, Euratom) No 1605/2002 (OJ L 218, 26.10.2012, p.1) (‘Financial Regulation No 966/2012’):
‘operating grant’ means direct financial contribution, by way of donation, from the budget in order to finance the
functioning of a body which pursues an aim of general EU interest or has an objective forming part of and supporting
an EU policy.
15
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
(v) doubtful debts;
(vi) currency exchange losses;
(vii) bank costs charged by the beneficiary’s bank for transfers from the Agency;
(viii) excessive or reckless expenditure;
(ix) deductible VAT;
(x) costs incurred during suspension of the implementation of the action (see Article 33);
(xi) in-kind contributions provided by third parties;
(b) costs declared under another EU or Euratom grant (including grants awarded by a Member
State and financed by the EU or Euratom budget and grants awarded by bodies other than the
Agency for the purpose of implementing the EU or Euratom budget); in particular, indirect
costs if the beneficiary is already receiving an operating grant financed by the EU or Euratom
budget in the same period;
(c) costs for staff of a national (or local) administration, for activities that are part of the
administration’s normal activities (i.e. not undertaken only because of the grant);
(d) costs (especially travel and subsistence costs) for staff or representatives of EU institutions,
bodies or agencies.
6.5 Consequences of declaration of ineligible costs
Declared costs that are ineligible will be rejected (see Article 26).
This may also lead to any of the other measures described in Chapter 6.
CHAPTER 4 RIGHTS AND OBLIGATIONS OF THE PARTIES
SECTION 1 RIGHTS AND OBLIGATIONS RELATED TO IMPLEMENTING THE
ACTION
ARTICLE 7 — GENERAL OBLIGATION TO PROPERLY IMPLEMENT THE ACTION
7.1 General obligation to properly implement the action
The beneficiaries must implement the action as described in Annex 1 and in compliance with the
provisions of the Agreement and all legal obligations under applicable EU, international and national
law.
7.2 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see
Article 27).
16
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 8 — RESOURCES TO IMPLEMENT THE ACTION — THIRD PARTIES
INVOLVED IN THE ACTION
The beneficiaries must have the appropriate resources to implement the action.
If it is necessary to implement the action, the beneficiaries may:
- purchase goods, works and services (see Article 9);
- call upon subcontractors to implement action tasks described in Annex 1 (see Article 10);
- call upon affiliated entities to implement action tasks described in Annex 1 (see Article 11).
In these cases, the beneficiaries retain sole responsibility towards the Agency and the other
beneficiaries for implementing the action.
ARTICLE 8a — IMPLEMENTATION OF ACTION TASKS BY BENEFICIARIES NOT
RECEIVING EU FUNDING
Not applicable
ARTICLE 9 — PURCHASE OF GOODS, WORKS OR SERVICES
9.1 Rules for purchasing goods, works or services
9.1.1 If necessary to implement the action, the beneficiaries may purchase goods, works or services.
The beneficiaries must make such purchases ensuring the best value for money or, if appropriate, the
lowest price. In doing so, they must avoid any conflict of interests (see Article 20).
The beneficiaries must ensure that the Agency, the Commission, the European Court of Auditors
(ECA) and the European Anti-fraud Office (OLAF) can exercise their rights under Articles 17 and
18 also towards their contractors.
9.1.2 Beneficiaries that are ‘contracting authorities’ within the meaning of Directive 2004/18/EC2 (or
2014/24/EU3) or ‘contracting entities’ within the meaning of Directive 2004/17/EC4 (or 2014/25/EU5)
must comply with the applicable national law on public procurement.
9.2 Consequences of non-compliance
2 Directive 2004/18/EC of the European Parliament and of the Council of 31 March 2004 on the coordination of
procedures for the award of public work contracts, public supply contracts and public service contracts (OJ L 134,
30.04.2004, p. 114).
3 Directive 2014/24/EU of the European Parliament and of the Council of 26 February 2014 on public procurement and
repealing Directive 2004/18/EC (OJ L 94, 28.3.2014, p. 65).
4 Directive 2004/17/EC of the European Parliament and of the Council of 31 March 2004 coordinating the procurement
procedures of entities operating in the water, energy, transport and postal services sectors (OJ L 134, 30.04.2004, p. 1).
5 Directive 2014/25/EU of the European Parliament and of the Council of 26 February 2014 on procurement by entities
operating in the water, energy, transport and postal services sectors and repealing Directive 2004/17/EC (OJ L 94,
28.3.2014, p. 243).
17
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
If a beneficiary breaches any of its obligations under Article 9.1.1, the costs related to the contract
concerned will be ineligible (see Article 6) and will be rejected (see Article 26).
If a beneficiary breaches any of its obligations under Article 9.1.2, the grant may be reduced (see
Article 27).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 10 — IMPLEMENTATION OF ACTION TASKS BY SUBCONTRACTORS
10.1 Rules for subcontracting action tasks
10.1.1 If necessary to implement the action, the beneficiaries may award subcontracts covering the
implementation of certain action tasks described in Annex 1.
Subcontracting may cover only a limited part of the action.
The beneficiaries must award the subcontracts ensuring the best value for money or, if appropriate,
the lowest price. In doing so, they must avoid any conflict of interests (see Article 20).
The tasks to be implemented and the estimated cost for each subcontract must be set out in Annex
1 and the total estimated costs of subcontracting per beneficiary must be set out in Annex 2. The
Agency may however approve subcontracts not set out in Annex 1 and 2 without amendment (see
Article 39), if:
- they are specifically justified in the periodic technical report and
- they do not entail changes to the Agreement which would call into question the decision
awarding the grant or breach the principle of equal treatment of applicants.
The beneficiaries must ensure that the Agency, the Commission, the European Court of Auditors
(ECA) and the European Anti-Fraud Office (OLAF) can exercise their rights under Articles 17 and
18 also towards their subcontractors.
10.1.2 The beneficiaries must ensure that their obligations under Articles 20, 21, 22 and 30 also apply
to the subcontractors.
Beneficiaries that are ‘contracting authorities’ within the meaning of Directive 2004/18/EC (or
2014/24/EU) or ‘contracting entities’ within the meaning of Directive 2004/17/EC (or 2014/25/EU)
must comply with the applicable national law on public procurement.
10.2 Consequences of non-compliance
If a beneficiary breaches any of its obligations under Article 10.1.1, the costs related to the subcontract
concerned will be ineligible (see Article 6) and will be rejected (see Article 26).
If a beneficiary breaches any of its obligations under Article 10.1.2, the grant may be reduced (see
Article 27).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 11 — IMPLEMENTATION OF ACTION TASKS BY AFFILIATED ENTITIES
18
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
11.1 Rules for calling upon affiliated entities to implement part of the action
11.1.1 The following 'affiliated entities'6 may implement the action tasks attributed to them in
Annex 1:
- FUNDACION PARA LA FORMACION E INVESTIGACION SANITARIAS DE LA REGION
DE MURCIA (FFIS), affiliated or linked to KG
- FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD (FPS), affiliated or linked to
KG
- Servicio Cántabro de Salud (SCS), affiliated or linked to KG
- GERENCIA REGIONAL DE SALUD DE CASTILLA Y LEON (SACYL), affiliated or linked
to KG
- CONSEJERIA DE SALUD y FAMILIAS DE LA JUNTA DE ANDALUCIA (CSFJA), affiliated
or linked to KG
- FUNDACION INSTITUTO DE INVESTIGACION MARQUES DE VALDECILLA (IDIVAL),
affiliated or linked to KG
- CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER
(IDIBAPS), affiliated or linked to KG
- AGENCIA DE QUALITAT I AVALUACIO SANITARIES DE CATALUNYA (AQUAS),
affiliated or linked to KG
- SERVICIO MURCIANO DE SALUD (SMS), affiliated or linked to KG
- ZAVOD ZA JAVNO ZDRAVSTVO FEDERACIJEBOSNE I HERCEGOVINE (ZZJZFBIH),
affiliated or linked to MCA
- MINISTARSTVO ZDRAVLJA I SOCIJALNE ZASTITE REPUBLIKE SRPSKE (MHSw-RS),
affiliated or linked to MCA
- HRVATSKI ZAVOD ZA ZDRAVSTVENO OSIGURANJE (CHIF), affiliated or linked to CIPH
- FAKULTNI NEMOCNICE OLOMOUC (UHO), affiliated or linked to MZCR
- REGION SYDDANMARK (RSD), affiliated or linked to RND
- SIHTASUTUS VILJANDI HAIGLA (VH), affiliated or linked to MSAE
6 For the definition, see Article 122 of the Financial Regulation (EU, Euratom) No 966/2012: entities affiliated to the
beneficiary are:
(a) entities that form a ‘sole beneficiary’ (i.e. where an entity is formed of several entities that satisfy the criteria for
being awarded a grant, including where the entity is specifically established for the purpose of implementing
an action to be financed by a grant);
(b) entities that satisfy the eligibility criteria and that do not fall within one of the situations referred to in Article
131(4) and that have a link with the beneficiary, in particular a legal or capital link, which is neither limited to
the action nor established for the sole purpose of its implementation.
19
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
- BAYERISCHES LANDESAMT FUR GESUNDHEIT UND LEBENSMITTELSICHERHEIT
(LGL), affiliated or linked to BAGSFI
- ZTG ZENTRUM FUR TELEMATIK IM GESUNDHEITSWESEN GMBH (ZTG-GmBH),
affiliated or linked to BAGSFI
- ARISTOTELIO PANEPISTIMIO THESSALONIKIS (AUTH), affiliated or linked to 4THYPE
- SEMMELWEIS EGYETEM (SU-HSMTC), affiliated or linked to AEEK
- JAHN FERENC DEL-PESTI KORHAZ ES RENDELOINTEZET (JFDPK), affiliated or linked
to AEEK
- AZIENDA ULSS 4 VENETO ORIENTALE (PROMIS), affiliated or linked to AGENAS
- REGIONE LOMBARDIA (LOMBARDIA), affiliated or linked to AGENAS
- AZIENDA UNITA SANITARIA LOCALE UMBRIA 1 (UMBRIA), affiliated or linked to
AGENAS
- MINISTERO DELLA SALUTE (MhH), affiliated or linked to AGENAS
- REGIONE MARCHE (MARCHE), affiliated or linked to AGENAS
- AGENZIA REGIONALE DI SANITA (TOSCANA), affiliated or linked to AGENAS
- AZIENDA SANITARIA LOCALE NA 2 NORD (ASL NA2), affiliated or linked to AGENAS
- BERNU KLINISKA UNIVERSITATES SLIMNICA VALSTS SIA (CCUH), affiliated or linked
to NVD
- SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE (SPMS), affiliated
or linked to ACSS
- UNIVERSIDADE NOVA DE LISBOA (ENSP/NOVA), affiliated or linked to ACSS
- ZAVOD ZA ZDRAVSTVENO ZAVAROVANJE SLOVENIJE THE HEALTH INSURANCE
INSTITUTE OF SLOVENIA (ZZZS), affiliated or linked to NIJZ
The affiliated entities may declare as eligible the costs they incur for implementing the action tasks
in accordance with Article 6.3.
The beneficiaries must ensure that the Agency, the Commission, the European Court of Auditors
(ECA) and the European Anti-Fraud Office (OLAF) can exercise their rights under Articles 17 and
18 also towards their affiliated entities.
11.1.2 The beneficiaries must ensure that their obligations under Articles 13, 15, 20, 21 and 22 also
apply to their affiliated entities.
11.2 Consequences of non-compliance
If any obligation under Article 11.1.1 is breached, the costs of the affiliated entity will be ineligible
(see Article 6) and will be rejected (see Article 26).
20
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
If any obligation under Article 11.1.2 is breached, the grant may be reduced (see Article 27).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 11a — FINANCIAL SUPPORT TO THIRD PARTIES
Not applicable
SECTION 2 RIGHTS AND OBLIGATIONS RELATED TO THE GRANT
ADMINISTRATION
ARTICLE 12 — GENERAL OBLIGATION TO INFORM
12.1 General obligation to provide information upon request
The beneficiaries must provide — during implementation of the action or afterwards and in accordance
with Article 25.2 — any information requested in order to verify eligibility of the costs, proper
implementation of the action and compliance with any other obligation under the Agreement.
12.2 Obligation to keep information up to date and to inform about events and
circumstances likely to affect the Agreement
Each beneficiary must keep information stored in the Participant Portal Beneficiary Register (via
the electronic exchange system; see Article 36) up to date, in particular, its name, address, legal
representatives, legal form and organisation type.
Each beneficiary must immediately inform the coordinator — which must immediately inform the
Agency and the other beneficiaries — of any of the following:
(a) events which are likely to affect significantly or delay the implementation of the action or the
EU’s financial interests, in particular:
(i) changes in its legal, financial, technical, organisational or ownership situation or those
of its affiliated entities and
(ii) changes in the name, address, legal form, organisation type of its affiliated entities;
(b) circumstances affecting:
(i) the decision to award the grant or
(ii) compliance with requirements under the Agreement.
12.3 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see
Article 27).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 13 — KEEPING RECORDS — SUPPORTING DOCUMENTATION
21
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
13.1 Obligation to keep records and other supporting documentation
The beneficiaries must — for a period of five years after the payment of the balance — keep records
and other supporting documentation, in order to prove the proper implementation of the action and
the costs they declare as eligible.
They must make them available upon request (see Article 12) or in the context of checks, reviews,
audits or investigations (see Article 17).
If there are on-going checks, reviews, audits, investigations, litigation or other pursuits of claims under
the Agreement (including the extension of findings; see Article 17), the beneficiaries must keep the
records and other supporting documentation until the end of these procedures.
The beneficiaries must keep the original documents. Digital and digitalised documents are considered
originals if they are authorised by the applicable national law. The Agency may accept non-original
documents if it considers that they offer a comparable level of assurance.
13.1.1 Records and other supporting documentation on the technical implementation
The beneficiaries must keep records and other supporting documentation on the technical
implementation of the action, in line with the accepted standards in the respective field.
13.1.2 Records and other documentation to support the costs declared
The beneficiaries must keep the records and documentation supporting the costs declared, in particular
the following:
(a) for actual costs: adequate records and other supporting documentation to prove the costs
declared, such as contracts, subcontracts, invoices and accounting records. In addition, the
beneficiaries’ usual cost accounting practices and internal control procedures must enable direct
reconciliation between the amounts declared, the amounts recorded in their accounts and the
amounts stated in the supporting documentation;
(b) for unit costs: not applicable;
(c) for flat-rate costs: adequate records and other supporting documentation to prove the eligibility
of the costs to which the flat-rate is applied. The beneficiaries do not need to identify the costs
covered or provide supporting documentation (such as accounting statements) to prove the
amount declared at a flat-rate;
(d) for lump sum costs: not applicable;
In addition, for personnel costs (declared as actual costs), the beneficiaries must keep time records
for the number of days declared. The time records must be in writing and approved by the persons
working on the action and their supervisors, at least monthly. In the absence of reliable time records
of the days worked on the action, the Agency may accept alternative evidence supporting the number
of days declared, if it considers that it offers an adequate level of assurance.
As an exception, for persons working exclusively on the action, there is no need to keep time records,
if the beneficiary signs a declaration confirming that the persons concerned have worked exclusively
on the action.
22
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
For costs declared by affiliated entities (see Article 11), it is the beneficiary that must keep the originals
of the financial statements and the certificates on the financial statements of its affiliated entities.
13.2 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, costs insufficiently substantiated
will be ineligible (see Article 6) and will be rejected (see Article 26), and the grant may be reduced
(see Article 27).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 14 — SUBMISSION OF DELIVERABLES
14.1 Obligation to submit deliverables
The coordinator must submit the ‘deliverables’ identified in Annex 1, in accordance with the timing
and conditions set out in it.
14.2 Consequences of non-compliance
If the coordinator breaches any of its obligations under this Article, the Agency may apply any of the
measures described in Chapter 6.
ARTICLE 15 — REPORTING — PAYMENT REQUESTS
15.1 Obligation to submit reports
The coordinator must submit to the Agency (see Article 36) the technical and financial report(s) set
out in this Article. These reports include request(s) for payment and must be drawn up using the forms
and templates provided in the electronic exchange system (see Article 36).
15.2 Reporting periods
The action is divided into the following ‘reporting periods’:
- RP1: from month 1 to month 18
- RP2: from month 19 to month 36
15.2a Request(s) for further pre-financing payment(s)
Not applicable
15.3 Periodic reports — Requests for interim payments
The coordinator must submit a periodic report within 60 days following the end of each reporting
period.
The periodic report must include the following:
(a) a ‘periodic technical report’ containing:
23
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
(i) an explanation of the work carried out by the beneficiaries;
(ii) an overview of the progress towards the objectives of the action, including milestones
and deliverables identified in Annex 1.
This report must include explanations justifying the differences between work expected
to be carried out in accordance with Annex 1 and that actually carried out;
(iii) a summary for publication by the Agency;
(iv) the answers to the ‘questionnaire’: covering issues related to the action implementation
and its impact;
(b) a ‘periodic financial report’ containing:
(i) an ‘individual financial statement’ (see Annex 4) from each beneficiary and from each
affiliated entity, for the reporting period concerned.
The individual financial statement must detail the eligible costs (actual costs and flat-rate
costs; see Article 6) for each budget category (see Annex 2).
The beneficiaries and affiliated entities must declare all eligible costs, even if — for
actual costs and flat-rate costs — they exceed the amounts indicated in the estimated
budget (see Annex 2). Amounts which are not declared in the individual financial
statement will not be taken into account by the Agency.
If an individual financial statement is not submitted for a reporting period, it may be
included in the periodic financial report for the next reporting period.
The individual financial statements of the last reporting period must also detail the
receipts of the action (see Article 5.3.3).
Each beneficiary and each affiliated entity must certify that:
- the information provided is full, reliable and true;
- the costs declared are eligible (see Article 6);
- the costs can be substantiated by adequate records and supporting documentation
(see Article 13) that will be produced upon request (see Article 12) or in the context
of checks, reviews, audits and investigations (see Article 17), and
- for the last reporting period: that all the receipts have been declared (see
Article 5.3.3);
(ii) an explanation of the use of resources and the information on subcontracting (see
Article 10) from each beneficiary and from each affiliated entity, for the reporting period
concerned;
(iii) not applicable;
(iv) a ‘periodic summary financial statement’, created automatically by the electronic
24
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
exchange system, consolidating the individual financial statements for the reporting
period concerned and including — except for the last reporting period — the request
for interim payment;
(v) a ‘certificate on the financial statements’ (drawn up in accordance with Annex 5) for
each beneficiary and for each affiliated entity, if:
- the (cumulative) amount of EU contribution it requests as reimbursement of actual
costs (and for which no certificate has yet been submitted) is EUR 150 000 or
more and
- the maximum EU contribution indicated, for that beneficiary or affiliated entity,
in the estimated budget (see Annex 2) as reimbursement of actual costs is
EUR 200 000 or more.
15.4 Final report — Request for payment of the balance
In addition to the periodic report for the last reporting period, the coordinator must submit the final
report within 60 days following the end of the last reporting period.
The final report must include the following:
(a) a ‘final technical report’ with a summary for publication containing:
(i) an overview of the results and their dissemination;
(ii) the conclusions on the action and
(iii) the impact of the action;
(b) a ‘final financial report’ containing a ‘final summary financial statement’, created
automatically by the electronic exchange system, consolidating the individual financial
statements for all reporting periods and including the request for payment of the balance.
15.5 Information on cumulative expenditure incurred
Not applicable
15.6 Currency for financial statements and conversion into euro
Financial statements must be drafted in euro.
Beneficiaries and affiliated entities with accounting established in a currency other than the euro
must convert the costs recorded in their accounts into euro at the average of the daily exchange
rates published in the C series of the Official Journal of the European Union, calculated over the
corresponding reporting period.
If no daily euro exchange rate is published in the Official Journal of the European Union for the
currency in question, they must be converted at the average of the monthly accounting rates published
on the Commission’s website, calculated over the corresponding reporting period.
25
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
Beneficiaries and affiliated entities with accounting established in euro must convert costs incurred
in another currency into euro according to their usual accounting practices.
15.7 Language of reports
All report(s) (including financial statements) must be submitted in the language of the Agreement.
15.8 Consequences of non-compliance
If the report(s) submitted do not comply with this Article, the Agency may suspend the payment
deadline (see Article 31) and apply any of the other measures described in Chapter 6.
If the coordinator breaches its obligation to submit the report(s) and if it fails to comply with this
obligation within 30 days following a written reminder, the Agency may terminate the Agreement
(see Article 34) or apply any of the other measures described in Chapter 6.
ARTICLE 16 — PAYMENTS AND PAYMENT ARRANGEMENTS
16.1 Payments to be made
The following payments will be made to the coordinator:
- a pre-financing payment;
- one or more interim payments, on the basis of the request(s) for interim payment (see
Article 15), and
- one payment of the balance, on the basis of the request for payment of the balance (see
Article 15).
16.2 Pre-financing payment — Amount
The aim of the pre-financing is to provide the beneficiaries with a float.
It remains the property of the EU until the payment of the balance.
The amount of the pre-financing payment will be EUR 1 999 613.00 (one million nine hundred and
ninety nine thousand six hundred and thirteen EURO).
The Agency will — except if Article 32 applies — make the pre-financing payment to the coordinator
within 30 days, either from the entry into force of the Agreement (see Article 42) or from 10 days
before the starting date of the action (see Article 3) , whichever is the latest.
16.3 Interim payments — Amount — Calculation
Interim payments reimburse the eligible costs incurred for the implementation of the action during
the corresponding reporting periods.
The Agency will pay to the coordinator the amount due as interim payment within 90 days from
receiving the periodic report (see Article 15.3), except if Articles 31 or 32 apply.
26
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
Payment is subject to the approval of the periodic report. Its approval does not imply recognition of
compliance, authenticity, completeness or correctness of its content.
The amount due as interim payment is calculated by the Agency in the following steps:
Step 1 – Application of the reimbursement rate
Step 2 – Limit to 90% of the maximum grant amount
16.3.1 Step 1 — Application of the reimbursement rate
The reimbursement rate (see Article 5.2) is applied to the eligible costs (actual costs and flat-rate costs;
see Article 6) declared by the beneficiaries and the affiliated entities (see Article 15) and approved by
the Agency (see above) for the concerned reporting period.
16.3.2 Step 2 — Limit to 90% of the maximum grant amount
The total amount of pre-financing and interim payments must not exceed 90% of the maximum grant
amount set out in Article 5.1. The maximum amount for the interim payment will be calculated as
follows:
{90% of the maximum grant amount (see Article 5.1)
minus
{pre-financing and previous interim payments}}.
16.4 Payment of the balance — Amount — Calculation
The payment of the balance reimburses the remaining part of the eligible costs incurred by the
beneficiaries for the implementation of the action.
If the total amount of earlier payments is greater than the final grant amount (see Article 5.3), the
payment of the balance takes the form of a recovery (see Article 28).
If the total amount of earlier payments is lower than the final grant amount, the Agency will pay the
balance within 90 days from receiving the final report (see Article 15.4), except if Articles 31 or 32
apply.
Payment is subject to the approval of the final report. Its approval does not imply recognition of
compliance, authenticity, completeness or correctness of its content.
The amount due as the balance is calculated by the Agency by deducting the total amount of pre-
financing and interim payments (if any) already made, from the final grant amount determined in
accordance with Article 5.3:
{final grant amount (see Article 5.3)
minus
{pre-financing and interim payments (if any) made}}.
If the balance is positive, it will be paid to the coordinator.
The amount to be paid may however be offset — without the beneficiaries’ consent — against any
27
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
other amount owed by a beneficiary to the Agency, the Commission or another executive agency
(under the EU or Euratom budget), up to the maximum EU contribution indicated, for that beneficiary,
in the estimated budget (see Annex 2).
If the balance is negative, it will be recovered from the coordinator (see Article 28).
16.5 Notification of amounts due
When making payments, the Agency will formally notify to the coordinator the amount due,
specifying that it concerns an interim payment or the payment of the balance.
For the payment of the balance, the notification will also specify the final grant amount.
In the case of reduction of the grant or recovery of undue amounts, the notification will be preceded
by the contradictory procedure set out in Articles 27 and 28.
16.6 Currency for payments
The Agency will make all payments in euro.
16.7 Payments to the coordinator — Distribution to the beneficiaries
Payments will be made to the coordinator.
Payments to the coordinator will discharge the Agency from its payment obligation.
The coordinator must distribute the payments between the beneficiaries without unjustified delay.
Pre-financing may however be distributed only:
(a) if 90% of the beneficiaries have acceded to the Agreement (see Article 40) and
(b) to beneficiaries that have acceded to the Agreement (see Article 40).
16.8 Bank account for payments
All payments will be made to the following bank account:
Name of bank: KUTXABANK, S.A
Full name of the account holder: ASOCIACION CENTRO EXCEL INTERNACIONAL
INVESTIG SOBRE CRONICIDAD
Full account number (including bank codes):
IBAN code: ES4920950611009111334073
16.9 Costs of payment transfers
The cost of the payment transfers is borne as follows:
- the Agency bears the cost of transfers charged by its bank;
- the beneficiary bears the cost of transfers charged by its bank;
- the party causing a repetition of a transfer bears all costs of the repeated transfer.
28
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
16.10 Date of payment
Payments by the Agency are considered to have been carried out on the date when they are debited
to its account.
16.11 Consequences of non-compliance
16.11.1 If the Agency does not pay within the payment deadlines (see above), the beneficiaries are
entitled to late-payment interest at the rate applied by the European Central Bank (ECB) for its main
refinancing operations in euros (‘reference rate’), plus three and a half points. The reference rate is
the rate in force on the first day of the month in which the payment deadline expires, as published in
the C series of the Official Journal of the European Union.
If the late-payment interest is lower than or equal to EUR 200, it will be paid to the coordinator only
upon request submitted within two months of receiving the late payment.
Late-payment interest is not due if all beneficiaries are EU Member States (including regional and
local government authorities or other public bodies acting on behalf of a Member State for the purpose
of this Agreement).
Suspension of the payment deadline or payments (see Articles 31 and 32) will not be considered as
late payment.
Late-payment interest covers the period running from the day following the due date for payment (see
above), up to and including the date of payment.
Late-payment interest is not considered for the purposes of calculating the final grant amount.
16.11.2 If the coordinator breaches any of its obligations under this Article, the grant may be reduced
(see Article 27) and the Agreement or the participation of the coordinator may be terminated (see
Article 34).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 17 — CHECKS, REVIEWS, AUDITS AND INVESTIGATIONS — EXTENSION
OF FINDINGS
17.1 Checks, reviews and audits by the Agency and the Commission
17.1.1 Right to carry out checks
The Agency or the Commission will — during the implementation of the action or afterwards — check
the proper implementation of the action and compliance with the obligations under the Agreement,
including assessing deliverables and reports.
For this purpose, the Agency or the Commission may be assisted by external persons or bodies.
The Agency or the Commission may also request additional information in accordance with Article 12.
The Agency or the Commission may request beneficiaries to provide such information to it directly.
Information provided must be accurate, precise and complete and in the format requested, including
electronic format.
29
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
17.1.2 Right to carry out reviews
The Agency or the Commission may — during the implementation of the action or afterwards —
carry out reviews on the proper implementation of the action (including assessment of deliverables
and reports) and compliance with the obligations under the Agreement.
Reviews may be started up to five years after the payment of the balance. They will be formally
notified to the coordinator or beneficiary concerned and will be considered to have started on the date
of the formal notification.
If the review is carried out on a third party (see Articles 9 to 11a), the beneficiary concerned must
inform the third party.
The Agency or the Commission may carry out reviews directly (using its own staff) or indirectly (using
external persons or bodies appointed to do so). It will inform the coordinator or beneficiary concerned
of the identity of the external persons or bodies. They have the right to object to the appointment on
grounds of commercial confidentiality.
The coordinator or beneficiary concerned must provide — within the deadline requested — any
information and data in addition to deliverables and reports already submitted (including information
on the use of resources). The Agency or the Commission may request beneficiaries to provide such
information to it directly.
The coordinator or beneficiary concerned may be requested to participate in meetings, including with
external experts.
For on-the-spot reviews, the beneficiaries must allow access to their sites and premises, including to
external persons or bodies, and must ensure that information requested is readily available.
Information provided must be accurate, precise and complete and in the format requested, including
electronic format.
On the basis of the review findings, a ‘review report’ will be drawn up.
The Agency or the Commission will formally notify the review report to the coordinator or beneficiary
concerned, which has 30 days to formally notify observations (‘contradictory review procedure’).
Reviews (including review reports) are in the language of the Agreement.
17.1.3 Right to carry out audits
The Agency or the Commission may — during the implementation of the action or afterwards —
carry out audits on the proper implementation of the action and compliance with the obligations under
the Agreement.
Audits may be started up to five years after the payment of the balance. They will be formally
notified to the coordinator or beneficiary concerned and will be considered to have started on the date
of the formal notification.
If the audit is carried out on a third party (see Articles 9 to 11a), the beneficiary concerned must inform
the third party.
The Agency or the Commission may carry out audits directly (using its own staff) or indirectly (using
30
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
external persons or bodies appointed to do so). It will inform the coordinator or beneficiary concerned
of the identity of the external persons or bodies. They have the right to object to the appointment on
grounds of commercial confidentiality.
The coordinator or beneficiary concerned must provide — within the deadline requested — any
information (including complete accounts, individual salary statements or other personal data) to
verify compliance with the Agreement. The Agency or the Commission may request beneficiaries to
provide such information to it directly.
For on-the-spot audits, the beneficiaries must allow access to their sites and premises, including to
external persons or bodies, and must ensure that information requested is readily available.
Information provided must be accurate, precise and complete and in the format requested, including
electronic format.
On the basis of the audit findings, a ‘draft audit report’ will be drawn up.
The Agency or the Commission will formally notify the draft audit report to the coordinator or
beneficiary concerned, which has 30 days to formally notify observations (‘contradictory audit
procedure’). This period may be extended by the Agency or the Commission in justified cases.
The ‘final audit report’ will take into account observations by the coordinator or beneficiary
concerned. The report will be formally notified to it.
Audits (including audit reports) are in the language of the Agreement.
The Agency or the Commission may also access the beneficiaries’ statutory records for the periodical
assessment of flat-rate amounts.
17.2 Investigations by the European Anti-Fraud Office (OLAF)
Under Regulations No 883/20137 and No 2185/968 (and in accordance with their provisions and
procedures), the European Anti-Fraud Office (OLAF) may — at any moment during implementation
of the action or afterwards — carry out investigations, including on-the-spot checks and inspections,
to establish whether there has been fraud, corruption or any other illegal activity affecting the financial
interests of the EU.
17.3 Checks and audits by the European Court of Auditors (ECA)
Under Article 287 of the Treaty on the Functioning of the European Union (TFEU) and Article 161 of
the Financial Regulation No 966/20129, the European Court of Auditors (ECA) may — at any moment
during implementation of the action or afterwards — carry out audits.
7 Regulation (EU, Euratom) No 883/2013 of the European Parliament and of the Council of 11 September 2013
concerning investigations conducted by the European Anti-Fraud Office (OLAF) and repealing Regulation (EC)
No 1073/1999 of the European Parliament and of the Council and Council Regulation (Euratom) No 1074/1999 (OJ
L 232, 18.09.2013, p. 1).
8 Council Regulation (Euratom, EC) No 2185/1996 of 11 November 1996 concerning on-the-spot checks and inspections
carried out by the Commission in order to protect the European Communities' financial interests against fraud and other
irregularities (OJ L 292, 15.11.1996, p. 2).
9 Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council of 25 October 2012 on the
financial rules applicable to the general budget of the Union and repealing Council Regulation (EC, Euratom) No
1605/2002 (OJ L 298, 26.10.2012, p. 1).
31
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
The ECA has the right of access for the purpose of checks and audits.
17.4 Checks, reviews, audits and investigations for international organisations
Not applicable
17.5 Consequences of findings in checks, reviews, audits and investigations — Extension of
findings
17.5.1 Findings in this grant
Findings in checks, reviews, audits or investigations carried out in the context of this grant may lead
to the rejection of ineligible costs (see Article 26), reduction of the grant (see Article 27), recovery of
undue amounts (see Article 28) or to any of the other measures described in Chapter 6.
Rejection of costs or reduction of the grant after the payment of the balance will lead to a revised final
grant amount (see Article 5.4).
Findings in checks, reviews, audits or investigations may lead to a request for amendment for the
modification of Annex 1 (see Article 39).
Checks, reviews, audits or investigations that find systemic or recurrent errors, irregularities, fraud or
breach of obligations may also lead to consequences in other EU or Euratom grants awarded under
similar conditions (‘extension of findings from this grant to other grants’).
Moreover, findings arising from an OLAF investigation may lead to criminal prosecution under
national law.
17.5.2 Findings in other grants
The Agency or the Commission may extend findings from other grants to this grant (‘extension of
findings from other grants to this grant’), if:
(a) the beneficiary concerned is found, in other EU or Euratom grants awarded under similar
conditions, to have committed systemic or recurrent errors, irregularities, fraud or breach of
obligations that have a material impact on this grant and
(b) those findings are formally notified to the beneficiary concerned — together with the list of
grants affected by the findings — no later than five years after the payment of the balance
of this grant.
The extension of findings may lead to the rejection of costs (see Article 26), reduction of the grant
(see Article 27), recovery of undue amounts (see Article 28), suspension of payments (see Article 32),
suspension of the action implementation (see Article 33) or termination (see Article 34).
17.5.3 Procedure
The Agency or the Commission will formally notify the beneficiary concerned the systemic or
recurrent errors and its intention to extend these audit findings, together with the list of grants affected.
17.5.3.1 If the findings concern eligibility of costs: the formal notification will include:
(a) an invitation to submit observations on the list of grants affected by the findings;
32
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
(b) the request to submit revised financial statements for all grants affected;
(c) the correction rate for extrapolation established by the Agency or the Commission on
the basis of the systemic or recurrent errors, to calculate the amounts to be rejected, if the
beneficiary concerned:
(i) considers that the submission of revised financial statements is not possible or practicable
or
(ii) does not submit revised financial statements.
The beneficiary concerned has 90 days from receiving notification to submit observations, revised
financial statements or to propose a duly substantiated alternative correction method. This period
may be extended by the Agency or the Commission in justified cases.
The Agency or the Commission may then start a rejection procedure in accordance with Article 26,
either on the basis of the revised financial statements, the alternative method or the correction rate
announced.
17.5.3.2 If the findings concern substantial errors, irregularities or fraud or serious breach of
obligations: the formal notification will include:
(a) an invitation to submit observations on the list of grants affected by the findings and
(b) the flat-rate the Agency or the Commission intends to apply according to the principle of
proportionality.
The beneficiary concerned has 90 days from receiving notification to submit observations or to
propose a duly substantiated alternative flat-rate.
The Agency or the Commission may then start a reduction procedure in accordance with Article 27,
either on the basis of the alternative flat-rate or the flat-rate announced.
17.6 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, any insufficiently substantiated costs
will be ineligible (see Article 6) and will be rejected (see Article 26).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 18 — EVALUATION OF THE IMPACT OF THE ACTION
18.1 Right to evaluate the impact of the action
The Agency or the Commission may carry out interim and final evaluations of the impact of the action
measured against the objective of the EU programme.
Evaluations may be started during implementation of the action and up to five years after the
payment of the balance. The evaluation is considered to start on the date of the formal notification
to the coordinator or beneficiaries.
33
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
The Agency or the Commission may make these evaluations directly (using its own staff) or indirectly
(using external bodies or persons it has authorised to do so).
The coordinator or beneficiaries must provide any information relevant to evaluate the impact of the
action, including information in electronic format.
18.2 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, the Agency may apply the measures
described in Chapter 6.
SECTION 3 OTHER RIGHTS AND OBLIGATIONS
ARTICLE 19 — PRE-EXISTING RIGHTS AND OWNERSHIP OF THE RESULTS
(INCLUDING INTELLECTUAL AND INDUSTRIAL PROPERTY
RIGHTS)
19.1 Pre-existing rights and access rights to pre-existing rights
Where industrial and intellectual property rights (including rights of third parties) exist prior to the
Agreement, the beneficiaries must establish a list of these pre-existing industrial and intellectual
property rights, specifying the owner and any persons that have a right of use.
The coordinator must — before starting the action — submit this list to the Agency.
Each beneficiary must give the other beneficiaries and their affiliated entities access to any pre-existing
industrial and intellectual property rights needed for the implementation of the action and compliance
with the obligations under the Agreement.
19.2 Ownership of results and rights of use
The results of the action (including the reports and other documents relating to it) are owned by the
beneficiaries.
The beneficiaries must give the Agency and the Commission the right to use the results for their
communication activities under Article 22.
19.3 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see
Article 27).
Such a breach may also lead to any of the other measures described in Chapter 6.
ARTICLE 20 — CONFLICT OF INTERESTS
20.1 Obligation to avoid a conflict of interests
The beneficiaries must take all measures to prevent any situation where the impartial and objective
34
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
implementation of the action is compromised for reasons involving economic interest, political or
national affinity, family or emotional ties or any other shared interest (‘conflict of interests’).
They must formally notify to the Agency without delay any situation constituting or likely to lead to
a conflict of interests and immediately take all the necessary steps to rectify this situation.
The Agency may verify that the measures taken are appropriate and may require additional measures
to be taken by a specified deadline.
20.2 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see
Article 27) and the Agreement or participation of the beneficiary may be terminated (see Article 34).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 21 — CONFIDENTIALITY
21.1 General obligation to maintain confidentiality
During implementation of the action and for five years after the payment of the balance, the parties
must keep confidential any data, documents or other material (in any form) that is identified as
confidential at the time it is disclosed (‘confidential information’).
They may use confidential information to implement the Agreement.
The confidentiality obligations no longer apply if:
(a) the disclosing party agrees to release the other party;
(b) the information becomes generally and publicly available, without breaching any
confidentiality obligation;
(c) the disclosure of the confidential information is required by EU or national law.
21.2 Consequences of non-compliance
If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see
Article 27).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 22 — PROMOTING THE ACTION — VISIBILITY OF EU FUNDING
22.1 Communication activities by the beneficiaries
22.1.1 General obligation to promote the action and its results
The beneficiaries must promote the action and its results.
22.1.2 Information on EU funding — Obligation and right to use the EU emblem
35
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
Unless the Agency requests or agrees otherwise, any communication activity related to the action
(including at conferences, seminars, in information material, such as brochures, leaflets, posters,
presentations, etc., in electronic form, via social media, etc.) and any infrastructure, equipment or
major results funded by the grant must:
- display the EU emblem and
- include the following text:
“This [insert appropriate description, e.g. report, publication, conference, infrastructure, equipment, insert
type of result, etc.] was funded by the European Union’s Health Programme (2014-2020).”
When displayed in association with another logo, the EU emblem must have appropriate prominence.
For the purposes of their obligations under this Article, the beneficiaries may use the EU emblem
without first obtaining approval from the Agency.
This does not, however, give them the right to exclusive use.
Moreover, they may not appropriate the EU emblem or any similar trademark or logo, either by
registration or by any other means.
22.1.3 Disclaimer excluding Agency and Commission responsibility
Any communication activity related to the action must indicate the following disclaimer:
"The content of this [insert appropriate description, e.g. report, publication, conference, etc.] represents
the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views
of the European Commission and/or the Consumers, Health, Agriculture and Food Executive Agency
(CHAFEA) or any other body of the European Union. The European Commission and the Agency do not
accept any responsibility for use that may be made of the information it contains.”
22.2 Communication activities by the Agency and the Commission
22.2.1 Right to use the beneficiaries’ materials, documents or information
The Agency and the Commission may use information relating to the action, documents notably
summaries for publication and public deliverables as well as any other material, such as pictures or
audio-visual material received from any beneficiary (including in electronic form).
This does not change the confidentiality obligations in Article 21, which still apply.
The right to use the beneficiary’s materials, documents and information includes:
(a) use for its own purposes (in particular, making them available to persons working for the
Agency, the Commission or any other EU institution, body, office or agency or body or
institutions in EU Member States; and copying or reproducing them in whole or in part, in
unlimited numbers);
(b) distribution to the public (in particular, publication as hard copies and in electronic or digital
format, publication on the internet, as a downloadable or non-downloadable file, broadcasting
by any channel, public display or presentation, communicating through press information
services, or inclusion in widely accessible databases or indexes);
36
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
(c) editing or redrafting for communication and publicising activities (including shortening,
summarising, inserting other elements (such as meta-data, legends, other graphic, visual, audio
or text elements), extracting parts (e.g. audio or video files), dividing into parts, use in a
compilation);
(d) translation;
(e) giving access in response to individual requests under Regulation No 1049/200110, without
the right to reproduce or exploit;
(f) storage in paper, electronic or other form;
(g) archiving, in line with applicable document-management rules, and
(h) the right to authorise third parties to act on its behalf or sub-license the modes of use set out
in Points (b), (c), (d) and (f) to third parties if needed for the communication and publicising
activities of the Agency or the Commission.
If the right of use is subject to rights of a third party (including personnel of the beneficiary), the
beneficiary must ensure that it complies with its obligations under this Agreement (in particular, by
obtaining the necessary approval from the third parties concerned).
Where applicable (and if provided by the beneficiaries), the Agency or the Commission will insert
the following information:
“© – [year] – [name of the copyright owner]. All rights reserved. Licensed to the Consumers, Health,
Agriculture and Food Executive Agency (CHAFEA) and the European Union (EU) under conditions.”
22.3 Consequences of non-compliance
If the beneficiary breaches any of its obligations under this Article, the grant may be reduced (see
Article 27).
Such breaches may also lead to any of the other measures described in Chapter 6.
ARTICLE 23 — PROCESSING OF PERSONAL DATA
23.1 Processing of personal data by the Agency and the Commission
Any personal data under the Agreement will be processed by the Agency or the Commission under
Regulation No 23/200111 and according to the ‘notifications of the processing operations’ to the Data
Protection Officer (DPO) of the Agency or the Commission (publicly accessible in the DPO register).
Such data will be processed by the ‘data controller’ of the Agency or the Commission, for the
purposes of implementing, managing and monitoring the Agreement or protecting the financial
interests of the EU or Euratom (including checks, reviews, audits and investigations; see Article 17).
10 Regulation (EC) No 1049/2001 of the European Parliament and of the Council of 30 May 2001 regarding public access
to European Parliament, Council and Commission documents, OJ L 145, 31.5.2001, p. 43.
11 Regulation (EC) No 45/2001 of the European Parliament and of the Council of 18 December 2000 on the protection
of individuals with regard to the processing of personal data by the Community institutions and bodies and on the free
movement of such data (OJ L 8, 12.01.2001, p. 1).
37
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
The persons whose personal data are processed have the right to access and correct their own personal
data. For this purpose, they must send any queries about the processing of their personal data to the data
controller, via the contact point indicated in the privacy statement(s) on the Agency and Commission
websites.
They also have the right to have recourse at any time to the European Data Protection Supervisor
(EDPS).
23.2 Processing of personal data by the beneficiaries
The beneficiaries must process personal data under the Agreement in compliance with applicable EU
and national law on data protection (including authorisations or notification requirements).
The beneficiaries may grant their personnel access only to data that is strictly necessary for
implementing, managing and monitoring the Agreement.
The beneficiaries must inform the personnel whose personal data are collected and processed by the
Agency or the Commission. For this purpose, they must provide them with the privacy statement(s)
(see above), before transmitting their data to the Agency or the Commission.
23.3 Consequences of non-compliance
If a beneficiary breaches any of its obligations under Article 23.2, the Agency may apply any of the
measures described in Chapter 6.
ARTICLE 24 — ASSIGNMENTS OF CLAIMS FOR PAYMENT AGAINST THE AGENCY
The beneficiaries may not assign any of their claims for payment against the Agency to any third
party, except if approved by the Agency on the basis of a reasoned, written request by the coordinator
(on behalf of the beneficiary concerned).
If the Agency has not accepted the assignment or the terms of it are not observed, the assignment
will have no effect on it.
In no circumstances will an assignment release the beneficiaries from their obligations towards the
Agency.
CHAPTER 5 DIVISION OF BENEFICIARIES’ ROLES AND RESPONSIBILITIES
ARTICLE 25 — DIVISION OF BENEFICIARIES’ ROLES AND RESPONSIBILITIES
25.1 Roles and responsibilities towards the Agency
The beneficiaries have full responsibility for implementing the action and complying with the
Agreement.
The beneficiaries are jointly and severally liable for the technical implementation of the action as
described in Annex 1. If a beneficiary fails to implement its part of the action, the other beneficiaries
become responsible for implementing this part (without being entitled to any additional EU funding
for doing so), unless the Agency expressly relieves them of this obligation.
38
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
The financial responsibility of each beneficiary is governed by Articles 28, 29 and 30.
25.2 Internal division of roles and responsibilities
The internal roles and responsibilities of the beneficiaries are divided as follows:
(a) Each beneficiary must:
(i) keep information stored in the Participant Portal Beneficiary Register (via the electronic
exchange system) up to date (see Article 12);
(ii) inform the coordinator immediately of any events or circumstances likely to affect
significantly or delay the implementation of the action (see Article 12);
(iii) submit to the coordinator in good time:
- individual financial statements for itself and its affiliated entities and, if required,
certificates on the financial statements (see Article 15);
- the data needed to draw up the technical reports (see Article 15);
- any other documents or information required by the Agency or the Commission
under the Agreement, unless the Agreement requires the beneficiary to submit this
information directly.
(b) The coordinator must:
(i) monitor that the action is implemented properly (see Article 7);
(ii) act as the intermediary for all communications between the beneficiaries and the Agency
(in particular, providing the Agency with the information described in Article 12), unless
the Agreement specifies otherwise;
(iii) provide a pre-financing guarantee if requested by the Agency (see Article 16.2);
(iv) request and review any documents or information required by the Agency and verify
their completeness and correctness before passing them on to the Agency;
(v) submit the deliverables and reports to the Agency (see Articles 14 and 15);
(vi) ensure that all payments are made to the other beneficiaries without unjustified delay
(see Article 16).
The coordinator may not subcontract the above-mentioned tasks.
25.3 Internal arrangements between beneficiaries — Consortium agreement
The beneficiaries must have internal arrangements regarding their operation and co-ordination to
ensure that the action is implemented properly. These internal arrangements must be set out in a written
‘consortium agreement’ between the beneficiaries, which may cover:
- internal organisation of the consortium;
39
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
- management of access to the electronic exchange system;
- distribution of EU funding;
- additional rules on rights and obligations related to pre-existing rights and results (see
Article 19);
- settlement of internal disputes;
- liability, indemnification and confidentiality arrangements between the beneficiaries.
The consortium agreement must not contain any provision contrary to the Agreement.
CHAPTER 6 REJECTION OF COSTS — REDUCTION OF THE GRANT —
RECOVERY — SANCTIONS — DAMAGES — SUSPENSION —
TERMINATION — FORCE MAJEURE
SECTION 1 REJECTION OF COSTS — REDUCTION OF THE GRANT — RECOVERY
— SANCTIONS
ARTICLE 26 — REJECTION OF INELIGIBLE COSTS
26.1 Conditions
The Agency will — at the time of an interim payment, at the payment of the balance or afterwards
— reject any costs which are ineligible (see Article 6), in particular following checks, reviews, audits
or investigations (see Article 17).
The rejection may also be based on the extension of findings from other grants to this grant (see
Article 17.5.2).
26.2 Ineligible costs to be rejected — Calculation — Procedure
Ineligible costs will be rejected in full.
If the rejection of costs does not lead to a recovery (see Article 28), the Agency will formally notify
the coordinator or beneficiary concerned of the rejection of costs, the amounts and the reasons why
(if applicable, together with the notification of amounts due; see Article 16.5). The coordinator or
beneficiary concerned may — within 30 days of receiving notification — formally notify the Agency
of its disagreement and the reasons why.
If the rejection of costs leads to a recovery, the Agency will follow the contradictory procedure with
pre-information letter set out in Article 28.
26.3 Effects
If the Agency rejects costs at the time of an interim payment or the payment of the balance, it will
deduct them from the total eligible costs declared, for the action, in the periodic or final summary
financial statement (see Article 15.3 and 15.4). It will then calculate the interim payment or payment
of the balance as set out in Article 16.3 or 16.4.
40
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
If the Agency — after an interim payment but before the payment of the balance — rejects costs
declared in a periodic summary financial statement, it will deduct them from the costs declared in the
next periodic summary financial statement or final summary financial statement. It will then calculate
the interim payment or payment of the balance as set out in Article 16.3 or 16.4.
If the Agency rejects costs after the payment of the balance, it will deduct the amount rejected from
the total eligible costs declared, by the beneficiary, in the final summary financial statement. It will
then calculate the revised final grant amount as set out in Article 5.4. If the revised final grant amount
is lower than the final grant amount, the Agency will recover the difference (see Article 28).
ARTICLE 27 — REDUCTION OF THE GRANT
27.1 Conditions
The Agency may — at the payment of the balance or afterwards — reduce the grant, if:
(a) a beneficiary (or a natural person who has the power to represent or take decisions on its behalf)
has committed:
(i) substantial errors, irregularities or fraud or
(ii) serious breach of obligations under the Agreement or during the award procedure
(including improper implementation of the action, submission of false information,
failure to provide required information, breach of ethical principles) or
(b) a beneficiary (or a natural person who has the power to represent or take decisions on its behalf)
has committed — in other EU or Euratom grants awarded to it under similar conditions —
systemic or recurrent errors, irregularities, fraud or serious breach of obligations that have a
material impact on this grant (extension of findings from other grants to this grant; see
Article 17.5.2).
27.2 Amount to be reduced — Calculation — Procedure
The amount of the reduction will be proportionate to the seriousness of the errors, irregularities or
fraud or breach of obligations.
Before reduction of the grant, the Agency will formally notify a ‘pre-information letter’ to the
coordinator or beneficiary concerned:
- informing it of its intention to reduce the grant, the amount it intends to reduce and the reasons
why and
- inviting it to submit observations within 30 days of receiving notification.
If the Agency does not receive any observations or decides to pursue reduction despite the observations
it has received, it will formally notify confirmation of the reduction (if applicable, together with the
notification of amounts due; see Article 16).
27.3 Effects
If the Agency reduces the grant at the time of the payment of the balance, it will calculate the
41
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
reduced grant amount for the action and then determine the amount due as payment of the balance
(see Article 5.3.4 and 16.4).
If the Agency reduces the grant after the payment of the balance, it will calculate the revised final
grant amount for the action or for the beneficiary concerned (see Article 5.4). If the revised final grant
amount is lower than the final grant amount, the Agency will recover the difference (see Article 28).
ARTICLE 28 — RECOVERY OF UNDUE AMOUNTS
28.1 Amount to be recovered — Calculation — Procedure
The Agency will — at the payment of the balance or afterwards — claim back any amount that
was paid but is not due under the Agreement.
The coordinator is fully liable for repaying debts of the consortium (under the Agreement) even if it
has not been the final recipient of those amounts.
In addition, the beneficiaries (including the coordinator) are jointly and severally liable for repaying
any unpaid debts under the Agreement (due by the consortium or any beneficiary, including late-
payment interest) — up to the maximum EU contribution indicated, for each beneficiary, in the
estimated budget (as last amended; see Annex 2).
Undue amounts paid by the Agency for costs declared by an affiliated entity will be considered as
amounts unduly paid to the beneficiary.
28.1.1 Recovery at payment of the balance
If the payment of the balance takes the form of a recovery (see Article 16.4), the Agency will formally
notify a ‘pre-information letter’ to the coordinator:
- informing it of its intention to recover, the amount due as the balance and the reasons why and
- inviting the coordinator to submit observations within 30 days of receiving notification.
If no observations are submitted or the Agency decides to pursue recovery despite the observations
it has received, it will confirm the amount to be recovered and formally notify to the coordinator a
debit note with the terms and the date for payment (together with the notification of amounts due;
see Article 16.5).
If payment is not made by the date specified in the debit note, the Agency or the Commission will
recover the amount:
(a) by ‘offsetting’ it — without the coordinator’s consent — against any amounts owed to the
coordinator by the Agency, Commission or another executive agency (from the EU or Euratom
budget).
In exceptional circumstances, to safeguard the EU’s financial interests, the Agency may offset
before the payment date specified in the debit note;
(b) not applicable;
(c) by holding the other beneficiaries jointly and severally liable — up to the maximum EU
42
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
contribution indicated, for each beneficiary, in the estimated budget (as last amended; see
Annex 2)
(d) by taking legal action (see Article 41) or by adopting an enforceable decision under
Article 299 of the Treaty on the Functioning of the EU (TFEU) and Article 79(2) of the
Financial Regulation No 966/2012.
If payment is not made by the date in the debit note, the amount to be recovered (see above) will be
increased by late-payment interest at the rate set out in Article 16.11, from the day following the
payment date in the debit note, up to and including the date the Agency or the Commission receives
full payment of the amount.
Partial payments will be first credited against expenses, charges and late-payment interest and then
against the principal.
Bank charges incurred in the recovery process will be borne by the beneficiary, unless Directive
2007/64/EC applies.
28.1.2 Recovery of amounts after payment of the balance
If — after the payment of the balance — the Agency revised the final grant amount for the action or
for the beneficiary concerned (see Article 5.4), due to a rejection of costs or reduction of the grant, and
the revised final grant amount is lower than the final grant amount (see Article 5.3), the Agency will:
- if the rejection or reduction does not concern a specific beneficiary or its affiliated entities:
claim back the difference from the coordinator (even if it has not been the final recipient of
the amount in question)
or
- otherwise: claim back the difference from the beneficiary concerned.
The Agency will formally notify a pre-information letter to the coordinator or beneficiary concerned:
- informing it of its intention to recover, the amount to be repaid and the reasons why and
- inviting it to submit observations within 30 days of receiving notification.
If no observations are submitted or the Agency decides to pursue recovery despite the observations
it has received, it will confirm the amount to be recovered and formally notify to the coordinator or
beneficiary concerned a debit note. This note will also specify the terms and the date for payment.
If payment is not made by the date specified in the debit note, the Agency or the Commission will
recover the amount:
(a) by ‘offsetting’ it — without the coordinator’s or beneficiary’s consent — against any amounts
owed to the coordinator or beneficiary by the Agency, Commission or another executive agency
(from the EU or Euratom budget).
In exceptional circumstances, to safeguard the EU’s financial interests, the Agency may offset
before the payment date specified in the debit note;
(b) by holding the other beneficiaries jointly and severally liable, up to the maximum EU
43
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
contribution indicated, for each beneficiary, in the estimated budget (as last amended; see
Annex 2)
(c) by taking legal action (see Article 41) or by adopting an enforceable decision under
Article 299 of the Treaty on the Functioning of the EU (TFEU) and Article 79(2) of the
Financial Regulation No 966/2012.
If payment is not made by the date in the debit note, the amount to be recovered (see above) will be
increased by late-payment interest at the rate set out in Article 16.11, from the day following the date
for payment in the debit note, up to and including the date the Agency or the Commission receives
full payment of the amount.
Partial payments will be first credited against expenses, charges and late-payment interest and then
against the principal.
Bank charges incurred in the recovery process will be borne by the beneficiary, unless Directive
2007/64/EC applies.
ARTICLE 29 — ADMINISTRATIVE SANCTIONS
In addition to contractual measures, the Agency or the Commission may also adopt administrative
sanctions under Articles 106 and 131(4) of the Financial Regulation No 966/2012 (i.e. exclusion from
future procurement contracts, grants and expert contracts and/or financial penalties).
SECTION 2 LIABILITY FOR DAMAGES
ARTICLE 30 — LIABILITY FOR DAMAGES
30.1 Liability of the Agency
The Agency cannot be held liable for any damage caused to the beneficiaries or to third parties as a
consequence of implementing the Agreement, including for gross negligence.
The Agency cannot be held liable for any damage caused by any of the beneficiaries or third parties
involved in the action, as a consequence of implementing the Agreement.
30.2 Liability of the beneficiaries
Except in case of force majeure (see Article 35), the beneficiaries must compensate the Agency for
any damage it sustains as a result of the implementation of the action or because the action was not
implemented in full compliance with the Agreement.
SECTION 3 SUSPENSION AND TERMINATION
ARTICLE 31 — SUSPENSION OF PAYMENT DEADLINE
31.1 Conditions
44
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
The Agency may — at any moment — suspend the payment deadline (see Article 16.2 to 16.4) if a
request for payment (see Article 15) cannot be approved because:
(a) it does not comply with the provisions of the Agreement (see Article 15);
(b) the technical or financial report(s) have not been submitted or are not complete or additional
information is needed, or
(c) there is doubt about the eligibility of the costs declared in the financial statements and additional
checks, reviews, audits or investigations are necessary.
31.2 Procedure
The Agency will formally notify the coordinator of the suspension and the reasons why.
The suspension will take effect the day notification is sent by the Agency (see Article 36).
If the conditions for suspending the payment deadline are no longer met, the suspension will be lifted
— and the remaining period will resume.
If the suspension exceeds two months, the coordinator may request the Agency if the suspension will
continue.
If the payment deadline has been suspended due to the non-compliance of the technical or financial
report(s) (see Article 15) and the revised report or statement is not submitted or was submitted but
is also rejected, the Agency may also terminate the Agreement or the participation of the beneficiary
(see Article 34.3.1(i)).
ARTICLE 32 — SUSPENSION OF PAYMENTS
32.1 Conditions
The Agency may — at any moment — suspend payments, in whole or in part for one or more
beneficiaries, if:
(a) a beneficiary (or a natural person who has the power to represent or take decision on its behalf)
has committed or is suspected of having committed:
(i) substantial errors, irregularities or fraud or
(ii) serious breach of obligations under this Agreement or during the award procedure
(including improper implementation of the action, submission of false information,
failure to provide required information, breach of ethical principles) or
(b) a beneficiary (or a natural person who has the power to represent or take decision on its behalf)
has committed — in other EU or Euratom grants awarded to it under similar conditions —
systemic or recurrent errors, irregularities, fraud or serious breach of obligations that have a
material impact on this grant (extension of findings from other grants to this grant; see
Article 17.5.2).
If payments are suspended for one or more beneficiaries, the Agency will make partial payment(s)
for the part(s) not suspended. If suspension concerns the payment of the balance, the payment (or
45
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
recovery) of the amount(s) concerned after suspension is lifted will be considered to be the payment
that closes the action.
32.2 Procedure
Before suspending payments, the Agency will formally notify the coordinator or beneficiary
concerned:
- informing it of its intention to suspend payments and the reasons why and
- inviting it to submit observations within 30 days of receiving notification.
If the Agency does not receive observations or decides to pursue the procedure despite the observations
it has received, it will formally notify confirmation of the suspension. Otherwise, it will formally
notify that the suspension procedure is not continued.
The suspension will take effect the day the confirmation notification is sent by the Agency.
If the conditions for resuming payments are met, the suspension will be lifted. The Agency will
formally notify the coordinator or beneficiary concerned.
During the suspension, the periodic report(s) for all reporting periods except the last one (see
Article 15.3) must not contain any individual financial statement(s) from the beneficiary concerned
and its affiliated entities. The coordinator must include them in the next periodic report after the
suspension is lifted or — if suspension is not lifted before the end of the action — in the last periodic
report.
The beneficiaries may suspend implementation of the action (see Article 33.1) or terminate the
Agreement or the participation of the beneficiary concerned (see Article 34.1 and 34.2).
ARTICLE 33 — SUSPENSION OF THE ACTION IMPLEMENTATION
33.1 Suspension of the action implementation, by the beneficiaries
33.1.1 Conditions
The beneficiaries may suspend implementation of the action or any part of it, if exceptional
circumstances — in particular force majeure (see Article 35) — make implementation impossible or
excessively difficult.
33.1.2 Procedure
The coordinator must immediately formally notify to the Agency the suspension (see Article 36),
stating:
- the reasons why and
- the expected date of resumption.
The suspension will take effect the day this notification is received by the Agency.
Once circumstances allow for implementation to resume, the coordinator must immediately formally
46
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
notify the Agency and request an amendment of the Agreement, to set the date on which the action
will be resumed, extend the duration of the action and make other changes necessary to adapt the action
to the new situation (see Article 39) — unless the Agreement or the participation of a beneficiary has
been terminated (see Article 34).
The suspension will be lifted with effect from the resumption date set out in the amendment. This
date may be before the date on which the amendment enters into force.
Costs incurred during suspension of the action implementation are not eligible (see Article 6).
33.2 Suspension of the action implementation, by the Agency
33.2.1 Conditions
The Agency may suspend implementation of the action or any part of it, if:
(a) a beneficiary (or a natural person who has the power to represent or take decisions on its behalf)
has committed or is suspected of having committed:
(i) substantial errors, irregularities or fraud or
(ii) serious breach of obligations under this Agreement or during the award procedure
(including improper implementation of the action, submission of false declaration, failure
to provide required information, breach of ethical principles) or
(b) a beneficiary (or a natural person who has the power to represent or take decisions on its behalf)
has committed — in other EU or Euratom grants awarded to it under similar conditions —
systemic or recurrent errors, irregularities, fraud or serious breach of obligations that have a
material impact on this grant (extension of findings from other grants to this grant; see
Article 17.5.2).
33.2.2 Procedure
Before suspending implementation of the action, the Agency will formally notify the coordinator or
beneficiary concerned:
- informing it of its intention to suspend the implementation and the reasons why and
- inviting it to submit observations within 30 days of receiving notification.
If the Agency does not receive observations or decides to pursue the procedure despite the observations
it has received, it will formally notify confirmation of the suspension. Otherwise, it will formally
notify that the procedure is not continued.
The suspension will take effect five days after confirmation notification is received (or on a later date
specified in the notification).
It will be lifted if the conditions for resuming implementation of the action are met.
The coordinator or beneficiary concerned will be formally notified of the lifting and the Agreement
will be amended, to set the date on which the action will be resumed, extend the duration of the action
and make other changes necessary to adapt the action to the new situation (see Article 39) — unless
the Agreement has already been terminated (see Article 34).
47
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
The suspension will be lifted with effect from the resumption date set out in the amendment. This date
may be before the date on which the amendment enters into force.
Costs incurred during suspension are not eligible (see Article 6).
The beneficiaries may not claim damages due to suspension by the Agency (see Article 30).
Suspension of the action implementation does not affect the Agency’s right to terminate the Agreement
or participation of a beneficiary (see Article 34), reduce the grant or recover amounts unduly paid
(see Articles 27 and 28).
ARTICLE 34 — TERMINATION OF THE AGREEMENT OR OF THE PARTICIPATION
OF ONE OR MORE BENEFICIARIES
34.1 Termination of the Agreement, by the beneficiaries
34.1.1 Conditions and procedure
The beneficiaries may terminate the Agreement.
The coordinator must formally notify termination to the Agency (see Article 36), stating:
- the reasons why and
- the date the termination will take effect. This date must be after the notification.
If no reasons are given or if the Agency considers the reasons do not justify termination, the Agreement
will be considered to have been ‘terminated improperly’.
The termination will take effect on the day specified in the notification.
34.1.2 Effects
The coordinator must — within 60 days from when termination takes effect — submit a periodic report
(for the open reporting period until termination; see Article 15.3) and the final report (see Article 15.4).
If the Agency does not receive the report(s) within the deadline (see above), only costs which are
included in an approved periodic report will be taken into account.
The Agency will calculate the final grant amount (see Article 5.3) and the balance (see Article 16.4)
on the basis of the report(s) submitted. Only costs incurred until termination are eligible (see Article 6).
Costs relating to contracts due for execution only after termination are not eligible.
Improper termination may lead to a reduction of the grant (see Article 27).
After termination, the beneficiaries’ obligations (in particular, Articles 15, 17, 18, 19, 20, 21, 22, 24,
26, 27 and 28) continue to apply.
34.2 Termination of the participation of one or more beneficiaries, by the beneficiaries
34.2.1 Conditions and procedure
48
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
The participation of one or more beneficiaries may be terminated by the coordinator, on request of
the beneficiary concerned or on behalf of the other beneficiaries.
The coordinator must formally notify termination to the Agency (see Article 36) and inform the
beneficiary concerned.
If the coordinator’s participation is terminated without its agreement, the formal notification must be
done by another beneficiary (acting on behalf of the other beneficiaries).
The notification must include:
- the reasons why;
- the opinion of the beneficiary concerned (or proof that this opinion has been requested in
writing);
- the date the termination takes effect. This date must be after the notification, and
- a request for amendment (see Article 39), with a proposal for reallocation of the tasks and the
estimated budget of the beneficiary concerned (see Annexes 1 and 2) and, if necessary, the
addition of one or more new beneficiaries (see Article 40). If termination takes effect after the
period set out in Article 3, no request for amendment must be included, unless the beneficiary
concerned is the coordinator. In this case, the request for amendment must propose a new
coordinator.
If this information is not given or if the Agency considers that the reasons do not justify termination,
the participation will be considered to have been terminated improperly.
The termination will take effect on the day specified in the notification.
34.2.2 Effects
The beneficiary concerned must submit to the coordinator:
(i) a technical report and
(ii) a financial statement covering the period from the end of the last reporting period to the date
when termination takes effect.
This information must be included by the coordinator in the periodic report for the next reporting
period (see Article 15.3).
If the request for amendment is rejected by the Agency (because it calls into question the decision
awarding the grant or breaches the principle of equal treatment of applicants), the Agreement may be
terminated according to Article 34.3.1(c).
If the request for amendment is accepted by the Agency, the Agreement is amended to introduce the
necessary changes (see Article 39).
Improper termination may lead to a reduction of the grant (see Article 27) or termination of the
Agreement (see Article 34).
49
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
After termination, the concerned beneficiary’s obligations (in particular Articles 15, 17, 18, 19, 21,
22, 24, 26, 27 and 28) continue to apply.
34.3 Termination of the Agreement or of the participation of one or more beneficiaries, by
the Agency
34.3.1 Conditions
The Agency may terminate the Agreement or the participation of one or more beneficiaries, if:
(a) one or more beneficiaries do not accede to the Agreement (see Article 40);
(b) a change to their legal, financial, technical, organisational or ownership situation (or those of
its affiliated entities) is likely to substantially affect or delay the implementation of the action
or calls into question the decision to award the grant;
(c) following termination of participation for one or more beneficiaries (see above), the necessary
changes to the Agreement would call into question the decision awarding the grant or breach
the principle of equal treatment of applicants (see Article 39);
(d) implementation of the action is prevented by force majeure (see Article 35) or suspended by
the coordinator (see Article 33.1) and either:
(i) resumption is impossible, or
(ii) the necessary changes to the Agreement would call into question the decision awarding
the grant or breach the principle of equal treatment of applicants;
(e) a beneficiary is declared bankrupt, being wound up, having its affairs administered by the
courts, has entered into an arrangement with creditors, has suspended business activities, or
is subject to any other similar proceedings or procedures under national law;
(f) a beneficiary (or a natural person who has the power to represent or take decisions on its
behalf) has been found guilty of professional misconduct, proven by any means;
(g) a beneficiary does not comply with the applicable national law on taxes and social security;
(h) a beneficiary (or a natural person who has the power to represent or take decisions on its
behalf) has committed fraud, corruption, or is involved in a criminal organisation, money
laundering or any other illegal activity;
(i) a beneficiary (or a natural person who has the power to represent or take decisions on its
behalf) has committed:
(i) substantial errors, irregularities or fraud or
(ii) serious breach of obligations under the Agreement or during the award procedure
(including improper implementation of the action, submission of false information,
failure to provide required information, breach of ethical principles);
(j) a beneficiary (or a natural person who has the power to represent or take decisions on its
behalf) has committed — in other EU or Euratom grants awarded to it under similar conditions
— systemic or recurrent errors, irregularities, fraud or serious breach of obligations that have
50
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
a material impact on this grant (extension of findings from other grants to this grant; see
Article 17.5.2);
(k) despite a specific request by the Agency, a beneficiary does not request — through the
coordinator — an amendment to the Agreement to end the participation of one of its affiliated
entities that is in one of the situations under points (e), (f), (g), (h), (i) or (j) and to reallocate
its tasks
34.3.2 Procedure
Before terminating the Agreement or participation of one or more beneficiaries, the Agency will
formally notify the coordinator or beneficiary concerned:
- informing it of its intention to terminate and the reasons why and
- inviting it, within 30 days of receiving notification, to submit observations and — in case of
Point (i.ii) above — to inform the Agency of the measures to ensure compliance with the
obligations under the Agreement.
If the Agency does not receive observations or decides to pursue the procedure despite the observations
it has received, it will formally notify to the coordinator or beneficiary concerned confirmation of
the termination and the date it will take effect. Otherwise, it will formally notify that the procedure
is not continued.
The termination will take effect:
- for terminations under Points (b), (c), (e), (g), (i.ii) and (k) above: on the day specified in the
notification of the confirmation (see above);
- for terminations under Points (a), (d), (f), (h), (i.i) and (j) above: on the day after the notification
of the confirmation is received.
34.3.3 Effects
(a) for termination of the Agreement:
The coordinator must — within 60 days from when termination takes effect — submit a periodic
report (for the last open reporting period until termination; see Article 15.3) and a final report
(see Article 15.4).
If the Agreement is terminated for breach of the obligation to submit reports (see Articles 15.8
and 34.3.1(i)), the coordinator may not submit any reports after termination.
If the Agency does not receive the report(s) within the deadline (see above), only costs which
are included in an approved periodic report will be taken into account.
The Agency will calculate the final grant amount (see Article 5.3) and the balance (see
Article 16.4) on the basis of the report(s) submitted. Only costs incurred until termination
takes effect are eligible (see Article 6). Costs relating to contracts due for execution only after
termination are not eligible.
This does not affect the Agency’s right to reduce the grant (see Article 27) or to impose
administrative sanctions (Article 29).
51
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
The beneficiaries may not claim damages due to termination by the Agency (see Article 30).
After termination, the beneficiaries’ obligations (in particular Articles 15, 17, 18, 19, 21, 22,
24, 26, 27 and 28) continue to apply.
(b) for termination of the participation of one or more beneficiaries:
The coordinator must — within 60 days from when termination takes effect — submit a request
for amendment (see Article 39), with a proposal for reallocation of the tasks and estimated
budget of the beneficiary concerned (see Annexes 1 and 2) and, if necessary, the addition of
one or more new beneficiaries (see Article 40). If termination is notified after the period set out
in Article 3, no request for amendment must be submitted unless the beneficiary concerned is
the coordinator. In this case the request for amendment must propose a new coordinator.
The beneficiary concerned must submit to the coordinator:
(i) a technical report and
(ii) a financial statement covering the period from the end of the last reporting period to the
date when termination takes effect.
This information must be included by the coordinator in periodic report for the next reporting
period (see Article 15.3).
If the request for amendment is rejected by the Agency (because it calls into question the
decision awarding the grant or breaches the principle of equal treatment of applicants), the
Agreement may be terminated according to Article 34.3.1(c).
If the request for amendment is accepted by the Agency, the Agreement is amended to
introduce the necessary changes (see Article 39).
After termination, the concerned beneficiary’s obligations (in particular Articles 15, 17, 18, 19,
20, 21, 22, 24, 26, 27 and 28) continue to apply.
SECTION 4 FORCE MAJEURE
ARTICLE 35 — FORCE MAJEURE
‘Force majeure’ means any situation or event that:
- prevents either party from fulfilling their obligations under the Agreement,
- was unforeseeable, exceptional situation and beyond the parties’ control,
- was not due to error or negligence on their part (or on the part of third parties involved in the
action), and
- proves to be inevitable in spite of exercising all due diligence.
The following cannot be invoked as force majeure:
52
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
- any default of a service, defect in equipment or material or delays in making them available,
unless they stem directly from a relevant case of force majeure,
- labour disputes or strikes, or
- financial difficulties.
Any situation constituting force majeure must be formally notified to the other party without delay,
stating the nature, likely duration and foreseeable effects.
The parties must immediately take all the necessary steps to limit any damage due to force majeure
and do their best to resume implementation of the action as soon as possible.
The party prevented by force majeure from fulfilling its obligations under the Agreement cannot be
considered in breach of them.
CHAPTER 7 FINAL PROVISIONS
ARTICLE 36 — COMMUNICATION BETWEEN THE PARTIES
36.1 Form and means of communication
Communication under the Agreement (information, requests, submissions, 'formal notifications', etc.)
must:
- be made in writing and
- bear the number of the Agreement.
Until the payment of the balance: all communication must be made through the electronic exchange
system and using the forms and templates provided there.
After the payment of the balance: formal notifications must be made by registered post with proof
of delivery (‘formal notification on paper’).
Communications in the electronic exchange system must be made by persons authorised according to
the Participant Portal Terms & Conditions. For naming the authorised persons, each beneficiary must
have designated — before the signature of this Agreement — a ‘legal entity appointed representative
(LEAR)’. The role and tasks of the LEAR are stipulated in his/her appointment letter (see Participant
Portal Terms & Conditions).
If the electronic exchange system is temporarily unavailable, instructions will be given on the Agency
and Commission websites.
36.2 Date of communication
Communications are considered to have been made when they are sent by the sending party (i.e. on
the date and time they are sent through the electronic exchange system).
Formal notifications through the electronic exchange system are considered to have been made when
they are received by the receiving party (i.e. on the date and time of acceptance by the receiving party,
53
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
as indicated by the time stamp). A formal notification that has not been accepted within 10 days after
sending is considered to have been accepted.
Formal notifications on paper sent by registered post with proof of delivery (only after the payment
of the balance) are considered to have been made on either:
- the delivery date registered by the postal service or
- the deadline for collection at the post office.
If the electronic exchange system is temporarily unavailable, the sending party cannot be considered
in breach of its obligation to send a communication within a specified deadline.
36.3 Addresses for communication
The electronic exchange system must be accessed via the following URL:
https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/myarea/projects
The Agency will formally notify the coordinator and beneficiaries in advance any changes to this URL.
Formal notifications on paper (only after the payment of the balance) addressed to the Agency must
be sent to the following address:
Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)
Health and Food Safety Unit Health and Food Safety Unit
Drosbach Building
L-2920 Luxembourg
Formal notifications on paper (only after the payment of the balance) addressed to the beneficiaries
must be sent to their legal address as specified in the Participant Portal Beneficiary Register.
ARTICLE 37 — INTERPRETATION OF THE AGREEMENT
37.1 Precedence of the Terms and Conditions over the Annexes
The provisions in the Terms and Conditions of the Agreement take precedence over its Annexes.
Annex 2 takes precedence over Annex 1.
37.2 Privileges and immunities
Not applicable
ARTICLE 38 — CALCULATION OF PERIODS, DATES AND DEADLINES
In accordance with Regulation No 1182/7112, periods expressed in days, months or years are calculated
from the moment the triggering event occurs.
12 Regulation (EEC, Euratom) No 1182/71 of the Council of 3 June 1971 determining the rules applicable to periods, dates
and time-limits (OJ L 124, 8/6/1971, p. 1).
54
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
The day during which that event occurs is not considered as falling within the period.
ARTICLE 39 — AMENDMENTS TO THE AGREEMENT
39.1 Conditions
The Agreement may be amended, unless the amendment entails changes to the Agreement which
would call into question the decision awarding the grant or breach the principle of equal treatment
of applicants.
Amendments may be requested by any of the parties.
39.2 Procedure
The party requesting an amendment must submit a request for amendment signed in the electronic
exchange system (see Article 36).
The coordinator submits and receives requests for amendment on behalf of the beneficiaries (see
Annex 3).
If a change of coordinator is requested without its agreement, the submission must be done by another
beneficiary (acting on behalf of the other beneficiaries).
The request for amendment must include:
- the reasons why;
- the appropriate supporting documents, and
- for a change of coordinator without its agreement: the opinion of the coordinator (or proof that
this opinion has been requested in writing).
The Agency may request additional information.
If the party receiving the request agrees, it must sign the amendment in the electronic exchange system
within 45 days of receiving notification (or any additional information the Agency has requested). If
it does not agree, it must formally notify its disagreement within the same deadline. The deadline may
be extended, if necessary for the assessment of the request. If no notification is received within the
deadline, the request is considered to have been rejected.
An amendment enters into force on the day of the signature of the receiving party.
An amendment takes effect on the date agreed by the parties or, in the absence of such an agreement,
on the date on which the amendment enters into force.
ARTICLE 40 — ACCESSION TO THE AGREEMENT
40.1 Accession of the beneficiaries mentioned in the preamble
The other beneficiaries must accede to the Agreement by signing the Accession Form (see Annex 3) in
the electronic exchange system (see Article 36) within 30 days after its entry into force (see Article 42).
55
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
They will assume the rights and obligations under the Agreement with effect from the date of its entry
into force (see Article 42).
If a beneficiary does not accede to the Agreement within the above deadline, the coordinator must
— within 30 days — request an amendment to make any changes necessary to ensure proper
implementation of the action. This does not affect the Agency's right to terminate the Agreement (see
Article 34).
40.2 Addition of new beneficiaries
In justified cases, the beneficiaries may request the addition of a new beneficiary.
For this purpose, the coordinator must submit a request for amendment in accordance with Article 39.
It must include an Accession Form (see Annex 3) signed by the new beneficiary in the electronic
exchange system (see Article 36).
New beneficiaries must assume the rights and obligations under the Agreement with effect from the
date of their accession specified in the Accession Form (see Annex 3).
ARTICLE 41 — APPLICABLE LAW AND SETTLEMENT OF DISPUTES
41.1 Applicable law
The Agreement is governed by the applicable EU law, supplemented if necessary by the law of
Belgium.
41.2 Dispute settlement
If a dispute concerning the interpretation, application or validity of the Agreement cannot be settled
amicably, the General Court — or, on appeal, the Court of Justice of the European Union — has sole
jurisdiction. Such actions must be brought under Article 272 of the Treaty on the Functioning of the
EU (TFEU).
As an exception, if such a dispute is between the Agency and ‘MINISTRY OF CIVIL AFFAIRS’,
‘MINISTARSTVO ZDRAVLJE’, the competent Belgian courts have sole jurisdiction.
If a dispute concerns administrative sanctions, offsetting or an enforceable decision under
Article 79(2) of the Financial Regulation No 966/2012 and Article 299 TFEU (see Articles 28, 29 and
30), the beneficiaries must bring action before the General Court — or, on appeal, the Court of Justice
of the European Union — under Article 263 TFEU. Actions against enforceable decisions must be
brought against the Commission (not against the Agency).
56
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
Associated with documentCHAFEA MGA — Multi:-v2.1
Ref. Ares(2020)3808356 20/07/2020
ARTICLE 42 — ENTRY INTO FORCE OF THE AGREEMENT
The Agreement will enter into force on the day of signature by the Agency or the coordinator,
depending on which is later.
SIGNATURES
For the coordinator For the Agency
[--TGSMark#signature-955006420_75_210--] [--TGSMark#signature-service_75_210--]
Esteban DE MANUEL KEENOY with ECAS id nmanuees signed in Signed by Veronique WASBAUER with ECAS id wasbave
the Participant Portal on 20/07/2020 at 10:49:19 (transaction id as an authorised representative on 20-07-2020 12:47:00
SigId-125904- (transaction id SigId-126829-
Dj0B2D0JivWZb3E2Mn1N68Yhs0aZXJ2Y6Sfbsk7ONpUnr4agNE4 Bhm5F8hFtv4otUbfw26rCBxCQ7UsSqABUDPVGzOm3AZR
bIEUscFevbPbiIiU1F73BzYp9yiJ3mzGYSa-
jpJZscgsw0KmE9q55QdRE4- pRxlCsSMQeSlOfozYbnFndZkMrT0NzTzzonVeEf4ubW-
YbeV7rG9SG8Vxt2fdf7QSdPdJC3CphBXDzf3oQzLnrwfoB5Zk95w jpJZscgsw0KmE9q55QdRE4-
FAr9lZQkdJiUMQhACY0bFAS5Z34kIP3Aqk). Timestamp by third Fy00MCQtpacLMNHURMxRI0zuwddLHzOeWKZR587iS41
party at PvlMWC4ktIC0EWg2VpJLxO9cyUehRg62bo4zTNaMFbbG)
Mon Jul 20 12:05:49 CEST 2020 Mon Jul 20 12:47:04 CEST 2020
57
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
EUROPEAN COMMISSION
Consumers, Health, Agriculture and Food Executive Agency
(CHAFEA)
The Director
ANNEX 1 (part A)
Project
NUMBER — 951442 — JADECARE
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Table of Contents
1.1. The project summary................................................................................................................................. 3
1.2. The list of beneficiaries..............................................................................................................................4
1.3. Workplan Tables - Detailed implementation..............................................................................................5
1.3.1. WT1 List of work packages........................................................................................................... 5
1.3.2. WT2 List of deliverables................................................................................................................ 6
1.3.3. WT3 Work package descriptions................................................................................................... 7
Work package 1........................................................................................................................... 7
Work package 2......................................................................................................................... 10
Work package 3......................................................................................................................... 17
Work package 4......................................................................................................................... 23
Work package 5......................................................................................................................... 29
Work package 6......................................................................................................................... 33
Work package 7......................................................................................................................... 38
Work package 8......................................................................................................................... 42
1.3.4. WT4 List of milestones................................................................................................................ 46
1.3.5. WT5 Critical Implementation risks and mitigation actions........................................................... 49
1.3.6 WT6 Summary of project effort in person-months........................................................................53
1.3.7. WT7 Tentative schedule of project reviews.................................................................................55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
1.1. The project summary
Project Number 1 951442 Project Acronym 2 JADECARE
One form per project
General information
Project title 3
Joint Action on implementation of digitally enabled integrated person-centred care
Starting date 4 01/10/2020
Duration in months 5 36
Call (part) identifier 6 HP-JA-2019
JA-03-2019
Topic
Joint Action on implementation of digitally enabled integrated person-centred care
Fixed EC Keywords
Integrated care, digitally, original good practices, next adopters, transfer, policy makers,
Free keywords
implementation, pilots,
Abstract 7
The journey of care delivery transformation in Europe is just at the beginning, and the underlying digital health
technologies that will support the transformation of health and care need to be purposefully designed, developed, and
must demonstrate cost-effectiveness potential.
The EU has launched a series of initiatives to support facing these challenges, as the EIP-AHA with actual twinning
amongst partners, various Joint Actions and EU funded projects. Based on this previous work, four early adopters
´ original Good Practice (oGP) were selected to be transferred to other EU countries (next adopters). concerning
integration, chronic conditions, multimorbidities, frail people and patients with complex needs, self-care, prevention
and population health, disease management and case management.
JADECARE intends to reinforce the capacity of health authorities to successfully address important aspects of health
system transformation, in particular the transition to digitally-enabled, integrated, person-centred care and support the
best practice transfer from the systems of the “early adopters” to the ones of the “next adopters”.
JADECARE is focusing on the transfer and adoption of four Good Practices, so-called oGPs: Basque Health strategy
in ageing and chronicity: integrated care, Catalan open innovation hub on ICT-supported integrated care services for
chronic patients, The OptiMedis Model-Population-based integrated care (Germany) and Digital roadmap towards an
integrated health care sector (Denmark).
JADECARE will involve partners from 17 countries all around Europe. providing a complete scenario of the
idiosyncrasy and differences that can be found. The local context, maturity of integrated care models, legal
frameworks, culture/values and relevant leaders are going to be considered for each of the 23 “next adopters”. The
methodology will allow the transference in different contexts: socioeconomic, cultural, legal, models and maturity of
health syst
Page 3 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
1.2. List of Beneficiaries
Project Number 1 951442 Project Acronym 2 JADECARE
List of Beneficiaries
Project Project
No Name Short name Country entry exit
month8 month
ASOCIACIÓN INSTITUTO DE
1 INVESTIGACIÓN EN SERVICIOS DE KG Spain 1 36
SALUD-KRONIKGUNE
Bosnia and
2 MINISTRY OF CIVIL AFFAIRS MCA 1 36
Herzegovina
HRVATSKI ZAVOD ZA JAVNO
3 CIPH Croatia 1 36
ZDRAVSTVO
MINISTERSTVO ZDRAVOTNICTVI
4 MZCR Czech Republic 1 36
CESKE REPUBLIKY
REGION NORDJYLLAND (NORTH
5 RND Denmark 1 36
DENMARK REGION)
6 SOTSIAALMINISTEERIUM MSAE Estonia 1 36
7 EUROMETROPOLE DE STRASBOURG EUSTRAS France 1 36
BEHOERDE FUER ARBEIT,
8 GESUNDHEIT, SOZIALES, FAMILIE UND BAGSFI Germany 1 36
INTEGRATION HAMBURG
4I DIOIKISI YGEIONOMIKIS
9 PERIFEREIAS MAKEDONIAS KAI 4THYPE Greece 1 36
THRAKIS
ALLAMI EGESZSEGUGYI ELLATO
10 AEEK Hungary 1 36
KOZPONT
AGENZIA NAZIONALE PER I SERVIZI
11 AGENAS Italy 1 36
SANITARI REGIONALI
12 NACIONALAIS VESELIBAS DIENESTS NVD Latvia 1 36
LIETUVOS RESPUBLIKOS SVEIKATOS
13 LR SAM Lithuania 1 36
APSAUGOS MINISTERIJA
ADMINISTRACAO CENTRAL DO
14 ACSS Portugal 1 36
SISTEMA DESAUDE IP
15 MINISTARSTVO ZDRAVLJE MoHRS Serbia 1 36
NACIONALNI INSTITUT ZA JAVNO
16 NIJZ Slovenia 1 36
ZDRAVJE
REGIONAL HEALTH AND SOCIAL CARE
17 HSCB United Kingdom 1 36
BOARD
Page 4 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
1.3. Workplan Tables - Detailed implementation
1.3.1. WT1 List of work packages
WP Person- Start End
WP Title Lead beneficiary10
Number9 months11 month12 month13
WP1 Coordination and management 1 - KG 99.00 1 36
WP2 Dissemination 10 - AEEK 69.00 1 36
WP3 EVALUATION 9 - 4THYPE 93.75 1 36
INTEGRATION IN
WP4 NATIONAL POLICIES AND 16 - NIJZ 162.65 1 36
SUSTAINABILITY
BASQUE HEALTH STRATEGY
IN AGEING AND CHRONICITY:
WP5 INTEGRATED CARE GOOD 1 - KG 137.74 1 36
PARCTICE: TRANSFER AND
ADOPTION
CATALAN OPEN INNOVATION
HUB ON ICT-SUPPORTED
INTEGRATED CARE SERVICES
WP6 1 - KG 85.03 1 36
FOR CHRONIC PATIENTS GOOD
PRACTICE: TRANSFER AND
ADOPTION
THE OPTIMEDIS MODEL-
POPULATION BAED
WP7 INTEGRATED CARE GOOD 7 - EUSTRAS 52.20 1 36
PRACTICE: TRANSFER AND
ADOPTION
DIGITAL ROADMAP TOWARDS
AN INTEGRATED HEALTH
WP8 5 - RND 105.48 1 36
CARE SECTOR GOOD PRACTICE
TRANSFER AND ADOPTION
Total 804.85
Page 5 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
1.3.2. WT2 list of deliverables
Due
Deliverable WP Dissemination
Deliverable Title Lead beneficiary Type 15 Date (in
Number14 number9 level16
months)17
D1.1 Project Handbook WP1 1 - KG Report Public 6
D2.1 Leaflet WP2 10 - AEEK Report Public 6
Websites,
D2.2 Project website WP2 8 - BAGSFI patents Public 6
filling, etc.
Dissemination and
D2.3 communication strategy WP2 10 - AEEK Report Public 6
and plan
Final report on
D2.4 WP2 10 - AEEK Report Public 36
Dissemination
Layman of the final
D2.5 WP2 10 - AEEK Report Public 36
report
Impact Assessment
D3.1 WP3 9 - 4THYPE Report Public 9
Plan
Interim Evaluation
D3.2 WP3 9 - 4THYPE Report Public 18
Report
D3.3 Final Evaluation Report WP3 9 - 4THYPE Report Public 36
Local Good Practices
D4.1 WP4 11 - AGENAS Report Public 15
and Action Plans
Blueprint on learning
D4.2 WP4 11 - AGENAS Report Public 35
from Good Practices
Characteristics of
JADECARE practices,
D4.3 leading to sustainability WP4 16 - NIJZ Report Public 36
and integration in
national policies
The Basque integrated
care approach original
D5.1 WP5 1 - KG Report Public 30
Good Practice and
transfer process
The Catalan Innovation
Hub original Good
D6.1 WP6 1 - KG Report Public 30
Practice and transfer
process
The Optimedis Model
D7.1 original Good Practice WP7 7 - EUSTRAS Report Public 30
and transfer process
The Danish roadmap
towards Integrated Care
D8.1 WP8 5 - RND Report Public 30
original Good Practice
and transfer process
Page 6 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
1.3.3. WT3 Work package descriptions
Work package number 9 WP1 Lead beneficiary 10 1 - KG
Work package title Coordination and management
Start month 1 End month 36
Objectives
KG will be the Leading Executive Organisation (LEO) of WP1.
This WP aims at adequately manage and coordinate the project. It will imply the following specific objectives:
-To provide technical, scientific, financial and administrative management and support
-To steer efforts of the partners for the achievement of milestones
-To elaborate a project management handbook defining general procedures for the project management and quality
assurance
-To monitor progress to avoid deviations
-To ensure ethical compliance
-To communicate with CHAFEA and SANTE
-To comply with the CHAFEA rules (financial, legal & administrative issues)
-To organize coordination meetings on a regular basis
Description of work and role of partners
WP1 - Coordination and management [Months: 1-36]
KG, MCA, CIPH, MZCR, RND, MSAE, EUSTRAS, BAGSFI, 4THYPE, AEEK, AGENAS, NVD, LR SAM,
ACSS, MoHRS, NIJZ, HSCB
T1.1: CONSORTIUM OPERATING PROCEDURES DEFINITION & QUALITY ASSURANCE (LEADER: KG,
PARTICIPANTS: ALL) (M1-M36)
KRONIKGUE will elaborate a Handbook for project management and quality assurance. It will include guidelines for
financial reporting, presentation standards for deliverables and reports to CHAFEA, measures to ensure timely reporting,
payment procedures plan and calendar, etc.
The Project Handbook is a quick reference manual for partners to consult management procedures. It will summarize
the Consortium organizational structure, decision-making procedures, the deliverables acceptance procedure, roles and
responsibilities, internal communication policy and quality and risk management procedures. It will provide the project
plans and the project change management plan. It becomes the basis for managing the project throughout its lifecycle
and is an important point of reference for all project members and stakeholders. The Project Handbook will be kept up
to date throughout the life of the project. For deliverables and other documents, it is expected that documents could be
associated to one or more tasks of the project and therefore has one or more contributors. Each deliverable has usually a
main contributor, which is also the partner responsible for the deliverable. This responsibility is always shared with the
WP Leads. All the deliverables must be submitted within the deadlines defined in the project. To guarantee the quality
of the document a reviewer/s will be assigned per each deliverable according to the expertise in the area. The Reviewer
assigned will review the reports and deliverables from each work package and will give feedback and comments in
advance of the submission date of the deliverable. The Lead beneficiary of a deliverable will take into consideration the
feedback from the reviewer and implement changes (if necessary).
Internal communication procedures will be defined in order to achieve the best results on the project execution.
KRONIKGUNE will support the communication between Competent Authorities and WP Leads and co-leaders and
will facilitate the relevant information/results exchange.
Different tools will be developed and updated during the project lifetime: project plans, action lists, risk register, project
stakeholder matrix, internal personnel lists and payment/budget evolution according to the internal and CHAFEA
financial rules.
T1.2: COORDINATION OF THE JA AND DAY-TO-DAY MANAGEMENT (KG, PARTICIPANTS: ALL) (M1-M36)
This task will involve coordination and management of administrative and financial matters, administrative support to
Competent Authorities, submission of high-quality deliverables, project progress monitoring, preparation of periodic
reports and communication with CHAFEA services and Project Officers for purposes of coordination. Kronikgune, as
Joint Action coordinator, will be in charge of this task supported by the rest of the involved parties in the project. The
Page 7 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
official Periodic Reporting Document will be submitted to CHAFEA in M18 and M36. The management structure and
progress monitoring of the Joint Action is described in depth in Section 9.
T1.3: CONSORTIUM MEETINGS (LEADER: KG, PARTICIPANTS: ALL) (M1-M36)
Consortium meetings will be held in a location with good access, contributing to keep transportation costs as low as
possible. The following set of meetings is foreseen:
-KICK-OFF MEETING: this first meeting will take place at the start of the project (M1).
-CONSORTIUM MEETINGS: consortium meetings will take place to ensure that the project is being properly carried
out, and to provide relevant guidelines (first meeting at M12-M13, second meeting at M24-M26 and third meeting at
M34-M36).
-FINAL CONFERENCE: at the end of the project, the final conference will take place in order to present the project
results and outcomes. All partners and EC representatives will be invited to these meetings.
-POLICY LEVEL MEETINGS: will be convened annually.
-MANAGERIAL VIRTUAL MEETINGS: Kronikgune will led dedicated teleconferences at convenience with
Competent Authorities, every 2 months approximately.
-TECHNICAL VIRTUAL MEETINGS: teleconferences between Kronikgune and WP Leads, co-leaders and task
leaders will be held every two weeks in order to monitor the technical aspects of WPs. Face-to-face meetings will be
held during consortium meetings.
T 1.4 ETHICAL MANAGEMENT (LEADER: KG, PARTICIPANTS: ALL) (M1-M36)
This activity will provide ethical oversight, analysis, and guidance on all aspects of the JA.
Task 1.4 will deal with ethical values, moral principles and social rules form the basis of social life as well as national
laws, regarding the whole provision of integrated care (change of model and service) and use of ICT tools, from a
holistic point of view: patients, healthcare professionals, carers or others.
T1.5. LEGAL MANAGEMENT (LEADER: KG, PARTICIPANTS: ALL) (M1-M36)
This task will deal with all contractual and other legal issues related to the Joint Action, which will primarily focus on
partnership management and formalization of updates of the work plan, roles and resources assignments as needed. In
particular, it will comprise Grant Agreement and Consortium Agreement implementation and amendments, support to
partners in legal issues, production of non-disclosure agreements.
MILESTONES
M1: Kick-off meeting (LB & LEO: KG) (M1)
M2: Periodic technical and financial report (LB & LEO: KG) (M18)
M3: Final technical and financial report (LB & LEO: KG) (M36)
Participation per Partner
Partner number and short name WP1 effort
1 - KG 67.00
2 - MCA 2.00
3 - CIPH 2.00
4 - MZCR 2.00
5 - RND 2.00
6 - MSAE 2.00
7 - EUSTRAS 2.00
8 - BAGSFI 2.00
9 - 4THYPE 2.00
10 - AEEK 2.00
11 - AGENAS 2.00
12 - NVD 0.00
Page 8 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Partner number and short name WP1 effort
CCUH 2.00
13 - LR SAM 2.00
14 - ACSS 2.00
15 - MoHRS 2.00
16 - NIJZ 2.00
17 - HSCB 2.00
Total 99.00
List of deliverables
Due
Deliverable
Deliverable Title Lead beneficiary Type 15
Dissemination level 16 Date (in
Number14
months)17
D1.1 Project Handbook 1 - KG Report Public 6
Description of deliverables
D1.1 : Project Handbook [6]
LB & LEO KG Will describe the consortium structure, roles and responsibilities, internal communication procedures,
quality assurance (for example, deliverable review process), activities monitoring, risk and issues management and
decision-making procedures, becoming the basis for managing and monitoring the project throughout its lifecycle.
Schedule of relevant Milestones
Due
Milestone
Milestone title Lead beneficiary Date (in Means of verification
number18
months)
Kick off meeting (LB & LEO:
MS1 Kick-off meeting 1 - KG 1
KG)
Periodic technical and
Periodic technical and
MS2 1 - KG 18 financial report sent to
financial report
CHAFEA (LB & LEO: KG)
Final technical and financial
Final technical and financial
MS3 1 - KG 36 report sent to CHAFEA (LB
report
& LEO: KG)
Page 9 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Work package number 9 WP2 Lead beneficiary 10 10 - AEEK
Work package title Dissemination
Start month 1 End month 36
Objectives
SU-HSMTC will be the Leading Executive Organization (LEO) of WP2 and BAGSFI the Co-Leading Executive
Organization.
The overall objective of Work Package 2 is to disseminate high quality information on Joint Action Digital Care
deliverables and progress to contribute to the development of a sustainable mechanism of advancing/providing high
quality services of integrated care in Europe. The work starts with initial communication activities to position the
JA on the EU landscape, generate recognition and understanding of the project goals and ambitions. This general
communication serves attracting key stakeholder groups listed in chapter 3, especially patients and their families and
employers, as well as health workforce and care provider organizations, insurance funds and policy makers. These
stakeholders are the end-users of the digitally enabled care solutions. The goal is to prepare and assist engagement of
stakeholders in the implementation of work packages (mainly WP5-8), not only to share the aims and objectives of the
Joint Action, but to learn the needs of the end-users as well. Among them, patients will be put into the focus in order
to strengthen the patient centered scope of the action. JADECARE will make use of available policy recommendations
and guidance to increase patient empowerment (delivered by other joint actions, e.g. eHAction, or good practices).
Involvement of key stakeholders is essential for the successful identification of real needs and analysation of next
adopters’ ecosystem. Research shall be reached out to be able to showcase existing digital offerings that can be
introduced to the end-users or further developed to meet unmet needs of patients and their care providers and payers.
Outreach to patients will have a special role in preparing and executing pilot actions to assist care provider organizations
and their staff to offer digital integrated health services. Results of patient involvement in the preparation phases (task
5.1, 6.1, 7.1 and 8.1, as well as 5.2, 6.2, 7.2 and 8.2) will be communicated and disseminated too.
Specific dissemination activities will follow to enhance and magnify the results, effect and impact of the common work,
and support the sustainability of best practice transfer and replication. In addition, end-users - especially patients - would
be informed about the results of the pilots in order to help to embed sustainable solutions into next adopters’ health
system and replicate the outcomes.
The specific objectives of the Work Package 2 are:
-To ensure that the results and deliverables of the Joint Action of digitally enabled integrated person-centered care are
known both to general public and the stakeholders.
-To actively identify and engage stakeholders throughout the course of the project in order to ensure that the results of
the project are applicable and appropriate to stakeholders.
-To improve knowledge, capacity and use of the JA methodologies, tools and practices by supporting the work of Work
Package 4 and 5 to 8 with relevant communication and engagement tools
Description of work and role of partners
WP2 - Dissemination [Months: 1-36]
AEEK, KG, MCA, CIPH, MZCR, RND, MSAE, EUSTRAS, BAGSFI, 4THYPE, AGENAS, NVD, LR SAM,
ACSS, MoHRS, NIJZ, HSCB
T2.1 EXTERNAL AND INTERNAL COMMUNICATION PLANS AND EXECUTION (LEADER: SU-HSMTC,
PARTICIPANTS: ALL) (M1-M36)
The task is providing the initial strategy for internal and external communication and dissemination. This document
will give an overview of the aims of the JA dissemination activities as well as setting up guidelines for the principles
and process flow of dissemination for internal project partners: when, who, to whom, how and what partners should
disseminate led, coordinated and regulated by WP2.
The over-arching ambition of the dissemination strategy is to ensure that, by the end of the 3-year timeline of the project,
the relevant European and member state level stakeholder groups will be aware of the results, they will align with and
support the project objectives, and engage in its activities on a sustainable basis. Thus, dissemination should be a vivid
activity and should support multi-stakeholder dialogue on integrated care in order to put the JA in a central position
in the domain of integrated care.
Page 10 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
The strategy is then transferred to action items (actual campaigns, events, workshops, webinars etc. and their timings)
in order to achieve the best impact of the project results.
This activity will organize, implement and coordinate the communication and dissemination actions addressed to make
JA information available to the target audiences. The Communication Plan developed in Task 2.1 will define the type
of activities that should be undertaken to reach the audiences more efficiently and provide the tools for doing so.
The initial dissemination channels have been identified to maximize impact and widespread reach to all target audiences,
at local, national and international levels:
-Website – delivered in T2.3
-Social media accounts (Twitter, Linkedin, YouTube)
-eNewsletter
-Events and webinars – delivered in T2.4
Task 2.1 will generate news items for the website, as well as rich content for the social media accounts, based on the
input and results of the implementation WPs and WP4.
The team will also support the event participation and presentations of the other WPs, as well as report about them in
social media feeds and the website. The content of the newsletter should be a joint effort of the consortium, reflecting
on the actual actions and results of the project.
In order to achieve the best coverage all other WPs should dedicate PM effort towards WP2, and maintain a lively internal
communication and information flow, so that fresh and interesting project results can be relayed towards stakeholders
and wider lay public.
The task will also monitor the quality and impact of the project dissemination by setting targeted KPIs, and following
their development (social media engagement, website visitors, event participation, etc.)
T2.2 VISUAL IDENTITY AND PROMOTIONAL MATERIALS (LEADER: SU-HSMTC, PARTICIPANTS: ALL)
(M1-M36)
As part of the dissemination strategy set out in T2.1 the WP2 team will create the visual identity of the project. After
choosing the final acronym of the project the logo, colors, design elements, font type, brand tool with all the rules
(including the EU rules) will be set and collected into the official House Style.
Once the branding is set promotional materials will be produced: leaflets, handouts, roll up, folders, posters, banners,
infographics. Content of these promotional materials should be aligned with the website narrative, the production of
which should be also a full consortium effort, in order to best articulate the goals and ambitions of the project.
Those project collaterals will be continuously monitored and updated mirroring the evolution and release of the project
results and achievements
T2.3 WEBSITE - (LEADER: ZTG GMBH, PARTICIPANTS: ALL) (M1-M36)
The website is essential to fulfil the overall objectives of Work Package 2. i.e. to disseminate high quality information on
all deliverables of JADECARE and hence to contribute to the development of a sustainable mechanism of advancing/
providing high quality services of integrated care in Europe. Overall:
-It helps to materialize the Communication Strategy for both external and internal communication
-It contributes to the impact of the project branding, press activities and social media
-It mirrors and extends the visual identity: logo, claim, key visual, etc.
-It serves as a central reference point for promotional materials: leaflets, roll up, folders, posters, press releases and
newsletters
-It serves likewise as central reference point for announcing events, stakeholders’ forums etc.
The project website is a focal point of all dissemination activities. It corresponds with all work packages and will provide
information on public events, press/publications etc.
Moreover, project deliverables, methods and tools are provided.
-The website is instrumental to implement the dissemination strategy, which may define specific tasks.
-It has to comply with all project branding (initially a “pre-branded” website may function as placeholder)
-It shares text and visual information with flyers, roll-ups etc. and serves as second level reference of all promotion.
-It serves as gateway for tools and methods that the project makes available, publicly and/or in reserved areas.
-It leverages synergies with social media campaigns, e.g. through a Twitter feed and providing reference information.
-Via partner information slots, Joint Action partners and affiliates can redirect visitors to their own websites.
The website aims to address a broad audience consisting of the general public (people, patients, media etc.) and
professional audiences in health and care as well as in the health and care administrations. Audience specific features
will be established as much as feasible and possible. Minimally, the search facility will allow specifying needs, interests
and stakeholder groups.
Page 11 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Like other dissemination materials, the website will also be adapted and tailored to local (local languages will however
only be supported for parts of the content to keep resources under control), national and European target groups,
including:
-Relevant scientific community
-Policy makers on issues related to healthcare
-Health Policy makers and experts
-Health professionals and other operators
-Municipalities and local health authorities
-Patients
-Carers or other social entities working in the field
-General population
The project website will be an easy to navigate entry point to a project-related repository of information. To fulfil this
task smoothly, these features and requirements – reflecting lessons learned in other projects - will be implemented for
accommodating the publishing and communication needs of JADECARE:
-Balanced, invitational homepage, attracting visitors’ interest for concepts and deliverables
-Careful branding and visualizations to demonstrate the added value of the project)
-Responsive web design, making the website accessible also for mobile devices
-Standard provision of elementary website objects (pages, resources (PDF), news, events, links etc.)
-Repository for resources and deliverables; preparation for fast accessibility
-Social media buttons and an option to display of recent project related tweets
-Efficient search facility, combining full text information and metadata per document
-Structured and simple navigation (no bells and whistles) as established by many large organizations today
To best support the task, technical implementation will build on top of well-established technologies like WordPress to
minimize development efforts. The website will be “responsive” (suitable for mobile as well as desktop devices) and
comply with Web Accessibility guidelines.
For internal communication, mailing lists, internal newsletters, joint calendaring and file sharing will be established.
The definition of the collaboration tools will be fine-tuned ahead of the project and fine-tuned within the first 3 months
of the project activities. Some criteria to be used are:
-Pre-existing knowledge and daily usage
-Extensible (or free) licensing
-Workflow integration
T2.4 EVENT ORGANIZATION, INCLUDING STAKEHOLDER FORUM - (LEADER: LGL, PARTICIPANTS: ALL)
(M1-M36)
Task 2.4 consists of the organization of events, especially the Stakeholders Forum each year and will be conducted by the
affiliated entity “Bavarian Health and Food Safety Authority” (LGL). The forum is intended to facilitate the exchange
of experience between the organizations participating in the Joint Action and relevant stakeholders. Thus, the current
status of the local implementation of best practices, emerging problems, but also further ideas and solutions can be
discussed. For this purpose, time slots for workshops are offered to the entities of WP4 to 8, specifically the next adopters.
Furthermore, there will be the opportunity to bring all participants up to date and to create a common understanding of
the Joint Action. The project management is given the opportunity to review the current implementation of the Joint
Action and to adjust it if necessary. In terms of content, there are links to WP4, task 4.2, so that knowledge transfer
is supported by the workshops mentioned above. As a positive side effect, the exchange is supported by networking
at the Stakeholders Forum.
The main tasks concerning the Stakeholder Forum are, Planning and Organizing the annual Stakeholder Forum,
especially:
-Providing a suitable location and catering
-Inviting participants of the Joint Action in consultation with leader WP1
-Defining the schedule in consultation with leader WP1
-Serving as a contact partner before, during and after the event
-Supporting the knowledge transfer and exchange during the event (time slots for workshops, networking activities)
-Organization of external speakers (as covered by the budget)
-A questionnaire regarding potential optimization potential (e.g. open questions in consultation with leader task 4.2,
event improvement)
Additionally, WP2, task 2.4, will prepare a regular calendar with the most relevant (scientific) events and share them
with partners in advance (publication via the homepage) to facilitate their participation - reminders via email will
Page 12 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
be distributed. Furthermore task 2.4 serves as a contact partner for other WPs in case of questions concerning event
organization.
Depending on the available budget, further events supporting the overall target of WP4, task 4.2 (“knowledge transfer”)
are planned:
-Organization of one workshop implied in WP4.1 at the beginning of the Joint Action (topic: identifying common
principles),
-Organization of one workshop for WP3 in 2021 (topic: preparation of the evaluation design)
-Organization of one workshop for WP4 in 2022 (topic: sustainability and final reporting)
-Organization of the study visits as planned in WP4, task 4.2
-Organization of webinars as required by the leaders of WP (e.g. internal coordination of next adopters).
MILESTONES
M4 - Project slide deck and branded templates (LB: AEEK, LEO:SU-HSMTC) (M3)
M5- Dissemination and communication plan (LB: AEEK, LEO:SU-HSMTC) (M6)
M6- Website launching (LB: BAGSFI, LEO: ZTG GMBH) (M6)
M7- Mid-term report on Dissemination (LB: AEEK, LEO:SU-HSMTC) (M18)
M8 - Final Conference (LB: BAGSFI, LEO: LGL) (M36)
Participation per Partner
Partner number and short name WP2 effort
1 - KG 1.00
FFIS 0.25
FPS 0.75
SCS 0.25
SACYL 1.00
CSFJA 0.25
IDIVAL 0.75
IDIBAPS 1.00
AQUAS 1.00
SMS 0.75
2 - MCA 1.00
ZZJZFBIH 1.00
MHSw-RS 1.00
3 - CIPH 1.00
4 - MZCR 1.00
UHO 1.00
5 - RND 1.00
RSD 1.00
6 - MSAE 1.00
VH 1.00
7 - EUSTRAS 1.00
8 - BAGSFI 1.00
LGL 5.00
Page 13 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Partner number and short name WP2 effort
ZTG-GmBH 5.00
9 - 4THYPE 1.00
AUTH 1.00
10 - AEEK 1.00
SU-HSMTC 19.00
JFDPK 1.00
11 - AGENAS 1.00
PROMIS 1.00
LOMBARDIA 1.00
UMBRIA 1.00
MhH 1.00
MARCHE 1.00
TOSCANA 1.00
ASL NA2 1.00
12 - NVD 1.00
CCUH 1.00
13 - LR SAM 1.00
14 - ACSS 1.00
ENSP/NOVA 1.00
15 - MoHRS 1.00
16 - NIJZ 1.00
ZZZS 1.00
17 - HSCB 1.00
Total 69.00
List of deliverables
Due
Deliverable
Deliverable Title Lead beneficiary Type 15
Dissemination level 16 Date (in
Number14
months)17
D2.1 Leaflet 10 - AEEK Report Public 6
Websites,
D2.2 Project website 8 - BAGSFI patents Public 6
filling, etc.
Dissemination and
D2.3 communication strategy 10 - AEEK Report Public 6
and plan
Final report on
D2.4 10 - AEEK Report Public 36
Dissemination
Page 14 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
List of deliverables
Due
Deliverable
Deliverable Title Lead beneficiary Type 15
Dissemination level 16 Date (in
Number14
months)17
Layman of the final
D2.5 10 - AEEK Report Public 36
report
Description of deliverables
D2.1 : Leaflet [6]
LB: AEEK, LEO:SU-HSMTC Summary presentation of JADECARE project, available in the 17 official languages of
the JADECARE countries.
D2.2 : Project website [6]
LB: BAGSFI, LEO: ZTG GMBH JADECARE dedicated website will have a public part and one accessible only to
the JADECARE participants.
D2.3 : Dissemination and communication strategy and plan [6]
LB: AEEK, LEO:SU-HSMTC Will include the specific communication and dissemination activities planned for
JADECARE. The dissemination and communication strategy will be detailed, including who the target audiences
and key stakeholders are based in the initial ones included in the proposal (Table 1), main topics (oGPs description,
how to transfer to next adopters, changes required in the system for the adoption, expected benefits for patients
and general population, impact envisioned), type of messages adapted to each stakeholder group, means to be
used (website, e-newsletter, social media, stakeholder forum, participation in international and national events and
organization of webinars), timeline (as described in the WP) and the translations into the 17 JADECARE required for
the dissemination materials.
D2.4 : Final report on Dissemination [36]
LB: AEEK, LEO:SU-HSMTC Report with all the dissemination activities developed during the whole project and the
analysis of the impact produced in the target groups.
D2.5 : Layman of the final report [36]
LB: AEEK, LEO:SU-HSMTC The Layman report will describe the background, challenges and overview of the
project, including project's specific objectives, the benefits of the innovative solution implemented, the partners
involved and the impact or results (core part of the report). Te European added value will be presented as well. The
report will be available in the 17 official languages represented in JADECARE countries and will be written for the
general public (to be accessible for all the stakeholders identified in the project).
Schedule of relevant Milestones
Due
Milestone
Milestone title Lead beneficiary Date (in Means of verification
number18
months)
Project slide deck and
Project slide deck and
MS4 10 - AEEK 3 branded templates (LB:
branded templates
AEEK, LEO:SU-HSMTC)
Dissemination and
Dissemination and
MS5 10 - AEEK 6 communication plan (LB:
communication plan
AEEK, LEO:SU-HSMTC)
Website launching (LB:
MS6 Website launching 8 - BAGSFI 6
BAGSFI, LEO: ZTG GMBH)
Mid-term report on Final Conference (LB:
MS7 10 - AEEK 18
Dissemination AEEK, LEO:SU-HSMTC)
Page 15 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Schedule of relevant Milestones
Due
Milestone
Milestone title Lead beneficiary Date (in Means of verification
number18
months)
Final conference of the
MS8 Final Conference 8 - BAGSFI 36 project (LB: BAGSFI, LEO:
LGL)
Page 16 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Work package number 9 WP3 Lead beneficiary 10 9 - 4THYPE
Work package title EVALUATION
Start month 1 End month 36
Objectives
AUTH will be the Leading Executive Organization (LEO) of WP3 and AQUAS the Co-Leading Executive Organization.
WP3 will:
-Provide a methodological framework for assessing the different features of the oGPs adopted to cover the requirements
and expectations.
-Assess the quality and compliance of the project process and stakeholders’ views inclusion and satisfaction
-Perform a systematic appraisal of the quality of the transfer and implementation process, understanding, evaluating
and reporting the experience of adopting oGPs in in heterogeneous next adopter sites.
-Evaluate the reinforcement of the capacity of health authorities to organise and deliver digitally-enabled, integrated,
person-centered care
-Evaluate the transfer the good practices (or their significant elements) from the oGPs to the “next adopters” in terms
of performance, acceptance, satisfaction and sustainability.
Description of work and role of partners
WP3 - EVALUATION [Months: 1-36]
4THYPE, KG, MCA, CIPH, MZCR, RND, MSAE, EUSTRAS, BAGSFI, AEEK, AGENAS, NVD, LR SAM,
ACSS, MoHRS, NIJZ
T3.1 PROJECT PROGRESS MONITORING (LEADER: AQUAS, PARTICIPANTS: ALL) (M1-M36)
This task will provide a systematic assessment of the quality and compliance of the project process and stakeholders’
views on inclusion and satisfaction. This task will oversee the establishment of the monitoring and internal evaluation
plan, which will be responsible for assessing the progress of the project. The main objectives of this task are: a) to verify
the planned implementation of the project and the achievement of the objectives using a comprehensive approach with
quantitative and qualitative methods and b) to provide key information to beneficiaries to correct the limitations detected
and boost the strengths in the development of activities, helping to produce the most valuable outputs and outcomes.
a) Design of the Monitoring and Internal Evaluation Plan, which will include a set of qualitative and quantitative
assessment indicators. These indicators will be output, outcome and process indicators, and will follow the RACER
strategy for SMART objectives. The Monitoring and Internal Evaluation Plan will define general indicators to all WPs
and a set of specific indicators for each WP. The definition of completion, acceptance or no completion criteria for
each indicator will be agreed with WP Leads, as well as the definition of thresholds for measuring the compliance with
process progress for each WP and for the overall project.
b) Ongoing evaluation and reporting activities.This stage includes the development of assessment tools, in order to
analyze project beneficiaries’ satisfaction and their perception in terms of project progress. To achieve this, surveys
(satisfaction of meetings’ participants) and others (interviews, protocols, focus groups, etc.) will be used. There will
be an ongoing share of brief summaries of main results of surveys from meetings and workshops, interviews and key
information to WP Leads and partners with the aim to keep improving stakeholder’s inclusion and satisfaction, as well
as overcoming experienced barriers in a timely manner. .
c) Measurement of project progress. This stage will include the monitoring of the project, with regular collection of
indicators from each WP, observational evaluations and completion of quality forms (collection of data quality process).
The assessment of the data will inform WP Leads and implementers on the development of the tasks in order to boost
strengths and overcome barriers timely, supporting the efficient use of resources, ensuring the needed support is provided
at any time during the project and at all levels.
d) Interim and Final reporting. This stage will produce the Interim Evaluation Report (M20), summarizing activities and
main results from the monitoring and evaluation, stakeholder’s satisfaction and quality forms from M1 to M18 of the
JA, and the Final Evaluation report (M36), with the final results of the monitoring and internal evaluation assessment,
which will include lessons learnt and recommendations.
T3.2 QUALITY ASSURANCE OF IMPLEMENTATION (LEADER: KG, PARTICIPANTS: NEXT ADOPTERS,
AUTH, AQUAS) (M1-M36)
This task is responsible for performing a systematic appraisal of the quality of the transfer and implementation
process, throughout the course of JADECARE, adaptable to the different needs and maturity of the early adopters. The
Page 17 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
main objectives of this task are a) to define an implementation methodology, b) to provide methodological support
to implementation sites during the operational phase, c) to monitor blended local Good Practice and Action Plans
implementation d) to monitor the next adopters’ pilot implementation and e) to analyse the factors that might have
influenced (positively or negatively) the implementation process.
The methodology will follow the next steps:
1) Scope Definition. Selection of elements of the oGPs that will be finally implemented and integrated in each local Good
Practice. Specifically, the core features will be identified (such as target population, risk stratification, care pathways,
patient empowerment and telemonitoring) and prioritized in terms of relevance, local needs, aspirations, leading to next
adopters´ final selection. This selection will consider implementation site´s capabilities and feasibility (needs, maturity
level, project time, resources and funding constraints).
2) Situation analysis. Performance of SWOT analysis to identify the action areas on which the implementation sites
have to focus based on the analysis of internal and external factors. These factors will be program-related (population,
risk stratification, care pathways, patient empowerment, telemonitoring etc.) and implementation-related (leadership,
engagement, institutional involvement, available resources). The SCIROCCO model will be used to recognize the
maturity requirements of oGPs contexts to facilitate the transfer and scaling-up to next adopters.
3) Local Good Practice and Action Plan. The Local Good Practices will be built upon local existing interventions,
will integrate specific features from selected original GP(s) and will describe how the implementation site provides
integrated care to citizens, including the new elements adopted. The Action Plan will produce the blueprint that outlines
the implementation of local Good Practices, will address relevant related issues identified in the SWOT analysis and
will define specific implementation objectives, activities, resources and indicators.
4) Operation phase. Using the Plan-Do-Study-Act (PDSA) method, that aims to facilitate the implementation and testing
interventions. Also, it will ensure the documentation of each step, in order to ensure technical robustness, quality, team
reflection and learning and capture knowledge and learning. Next adopters' implementation will be monitored on this
operation phase and specific templates and procedures will be developed for this purpose.
5) Implementation process analysis. Process progress questionnaires will be sent to implementers. At the same time,
observational evaluation of implementations will be performed. Blended Framework for Implementation Research
(CFIR) will be used to analyze the factors that might have influenced (positively or negatively) the implementation
process.
6) Reporting of the implementation. SQUIRE 2.0 will be used to report the implementation study to enhance the evidence
base and transferability potential.
Kronikgune will be in charge of the methodological support at centralized level. Different actions will be taken to enable
next adopters to perform the activities:
-Workshop at Kick off meeting: the methodology for the scope definition will be explained by Kronikgune
-Workshop at study visits: dedicated sessions led by Kronikgune to present the methodology to perform the SWOT
analysis and to define local interventions and Action Plans.
-Teleconference: to monitor the SWOT analysis planning in each site
-Teleconference: to review the output of the SWOT analysis of each site
-Webinar: to refresh the methodology to define the local interventions and Action Plans
-Teleconference: review the Action Plans of each site
-Workshop at 1st Consortium Meeting: next adopters present their local GP and Action Plan and the methodology of
PDSA cycles is explained by Kronikgune
-Teleconference: to review the planning of the activities (Planning phase of PDSA)
-Sessions during the thematic workshops: next adopters present their learnings and experience during the first months
of the implementation and Kronikgune provides support and coaching if needed
-Webinar: the methodology for implementation experience reporting is explained by Kronikgune
The results of this task will be analyzed and summarized in the interim and final evaluation reports accordingly.
T3.3. IMPACT EVALUATION (LEADER: AUTH, PARTICIPANTS: NEXT ADOPTERS, AQUAS, KG) (M1-M36)
The impact of the Project will be measured at two levels: a) the Joint Action in overall (including impact on external
stakeholders) and b) the next adopters. The former, will be based on the specific objectives:
-To support and reinforce digitally enabled integrated person-centered care (DEIPCC) in 23 European settings with
different degrees of maturity
-To improve next adopters´ digital transformation
-To support the next adopters in facilitating the sustainability of the practice with plans for actions at local/regional/
national level
-To create a community of stakeholders that includes caregivers, healthcare experts, academia, industry, policy makers
and /or general public.
Page 18 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
-To perform a systematic appraisal of the quality of the transfer and implementation process, understanding, evaluating
and reporting the experience of adopting oGPs in heterogeneous next adopter sites.
-Quality, compliance and usefulness
-To improve knowledge and skills of transfer methodologies and tools
It is directly related to WP4, which deeply analyses the impact of the Joint Action at policy level and focuses on GP
sustainability.
Implementation of Good Practices at next adopters’ sites evaluation will based on the SMART objectives and KPIs
identified in the transfer work Packages for each site Action Plan. At next adopters level evaluation will be customized
in each site according to the SMART objectives and key performance indicators of the local Good Practice and Action
Plans defined in the transfer Work Packages (WP 5-8). They will includer general dimensions and digital transformation.
Regarding general dimensions, the KPIs will include:
-scope and degree of adoption of original Good Practices (oGPs),
-specific process, pathway reorganization and change management,
-the involvement and commitment of key stakeholders,
-the implementation experience,
-continuity and sustainability of the practice,
-readiness of the organization to uptake digitalization.
Regarding digital transformation, the KPIs will include:
-digital health system infrastructure;
-risk stratification and data analytics,
-use of technologies including Electronic Health Record, personal health folder and electronic prescription,
-citizen empowerment and use of patient reported data,
-innovation initiatives on integrated care reorganization of care pathways, workforce roles and skills,
-training and research programs,
-access to health services,
-management of change towards digitalization,
-ethical aspects of digitalization.
For the quantification of the aforementioned, a network of stakeholders will be built in each participating country and
their degree of usefulness and acceptance regarding the GP will be measured through questionnaires and interviews and
other evaluation techniques. LIWGs and Work Package leaders will provide this information on the implementation
process via periodic data collection. Surveys of usefulness among patients treated in sites which implemented the GP
in each participating country will be distributed. The customization of the indicators will be framed into transfer WPs
(WP 5-8) during the definition of specific interventions and action to implement.
3.3.1. Definition of the Impact Assessment Plan. During this stage the impact indicators will be identified. Establishing
the general and digital transformation indicators involves their definition (numerator and denominator and time frame)
that provides the evidence that will allow us to determine whether the Local GP objectives have been achieved. The
target levels, according to the SMART objectives will be established. This evaluation will involve a mix of qualitative
and quantitative methods. oGP owners will assist in defining the KPIs. The information that need to be collected and
the collection methods will be identified. Different sources will be used such as:
-Routine project statistics (client records, training registers)
-Management information (project documents and reports)
-National or local health statistics
-Baseline-end line surveys (target group, key informants)
-Semi-structured Interviews (general or key informants)
-Focus groups (discussions with patients, caregivers and healthcare providers)
-Observation (client-provider interactions)
The evaluation in order to assess whether the observed effects can be attributed to the adoption of GP will be designed.
3.3.2 The impact assessment evaluation. I) The data collection. All the questionnaires/surveys will be administered
and the interviews/focus groups will be conducted. All the information gained will be checked in order to assure
their accuracy and will be translated into useable forms for analysis. Ii) The data analysis and reporting. Content (for
qualitative data) or statistical (for quantitative data) analysis will be performed and results will be reported. The oGP
owners will assist in interpretation, understanding, and deployment of experience and extraction of key-learnings
The results of this task will be analyzed and summarized in the interim and final evaluation reports (deliverables D3.2
and D3.3 respectively)
MILESTONES
Page 19 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
M9 Monitoring and Evaluation Plan (LB: 4RTHYPE, LEO: AUTH) (M8)
M10 Implementation strategy in place (LB & LEO: KG) (M9)
M11 Impact Assessment Plan (LB: 4RTHYPE, LEO: AUTH) (M9)
M12 Interim Evaluation ( LB: 4RTHYPE, LEO: AUTH) (M18)
M13 Final Evaluation (LB: 4RTHYPE, LEO: AUTH) (M36)
Participation per Partner
Partner number and short name WP3 effort
1 - KG 10.00
FFIS 1.00
FPS 2.00
SCS 1.00
SACYL 2.00
CSFJA 0.75
IDIVAL 2.00
AQUAS 13.00
SMS 1.00
2 - MCA 0.00
ZZJZFBIH 2.00
MHSw-RS 2.00
3 - CIPH 2.00
4 - MZCR 0.00
UHO 2.00
5 - RND 2.00
6 - MSAE 0.00
VH 2.00
7 - EUSTRAS 2.00
8 - BAGSFI 2.00
9 - 4THYPE 0.00
AUTH 20.00
10 - AEEK 0.00
JFDPK 2.00
11 - AGENAS 0.00
LOMBARDIA 2.00
UMBRIA 2.00
MARCHE 2.00
TOSCANA 2.00
ASL NA2 2.00
12 - NVD 0.00
Page 20 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Partner number and short name WP3 effort
CCUH 2.00
13 - LR SAM 2.00
14 - ACSS 2.00
SPMS 1.00
ENSP/NOVA 2.00
15 - MoHRS 2.00
16 - NIJZ 0.00
ZZZS 2.00
Total 93.75
List of deliverables
Due
Deliverable
Deliverable Title Lead beneficiary Type15 Dissemination level16 Date (in
Number14
months)17
D3.1 Impact Assessment Plan 9 - 4THYPE Report Public 9
Interim Evaluation
D3.2 9 - 4THYPE Report Public 18
Report
D3.3 Final Evaluation Report 9 - 4THYPE Report Public 36
Description of deliverables
D3.1 : Impact Assessment Plan [9]
LB: 4RTHYPE, LEO: AUTH Will include the evaluation framework (objectives, process, output and outcomes
indicators), analysis plan (quantitative and qualitative), data management procedures and templates, responsibilities
and timeline. The evaluation framework will be the same for all the 23 JADECARE next adopters. Project progress
monitoring plan and the methodology for the implementation quality assurance will be included as well. .
D3.2 : Interim Evaluation Report [18]
LB: 4RTHYPE, LEO: AUTH Demonstration of how JADECARE activities are monitored within the project,
including the preliminary evaluation of the KPIs (mainly process indicators) defined in JADECARE and the local
Action Plans. If deviations in indicators achievement are detected, improvement or corrective actions will be
identified.
D3.3 : Final Evaluation Report [36]
LB: 4RTHYPE, LEO: AUTH The final evaluation will include the impact at next adopters’ level. The key
performance indicators of the local Good Practice and Action Plans defined in the transfer Work Packages (WP
5-8) will be analyzed. They will include general dimensions (scope and degree of adoption of oGPs, specific
process, pathway reorganization and change management, the involvement and commitment of key stakeholders,
the implementation experience and continuity and sustainability of the practices, and readiness of the organization
to uptake digitalization) and digital transformation (digital health system infrastructure, risk stratification and data
analytics, use of technologies, citizen empowerment and use of patient reported data, innovation initiatives on
integrated care, reorganization of care pathways, workforce roles and skills and training and research programs,
access to health services, management of change towards digitalization, ethical aspects of digitalization). The final
report will include the assessment of the quality and compliance of the project process and stakeholders’ views on
inclusion and satisfaction, providing lessons learnt and recommendations.
Page 21 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Schedule of relevant Milestones
Due
Milestone
Milestone title Lead beneficiary Date (in Means of verification
number18
months)
Monitoring and evaluation
Monitoring and Evaluation
MS9 9 - 4THYPE 8 plan (LB: 4RTHYPE, LEO:
Plan
AUTH)
Implementation strategy in Implementation strategy in
MS10 1 - KG 9
place place (LB & LEO: KG)
Impact Assessment Plan (LB:
MS11 Impact Assessment Plan 9 - 4THYPE 9
4RTHYPE, LEO: AUTH)
Interim Evaluation ( LB:
MS12 Interim Evaluation 9 - 4THYPE 18
4RTHYPE, LEO: AUTH)
Final Evaluation (LB:
MS13 Final Evaluation 9 - 4THYPE 9
4RTHYPE, LEO: AUTH)
Page 22 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Work package number 9 WP4 Lead beneficiary 10 16 - NIJZ
Work package title INTEGRATION IN NATIONAL POLICIES AND SUSTAINABILITY
Start month 1 End month 36
Objectives
NIJZ will be the Leading Executive Organization (LEO) of WP4 and AGENAS the Co-Leading Executive Organization.
Objectives:
-Identify general principles and individual characteristics of successful implementation of good practices, based on oGPs
-Support exchange of knowledge and experiences of implementation by next adopters including study visits and thematic
workshops
-Support next adopters in a mix-match approach to blend objectives and activities related to core features from different
oGP in one local Good Practice and Action Pla
-Generate recommendations and guidance for uptake of good practices with new knowledge and understanding, based
on the results of implementation by next adopters
-Support next adopters to facilitate the sustainability of the practice by strategy and plans for actions at local/regional/
national level
-Present a potential use of results and deliverables of JADECARE for further building up the capacity of national and
regional authorities to organize and deliver integrated person-centered care including integration in policies
-Deliver guiding material to support the countries scale up of JADECARE results and to support sustainability after
the end of the JADECARE project
Description of work and role of partners
WP4 - INTEGRATION IN NATIONAL POLICIES AND SUSTAINABILITY [Months: 1-36]
NIJZ, KG, MCA, CIPH, MZCR, RND, MSAE, EUSTRAS, BAGSFI, 4THYPE, AEEK, AGENAS, NVD, LR SAM,
ACSS, MoHRS, HSCB
TASK 4.1. IDENTIFY CORE CHARACTERISTICS OF OGPS AND GENERAL PRINCIPLES (LEADER: BAGSFI,
PARTICIPANTS: NEXT ADOPTERS, EARLY ADOPTERS, NIJZ, AGENAS) (M1-M9)
The activities are:
-To facilitate first in depth oGPs presentation, based on the common template prepared by 4.1 (M1, at kick-off meeting),
and assessment of expectations from JA partners (M1, at kick-off meeting, using DELPHI questionnaire)
-To develop the methodology for identification of core features (population approach/data analytics, coordination/
pathways, patient empowerment, IT support, etc.), context characteristics (SCIROCCO Maturity Model) and core
characteristics of implementation process of oGPs (based on CFIR), in alignment with WP3 (M2)
-To identify and analyze core features, context characteristics and core characteristics of implementation process of
the oGPs; the analyses of the oGPs (how they were implemented step-by-step, how problems were resolved etc.) will
provide input to the Deliverables 5.1, 6.1, 7.1 and 8.1.
-To report on general principles of successful implementation, based on oGPs (M9), input to Deliverables 4.1, 4.2 and 4.3
TASK 4.2. KNOWLEDGE EXCHANGE AND GENERATION (BAGSFI, ALL PARTICIPANTS) (M1-M36)
Organize activities to support knowledge exchange and generation including:
-Set up and support learning community, to promote knowledge generation/exchange, to facilitate implementation
(such as organization of webinars, workshops, face-to-face meetings, mentoring from experts, availability of tools and
knowledge resources etc.)
-Prepare structure and templates, organize and report on study visits of next adopters at oGPs sites; the visits will be
organized before local Good Practices and Action Plans are prepared, to share in detail core features, core context
characteristics and core characteristics of implementation and sustainability process of oGPs, as identified in 4.1. The
summary report of the visits (M12) will provide input to Deliverables 4.1.
-Prepare structure and templates of thematic workshops, organized during the implementation phase by next adopters
with the support of WP5-8 leaders and co-leaders, that will also be responsible for reporting. These workshops/
have three key roles: 1) bring visibility to next adopters at local/regional/national level and boost communication
with stakeholders, that are important for the sustainability; 2) intermediate self-evaluation of the progress of the
implementation with a potential to start next PDSA cycle and 3) give structured feedback to the JA leadership regarding
the chosen methods to plan and support implementation. The best timing would be agreed with individual next adopters.
The summary report will be prepared by Task 4.2 (M27) and will provide input to Deliverables 4.2 and 4.3. The
Page 23 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
realization will be carried out collectively by BAGSFI Hamburg and the two affiliated entities Bavarian Health and
Food Safety Authority (LGL) and North Rheine-Westphalia.
TASK 4.3. MERGING ACTION PLANS OF NEXT ADOPTERS’ LOCAL GP (LEADER: AGENAS,
PARTICIPANTS: NEXT ADOPTERS, EARLY ADOPTERS, NIJZ) (M6-M15)
This task will support WP5-8 leaders and next adopters to develop their local Good Practice and Action Plans. The local
Good Practices will describe how the practice to transfer looks like, how they are set up, the locations, the target groups,
the number of citizens/patients covered by each pilot etc.; whereas the local Action Plan will define the concrete actions
(what) needed for the implementation, the responsible actor (who), timeline (when) and the settings (where). For those
next adopters with a mix-match approach adopting core features from more than one oGP, it will coordinate the effort
of putting together (consolidating/blending) the inputs from scope, situation analysis, objectives and implementation
activities of each of the oGP features developed in the respective transfer work package (WP5-8). It will be based on
identified common principles of oGPs (T4.1) and study visits outputs (T4.2), and taking into account transfer Work
Packages tasks 1, 2 and 3 results (WP5-8). The support will include: addressing scope, relevant related issues identified
in the SWOT analysis and identification of specific implementation objectives, activities, resources and indicators.
The special support given to next adopters willing to mix and match different oGP features, identifying problems (gaps,
overlaps and contradictions) and thus aiming for a sound and effective implementation. Special assistance will be
provided already in the scope definition phase and SWOT analysis phase to avoid fragmented processes as conflicting
or duplicate interventions and insuring to provide a unique and effective action plan of the mix-and-match next adopters.
To identify common issues in WP5, 6, 7 and 8 activities by:
-Collecting x.1, x.2, x.3 results (input to Deliverable 4.1)
-Identifying common issues
-Agreeing (with task x.1, x.2, x.3 leaders) on the common issues list (input to Deliverable 4.2) to ensure soundness and
effectiveness of next adopters local implementation action plans and blueprints by:
-Defining the methodology to blend Individual implementation action plans on next adopters’ (input to Deliverable 4.2)
-Exchange the methodology with next adopters and provide on-line support
-Reviewing the proposed action plans by the next adopters and suggesting actions to boost synergies and resolve
problems. Results will be discussed locally, but also in transferability sessions, such as workshops among partners (input
to Deliverable 4.1).
TASK 4.4. RECOMMENDATIONS AND GUIDANCE FOR UPTAKE OF GOOD PRACTICES (LEADER:
AGENAS, PARTICIPANTS: ALL PARTICIPANTS) (M27-M35)
Based on WP5-8 local implementation reports and WP3 outputs, propose recommendations including lessons learnt to:
-Illustrate potential implications and how to support the implementation or the adoption of an identified good practice,
based on CFIR and SQURE 2.0 reports and by collecting and reviewing lessons learnt from WP5-8 and to define
common implementation principles (input to Deliverable 4.2).
-Co-creation (i.e. together with next adopters and with task 4.5) of guidelines and standard operation procedures for good
practice uptake, including core elements to assure scale up and sustainability after the end of the project to guarantee
further implementation at a European level (including sustainability at national or on the local or regional level, together
with task 4.5) - input to Deliverable 4.2.
TASK 4.5. SUSTAINABILITY STRATEGY AND ACTION PLAN OF NEXT ADOPTERS’ PRACTICES (LEADER:
NIJZ, PARTICIPANTS: ALL PARTICIPANTS) (M1 - M35)
The activities are:
-To discuss and define core elements for sustainability with JADECARE partners. These include identification of the
holder of sustainability planning process, what should be sustainable including expected results, assessment of the
context/situation, planning for support of key stakeholders and community. It also addresses the assessment of long-term
stability and flexibility of the holder and the strategic partnerships, the strategic financial planning and the development
of action plan (detailed description for next 1-2 years). The core elements for sustainability will be input to Deliverable
4.3.
-To assure that elements of sustainability are addressed in analyses of individual original GPs.
-To assure that elements of sustainability are addressed in individual implementation action plans, during the
implementation and in individual implementation reports.
-To facilitate establishment and collaboration among next adopters and key stakeholders identified to be important
to assure sustainability as local/regional/national networks, aligned with activities of 4.2, 4.4 and 4.6. Patients’
representative organizations and representatives of healthcare professionals will be obligatory members of local
implementation working groups and/or of the local/regional/national networks, depending on the focus of the next
adopter’s practice.
Page 24 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
-To support development of sustainability strategy and action plan via templates, provided by NIJZ. Next adopters will be
the driving forces of the process and the final elaboration of sustainability strategy and action plan, that will be finalized
during workshop/focus group/policy dialogue in the reporting period. The results will give input into Deliverable 4.3.
-To prepare a summary report with core findings, that is an input to Deliverable 4.3.
TASK 4.6 POLICY BOARD (LEADER: NIJZ, PARTICIPANTS: ALL PARTICIPANTS) (M1-M36)
The aims of the policy board are to support successful design and implementation of local Good Practices in next
adopters from the focus of sustainability, to further reinforce capacities of national and/or regional care authorities to
organize and deliver integrated person centered care based on lessons learnt, including integration in policies, and to
co-create EU added value of the JADE CARE.
Policy board has therefore two main advisory roles: 1. alignment of local Good Practices to national, regional and/
or local policies, strategies, plans and/or program, such as the broader context of legal framework, potential political/
policy support, funding stability, strategic partnerships and strategic planning and to national, regional and/or local
leadership; 2. Identifying and building up potential EU added value of JADECARE such as implementing EU legislation,
achieving economies of scale, promoting best practice, benchmarking for decision making, considering cross-border
threats, fostering movement of people and/or networking. Policy Board discussions in the format of Policy dialogues
will address ways to reinforce the capacity of health authorities to successfully address the health system transformation,
in particular the transition to digitally-enabled, integrated, person-centred care.
Members of the policy board: all competent authorities of JADECARE that are MoHs, national focal points for Health
Programme at EC (or other representatives of MSs identified by them) from those MSs from EU and EEA that do
not participate in JADECARE, representative of DG Sante and CHAFEA, and all other policy-oriented stakeholder
that implementers will find at their sustainability-related analyses as important, such as Statutory Health Insurance in
Bismarckian health systems. First membership list will be available by M3, and will be kept open, since competent
authorities and next adopters may identify important policy-level stakeholders to be invited during development
and implementation of the activities. However, maximum number of members should not exceed 32. Members of
Policy Board from countries of next adopters will include local/regional/national networks (see Task 4.5), and will
participate during the process and the final elaboration of local Good Practice sustainability strategy and action plans
by participating in the respective workshop/focus group/policy dialogue, that will be held during reporting period. An
obligatory element of sustainability strategy and action plan will be the potential integration of JADECARE results into
country’s policy. Action plans will specifically detail how the involved MS could contribute/support sustainability and
could potentially integrate the results of the projects in their national/regional policies, as appropriate, including visibility
of European Union co-funding and potential institutions outside JADECARE (EIT HEALTH, other Member states,
International Organizations…)". Core messages to support evidence-based policy making with respect to sustainability
of JADECARE result will be an input to Deliverable 4.3.
Policy Board will be led by NIJZ with support of AGENAS/MoH Italy; secretariat will be provided by NIJZ. Operating
procedures will be prepared by NIJZ and /MoH Italy by the first meeting in M9-M12, when needs assessment from
the perspective of members of policy board will be performed by NIJZ. Policy board will meet three times as face to
face meetings.
MILESTONES
M14 General principles of successful implementation described (LB & LEO: BAGSFI) (M9)
M15 Summary reports from study visits at oGPs sites finalized (LB & LEO: BAGSFI) (M10)
M16 Common issues from needs and scope (x.1), situation analysis (x.2), interventions and actions (x.3) identified (LB
& LEO: AGENAS) (M15)
M17 Summary report from meetings of policy board (LB & LEO: NIJZ) (M36)
Participation per Partner
Partner number and short name WP4 effort
1 - KG 3.00
FFIS 1.00
FPS 2.00
SCS 1.00
Page 25 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Partner number and short name WP4 effort
SACYL 2.00
CSFJA 1.00
IDIVAL 2.25
IDIBAPS 2.00
SMS 1.00
2 - MCA 3.00
ZZJZFBIH 2.00
MHSw-RS 2.00
3 - CIPH 1.40
4 - MZCR 4.00
UHO 2.00
5 - RND 4.00
RSD 3.00
6 - MSAE 3.00
VH 2.00
7 - EUSTRAS 3.00
8 - BAGSFI 5.25
LGL 2.25
ZTG-GmBH 2.75
9 - 4THYPE 4.00
10 - AEEK 5.00
JFDPK 2.00
11 - AGENAS 18.25
LOMBARDIA 2.00
UMBRIA 2.00
MhH 3.00
MARCHE 2.00
TOSCANA 2.00
ASL NA2 2.00
12 - NVD 0.00
CCUH 4.00
13 - LR SAM 4.00
14 - ACSS 2.75
SPMS 1.00
ENSP/NOVA 1.75
15 - MoHRS 4.00
Page 26 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Partner number and short name WP4 effort
16 - NIJZ 43.00
ZZZS 2.00
17 - HSCB 3.00
Total 162.65
List of deliverables
Due
Deliverable
Deliverable Title Lead beneficiary Type15 Dissemination level16 Date (in
Number14
months)17
Local Good Practices and
D4.1 11 - AGENAS Report Public 15
Action Plans
Blueprint on learning
D4.2 11 - AGENAS Report Public 35
from Good Practices
Characteristics of
JADECARE practices,
D4.3 leading to sustainability 16 - NIJZ Report Public 36
and integration in
national policies
Description of deliverables
D4.1 : Local Good Practices and Action Plans [15]
LB & LEO:AGENAS Comprehensive description of the local Good Practices of each pilot (how the practice to
transfer looks like, how they are set up, the locations, the target groups, the number of citizens/patients covered by
each pilot etc.) and the local Action Plans will be documented. The outputs from the scope definition and the situation
analysis (WP5-WP8) will be key for Good Practice and Action Plans definition. The next adopters following the
mix-match approach will describe their local Good Practice and Action Plan with input coming from more than one
transfer WP.
D4.2 : Blueprint on learning from Good Practices [35]
LB & LEO: AGENAS Guidelines and operation procedures for JADECARE good practice transfer, including core
elements to assure scale up and sustainability after the end of the project. This document will support good practice
transfer beyond JADECARE.
D4.3 : Characteristics of JADECARE practices, leading to sustainability and integration in national policies [36]
LB & LEO: AGENAS Description of characteristics of JADECARE, that facilitate sustainability and integration into
(national) policies. How JADECARE has helped Member States to support and reinforce their capacity for digitally
enabled patient centered integrated care will be included.
Schedule of relevant Milestones
Due
Milestone
Milestone title Lead beneficiary Date (in Means of verification
number18
months)
General principles of
General principles of
successful implementation
MS14 successful implementation 8 - BAGSFI 9
described (LB & LEO:
described
BAGSFI)
Page 27 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Schedule of relevant Milestones
Due
Milestone
Milestone title Lead beneficiary Date (in Means of verification
number18
months)
Summary reports from study
Summary reports from study
MS15 8 - BAGSFI 10 visits at oGPs sites finalized
visits at oGPs sites finalized
(LB & LEO: BAGSFI)
Common issues from needs
Common issues from needs
and scope (x.1), situation
and scope (x.1), situation
MS16 11 - AGENAS 15 analysis (x.2), interventions
analysis (x.2), interventions
and actions (x.3) identified
and actions (x.3) identified
(LB & LEO: AGENAS)
Summary report from
Summary report from
MS17 16 - NIJZ 36 meetings of policy board (LB
meetings of policy board
& LEO: NIJZ)
Page 28 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Work package number 9 WP5 Lead beneficiary 10 1 - KG
BASQUE HEALTH STRATEGY IN AGEING AND CHRONICITY: INTEGRATED
Work package title
CARE GOOD PARCTICE: TRANSFER AND ADOPTION
Start month 1 End month 36
Objectives
KG will be the Leading Executive Organization (LEO) of WP5 and AUTH the Co-Leading Executive Organization.
The main objectives of WP5 are:
-To select the core features of the oGP that next adopter´s will work on.
-To perform the situation analysis and define the strategic actions of next adopters
- To define the specific interventions and actions that will be transferred to next adopters.
-To facilitate and support the transfer of oGP features to next adopters´ context.
Description of work and role of partners
WP5 - BASQUE HEALTH STRATEGY IN AGEING AND CHRONICITY: INTEGRATED CARE GOOD
PARCTICE: TRANSFER AND ADOPTION [Months: 1-36]
KG, MCA, CIPH, MZCR, RND, MSAE, 4THYPE, AGENAS, LR SAM, ACSS, MoHRS
TASK 5.1. NEEDS AND SCOPE DEFINITION (LEADER: KG, PARTICIPANTS: NEXT ADOPTERS, AUTH) (M1-
M3)
Next adopters will have the opportunity to know better the original GP (oGP) in a dedicated workshop during the
Kick off meeting by month 1 (T4.1). First, Kronikgune will explain the methodology for the scope definition which
is mainly delimited by selecting the features of the intervention that will be finally implemented. Then, following this
methodology, Kronikgune will describe in depth the core features of the oGP implemented in the Basque Country
that are structural and functional integration of health organizations, integrated care pathways in routine practice,
eHealth strategy and patient empowerment approach (classification according to health literacy, provision of appropriate
empowerment services and empowerment assessment). Elements of sustainability will be stressed out at all aspects.
Next adopters will pre-select the core features in which they are initially interested in. Moreover, Kronikgune will
provide a detailed description of the oGP and how it was implemented step-by-step in the Basque Country (resources
and capabilities needed, barriers and facilitators, how problems were resolved etc.) in D5.1.
Then, at next adopter´s site, local teams (including patients ‘perspective), depending on their needs, expectations,
strategic objectives, real possibilities and existing local interventions, will choose the final core features by month 3.
Kronikgune will support next adopters during this process if required.
TASK 5.2. SITUATION ANALYSIS (LEADER: AUTH, PARTICIPANTS: NEXT ADOPTERS, KG) (M4-M7)
Study visits will be organized in order to provide next adopters with the possibility to acquire deep knowledge on specific
aspects of the oGP and establish close contact with the stakeholders involved in the oGP implementation (T4.2). Core
features, context characteristics using the Scirocco Maturity Model and the implementation process based on CFIR will
be analyzed and shared by stakeholders of the Basque Country during the study visit. Elements of sustainability will
be highlighted as crucial aspects to be considered for the transfer and adoption. This analysis will help next adopters
in understanding the requirements for adoption.
During the study visit Kronikgune will have a dedicated session to explain the SWOT analysis (what it is, how to
perform, stakeholders needed, templates provided). Next adopters will have the opportunity to test the methodology
so the procedures are clear to replicate at home with their local teams. In addition, Kronikgune will introduce the
methodology for interventions and actions definition.
Next adopters will perform a SWOT analysis at their site. Before the SWOT meeting with their teams, next adopters will
participate in a webinar organized by AUTH, together with Kronikgune. The aim of this virtual meeting is to support
next adopters in SWOT analysis planning.
Then, next adopters will perform the SWOT analysis related to the selected core feature(s) of the oGP. The dimensions
of the Scirocco Maturity Model that were considered relevant for the implementation by the stakeholders of the Basque
Country during the study visit will be considered as well. Two perspectives will be studied in the SWOT: original GP-
related and local implementation-related. The former can include examples of existing assets related to the oGP features
to be adopted such as existing data bases and ICT infrastructure, trained staff or positive results in health outcomes of
Page 29 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
integrated care pilots. The latter can include examples such as existence of resources, information systems or leadership
(clinical professionals and managers promote the integrated care approach).
The SWOT analysis output will provide next adopters with a clear view of their improvement areas, priorities and
the strategic action required for planning the implementation and its sustainability. The SWOT analysis shall deliver
information on needs and the readiness of the next adopters’ key stakeholders for transferring knowledge, solutions,
experiences and learnings into their ecosystem regarding the core features of the oGP; potential barriers preventing the
next adopters to prepare, implement, maintain and replicate the transfer, including ranking the barriers by their impacts,
strength and resources required to eliminate them; gaps that might not be covered by the transfer from the specific oGP
to the next adopters’ ecosystem or potential areas of transfer from other oGPs to cover the identified gaps. Next adopter
and AUTH will jointly review the SWOT output in a webinar. It might happen that the SWOT affects to the scope
definition, so an iterative process can be envisioned.
TASK 5.3. SPECIFIC INTERVENTIONS AND ACTIONS (LEADER: AGENAS, PARTICIPANTS: NEXT
ADOPTERS, KG, AUTH, AQUAS, NIJZ) (M8-M10)
A virtual meeting will be organized by Kronikgune in order to refresh the methodology for interventions and actions
definition introduced in the study visits. Kronikgune will be responsible for leading the webinar and providing guidelines
and templates.
Local teams, based on the scope, improvement areas and strategic actions, will (i) set up concrete objectives, (ii)
define activities to reach the previous objectives (called “Change Package”) (iii) specify Key Performance indicators
(process or health-related) based on WP3 and WP4 guidelines and (iv) plan activities to support sustainability. If a given
next adopter is interested in implementing the Basque patient empowerment programme for multimorbid patients, the
adaptation of the programme to the new context is needed. The example of objective, activity and indicators is provided
below:
-Objective: to design an effective and sustainable empowerment programme
-Activity: create a multidisciplinary working group including all stakeholders ensuring that all perspectives are covered
(nurses of primary care and hospital, researchers, patients and patient´s relatives, health managers)
Indicators:
-No of primary care nurses involved
-No of hospital nurses involved
-No of researchers involved
-No patients involved
-No of patient´s relatives involved
-No of health managers involved
Next adopters will be supported by AGENAS, AUTH, AQuAS, NIJZ and Kronikgune.
Then, next adopters will virtually share and review their local interventions and actions with AGENAS and Kronikgune
by month 10 to make any refinement if needed.
The next adopters who have selected core features from more than one oGP (mix and match strategy will blend the
interventions and action from different transfer WPs. This task will be led by AGENAS as T4.3 leader. At the end, all
next adopters, irrespective of the transfer strategy chosen, will define their local GP (lGP)and Action Plan.
During the annual Consortium Meeting by month 12, next adopters will present their local GP and Action Plans in a
dedicated session. Discussion will be encouraged specially to analyse GP and Action Plans from ambition, feasibility and
sustainability perspectives. This session will be supported by AGENAS and NIJZ as T4.3 and T4.5 leaders, respectively.
During the annual Consortium Meeting Kronikgune will explain the PDSA methodology. Next adopters will actively
participate to ensure that the methods and procedures are clear and allow them to start with the implementation.
TASK 5.4. IMPLEMENTATION (LEADER: KG, PARTICIPANTS: NEXT ADOPTERS, AGENAS, AUTH) (M13-
M36)
Next adopters will extend and develop the previously defined Action Plan with a more detailed planning of the
activities and defining concrete actors (who), functions and roles (what), timeframe (when) and setting (where). They
will share the planning with Kronikgune in a dedicated teleconference to guarantee that everything is in place. Then,
implementation will start, and specific interventions will roll out based on PDSA. Next adopters will complete at least
one PDSA cycle and will commit to promote the implementation beyond the Joint Action via refined sustainability plan.
During the first months of the implementation (month 15-18), a maximum of three thematic workshops/study visits
(T4.2) will be organized at three next adopter sites. Each workshop will focus on a limited number of specific
core features. For example, (i) Risk stratification approach, (ii) Integrated care and Health strategy and (iii) Patient
empowerment. The role of the thematic workshop/study visit is also a) to bring visibility to next adopters at
Page 30 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
local/regional/national level & boost communication with stakeholders, that are important for the sustainability, b)
intermediate (self-) evaluation of the progress of the implementation with a potential to start next PDSA cycle, c)
give structured feedback to the JA leadership regarding the chosen methods to plan and support implementation. The
summary report of all thematic workshops/study visits at next adopters’ site will be prepared by Task 4.2, based on
the reports of next adopters.
Next adopters will attend the thematic workshops in which the core features they selected are discussed. These
workshops will be a great scenario to share learning and experiences between stakeholders involved in the
implementation of a given core feature in Basque Country and the local teams of next adopters.
During the implementation, Kronikgune will schedule monthly teleconferences to closely monitor the progress of next
adopters. Kronikgune will support and coach implementers.
After the 12-month implementation, next adopters will report the whole implementation experience using the SQUIRE
2.0 tool. Kronikgune will support next adopters in the report development. This report will contain specific elements
regarding local GP sustainability beyond the Joint Action. In the last annual Consortium Meeting (month 30
approximately), next adopters will present their implementation report to (i) share their experience and learning and (ii)
collect feedback from partners that will help refining the final report.
MILESTONES
M18 Complete scope definition of the WP5 implementation sites (LB & LEO: KG) (M3)
M19 Complete situation analysis (SWOT) of the WP5 implementation sites (LB: 4RTHYPE, LEO: AUTH) (M7)
M20 Define specific interventions and action, for all WP5 implementation sites (LB & LEO: AGENAS) (M10)
M21 Implementation started (LB & LEO: KG) (M15)
Participation per Partner
Partner number and short name WP5 effort
1 - KG 13.00
FPS 5.00
CSFJA 1.00
2 - MCA 0.00
ZZJZFBIH 7.00
3 - CIPH 2.80
CHIF 2.00
4 - MZCR 0.00
UHO 5.34
5 - RND 7.50
6 - MSAE 0.00
VH 4.60
9 - 4THYPE 15.00
AUTH 3.00
11 - AGENAS 3.00
UMBRIA 14.00
TOSCANA 14.00
13 - LR SAM 7.50
14 - ACSS 8.00
SPMS 4.00
Page 31 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Partner number and short name WP5 effort
ENSP/NOVA 6.00
15 - MoHRS 15.00
Total 137.74
List of deliverables
Due
Deliverable
Deliverable Title Lead beneficiary Type15 Dissemination level16 Date (in
Number14
months)17
The Basque integrated
care approach original
D5.1 1 - KG Report Public 30
Good Practice and
transfer process
Description of deliverables
D5.1 : The Basque integrated care approach original Good Practice and transfer process [30]
LB & LEO: KG This deliverable will document: -The description of the “Basque integrated care approach” oGP,
including: main blocks and core features identified in Task 4.1, the implementation requirements and process,
barriers found and solutions identified, lessons learnt and recommendations and the present situation of the oGP. -The
implementation process of the “Basque integrated care approach” in each next adopter´s site will be described: how
it started, who was involved, who was “coached”, how the original practice was adapted, which of its elements were
chosen, what other elements were added and from where, resources and capabilities needed, technology required,
barriers and facilitators and how elements needed for local GP sustainability have been tackled.
Schedule of relevant Milestones
Due
Milestone
Milestone title Lead beneficiary Date (in Means of verification
number18
months)
Complete scope definition of
Complete scope definition of
MS18 1 - KG 3 the WP5 implementation sites
the WP5 implementation sites
(LB & LEO: KG)
Complete situation analysis
Complete situation analysis
(SWOT) of the WP5
MS19 (SWOT) of the WP5 9 - 4THYPE 7
implementation sites (LB:
implementation sites
4RTHYPE, LEO: AUTH)
Define specific interventions
Define specific interventions
and action, for all WP5
MS20 and action, for all WP5 11 - AGENAS 10
implementation sites (LB &
implementation sites
LEO: AGENAS)
Implementation started -WP5
MS21 Implementation started -WP5 1 - KG 15
(LB & LEO: KG)
Page 32 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Work package number 9 WP6 Lead beneficiary 10 1 - KG
CATALAN OPEN INNOVATION HUB ON ICT-SUPPORTED INTEGRATED CARE
Work package title SERVICES FOR CHRONIC PATIENTS GOOD PRACTICE: TRANSFER AND
ADOPTION
Start month 1 End month 36
Objectives
IDIBAPS will be the Leading Executive Organization (LEO) of WP6 and AEEK the Co-Leading Executive
Organization.
The Catalan Open Innovation Hub is conceived to serve the entire population of Catalonia (ES), 7.6M citizens. The
target group is chronic patients with focus on multimorbidity management and on patients with complex health and
social care needs. Accordingly, it encompasses both vertical (specialized vs. community-based care) and horizontal
(healthcare vs. social support) integrations, combining a population-health orientation with a collaborative adaptive case
management approach. The Catalan oGP has a two fold objectives:
(i) To foster cross-country transferability of fully adopted achievements at Catalan level, contributing to a collaborative
European network aiming to promote generation, deployment and evaluation of digitally-supported innovative health
services
(ii) To further consolidate regional implementation of ongoing specific key and singular levers of change in Catalonia
In order to efficiently organize transferability to next adopters, we have identified five well-defined blocks with high
potential for implementation by next adopters, as well as specific actions within each of them, as indicated below, in
T6.1:
1. Health risk assessment: population-based and enhanced clinical decision making (Block 1)
2. Promotion of healthy life styles (Block 2)
3. Vertical and Horizontal integration experiences adopted in Catalonia (Block 3)
4. Innovative assessment and regulatory aspects of digitally-supported integrated care services (Block 4)
5. Digital support of integrated care services (Block 5)
Description of work and role of partners
WP6 - CATALAN OPEN INNOVATION HUB ON ICT-SUPPORTED INTEGRATED CARE SERVICES
FOR CHRONIC PATIENTS GOOD PRACTICE: TRANSFER AND ADOPTION [Months: 1-36]
KG, MZCR, MSAE, AEEK, AGENAS
TASK 6.1. NEEDS AND SCOPE DEFINITION (LEAD: IDIBAPS, PARTICIPANTS: NEXT ADOPTERS, AEEK)
(M1-M3)
The Catalan oGP evolves fully aligned with the Chronic Care Program formulated and executed within the Catalan
Health Plan 2016-2020 from the Dept of Health, Generalitat de Catalunya, the regional government. The Catalan
oGP articulates an extensive network of organizations (governmental, private non-profit and private for-profit) holding
contracts with the single public payer (CatSalut). They show different profiles and degrees of participation in the
initiative. IDIBAPS plays an umbrella role coordinating their participation into the JADEIPCC, with full alignment with
the Catalan Dept of Health. It is of note that the RIS3CAT project Nextcare 2016-2019 (http://www.nextcarecat.cat/)
has played a seminal role in the Catalan oGP by generating synergies between several innovation initiatives and fully
adopted practices.
Specific features, by Blocks, offered by the oGP to be considered by next adopters in the implementation sites are:
-Block 1: (i) Population-based risk stratification tool (GMA, adjusted-morbidity groups, incorporating progressively
additional clinical variables and data on social determinants); (ii) Health data management strategy (Catalan Health
Surveillance System, CHSS); and, (iii) Enhanced multilevel clinical risk assessment strategy.
-Block 2: (i) Pre-habilitation program with a trimodal approach (Physical Activity/Exercise; Nutritional balance; and,
Mindfulness); and, (ii) Comprehensive rehabilitation for chronic patients.
-Block 3: Successful deployments encompassing vertical and horizontal integration experiences adopted by different
providers. Selected cases are: (i) Programme for complex chronic and frail patients; (ii) Complex patient management
linking tertiary care and community; (iii) Healthcare support programmes for nursing homes; and, (iv) Integrated care
for admission avoidance of subacute and frail patients.
Page 33 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
-Block 4: (i) Practicalities of the evaluation framework reported by Baltaxe ; (ii) Regulatory aspects associated with
patient’ self-tracking biological data, PROMS/PREMS through the Catalan Personal Health Folder (La Meva Salut,
opened to caregivers in patients with severe disability/cognitive impairment); and, (iii) Differential regulatory aspects
of health data management for quality assurance and for research purposes (PADRIS program), respectively.
-Block 5: Includes fully adopted digital tools supporting services at regional level, such as: (i) Shared regional health
record (HC3); (ii) Personal Health Folder (La Meva Salut); and, (iv) Electronic prescription, as well as current
deployment of enhanced digital transformation initiatives under the SISCAT program (2019 -2024), including cloud-
based strategies, collaborative adaptive case management tools, unified care plan across healthcare tiers/provider for
complex chronic patients, etc. The rationale formulated by Baltaxe will be proposed as a methodological approach.
Next adopters will have the opportunity to know better the Catalan GP in a dedicated workshop, organised by Task
4.1 and oGPs, during the Kick off meeting by month 1. First, Kronikgune will explain the methodology for the scope
definition which is mainly delimited by selecting the features of the intervention that will be finally implemented. Then,
following this methodology, the Catalan GP will describe in depth the core features of the oGP implemented in Catalonia
(ES) (7,6 M inhabitants) that are encompasses. Next adopters will pre-select the core features in which they are initially
interested in. Moreover, IDIBAPS will provide a detailed description of the oGP and how it was implemented step-by-
step in Catalonia (resources and capabilities needed, barriers and facilitators, how problems were resolved etc.) in D6.1.
Then, at next adopter´s site, local teams (including patients´ perspective), depending on their needs, expectations,
strategic objectives, real possibilities and existing local interventions, will choose the final core features by month 3.
The Catalan GP will support next adopters during this process if required.
TASK 6.2. SITUATION ANALYSIS (LEADER: AEEK, PARTICIPANTS: NEXT ADOPTERS, IDIBAPS) (M4-M7)
Study visits at Catalan GP site will be organized by IDIBAPS order to provide next adopters with the possibility
to acquire deep knowledge on specific aspects of the Catalan GP and establish close contact with the stakeholders
involved in the Catalan GP implementation. General outline of the study visits will be developed by Task 4.2. Core
features, context characteristics using the Scirocco Maturity Model and the implementation process based on CFIR will
be analysed and shared by Catalan GP during the study visit. Elements of sustainability will be highlighted by input
of Task 4.5 as crucial aspects to be considered for the transfer and adoption. This analysis will help next adopters in
understanding the requirements for adoption.
During the study visit IDIBAPS will have a dedicated session to explain the methodology of SWOT analysis (what
it is, how to perform, stakeholders needed, templates provided). Next adopters will have the opportunity to test the
methodology, so the procedures are clear to replicate at home with their local teams. In addition, Kronikgune will
introduce the methodology for interventions and actions definition, and Task 4.5 on general approach to develop
sustainability plans.
Next adopters will perform a SWOT analysis at their site. Before the meeting of local teams to prepare the SWOT, next
adopters will participate in a webinar organized by AEEK, together with IDIBAPS. The aim of this virtual meeting is
to support next adopters in SWOT analysis planning.
Then, next adopters will perform the SWOT analysis related to the selected core feature(s) of the oGP. The dimensions
of the Scirocco Maturity Model that were considered relevant for the implementation by IDIBAPS during the study visit
will be considered as well. Two perspectives will be studied in the SWOT: original GP-related and implementation-
related. The former can include examples such as implementation of the GMA as the risk stratification approach in
Catalonia was seen as an opportunity by health policy makers and primary care professionals. The latter can include
examples such as cost-effectiveness of home hospitalization in Barcelona-Esquerra (AISBE) was considered strengths
by professionals, patients and policy makers.
The SWOT analysis output will provide next adopters with a clear view of their improvement areas, priorities and the
strategic action required for planning the implementation. The SWOT analysis shall deliver information on needs and
the readiness of the next adopters’ key stakeholders for transferring knowledge, solutions, experiences and learnings into
their ecosystem regarding the 5 blocks of the oGP; potential barriers preventing the next adopters to prepare, implement,
maintain and replicate the transfer, including ranking the barriers by their impacts, strength and resources required to
eliminate them; gaps that might not be covered by the transfer from the specific oGP to the next adopters’ ecosystem or
potential areas of transfer from other oGPs to cover the identified gaps. Next adopter and IDIBAPS will jointly review
the SWOT output in a webinar. It might happen that the SWOT affects to the scope definition, so an iterative process
can be envisioned.
TASK 6.3. SPECIFIC INTERVENTIONS AND ACTIONS (LEADER: AGENAS, PARTICIPANTS: NEXT
ADOPTERS, AUTH, AQUAS, NIJZ, IDIBAPS, AEEK) (M8-M10)
A virtual meeting will be organized by Kronikgune in order to refresh the methodology for interventions and actions
definition introduced in the study visits at oGPs sites. Kronikgune will be responsible for leading the webinar and
Page 34 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
providing guidelines and templates. Core elements of sustainability will also be presented by Task 4.5, that will also
support defining the actions to be taken by next adopters.
Local teams, based on the scope, improvement areas and strategic actions, will (i) set up concrete objectives, (ii) define
activities to reach the previous objectives (called “Change Package”) and (iii) specify Key Performance indicators
(process or health-related), (iv) plan activities to support sustainability. For example, if a given next adopter is interested
in implementing the rehabilitation program for perioperative care from the Catalan GP, the adaptation of the program
to the new context is needed. The transferability process includes: (i) Definition of objectives, which involves to
design efficient service workflows and to build-up a sustainable empowerment program; (ii) Capacity building, create a
multidisciplinary working group including all stakeholders ensuring that all perspectives are covered and infrastructure,
as well as logistics, are in place; and, (iii) Define KPIs considering health outcomes/costs indicators, process indicators
and structure indicators. Next adopters will be supported by AGENAS, AUTH, AQuAS, NIJZ and IDIBAPS.
Then, next adopters will virtually share and review their local interventions and actions with AGENAS and the Catalan
GP by month 10 to make any refinement if needed.
The next adopters who have selected core features from more than one oGP (mix and match strategy will blend the
interventions and action from different transfer WPs. This task will be led by AGENAS as T4.3 leader. At the end, all
next adopters, irrespective of the transfer strategy chosen, will define their local GP (lGP) and Action Plan.
During the annual Consortium Meeting by month 12, next adopters will present their local GP and Action Plans in a
dedicated session. Discussion will be encouraged specially to analyse GP and Action Plans from ambition, feasibility and
sustainability perspectives. This session will be supported by AGENAS and NIJZ as T4.3 and T4.5 leaders, respectively.
During the annual Consortium Meeting, Kronikgune will explain the PDSA methodology. Next adopters will actively
participate to ensure that the methods and procedures are clear and allow them to start with the implementation.
TASK 6.4. IMPLEMENTATION (LEADER: IDIBAPS, PARTICIPANTS: NEXT ADOPTERS, AGENAS, AEEK)
(M13-M36)
Next adopters will extend and develop the previously defined Action Plan with a more detailed planning of the activities
and definition of the concrete actors (who), functions and roles (what), timeframe (when) and setting (where). They will
share the planning with IDIBAPS and Kronikgune in a dedicated teleconference to guarantee that everything is in place.
Then, implementation will start, and specific interventions will roll out based on PDSA. Next adopters will complete
at least one PDSA cycle and will commit to promote the implementation beyond the Joint Action in line with the
sustainability plan that will evolve during implementation based on barriers and opportunities encountered. Local/
regional/national networks among next adopters and stakeholders identified to be important to assure sustainability
should be established and facilitated by Task 4.5 if needed.
During the first month of the implementation (month 15-18), a maximum of three thematic workshops will be organized
by Task 4.2 at three next adopter´s sites to support the learning community. Each workshop will focus on a limited
number of specific core features. For example: (i) Risk assessment strategies; (ii) Implementation of integrated care
services; and, (iii) Digital transformation. The role of the thematic workshop/study visit is also a) to bring visibility
to next adopters at local/regional/national level & boost communication with stakeholders, that are important for the
sustainability, b) intermediate (self-) evaluation of the progress of the implementation with a potential to start next PDSA
cycle, c) give structured feedback to the JA leadership regarding the chosen methods to plan and support implementation.
The summary report of all thematic workshops/study visits at next adopters’ site will be prepared by Task 4.2, based on
the reports of next adopters. Next adopters will attend the thematic workshops in which the core features they selected
are discussed. These workshops will be a great scenario to share learning and experiences between stakeholders involved
in the implementation of a given core feature in Catalonia and the local teams of next adopters.
During the implementation, IDIBAPS will schedule monthly teleconferences to closely monitor the progress of next
adopters. IDIBAPS will support and coach implementers.
After the 12-month implementation, next adopters will report the whole implementation experience using the SQUIRE
2.0 Guidelines. IDIBAPS and Kronikgune will support next adopters in the report development. This report will contain
specific elements regarding local GP sustainability beyond the Joint Action. In the last annual Consortium Meeting
(month 30 approximately), next adopters will present their implementation report to (i) share their experience and
learning and (ii) collect feedback from partners that will help refining the final report.
MILESTONES
M22 Complete scope definition of the WP6 implementation sites (LB: KG, LEO: IDIBAPS) (M3)
M23 Complete situation analysis (SWOT) of the WP6 implementation sites (LB & LEO: AEEK) (M7)
M24 Define specific interventions and action, for all WP6 implementation sites (LB & LEO: AGENAS) (M10)
M25 Implementation started (LB: KG, LEO: IDIBAPS) (M15)
Page 35 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Participation per Partner
Partner number and short name WP6 effort
1 - KG 0.00
FPS 5.00
CSFJA 1.00
IDIBAPS 13.00
4 - MZCR 0.00
UHO 5.33
6 - MSAE 0.00
VH 4.70
10 - AEEK 9.00
JFDPK 16.00
11 - AGENAS 3.00
MARCHE 14.00
ASL NA2 14.00
Total 85.03
List of deliverables
Due
Deliverable
Deliverable Title Lead beneficiary Type15 Dissemination level16 Date (in
Number14
months)17
The Catalan Innovation
Hub original Good
D6.1 1 - KG Report Public 30
Practice and transfer
process
Description of deliverables
D6.1 : The Catalan Innovation Hub original Good Practice and transfer process [30]
LB: KG, LEO: IDIBAPS This deliverable will document: -The description of the “Catalan Innovation Hub” oGP,
including: main blocks and core features identified in Task 4.1, the implementation requirements and process step-
by-step, barriers found and solutions identified, lessons learnt and recommendations and the present situation of the
oGP. -The implementation process of the “Catalan Innovation Hub” in each next adopter´s site will be described: how
it started, who was involved, who was “coached”, how the original practice was adapted, which of its elements were
chosen, what other elements were added and from where, resources and capabilities needed, technology required,
barriers and facilitators and how elements needed for local GP sustainability have been tackled.
Page 36 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Schedule of relevant Milestones
Due
Milestone
Milestone title Lead beneficiary Date (in Means of verification
number18
months)
Complete scope definition of
Complete scope definition of
MS22 1 - KG 3 the WP6 implementation sites
the WP6 implementation sites
(LB: KG, LEO: IDIBAPS)
Complete situation analysis
Complete situation analysis
(SWOT) of the WP6
MS23 (SWOT) of the WP6 10 - AEEK 7
implementation sites (LB &
implementation sites
LEO: AEEK)
Define specific interventions
Define specific interventions
and action, for all WP6
MS24 and action, for all WP6 11 - AGENAS 10
implementation sites (LB &
implementation sites
LEO: AGENAS)
Implementation started (LB:
MS25 Implementation started -WP6 1 - KG 15
KG, LEO: IDIBAPS)
Page 37 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Work package number 9 WP7 Lead beneficiary 10 7 - EUSTRAS
THE OPTIMEDIS MODEL-POPULATION BAED INTEGRATED CARE GOOD
Work package title
PRACTICE: TRANSFER AND ADOPTION
Start month 1 End month 36
Objectives
OPTIMEDIS will be the Leading Executive Organization (LEO) of WP7 and NIJZ the Co-Leading Executive
Organization.
Optimedis is a private company will participate as a subcontractor of EUSTRAS (see section 9.4)
The main objective of WP7 will be:
-To select the core features of the original oGP that next adopter´s will work on.
-To perform the situation analysis and define the strategic actions of next adopters
-To define the specific interventions and actions that will be transferred to next adopters.
-To facilitate and support the transfer of oGP features to next adopters´ context.
Description of work and role of partners
WP7 - THE OPTIMEDIS MODEL-POPULATION BAED INTEGRATED CARE GOOD PRACTICE:
TRANSFER AND ADOPTION [Months: 1-36]
EUSTRAS, MCA, RND, MSAE, AGENAS, NIJZ
TASK 7.1. NEEDS AND SCOPE DEFINITION (LEADER: EUSTRAS(OPTIMEDIS), PARTICIPANTS: NEXT
ADOPTERS, NIJZ) (M1-M3)
Next adopters will have the opportunity to know better the original GP (oGP) and the learnings of OptiMedis (OM)
in between in other locations/regions in a dedicated workshop, organised by Task 4.1 and oGPs, during the Kick off
meeting by month 1. First, Kronikgune will explain the methodology for the scope definition which is mainly delimited
by selecting the features of the intervention that will be finally implemented. Then, following this methodology, OM
will describe in depth the core features of the oGP implemented in Kinzigtal, Billstedt-Horn and Werra-Meißner that are
health data warehouse, IT supported information continuity between providers, patient activation and a shared savings
approach. Next adopters will pre-select the core features in which they are initially interested in. Moreover, Optimedis
will provide a detailed description of the oGP and how it was implemented step-by-step in Germany (resources and
capabilities needed, barriers and facilitators, how problems were resolved etc.) in D7.1.
At Kick-off meeting, WP7 leader and coleader will present the general outline of WP7 leadership and management plan
at all phases of the implementation, including final reporting.
At next adopter´s site, local teams (including patient ‘perspectives), depending on their needs, expectations, strategic
objectives, real possibilities and existing local interventions, will choose the final core features by month 3. OM will
support next adopters during this process if required.
TASK 7.2. SITUATION ANALYSIS (LEADER: NIJZ, PARTICIPANTS: NEXT ADOPTERS,
EUSTRAS(OPTIMEDIS)) (M4-M7)
Study visits at oGP site will be organized by OM in order to provide next adopters the possibility to acquire deep
knowledge on specific aspects of the oGP and establish close contact with the stakeholders involved in the oGP
implementation. General outline of the study visits will be developed by Task 4.2 and collect the reports. Core features,
context characteristics using the Scirocco Maturity Model and the implementation process based on CFIR will be
analysed and shared by OM during the study visit. Elements of sustainability will be highlighted by input of Task 4.5
as crucial aspects to be considered for the transfer and adoption. This analysis will help next adopters in understanding
the requirements for adoption.
During the study visit Kronikgune will have a dedicated session to explain the methodology of SWOT analysis (what
it is, how to perform, stakeholders needed, templates provided). Next adopters will have the opportunity to test the
methodology, so the procedures are clear to replicate at home with their local teams. In addition, Kronikgune will
introduce the methodology for interventions and actions definition, and Task 4.5 on general approach to develop
sustainability plans.
Next adopters will perform a SWOT analysis at their site. Before the meeting of local teams to prepare the SWOT, next
adopters will participate in a webinar organized by NIJZ, together with Kronikgune (Task 3.2). The aim of this virtual
meeting is to support next adopters in SWOT analysis planning.
Page 38 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Then, next adopters will perform the SWOT analysis related to the selected core feature(s) of the oGP. The dimensions
of the Scirocco Maturity Model that were considered relevant for the implementation by OM during the study visit will
be considered as well. Two perspectives will be studied in the SWOT: original GP-related and implementation-related.
The former can include examples such as the use of routine health information databases to construct performance
feedback reports to health care providers that encourage evidence-based prescription and therapy. The latter can include
examples such as the availability of a functioning governance structure for existing health care providers in order to
support seamless implementation of the characteristics of the good practice.
The SWOT analysis output will provide next adopters with a clear view of their improvement areas, priorities and the
strategic action required for planning the implementation. The SWOT analysis shall deliver information on needs and
the readiness of the next adopters’ key stakeholders for transferring knowledge, solutions, experiences and learnings into
their ecosystem regarding the 5 blocks of the oGP; potential barriers preventing the next adopters to prepare, implement,
maintain and replicate the transfer, including ranking the barriers by their impacts, strength and resources required to
eliminate them; gaps that might not be covered by the transfer from the specific oGP to the next adopters’ ecosystem
or potential areas of transfer from other oGPs to cover the identified gaps. Next adopter and NIJZ will jointly review
the SWOT output in a webinar. It might happen that the SWOT affects to the scope definition, so an iterative process
can be envisioned.
TASK 7.3. SPECIFIC INTERVENTIONS AND ACTIONS (LEADER: AGENAS, PARTICIPANTS: NEXT
ADOPTERS, AUTH, AQUAS, NIJZ, EUSTRAS(OPTIMEDIS)) (M8-M10)
A virtual meeting will be organized by Kronikgune in order to refresh the methodology for interventions and actions
definition introduced in the study visits at oGPs sites. Kronikgune will be responsible for leading the webinar and
providing guidelines and templates. Core elements of sustainability will also be presented by Task 4.5, which will also
support defining the actions to be taken by next adopters.
Local teams, based on the scope, improvement areas and strategic actions, will (i) set up concrete objectives, (ii) define
activities to reach the previous objectives (called “Change Package”) and (iii) specify Key Performance indicators
(process or health-related), (iv) plan activities to support sustainability. For example, if a next adopter is interested
in adapting a community outreach centre/activity to improve patient empowerment and health literacy then various
context factors such as morbidity, social demographics, migrant population, economic development and service delivery
structures need to be considered. Indicators would be % of people with insufficient language skills, % of people
with limited health literacy, % of people experiencing difficulties in accessing primary/secondary care, % of hospital
admissions sensitive to primary care improvements. Next adopters will be supported by AGENAS, AUTH, AQuAS,
NIJZ and OM.
Then, next adopters will virtually share and review their local interventions and actions with AGENAS and
Eurométropole/OptiMedis by month 10 to make any refinement if needed.
The next adopters who have selected core features from more than one oGP (mix and match strategy) will blend the
interventions and action from different transfer WPs. This task will be led by AGENAS as T4.3 leader. At the end, all
next adopters, irrespective of the transfer strategy chosen, will define their local GP (lGP) and Action Plan.
During the annual Consortium Meeting by month 12, next adopters will present their local GP and Action Plans in a
dedicated session. Discussion will be encouraged especially to analyse GP and Action Plans from ambition, feasibility
and sustainability perspectives. This session will be supported by AGENAS and NIJZ as T4.3 and T4.5 leaders,
respectively.
During the annual Consortium Meeting Kronikgune will explain the PDSA methodology. Next adopters will actively
participate to ensure that the methods and procedures are clear and allow them to start with the implementation.
TASK 7.4. IMPLEMENTATION (LEADER : EUSTRAS(OPTIMEDIS), PARTICIPANTS: NEXT ADOPTERS,
AGENAS, NIJZ) (M13-M36)
Next adopters will extend and develop the previously defined Action Plan with a more detailed planning of the activities
and definition of the concrete actors (who), functions and roles (what), timeframe (when) and setting (where). They
will share the planning with (Eurométropole/OptiMedis) and Kronikgune in a dedicated teleconference to guarantee
that everything is in place.
Then, implementation will start and specific interventions will roll out based on PDSA. PDSA processes will not be
directed at patients to avoid potential ethical and time-management issues regarding patient recruitment, consent, and
follow-up, but rather programme management improvement processes. Next adopters, at least, will complete one PDSA
cycle and will commit to promote the implementation beyond the Joint Action in line with the sustainability plan that
will evolve during implementation based on barriers and opportunities encountered. Local/regional/national networks
among next adopters and stakeholders identified to be important to assure sustainability should be established and
facilitated by Task 4.5 if needed.
Page 39 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
During the first month of the implementation (month 15-18), a maximum of three thematic workshops will be organized
by Task 4.2 at three next adopters´ sites to support the learning community. Each workshop will focus on a limited
number of specific core features. For example, issues to be discussed could be best practices to increase patient activation
in different contexts, strategies to increase physician collaboration for multi-morbid chronic patients; IT tools to provide
seamless care etc. Next adopters will attend the thematic workshops in which the core features they selected are
discussed. These workshops will be a great scenario to share learning and experiences between stakeholders involved
in the implementation of a given core feature in Kinzigal, Billstedt-Horn and Werra-Meißner and the local teams of
next adopters.
During the implementation, Eurométropole/OptiMedis will schedule monthly teleconferences to closely monitor the
progress of next adopters. Eurométropole/OptiMedis will support and coach implementers.
Organization of study visits at next adopters’ site will be strongly encouraged and supported by Task 4.2 in order to:
a) bring visibility to next adopters at local/regional/national level and boost communication with stakeholders, that are
important for the sustainability, b) intermediate (self-)evaluation of the progress of the implementation with a potential to
start next PDSA cycle, c) give structured feedback to the JA leadership regarding the chosen methods to plan and support
implementation. They may be joined to thematic workshops, if not too early with respect to the level of implementation.
The summary report of all study visits at next adopters’ site will be prepared by Task 4.2, based on the reports of next
adopters.
After the 12-month implementation, next adopters will report the whole implementation experience using the SQUIRE
2.0 guidelines. Eurométropole/OptiMedis and Kronikgune will support next adopters in the report development. This
report will contain specific elements regarding local GP sustainability beyond the Joint Action. In the last annual
Consortium Meeting (month 30 approximately), next adopters will present their implementation report to (i) share their
experience and learning and (ii) collect feedback from partners that will help refining the final report.
MILESTONES
M26 Complete scope definition of the WP7 implementation sites (LB: EUSTRAS, LEO: Optimedis) (M3)
M27 Complete situation analysis (SWOT) of the WP7 implementation sites (LB & LEO: NIJZ) (M7)
M28 Define specific interventions and action, for all WP7 implementation sites (LB & LEO: AGENAS) (M10)
M29 Implementation started (LB: EUSTRAS, LEO: Optimedis) (M15)
Participation per Partner
Partner number and short name WP7 effort
2 - MCA 0.00
ZZJZFBIH 7.00
MHSw-RS 14.00
5 - RND 7.50
6 - MSAE 0.00
VH 4.70
7 - EUSTRAS 6.00
11 - AGENAS 3.00
16 - NIJZ 0.00
ZZZS 10.00
Total 52.20
Page 40 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
List of deliverables
Due
Deliverable
Deliverable Title Lead beneficiary Type 15
Dissemination level 16 Date (in
Number14
months)17
The Optimedis Model
D7.1 original Good Practice 7 - EUSTRAS Report Public 30
and transfer process
Description of deliverables
D7.1 : The Optimedis Model original Good Practice and transfer process [30]
LB: EUSTRAS, LEO: Optimedis The deliverable will document: -The description of the “Optimedis Model” oGP,
including: main blocks and core features identified in Task 4.1, the implementation requirements and process step-by-
step, barriers found and solutions identified, lessons learnt and recommendations and the present situation of the oGP.
The implementation process of the “Optimedis Model” in each next adopter´s site will be described: how it started,
who was involved, who was “coached”, how the original practice was adapted, which of its elements were chosen,
what other elements were added and from where, resources and capabilities needed, technology required, barriers and
facilitators and how elements needed for local GP sustainability have been tackled
Schedule of relevant Milestones
Due
Milestone
Milestone title Lead beneficiary Date (in Means of verification
number18
months)
Complete scope definition
Complete scope definition of of the WP7 implementation
MS26 7 - EUSTRAS 3
the WP7 implementation sites sites (LB: EUSTRAS, LEO:
Optimedis)
Complete situation analysis
Complete situation analysis
(SWOT) of the WP7
MS27 (SWOT) of the WP7 16 - NIJZ 7
implementation sites (LB &
implementation sites
LEO: NIJZ)
Define specific interventions
Define specific interventions
and action, for all WP7
MS28 and action, for all WP7 11 - AGENAS 10
implementation sites (LB &
implementation sites
LEO: AGENAS)
Implementation started -
MS29 Implementation started-WP7 7 - EUSTRAS 15 WP7 (LB: EUSTRAS, LEO:
Optimedis)
Page 41 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Work package number 9 WP8 Lead beneficiary 10 5 - RND
DIGITAL ROADMAP TOWARDS AN INTEGRATED HEALTH CARE SECTOR
Work package title
GOOD PRACTICE TRANSFER AND ADOPTION
Start month 1 End month 36
Objectives
RSD will be the Leading Executive Organization (LEO) of WP8 and UHO the Co-Leading Executive Organization.
The main objectives will be:
-To select the core features of the original oGP that next adopter´s will work on.
-To perform the situation analysis and define the strategic actions of next adopters
-To define the specific interventions and actions that will be transferred to next adopters.
-To facilitate and support the transfer of oGP features to next adopters´ context.
Description of work and role of partners
WP8 - DIGITAL ROADMAP TOWARDS AN INTEGRATED HEALTH CARE SECTOR GOOD PRACTICE
TRANSFER AND ADOPTION [Months: 1-36]
RND, KG, CIPH, MZCR, AGENAS, NVD, LR SAM
TASK 8.1. NEEDS AND SCOPE DEFINITION (LEADER: RSD, PARTICIPANTS: NEXT ADOPTERS, UHO) (M1-
M3)
Next adopters will have the opportunity to know better the oGP in a dedicated workshop during the Kick off meeting
by month 1 (T4.1). First, Kronikgune will explain the methodology for the scope definition which is mainly delimited
by selecting the features of the intervention that will be finally implemented. Then, following this methodology,
the Region of Southern Denmark will describe in depth the core features of the oGP, Roadmap towards Integrated
Care, implemented in the Region of Southern Denmark. The Roadmap towards Integrated Care consists of different
elements that together make up the foundation for the digital and cross sectorial communication. They are: (i)
Cross sectorial digital communication: standards and agreements, including health agreements, messaging standards,
SAM:BO Agreement, (ii) Cross sectorial digital communication: Additional solutions to support complex disease areas,
including Tele-COPD, Tele-psychiatry, My Patient Journey, Online physical rehabilitation, Digital Health Centre and
Geri Toolbox. Across all elements the key success factors are a strong collaboration between the different organizations
in the regional eco-system consisting of academia, knowledge institutions and private companies; a focus on user
involvement of both professionals and end-users in co-designing solutions and implementation processes; a good public-
private partnership and preferably and agile one as well as a strong IT infrastructure to make digital communication
possible.
Next adopters will pre-select the core features in which they are initially interested in. Moreover, RSD will provide
a detailed description of the oGP and how it was implemented step-by-step in Denmark (resources and capabilities
needed, barriers and facilitators, how problems were resolved etc.) in D8.1.
Then, at next adopter´s site, local teams (including patients ‘perspective), depending on their needs, expectations,
strategic objectives, real possibilities and existing local interventions, will choose the final core features by month 3.
The Health Innovation Centre, representing the Region of Southern Denmark in the Joint Action, will support next
adopters during this process if required.
TASK 8.2. SITUATION ANALYSIS (LEADER: UHO, PARTICIPANTS: NEXT ADOPTERS, RSD) (M4-M7)
Study visits will be organized in order to provide next adopters the possibility to acquire deep knowledge on specific
aspects of the oGP and establish close contact with the stakeholders involved in the oGP implementation (T4.2). Core
features, context characteristics using the Scirocco Maturity Model and the implementation process based on CFIR
will be analysed and shared by the Health Innovation Centre of Southern Denmark during the study visit. Elements of
sustainability will be highlighted as crucial aspects to be considered for the transfer and adoption. This analysis will
help next adopters in understanding the requirements for adoption.
During the study visit Kronikgune will have a dedicated session to explain the SWOT analysis (what it is, how to
perform, stakeholders needed, templates provided). Next adopters will have the opportunity to test the methodology
so the procedures are clear to replicate at home with their local teams. In addition, Kronikgune will introduce the
methodology for interventions and actions definition.
Page 42 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Next adopters will perform a SWOT analysis at their site. Before the SWOT meeting with their teams, next adopters will
participate in a webinar organized by the Health Innovation Centre of Southern Denmark, together with Kronikgune.
The aim of this virtual meeting is to support next adopters in SWOT analysis planning.
Then, next adopters will perform the SWOT analysis related to the selected core feature(s) of the oGP. The dimensions
of the Scirocco Maturity Model that were considered relevant for the implementation by the Health Innovation Centre
of Southern Denmark during the study visit will be considered as well. Two perspectives will be studied in the SWOT:
original GP-related and implementation-related. The former can include examples such as resistance to change, technical
barriers or the lack of available local resources. The latter can include examples such as increasing the communication
and understanding across different sectors, a higher degree of patient involvement and a focus on patient pathways and
safety.
The SWOT analysis output will provide next adopters with a clear view of their improvement areas, priorities and
the strategic action required for planning the implementation and its sustainability. The SWOT analysis shall deliver
information on needs and the readiness of the next adopters’ key stakeholders for transferring knowledge, solutions,
experiences and learnings into their ecosystem regarding the 5 blocks of the oGP; potential barriers preventing the next
adopters to prepare, implement, maintain and replicate the transfer, including ranking the barriers by their impacts,
strength and resources required to eliminate them; gaps that might not be covered by the transfer from the specific oGP
to the next adopters’ ecosystem or potential areas of transfer from other oGPs to cover the identified gaps. Next adopter
and the Health Innovation Centre of Southern Denmark will jointly review the SWOT output in a webinar. It might
happen that the SWOT affects to the scope definition, so an iterative process can be envisioned.
TASK 8.3. SPECIFIC INTERVENTIONS AND ACTIONS (LEADER: AGENAS, PARTICIPANTS: NEXT
ADOPTERS, AUTH, AQUAS, NIJZ, RSD, UHO) (M8-M10)
A virtual meeting will be organized by Kronikgune in order to refresh the methodology for interventions and actions
definition introduced in the study visits. Kronikgune will be responsible for leading the webinar and providing guidelines
and templates.
Local teams, based on the scope, improvement areas and strategic actions, will (i) set up concrete objectives, (ii)
define activities to reach the previous objectives (called “Change Package”) (iii) specify Key Performance indicators
(process or health-related), and (iv) plan activities to support sustainability. For example, if a given next adopter is
interested in implementing the Online Rehabilitation Platform an adaptation of the solution is needed. This would
include subtexting the training videos, translating the information material and training key personnel in using the
platform. Key Performance indicators could be the number of available videos to be used in the individually designed
training programmes, number of therapists using the platform as a supplement in the rehabilitation plan and the number
of patients using the platform at home as well as their indications of pain and difficulty level. Next adopters will be
supported by AGENAS, AUTH, AQuAS, NIJZ and the Health Innovation Centre of Southern Denmark.
Then, next adopters will virtually share and review their local interventions and actions with AGENAS and the Health
Innovation Centre by month 10 to make any refinement if needed.
The next adopters who have selected core features from more than one oGP (mix and match strategy will blend the
interventions and action from different transfer WPs. This task will be led by AGENAS as T4.3 leader. AT the end, all
next adopters, irrespective of the transfer strategy chosen, will define their local GP (lGP)and Action Plan.
During the annual Consortium Meeting by month 12, next adopters will present their local GP and Action Plans in a
dedicated session. Discussion will be encouraged especially to analyse GP and Action Plans from ambition, feasibility
and sustainability perspectives. This session will be supported by AGENAS and NIJZ as T4.3 and T4.5 leaders,
respectively.
During the annual Consortium Meeting Kronikgune will explain the PDSA methodology. Next adopters will actively
participate to ensure that the methods and procedures are clear and allow them to start with the implementation.
TASK 8.4. IMPLEMENTATION (LEADER: RSD, PARTICIPANTS: NEXT ADOPTERS, AGENAS, UHO) (M13-
M36)
Next adopters will extend and develop the previously defined Action Plan with a more detailed planning of the activities
and defining concrete actors (who), functions and roles (what), timeframe (when) and setting (where). They will share
the planning with the Health Innovation centre of Southern Denmark and Kronikgune in a dedicated teleconference to
guarantee that everything is in place.
Then, implementation will start, and specific interventions will roll out based on PDSA. Next adopters will complete at
least one PDSA cycle and will commit to promote the implementation beyond the Joint Action.
During the first months of the implementation (month 15-18), a maximum of three thematic workshops will be organized
at three next adopters’ sites (T4.2w). Each workshop will focus on a limited number of specific core features. For
example, electronic standards, organization of cross-sectoral communication and patient involvement. Next adopters
Page 43 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
will attend the thematic workshops in which the core features they selected are discussed. These workshops will be a
great scenario to share learning and experiences between stakeholders involved in the implementation of a given core
feature in the Region of Southern Denmark and the local teams of next adopters. The role of the thematic workshop/
study visit is also a) to bring visibility to next adopters at local/regional/national level and boost communication
with stakeholders, that are important for the sustainability, b) intermediate (self-)evaluation of the progress of the
implementation with a potential to start next PDSA cycle, c) give structured feedback to the JA leadership regarding
the chosen methods to plan and support implementation. The summary report of all thematic workshops/study visits at
next adopters’ site will be prepared by Task 4.2, based on the reports of next adopters.
During the implementation, the Health Innovation Centre of Southern Denmark will schedule monthly teleconferences
to closely monitor the progress of next adopters. The Health Innovation Centre of Southern Denmark will support and
coach implementers.
After the 12-month implementation, next adopters will report the whole implementation experience using the SQUIRE
2.0 tool. The Health Innovation Centre of Southern Denmark and Kronikgune will support next adopters in the report
development. This report will contain specific elements regarding local GP sustainability beyond the Joint Action. In
the last annual Consortium Meeting (month 30 approximately), next adopters will present their implementation report
to (i) share their experience and learning and (ii) collect feedback from partners that will help refining the final report.
MILESTONES
M30 Complete scope definition of the WP8 implementation sites (LB: RND: LEO: RSD) (M3)
M31 Complete situation analysis (SWOT) of the WP8 implementation sites (LB: MCZR, LEO: UHO) (M7)
M32 Define specific interventions and action, for all WP8 implementation sites (LB & LEO: AGENAS) (M10)
M33 Implementation started (LB: RND: LEO: RSD) (M15)
Participation per Partner
Partner number and short name WP8 effort
1 - KG 0.00
FFIS 3.25
SCS 4.00
SACYL 14.00
IDIVAL 7.00
SMS 7.00
3 - CIPH 3.00
CHIF 3.40
4 - MZCR 0.00
UHO 5.33
5 - RND 0.00
RSD 13.00
11 - AGENAS 3.00
LOMBARDIA 14.00
12 - NVD 6.00
CCUH 15.00
13 - LR SAM 7.50
Total 105.48
Page 44 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
List of deliverables
Due
Deliverable
Deliverable Title Lead beneficiary Type 15
Dissemination level 16 Date (in
Number14
months)17
The Danish roadmap
towards Integrated Care
D8.1 5 - RND Report Public 30
original Good Practice
and transfer process
Description of deliverables
D8.1 : The Danish roadmap towards Integrated Care original Good Practice and transfer process [30]
LB: RND, LEO: RSD -The description of the “Danish Roadmap towards Integrated Care” oGP, including: main
blocks and core features identified in Task 4.1, the implementation requirements and process step-by-step, barriers
found and solutions identified, lessons learnt and recommendations and the present situation of the oGP. -The
implementation process of the “Danish Roadmap towards Integrated Care” in each next adopter´s site will be
described: how it started, who was involved, who was “coached”, how the original practice was adapted, which
of its elements were chosen, what other elements were added and from where, resources and capabilities needed,
technology required, barriers and facilitators and how elements needed for local GP sustainability have been tackled.
Schedule of relevant Milestones
Due
Milestone
Milestone title Lead beneficiary Date (in Means of verification
number18
months)
Complete scope definition of
Complete scope definition of
MS30 5 - RND 3 the WP8 implementation sites
the WP8 implementation sites
(LB: RND: LEO: RSD)
Complete situation analysis
Complete situation analysis
(SWOT) of the WP8
MS31 (SWOT) of the WP8 4 - MZCR 7
implementation sites (LB:
implementation sites
MCZR, LEO: UHO)
Define specific interventions
Define specific interventions
and action, for all WP8
MS32 and action, for all WP8 11 - AGENAS 10
implementation sites (LB &
implementation sites
LEO: AGENAS)
Implementation started - WP8
MS33 Implementation started - WP8 5 - RND 15
(LB: RND: LEO: RSD)
Page 45 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
1.3.4. WT4 List of milestones
Due
Milestone WP
Milestone title Lead beneficiary Date (in Means of verification
number18 number9
months)17
Kick off meeting (LB & LEO:
MS1 Kick-off meeting WP1 1 - KG 1
KG)
Periodic technical and
Periodic technical and
MS2 WP1 1 - KG 18 financial report sent to
financial report
CHAFEA (LB & LEO: KG)
Final technical and financial
Final technical and
MS3 WP1 1 - KG 36 report sent to CHAFEA (LB
financial report
& LEO: KG)
Project slide deck and
Project slide deck and
MS4 WP2 10 - AEEK 3 branded templates (LB:
branded templates
AEEK, LEO:SU-HSMTC)
Dissemination and
Dissemination and
MS5 WP2 10 - AEEK 6 communication plan (LB:
communication plan
AEEK, LEO:SU-HSMTC)
Website launching (LB:
MS6 Website launching WP2 8 - BAGSFI 6
BAGSFI, LEO: ZTG GMBH)
Mid-term report on Final Conference (LB:
MS7 WP2 10 - AEEK 18
Dissemination AEEK, LEO:SU-HSMTC)
Final conference of the
MS8 Final Conference WP2 8 - BAGSFI 36 project (LB: BAGSFI, LEO:
LGL)
Monitoring and evaluation
Monitoring and
MS9 WP3 9 - 4THYPE 8 plan (LB: 4RTHYPE, LEO:
Evaluation Plan
AUTH)
Implementation Implementation strategy in
MS10 WP3 1 - KG 9
strategy in place place (LB & LEO: KG)
Impact Assessment Impact Assessment Plan (LB:
MS11 WP3 9 - 4THYPE 9
Plan 4RTHYPE, LEO: AUTH)
Interim Evaluation ( LB:
MS12 Interim Evaluation WP3 9 - 4THYPE 18
4RTHYPE, LEO: AUTH)
Final Evaluation (LB:
MS13 Final Evaluation WP3 9 - 4THYPE 9
4RTHYPE, LEO: AUTH)
General principles General principles of
of successful successful implementation
MS14 WP4 8 - BAGSFI 9
implementation described (LB & LEO:
described BAGSFI)
Summary reports from Summary reports from study
MS15 study visits at oGPs WP4 8 - BAGSFI 10 visits at oGPs sites finalized
sites finalized (LB & LEO: BAGSFI)
Common issues from Common issues from needs
needs and scope (x.1), and scope (x.1), situation
MS16 situation analysis (x.2), WP4 11 - AGENAS 15 analysis (x.2), interventions
interventions and and actions (x.3) identified
actions (x.3) identified (LB & LEO: AGENAS)
Page 46 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Due
Milestone WP
Milestone title Lead beneficiary Date (in Means of verification
number18 number9
months)17
Summary report from Summary report from
MS17 meetings of policy WP4 16 - NIJZ 36 meetings of policy board (LB
board & LEO: NIJZ)
Complete scope Complete scope definition of
MS18 definition of the WP5 WP5 1 - KG 3 the WP5 implementation sites
implementation sites (LB & LEO: KG)
Complete situation Complete situation analysis
analysis (SWOT) of the (SWOT) of the WP5
MS19 WP5 9 - 4THYPE 7
WP5 implementation implementation sites (LB:
sites 4RTHYPE, LEO: AUTH)
Define specific Define specific interventions
interventions and and action, for all WP5
MS20 WP5 11 - AGENAS 10
action, for all WP5 implementation sites (LB &
implementation sites LEO: AGENAS)
Implementation started Implementation started -WP5
MS21 WP5 1 - KG 15
-WP5 (LB & LEO: KG)
Complete scope Complete scope definition of
MS22 definition of the WP6 WP6 1 - KG 3 the WP6 implementation sites
implementation sites (LB: KG, LEO: IDIBAPS)
Complete situation Complete situation analysis
analysis (SWOT) of the (SWOT) of the WP6
MS23 WP6 10 - AEEK 7
WP6 implementation implementation sites (LB &
sites LEO: AEEK)
Define specific Define specific interventions
interventions and and action, for all WP6
MS24 WP6 11 - AGENAS 10
action, for all WP6 implementation sites (LB &
implementation sites LEO: AGENAS)
Implementation started Implementation started (LB:
MS25 WP6 1 - KG 15
-WP6 KG, LEO: IDIBAPS)
Complete scope definition
Complete scope
of the WP7 implementation
MS26 definition of the WP7 WP7 7 - EUSTRAS 3
sites (LB: EUSTRAS, LEO:
implementation sites
Optimedis)
Complete situation Complete situation analysis
analysis (SWOT) of the (SWOT) of the WP7
MS27 WP7 16 - NIJZ 7
WP7 implementation implementation sites (LB &
sites LEO: NIJZ)
Define specific Define specific interventions
interventions and and action, for all WP7
MS28 WP7 11 - AGENAS 10
action, for all WP7 implementation sites (LB &
implementation sites LEO: AGENAS)
Implementation started -
Implementation started-
MS29 WP7 7 - EUSTRAS 15 WP7 (LB: EUSTRAS, LEO:
WP7
Optimedis)
Complete scope Complete scope definition of
MS30 definition of the WP8 WP8 5 - RND 3 the WP8 implementation sites
implementation sites (LB: RND: LEO: RSD)
Page 47 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Due
Milestone WP
Milestone title Lead beneficiary Date (in Means of verification
number18 number9
months)17
Complete situation Complete situation analysis
analysis (SWOT) of the (SWOT) of the WP8
MS31 WP8 4 - MZCR 7
WP8 implementation implementation sites (LB:
sites MCZR, LEO: UHO)
Define specific Define specific interventions
interventions and and action, for all WP8
MS32 WP8 11 - AGENAS 10
action, for all WP8 implementation sites (LB &
implementation sites LEO: AGENAS)
Implementation started Implementation started - WP8
MS33 WP8 5 - RND 15
- WP8 (LB: RND: LEO: RSD)
Page 48 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
1.3.5. WT5 Critical Implementation risks and mitigation actions
Risk
Description of risk WP Number Proposed risk-mitigation measures
number
The face-to-face meetings planned would be
adapted to the COVID-19 situation by either
transforming them into virtual conferences,
webinars or workshops in the case of big events or
Due to COVID-19 crisis, into small focus-groups/working events that can
difficulties to organize follow the social distancing needs and measures.
face-to-face meetings due Specific working methodologies will be put in
to restrictions resulting WP1, WP2, WP3, WP4, place to make the meetings as productive as
1
from national emergency WP5, WP6, WP7, WP8 face-to-face meetings. It is not expected to have
measures including travel important changes in the budget distribution
restrictions, social distancing only an update of the number of travels and final
and confinements destinations if the large meetings are postponed
or cancelled and more small meetings are finally
necessary. This will be adapted to match the
working plan but it is not expected to sought an
amendment.
Local implementation working groups will
include stakeholders from different settings
(primary care, hospital care, information system
department, healthcare directorate etc.) with
Due to COVID-19 crisis, low different profiles, expertise and experience
participation of clinicians, WP2, WP3, WP4, WP5, (managers, doctors, nurses, IT technicians).
2
IT technicians and decision WP6, WP7, WP8 Professionals not dealing (at front line) with
makers in JADECARE COVID-19 will be selected. The size of these
meetings will be small enough to fulfil the
requirements of social distancing. In addition,
virtual meetings will be organized with front line
clinicians and staff.
Previous work has been done during the
preparation of the JA. General management
Progress starting too late and procedures have been designed to detect any
WP1, WP2, WP3, WP4,
3 the project resulting in poor deviation from the initial plan and an experienced
WP5, WP6, WP7, WP8
delivery and project outcome and robust management team will lead the project.
Kick off meeting has been carefully designed to
coherently launch all the simultaneous activities.
The coordinator will check, 15 days earlier of the
Deliverables or official deadline the status of any of deliverable to be sent
4 notifications to the CHAFEA WP1 to CHAFEA. In case there is a delay, it will be
arrive late informed and justified beforehand establishing the
real deadline.
The Budget has been carefully designed,
discussed and agreed with all the participants.
Considering the option of miss and match the
Financial deviations/ Budget
amount of budget indicated for WP5-8 could
5 issues don´t allow to develop WP1
be transferred from one to other of this WP. A
the activities
financial manager will lead the evaluation and
monitoring of use of resources and justification by
all the partners.
All partners have designed by the corresponding
6 A partner leaves the project WP1
health systems in their countries demonstrating
Page 49 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Risk
Description of risk WP Number Proposed risk-mitigation measures
number
the commitment to the project. The rest of
the consortium will try to assume the partner
objectives, responsibilities and resources. In case
the responsibilities reallocation is not possible,
the consortium will look for other partner with the
same profile.
The project has included experts in the field that
will lead the WP. A strong focus will be put in
the creation a solid and catchy visual identity that
Results not disseminated as
7 WP2 will be included in the promotional material. The
expected
communication team will lead the commitment
of all communication departments from entities
involved in the project.
Promotion of the activities will be a key element
of the project as described in WP2. In addition,
the policy board included in JADECARE will
allow maximizing the participation of policy
8 Few attendees at events WP2
makers, activities included in WP5-8, involving
local teams, will allow the contact with the rest of
the stakeholders that will get to know at first hand
the details and impact of the project.
The impact of the Project will be measured
in two levels: a) the Joint Action in overall
(including impact on external stakeholders) and
b) the next adopters. SMART key performance
indicators will be tailored to each next adopter
according to the local GGPP implemented to
avoid unnecessary duplication or unrealistic
WP3, WP4, WP5, WP6, indicators. The customization of the indicators
9 No agreement on indicators
WP7, WP8 will be framed into transfer WPs (WP 5-8)
during the definition of specific interventions
and action to implement. Leaders of WP3 have
a proven track record in evaluation of impact/
interventions/implementations and have designed
also indicators to provide key information to
partners to correct the limitations and boost the
strengths.
WP3 has been designed to provide a
methodological framework for assessing the
different adopted features. The WP3 has a
WP3, WP4, WP5, WP6,
10 Evaluation is not feasible thorough plan to monitor the progress of the
WP7, WP8
project as well as the impact by using tailored
indicators that will be reviewed and updated if
necessary.
JADECARE is going to create stable stakeholders
´ communities where generation and exchange
of knowledge will be promoted. Workshops,
interviews, questionnaires will be used to identify
No real integration in
11 WP4 the barriers and key elements to be considered to
national policies
really achieve the change. In addition, a policy
board will be included in the project where all the
policy-oriented stakeholder will find sustainability
analysis for the action. Ministries of health
Page 50 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Risk
Description of risk WP Number Proposed risk-mitigation measures
number
will be included in JADECARE as partners or
as members of the Policy Board. A report on
sustainability and integration in national policies
will be generated.
All the oGPs are nowadays running in the
corresponding countries, where the sustainability
has been recognized. The next adopters have
the real capacity of implement at long term the
selected strategy, national or regional health
systems. In addition, Recommendation sand
guidance for uptake of GP will be a key task in the
Sustainability it is not
12 WP4 project leading to a co-creation of guidelines and
feasible
standard operation procedures for GP uptake will
be co-created considering the idiosyncrasy of the
regions. . Actions plans of next adopters will be
developed based on common principles and study
visits outputs. Task 4.6 will generate the tools to
work in this sustainability and how to include the
policy representatives in the project.
All next adopters have participated in dedicated
webinars during the preparation of the JA to know
in detail the oGP. In fact, the applicants have
oGPs don´t meet the
13 WP5, WP6, WP7, WP8 shown their initial interest in one or several of
expectations of next adopters
the oGPs. In addition, next adopters will have the
opportunity of tailoring the local GPs by mixing
and matching specific oGP features.
All next adopters have included in the joint action,
professionals, centers and patients willing to
Professionals, patients and participate in the preparation and initial piloting
14 general population don´t WP5, WP6, WP7, WP8 of the corresponding GP. All the next adopters
participate in JADECARE will use resources from CHAFEA to develop the
project and have committed their own resources to
guarantee the development of the activities.
Next adopters will have the opportunity to know
better the original GP (oGP) in a dedicated
workshop during the Kick off meeting by month
1. In addition, study visits will be organized in
order to provide next adopters the possibility
GP can´t be understood by
15 WP5, WP6, WP7, WP8 to acquire deep knowledge on specific aspects
next adopters
of the oGP and establish close contact with the
stakeholders involved in the oGP implementation.
Besides, a SWOT analysis will be developed to
have a clear view of the areas of improvement,
priorities and the strategic action required.
Key stakeholders for the change are included in
JADECARE as CA, AE and belonging to different
boards. In addition, SWOT analysis will deliver
Cultural, financial,
information on needs and the readiness of the
professional, healthcare
16 WP5, WP6, WP7, WP8 next adopters´ key stakeholders for transferring
systems barriers hampered
knowledge, solutions. Specific interventions and
the implementation of GPs
actions are designed to deploy implementations
in next adopters. The local teams guided by
the owners of oGP will extend and develop
Page 51 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Risk
Description of risk WP Number Proposed risk-mitigation measures
number
tailored defined Actions plans to promote the
implementation of the JA.
The maturity level of digital health has been
analyzed in each of the participating countries as
described in section 5.1.5. JADECARE doesn´t
aim to implement new solutions in each region
Different level of digital
but to settle the bases to really implement the
17 health and integrated care WP5, WP6, WP7, WP8
digital integrated care solutions at short term.
maturity
The roadmap for real change and implementation
will be developed in JADECARE identifying the
barriers, obstacles, necessities and steps to be
taken.
Page 52 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
1.3.6. WT6 Summary of project effort in person-months
Total Person/Months
WP1 WP2 WP3 WP4 WP5 WP6 WP7 WP8
per Participant
1 - KG 67 1 10 3 13 0 0 0 94
· FFIS 0 0.25 1 1 0 0 0 3.25 5.50
· FPS 0 0.75 2 2 5 5 0 0 14.75
· SCS 0 0.25 1 1 0 0 0 4 6.25
· SACYL 0 1 2 2 0 0 0 14 19
· CSFJA 0 0.25 0.75 1 1 1 0 0 4
· IDIVAL 0 0.75 2 2.25 0 0 0 7 12
· IDIBAPS 0 1 0 2 0 13 0 0 16
· AQUAS 0 1 13 0 0 0 0 0 14
· SMS 0 0.75 1 1 0 0 0 7 9.75
2 - MCA 2 1 0 3 0 0 0 0 6
· ZZJZFBIH 0 1 2 2 7 0 7 0 19
· MHSw-RS 0 1 2 2 0 0 14 0 19
3 - CIPH 2 1 2 1.40 2.80 0 0 3 12.20
· CHIF 0 0 0 0 2 0 0 3.40 5.40
4 - MZCR 2 1 0 4 0 0 0 0 7
· UHO 0 1 2 2 5.34 5.33 0 5.33 21
5 - RND 2 1 2 4 7.50 0 7.50 0 24
· RSD 0 1 0 3 0 0 0 13 17
6 - MSAE 2 1 0 3 0 0 0 0 6
· VH 0 1 2 2 4.60 4.70 4.70 0 19
7 - EUSTRAS 2 1 2 3 0 0 6 0 14
8 - BAGSFI 2 1 2 5.25 0 0 0 0 10.25
Page 53 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Total Person/Months
WP1 WP2 WP3 WP4 WP5 WP6 WP7 WP8
per Participant
· LGL 0 5 0 2.25 0 0 0 0 7.25
· ZTG-GmBH 0 5 0 2.75 0 0 0 0 7.75
9 - 4THYPE 2 1 0 4 15 0 0 0 22
· AUTH 0 1 20 0 3 0 0 0 24
10 - AEEK 2 1 0 5 0 9 0 0 17
· SU-HSMTC 0 19 0 0 0 0 0 0 19
· JFDPK 0 1 2 2 0 16 0 0 21
11 - AGENAS 2 1 0 18.25 3 3 3 3 33.25
· PROMIS 0 1 0 0 0 0 0 0 1
· LOMBARDIA 0 1 2 2 0 0 0 14 19
· UMBRIA 0 1 2 2 14 0 0 0 19
· MhH 0 1 0 3 0 0 0 0 4
· MARCHE 0 1 2 2 0 14 0 0 19
· TOSCANA 0 1 2 2 14 0 0 0 19
· ASL NA2 0 1 2 2 0 14 0 0 19
12 - NVD 0 1 0 0 0 0 0 6 7
· CCUH 2 1 2 4 0 0 0 15 24
13 - LR SAM 2 1 2 4 7.50 0 0 7.50 24
14 - ACSS 2 1 2 2.75 8 0 0 0 15.75
· SPMS 0 0 1 1 4 0 0 0 6
· ENSP/NOVA 0 1 2 1.75 6 0 0 0 10.75
15 - MoHRS 2 1 2 4 15 0 0 0 24
16 - NIJZ 2 1 0 43 0 0 0 0 46
· ZZZS 0 1 2 2 0 0 10 0 15
17 - HSCB 2 1 0 3 0 0 0 0 6
Total Person/Months 99 69 93.75 162.65 137.74 85.03 52.20 105.48 804.85
Page 54 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
1.3.7. WT7 Tentative schedule of project reviews
Review Tentative Planned venue
Comments, if any
number 19 timing of review
RV1 12 Chafea/DG SANTE As deemed by the PO
RV2 30 Chafea/DG SANTE As deemed by the PO
Page 55 of 55
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
1. Project number
The project number has been assigned by the Commission as the unique identifier for your project. It cannot be
changed. The project number should appear on each page of the grant agreement preparation documents (part A
and part B) to prevent errors during its handling.
2. Project acronym
Use the project acronym as given in the submitted proposal. It can generally not be changed. The same acronym should
appear on each page of the grant agreement preparation documents (part A and part B) to prevent errors during its
handling.
3. Project title
Use the title (preferably no longer than 200 characters) as indicated in the submitted proposal. Minor corrections are
possible if agreed during the preparation of the grant agreement.
4. Starting date
Unless a specific (fixed) starting date is duly justified and agreed upon during the preparation of the Grant Agreement,
the project will start on the first day of the month following the entry into force of the Grant Agreement (NB : entry into
force = signature by the Agency). Please note that if a fixed starting date is used, you will be required to provide a written
justification.
5. Duration
Insert the duration of the project in full months.
6. Call (part) identifier
The Call (part) identifier is the reference number given in the call or part of the call you were addressing, as indicated
in the publication of the call in the Official Journal of the European Union. You have to use the identifier given by the
Commission in the letter inviting to prepare the grant agreement.
7. Abstract
8. Project Entry Month
The month at which the participant joined the consortium, month 1 marking the start date of the project, and all other start
dates being relative to this start date.
9. Work Package number
Work package number: WP1, WP2, WP3, ..., WPn
10. Lead beneficiary
This must be one of the beneficiaries in the grant (not a third party) - Number of the beneficiary leading the work in this
work package
11. Person-months per work package
The total number of person-months allocated to each work package.
12. Start month
Relative start date for the work in the specific work packages, month 1 marking the start date of the project, and all other
start dates being relative to this start date.
13. End month
Relative end date, month 1 marking the start date of the project, and all end dates being relative to this start date.
14. Deliverable number
Deliverable numbers: D1 - Dn
15. Type
Please indicate the type of the deliverable using one of the following codes:
R Document, report
DEM Demonstrator, pilot, prototype
DEC Websites, patent fillings, videos, etc.
OTHER
ETHICS Ethics requirement
ORDP Open Research Data Pilot
DATA data sets, microdata, etc.
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
16. Dissemination level
Please indicate the dissemination level using one of the following codes:
PU Public
CO Confidential, only for members of the consortium (including the Commission Services)
EU-RES Classified Information: RESTREINT UE (Commission Decision 2005/444/EC)
EU-CON Classified Information: CONFIDENTIEL UE (Commission Decision 2005/444/EC)
EU-SEC Classified Information: SECRET UE (Commission Decision 2005/444/EC)
17. Delivery date for Deliverable
Month in which the deliverables will be available, month 1 marking the start date of the project, and all delivery dates
being relative to this start date.
18. Milestone number
Milestone number:MS1, MS2, ..., MSn
19. Review number
Review number: RV1, RV2, ..., RVn
20. Installation Number
Number progressively the installations of a same infrastructure. An installation is a part of an infrastructure that could be
used independently from the rest.
21. Installation country
Code of the country where the installation is located or IO if the access provider (the beneficiary or linked third party) is
an international organization, an ERIC or a similar legal entity.
22. Type of access
VA if virtual access,
TA-uc if trans-national access with access costs declared on the basis of unit cost,
TA-ac if trans-national access with access costs declared as actual costs, and
TA-cb if trans-national access with access costs declared as a combination of actual costs and costs on the basis of
unit cost.
23. Access costs
Cost of the access provided under the project. For virtual access fill only the second column. For trans-national access
fill one of the two columns or both according to the way access costs are declared. Trans-national access costs on the
basis of unit cost will result from the unit cost by the quantity of access to be provided.
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
HISTORY OF CHANGES
# Original Response and/or content change made to the DoA to be submitted for the Grant
submitted Agreement
#1 tables 7.1, table As requested, moved these tables to the Part A of Annex 1 to the Grant Agreement.
8, table 7.2, table Also, some mistakes have been amended.
9.3, table 10.2.
#2 Description of Task 1.1, 3.2 and 4.3 have been updated as well as description of WP5-8.
WPs have T1.1 "Consortium operating procedures and quality assurance" will cover this
updated activity. A clearer description has been included in the T1.1 description:
considering the "For deliverables and other documents, it is expected that documents could be
comments associated to one or more tasks of the project and therefore has one or more
included in the contributors. Each deliverable has usually a main contributor, which is also the partner
ESR and the responsible for the deliverable. This responsibility is always shared with the WP
revision made leader. All the deliverables must be submitted within the deadlines defined in the
by CHAFEA project. To guarantee the quality of the document a reviewer/s will be assigned per
and DGSANTE each deliverable according to the expertise in the area. The Reviewer assigned will
review the reports and deliverables from each work package and will give feedback
and comments in advance of the submission date of the deliverable. The Lead
beneficiary of a deliverable will take into consideration the feedback from the
reviewer and implement changes (if necessary)."
AGENAS is responsible for T4.3 " Merging action plans of the next adopters´ local
GP" and TX.3 "Specific interventions and actions" of transfer WPs. The choice of
having the same organization leading these tasks is to ensure that the process of
preparing the implementation of components from different original GP (mix-match
approach) is aligned and coordinated, avoiding duplicities, overlappings and gaps and
boosting synergies. At early stage, during the pre-implementation phase, AGENAS
will monitor the development of the Action Plans, putting special attention to next
adopters who have selected core features from distinct original GP.
A total of four study visits (one per original good practice) are planned in the concept,
which will be supplemented by workshops and the annual meeting. The study visits
are supposed to give all next adopters a practical insight into the best practices and
are therefore planned at the beginning of the implementation phase. In addition,
workshops, webinar and teleconferences will be organized where the next adopters
can address any problems that arise, exchange experiences and get feedback and
support from oGPs and partners responsible for the methodological part (Kronikgune,
AGENAS, NIJZ).
The task 3.2 has been extended with the information on specific support activities:
Workshop at Kick off meeting: the methodology for the scope definition will
be explained by Kronikgune
Workshop at study visits: dedicated sessions led by Kronikgune to present the
methodology to perform the SWOT analysis and to define local interventions
and Action Plans.
Teleconference: to monitor the SWOT analysis planning in each site
Teleconference: to review the output of the SWOT analysis of each site
Webinar: to refresh the methodology to define the local interventions and
Action Plans
Teleconference: review the Action Plans of each site
Workshop at 1st Consortium Meeting: next adopters present their local GP and
Action Plan and the methodology of PDSA cycles is explained by Kronikgune
Teleconference: to review the planning of the activities (Planning phase of
PDSA)
Sessions during the thematic workshops: next adopters present their learnings
and experience during the first months of the implementation and Kronikgune
provides support and coaching if needed
JADECARE- 951442
Webinar: the methodology Associated with document Ref. Ares(2020)3808356 - 20/07/2020
for implementation experience reporting is
explained by Kronikgune
New KPIs regarding general dimensions and digital transformation have been
included in T3.3. Impact evaluation.
In the transfer WPs, original GP owners are responsible for providing a detailed
description of their GPs, the needs and scope definition and implementations tasks,
whereas a next adopter is leading the situation analysis. AGENAS is in charge of the
"Specific interventions and action plans" in all transfer WPs. This strategy or
methodology seems to be practical and logical because: (i) the original GP
representatives can guide next adopters druing the scope definition and
implementation as they have experienced the same process in the past; (ii) one next
adopter coordinates situation analysis activity and can bring their real experience to
help other; and (iii) AGENAS can support next adopters in the final action plan
elaboration as they lead T4.3 as well. Having this approach allows original GP to have
greater visibility and responsibility in the transfer and adoption process.
The role of AGENAS is key for the coordination between WP4 and transfer WPs.
AGENAS is responsible for T4.3 "Blending action plans of the next adopters´ local
GP" and TX.3 "Specific interventions and actions" of transfer WPs. The choice of
having the same organization leading these tasks is to ensure that the process of
preparing the implementation of components from different original GP (mix-match
approach) is aligned and coordinated, avoiding duplicities, overlappings and gaps and
boosting synergies. At early stage, during the pre-implementation phase, AGENAS
will monitor the development of the Action Plans, putting special attention to next
adopters who have selected core features from distinct original GP.
The interdependency between WPs, tasks and deliverables has been clarified in
section 7.1, Overview of WPs with the inclusion of a new table.
#3 General and The policy expectation of reinforce the capacity of health authorities to address the
Specific important aspects of health systems transformations successfully has been included
objectives more clearly both in the general and specific objectives. The specific objective
(number one) regarding this expectation has been reformulated and the target values
have been modified.
Specific objectives have been updated:
"Specific Objectives and process, output and outcome indicators have been defined
in section 2.2.
A specific objective (number 6) addresses the degree of deployment of digitally
enabled integrated person-centred care (DEIPCC) in 24 European Regions with
different degrees of maturity. It sets different targets according to the baseline
maturity of the regions. There are process indicators such as the number of original
Good Practice´ (oGPs) features addressed in transfer process, the number of blended
next adopters Good Practices and Action Plans implemented. Output indicator include
Increased capacity to implement DEIPCC (including topics such as use of
technologies in care services, reorganization of care pathways and building capacity
of individuals and communities) and small-scale and large-scale deployment and/or
extended institutionalisation of DEIPCC. The outcome/impact indicator(s) is the
estimated target population of JADECARE.
Surveys and questionnaires to health professionals and patients are an excellent way
to receive important feedback about the real experiences and outcomes of the GP
adopted. The questions will be figured out in the future, when the information about
the implemented core features and progress of the practice are clears. Also, individual
interviews can be of profit in some cases to certain key actors of the implementation.
This qualitative approach is included in WP3."
#4 Political The context of the project has been detailed including the actual investment in
relevance healthcare in each of the participating countries, as well as the context of the
healthcare and the digital health services status.
#5 Methods and Description of original GP have been modified so the four of them are similarly
means written.
2 146
JADECARE- 951442
The table with the interested of nextAssociated
adopterswith
in document Ref. Ares(2020)3808356 - 20/07/2020
the original GP has been modified
according to the latest changes: Romania, Poland and one of the Spanish regions
(Extremadura) have left the Joint Action and the remaining Spanish regions have
selected the Danish GP.
The description of the Figure 5 has been extended:
"Most of the next adopters are willing to work on various dimensions in JADECARE,
having the use of technologies in care services (80,77%), use of patient reported data
(69,23%) reorganization of care pathways (61,54%), workforce roles and skills with
technology (57,69%) and citizen empowerment (57,69%) as the most prominent
relevance. Fortunately, the oGPs deal with these areas and their specific core features,
which are the transferable elements, provide concrete solutions or strategies. Next
adopters will select core features of one or more oGPs in order to tackle with the
challenges that the aforementioned dimensions entail."
Next adopters have provided information concerning the size of the implementation
(geographical area, size of the target population, number of healthcare professionals
involved, number of healthcare organizations participating). The table has been
inserted in "Next adopters in JADECARE section".
Information on the digitalization level of next adopters to support the modernisation
of health and social care systems have been described.
In the evaluation section, how policy expectations and SMART indicators are
associated is described. A table illustrating the relationship between policy
expectations, objectives, process indicators, outputs, outcomes and analysis approach
has been added.
#6 Deliverables Some deliverables have been renamed in order to be self-explanatory and descriptions
have been modified to be clearer.
We have added a new deliverable in WP1 D1.1 Project handbook that have been
eliminated from the Milestones
We have eliminated the (old) D2.4 Mid-term report on Dissemination and add it as a
milestone. Target group, means of communication, timeline, languages and content
(main pointshave been described for deliverable D2.3: in addition, interested public,
language(s) and content (main points) have been addressed for Layman Report that
now is D2.5 instead of D2.6.
We have added a new deliverable in WP4. D4.1 “Local Good Practices and Action
Plans (see 2.2).
The description of D3.1, D3.2 and D3.3 have been further elaborated.
The old deliverable D4.1, “Handbook on learning from good practices” is now the
D4.2 “Blueprint on learning from good practices". The actual D4.2 deliverable will
include information on guidelines and standard operation procedures for good
practice uptake, including core elements to assure scale up and sustainability after the
end of the project to guarantee further implementation at a European level. Tasks 4.4
and 4.5 have been re-described accordingly.
The new D4.1 deliverable "Local Good Practices and Action Plans” ill depict the
scope definition, situation analysis and action plans of each next adopter (including
merging of action plans where mix-match approach is selected).
The deliverables of transfer WPs (D5.1, D6.1, D7.1 and D8.1) will now contain
detailed information of the Good practices, including main block and core features
identified in T4.1, implementation requirements and process step-by-step, barriers
found and solutions identified, lessons learnt and recommendations and the present
situation of the oGP, and of the implementation process in each next adopter´s site.
The operational phase based on PDSA cycles will be described, how the planned
activities of the Action Plans have been implemented, the results obtained and the
adaptations incorporated to improve the deployment of interventions.
The content of the deliverables are described in detail in each WP. All this information
has been updated in the deliverable and milestone’s tables as well.
#7 Risks New risks related to the management of worldwide crisis like the one generated by
COVID-19 have been added.
#8 Quality and The selection of the oGP by the SGPP has been included in the section.
capacity of hte Description of partners have been balanced and homogenized, and some mistakes
partnerhip. have been corrected.
3 146
JADECARE- 951442
#9 Budget Budget has been updated according Associated with document Ref. Ares(2020)3808356 - 20/07/2020
with the changes in the selection of the oGP by
some entities as well as by the departure of Romania, Poland and Extremadura.
Resources allocated to next adopters are not expected to cover implementation costs.
The overall budget of the JA (5 million Euros) can realistically only cover
management, methodological analysis, knowledge exchange, evaluation and
reporting activities. we expect these to be quite similar for all next aopters regardless
the final scope of their implementation. Technology procurement, upgrading and
implementation, staff training and deployment and other costs cannot be covered.
Therefore, all next adopters will have to fund them with their own budgets. The scope
and depth of Good Practice implementation and therefore the total amount of money
that they will spend will be quite heterogenous and will depend on them.
All comments by the Financial Officer are considered in the Budget details:
Although the budget has not been changed, it can be confirmed that
implementation activities with national scope only are excluded from the
budget. Budget has been updated according with the changes in the selection
of the oGP by some entities as well as by the departure of Romania, Poland and
Extremadura. All Spanish regions except Extremadura, who leaves the Joint
Action, have selected the Danish original Good Practice, so they have the same
estimated costs. Changes in the DoA and in the budget have been made
accordingly.
Some beneficiaries estimate staff costs for “implementation experts” and it has
been confirmed that implementation experts are staff members of beneficiaries/
affiliated entities.
“Unit cost” has not been the model to estimate the travel costs: The transfer and
implementation methodology that will be used foresees similar number of face
to face meetings, workshops or study visits. It is not a question of facilitating
the Project Planning but optimize resources and time available for the whole
process. Specific issues such as the constraints that may arise due to special
needs or differences in travel fees will be dealt with locally by each partner.
Changes may be needed to adapt to the post COVID19 situation but they cannot
be estimated yet. A contingency plan has been foreseen and described in the
Risk Analysis.
CSFJA has modified its budget. SAS staff members will not allocate hours to
JADECARE.
IDIBAPS has added a new staff function, Project Manager. They have modified
the budget. Now the total effort is allocated between Project manager (12 PM)
and Senior researcher (4 PM).
The 2 affiliated entities of MCA have exactly the same budget because they
have similar roles and costs salaries and they have the same tasks to do in their
autonomous entities: the Federation of Bosnia and Herzegovina and Republika
Srpska.
CIPH has planned more than one senior researcher in this project. They will
work for 9,3 PM (in 3 years) in total.
UHO (affiliated entity of MZCR) have modified the description of the
functions and has updated the budget. Regional stakeholders will not allocate
hours to JADECARE.
EUROSTRAS has modified its budget following the recommendations and has
included an audit costs in order to include a certified financial statement , CFS
report. Thematic workshops remain, but budget has been adjusted.
BAGSFI and also for their affiliated entities, LGL and ZTG: the different
functions have the same monthly rate because, although functions are different,
profiles requested for the tasks and responsibilities to be performed are
equivalent, so monthly rates are similar.
NOVA has modified the staff function. 2 researchers (master scholarships),
will work on the action.
NIJZ has modified its budget following the recommendations and has included
an audit costs in order to include a certified financial statement , CFS report.
4 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
#10 Roles and New roles have been defined in sections 5.2, 9.1 and 9.2 to adapt the proposal to the
responsibilities Participant Portal’s template and to clarify participants’ responsibilities; Leading
Beneficiaries and Leading and Co-leading Executive Organizations.
Coordination and implementation roles and activities in the Joint Action will be
performed by CAs (as Leading Beneficiaries, LB), and AEs. AEs can act as Leading
Executive Organisations (LEO) and Co-Leading Executive Organisations. CAs and
AEs are responsible for Work Packages and/or Tasks and contribute to the
Deliverables and Milestones as described in the JADECARE Joint Action.
Responsibilities of all CAs and AEs in charge of WPs, tasks and/or milestones have
been further defined and clarified.
5 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
TABLE OF CONTENTS
2.1 PROBLEM ANALYSIS INCLUDING EVIDENCE BASE ....................................................................... 6
2.2 AIMS AND OBJECTIVES OF THE PROJECT ........................................................................................ 8
2.3 STAKEHOLDER - TARGET GROUPS.................................................................................................... 11
2.4 POLITICAL RELEVANCE ........................................................................................................................ 13
2.5 METHODS AND MEANS ........................................................................................................................... 22
2.6 EXPECTED OUTCOMES AND BENEFITS OF THE PROJECT ........................................................ 55
2.7 GANTT CHART........................................................................................................................................... 56
2.8 PROJECT MANAGEMENT STRUCTURE ............................................................................................. 65
2.9 BUDGET ....................................................................................................................................................... 92
2.1 PROBLEM ANALYSIS INCLUDING EVIDENCE BASE
Life expectancy in the European Union has increased significantly in the last 50 years. In 2016, life expectancy at
birth was 81 years across the 28 EU member states1. By 2030, 22% of the population will be 65 and over2, 7% older
in 2010. The proportion of people aged 80 years or more is expected to reach 14.6 % by 21003. Advanced age is often
linked to multiple diseases with complex needs4. In the years to come, the number of people suffering from chronic
diseases will increase exponentially. However, the available evidence shows that a sizable number of younger people
also suffer from multiple diseases5.
Chronic diseases affect over one-third of the European population6. As a consequence, there is a growing demand for
health care services and social care services to help such patients perform their everyday activities. People with
chronic diseases, especially those with multimorbidity, need a long-term response, which should be coordinated by
different health and social professionals7. This creates diverse needs8 which challenge the patients and health services9,
several specific challenges are affecting the health and care delivery models in Europe.
As the number and complexity of health conditions increase, with overlaying episodes of acute illness, the type and
number of care providers contributing to the care of individuals also increases. Patients with several chronic
conditions may visit up to 16 physicians in a single year10.
INTEGRATED PERSON-CENTERED CARE
The ageing of the population with the growing burden of chronic conditions and multimorbidity is steadily increasing
the demand for a more extended and efficient care and a more intelligent outcome-based delivery of personalized
care. Unfortunately, many of the existing European medical models focus primarily on short- and medium-term
interventions for single conditions, failing to integrate the care planning of the providers and often overlooking the
interconnections between different chronic diseases11.
The absence of a coordinated approach to health and social care increases the difficulties in aligning and coordination
of across care teams and care settings. This seriously compromises the ability of health systems to provide universal,
equitable, high-quality and financially sustainable care12. It in specialization with "siloed" and fragmented care
approaches, due to poor communication and information sharing, causing shortcomings and gaps or patients
with chronic conditions and long-term care needs.
The evidence suggests that developing integrated person-centered care should generate significant improvements in
the care and health of all citizens. This should include enhanced quality and access to care, health and clinical
outcomes, health literacy and self-care. The satisfaction of patients and job satisfaction for health and care
professionals would also improve, as would the efficiency of services. The overall costs would be reduced13. Person-
1
Health at a Glance 2018: https://ec.europa.eu/health/sites/health/files/state/docs/2018_healthatglance_rep_en.pdf
2
OECD: Economic, Environmental and Social Statistics. http://dx.doi.org/10.1787/factbook-2009-3-en
3
Eurostat. Population structure and ageing. http://ec.europa.eu/eurostat/statistics-explained/index.php/Population_structure_and_ageing (Accessed 13 October
2019)
4
The King’s Fund, ‘Providing integrated care for older people with complex needs: Lessons from seven international case studies’.
http://www.kingsfund.org.uk/publications/providing-integrated-care-older-people-complex-needs
5
Barnett K, Mercer S, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical
education: a cross-sectional study. Lancet 2012;380:37-43.
6
European Commission, Communication from the Commission to the European Parliament and the Council: Taking forward the Strategic Implementation Plan
of the European
7
Piette, J., Richardson, C. and Valenstein, M. (2004) Addressing the needs of patients with multiple chronic illnesses: the case of diabetes and depression, Am
J Manage Care, 10: 152–62.
8
https://link.springer.com/article/10.1007/s11136-015-1102-8
9
Wagner EH. Meeting the needs of chronically ill people. BMJ 2001; 323: 945–946.
10
Pham HH, et al. Care patterns in Medicare and their implications for pay for performance. N Engl J Med 2007;356:1130-9
11
Building a Workable Model for the Holistic Management of Chronic Conditions in Europe, October 2012, EPPOSI AIP-CCM White paper
12
Nolte E, McKee M, eds. Caring for people with chronic conditions. A health system perspective. Maidenhead: Open University Press/McGraw Hill Education,
2008.
13
Goodwin, N Dixon A, Anderson G, Wodchis W. Providing integrated care for older people with complex needs; lessons from seven international case studies.
The London: The King’s Fund; 2014
6 146
JADECARE- 951442
centered care identifies health concerns and needs, shared health Associated
objectiveswith document Ref. Ares(2020)3808356 - 20/07/2020
and healthcare goals, and appropriate
healthcare activities, associated with the healthcare process.
This requires that European countries move towards a more integrated person-centered approach14 to care delivery.
This approach should be designed in a way that coordinates services around the needs of the citizens and puts them
in the center, enabling them to participate in, and make informed decisions, about their care15. Many countries are
already implementing some form of integrated care even though the nature and scope of their approaches differ16.
However, many health systems have already experienced and acknowledged difficulties in introducing good quality
integrated care17.
DIGITAL INNOVATION TO ENABLE INTEGRATED PERSON CENTERED CARE
Innovative solutions are needed to deliver integrated person-centered services based on citizen's needs through new
technologies, products and organizational changes. Digital innovation has the potential to facilitate and support these
changes by improving the coordination and up-to-date information channels and delivering more targeted,
personalized, effective and efficient healthcare18. The Communication on Digital Transformation of Health and Care
in the Digital Single Market identifies three priorities19: (i) secure access of the citizens to their health data, also
across borders, (ii) personalized medicine using shared European data infrastructure and (iii) citizen empowerment
by employing digital tools for collecting user feedback and person-centered care.
Such innovative digital tools and services have demonstrated that help delivering integrated patient centered care to
the population improving the quality of integrated care, for reducing costs and also facilitating innovative models of
integrated care20. To harvest the full benefits of integrated digitally enabled person centered care, digital health tools
need to be integrated into healthcare and social care delivery systems. However, the difficulties implicit in the
design, implementation, transfer and evaluation of integrated care are still to be overcome.
IMPLEMENTATION AND TRANSFER OF INTEGRATED PERSON CENTERED CARE SOLUTIONS
The journey of care delivery transformation in Europe is still in its first stage. The underlying digital health
technologies that will support this transformation need to be purposefully designed, developed, and must demonstrate
cost-effectiveness potential. It is a complex program of change which requires adequate methods, processes, tools
and techniques21. To speed up the adoption of integrated person-centered care solutions in Europe, Member states
need to improve their capacity to redesign and improve their healthcare systems. This requires simultaneous
operations at three levels: at the system level (strategy, governance and allocation of resources); at the service level
(commissioning, operations and service redesign); and at the interface between service users, carers and their care
providers (delivery of care in new and better ways)22.
The systematic incorporation of evidence-based interventions into practice and policy can improve healthcare
performance and outcomes23. However, population-wide health improvements depend on large-scale implementation
of effective health interventions24. The transfer and spread of innovation from their sites of origin to other regions
could accelerate the progress in Europe. One key lesson learned from the successful cases of implementation of
integrated care25 is that the approach has to be adapted to local context and needs, otherwise he intervention(s) may
not deliver the expected benefits. Care authorities should focus their care integration ambitions on local
circumstances. Attainment of the broad health system goals, including quality, accessibility, efficiency and equity,
are objectives against which to judge new digital health services.26
The EU has launched a series of initiatives to support facing these challenges, such as the European Innovation
Partnership on Active and Healthy Ageing (EIP on AHA) with twinning between partners, various Joint Actions such
as CHRODIS, CHRODIS Plus, and eHAction, and EU-funded projects ACT@Scale, CAREWELL,
BEYONDSILOS, SCIROCCO, SCIROCCO Exchange, SEPEN, C3Cloud or VIGOUR among others.
Following the meeting of the Steering Group on Health Promotion and Prevention and Management on Non-
Communicable Diseases (SGPP) in February 2019, four early adopters of original Good Practices (oGP) were
14
WHO, World Health Organization. Framework on integrated, person-centered health services, 2016. http://www.who.int/servicedeliverysafety/areas/people-
centered-care/en/
15
Co-production recognises that people have assets such as knowledge, skills, characteristics, experience friends, family, colleagues and communities.” McColl-
Kennedy, Janet R., et al. "Health care customer value co-creation practice styles." Journal of Service Research (2012): 1094670512442806.
16
Nolte E, Knai C, McKee M, eds. Managing chronic conditions - experience in eight countries. Observatory Studies Series No. 15.Copenhagen: World Health
Organization, on behalf of the European Observatory on Health Systems and Policies, 2008.
17
Gröne O, Garcia-Barbero M (2002): Trends in Integrated Care - Reflections on Conceptual Issues. WHO.
18
2014 Communication from the European Commission on "effective, accessible and resilient health systems" and the Annual Growth Survey 2016
19
https://ec.europa.eu/digital-single-market/en/european-policy-ehealth
20
https://www.ijic.org/articles/10.5334/ijic.3051/
21
Blueprint 2017
22
Deliverable 4.2 – C3Cloud project
23
Foy R, Sales A, Wensing M, Aarons GA, Flottorp S, Kent B, et al. Implementation science: a reappraisal of our journal mission and scope
24
Durlak JA, DuPre EP. Implementation Matters: A Review of Research on the Influence of Implementation on Program Outcomes and the Factors Affecting
Implementation. Am J Community Psychol. 2008 Jun 1;41(3–4):327–50.
25
EC, European Commission. Tools and Methodologies to Assess Integrated Care in Europe, 2017
26
Assessing the Impact of Digital Transformation of Health Services Expert Panel on effective ways of investing in Health (EXPH)
https://ec.europa.eu/health/expert_panel/sites/expertpanel/files/docsdir/022_digitaltransformation_en.pdf
7 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
selected to transfer these oGP to other EU Member States (next adopters). These oGPs cover integration, chronic
conditions, multimorbidities, frail people and patients with complex needs, self-care, prevention and population
health, disease management and case management. The selected oGPs were:
Basque Health Strategies in ageing and chronicity: integrated care (Spain)
Catalan open innovation hub on ICT-supported integrated care services for chronic patients (Spain)
The OptiMedis Model – Population-Based Integrated Care (as implemented in Gesundes Kinzigtal) (Germany)
Digital roadmap towards an integrated health care sector (Region of Southern Denmark, Denmark)
Basque Health Strategies for ageing and chronicity: integrated care good practice is a population model based on
preventive interventions, patient empowerment, and personalized medical care. It places particular emphasis on the
continuity of care, security, adherence and improving the patient experience. It includes “Integrated Care
Organizations” (ICO) with Joint Governance bodies for primary care and hospital, with a defined population
catchment area; multidimensional assessment and action for people aged 70 or older (Care Plan for the Elderly). It
includes risk stratification and care plans based on the needs for a complex patient, new nursing roles (such as liaison
nurses and case managers), safety in polypharmacy management, patient empowerment and self-management and
social and health coordination. It is supported by an eHealth strategy and a 24X7 Nursing Call Centre.
The Catalan open innovation hub on ICT-supported integrated care services for chronic patients is conceived to serve
the entire population of Catalonia (7.6M citizens). However, the target is chronicity with focus on multimorbidity
management and on citizens with complex health and social care needs. Accordingly, it encompasses both vertical
(specialized vs. community-based care) and horizontal (healthcare vs. social support) integrations, combining a
population-health orientation with a collaborative adaptive case management approach. The practice proposes five
blocks, with up to eighteen specific features, for transferability to next adopters. Briefly, the five blocks are: B1-
Health risk assessment: population-based and enhanced clinical decision making; B2- Promotion of healthy lifestyles;
B3- Vertical and Horizontal integration experiences adopted in Catalonia, B4- Innovative assessment and regulatory
aspects and B5- Digital support of integrated care services.
The OptiMedis Model – Population-Based Integrated Care is a management company of integrated care networks,
providing advanced data analytics and designing innovative care models with a focus on population health
management. Its aim is to achieve the Quadruple Aim, improving population health, improving the patient experience
of care, reducing unnecessary costs and ensuring provider satisfaction. The basis of its work is a shared savings
contract with insurers and a model including strong stakeholder engagement, electronic integration across providers,
patient involvement and empowerment, and data-driven management. The model focuses on patients with high needs
and high costs, but also emphasizes prevention, health promotion and public health to generate value for the
population in the long run.
The Roadmap towards Integrated Care implemented in the Region of Southern Denmark consists of different parts
of an integrated and digital patient-centered approach. The foundation is the SAM:BO27, which is a regional
collaboration agreement between all actors in the health care sector in the Region. The goal of the agreement is to
ensure cohesive and integrated patient experiences and the result is among other elements patient care pathways,
which are based on nationally adopted standards with more than 65,000 standardized electronic messages transmitted
daily in the Region. On top of this foundation are several services, such as the Generic Telemedicine Platform, Digital
Health Centre, Tele-COPD and Tele Psychiatry. The common feature is using technology to bring more flexibility
and quality to the patients as well as using the clinical resources better.
JADECARE will contribute to innovative, efficient and sustainable health systems, providing
expertise and sharing good practices to assist the Member States in undertaking health system
reforms. It will enable the participating national authorities and those beyond the Consortium, to
benefit from efficient solutions in digitally enabled integrated person-centered care developed by
the early adopters of the original Good Practices (oGPs).
2.2 AIMS AND OBJECTIVES OF THE PROJECT
GENERAL OBJECTIVES OF THE PROJECT
The general goals of JADECARE are:
To reinforce the capacity of health authorities to address all the important aspects of health system
transformation successfully, in particular the transition to digitally enabled, integrated, person-centered care
To support the best practice transfer from the systems of the “early adopters” to the “next adopters”.
27
Strategic Intelligence Monitor on Personal Health Systems Phase 3 (SIMPHS3) - SAM:BO (Denmark) Case Study Report
8 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Health authorities will strengthen their capacity for digitally enabled, integrated, person-centered care by improving
knowledge in the use of implementation methodologies, adopting a systematic appraisal of the quality of practice
transfer and including sustainability elements in the transferred local good practices. Authorities will participate in a
community of stakeholders that explores ways to boost and leverage the inclusion of digitally enabled, integrated,
person-centered care at policy level.
The transfer of the best practices from early adopters selected by the SGPP will be focused on the preparation of the
local environment for the implementation. Depending on local circumstances, the appropriate strategies will be
formulated and resources committed. A learning community will be created for developing, collecting and
exchanging knowledge through “twinning actions”, dedicated seminars and workshops, and other activities.
JADECARE will reinforce the capacity of care authorities to:
Support the change management and re-organize the existing care models as a result of piloting that will be done
in WP5-8. JADECARE will generate data on the impact of the change and establish a common framework and
methodology of how integrated care (IC) should be delivered
Embed digital technologies and tools in the care services: all oGPs are based on the use of digital technologies
and tools and the JA will also analyze how the implementation could be done in a broad range of situations from
digital illiterate health systems to very advanced ones
Re-organize patient pathways in sites including the experience and point of view of the patients
Consider and monitor health workforce roles and skills with digital technologies and data development
Build the capacity of individuals and communities to participate in the care process
Empower citizens in active participation in healthcare decision making, including the use of patient reported data
Analyze new payment methods
Evaluate new performance assessment methods
The scope, scale and extent of these general objectives will be customized for each of the next adopters according to
their needs and their interest in local strategies and action plans.
SPECIFIC OBJECTIVE(S) OF THE PROJECT
The objectives of the Project will be established at two levels: A) the Joint Action in overall and B) the next adopters
practice implementation.
(A) At Joint Action level, Specific Objectives address ambition, impact, deployment and management. Each of
them has process, output and outcome indicators defined. Objectives 1 to 4 address the ambition and impact of
JADECARE and are mainly related to the policy expectation of reinforcing the capacity of health authorities to
successfully address important aspects of health system transformation, in particular the transition to digitally-
enabled, integrated, person-centred care. Objectives 5 to 7 address the policy expectation related to supporting
best practice transfer. Objective 8 deals with the usefulness of the project.
Specific Objective 1 Target value
To support and reinforce digitally enabled integrated person-centered care (DEIPCC) in
24 European settings with different degrees of maturity
Process Indicator(s)
Number of oGPs´ features covered in transfer process 8
Number of next adopters Good Practices and Action Plans 23
Action plans implemented including pathway reorganization, digital technologies and 80%
tools, change management and training and research programs measures
Output Indicator(s)
Increased capacity to implement DEIPCC. 15 Settings (countries,
regions, or areas)
Small-scale deployment DEIPCC. 7 Settings
Large-scale deployment and/or extended institutionalization of DEIPCC 1 Setting
Outcome/Impact Indicator(s)
Estimated target population in JADECARE 50,000 people
Specific Objective 2 Target value
JADECARE is useful for governments´ commitment to support for further building the
capacity to deliver integrated person-centered care.
Process Indicator(s)
Number of MoHs of JADECARE competent authorities represented in the Policy Board 17
Number of MoH (or national focal points for Health Programme at EC) from MSs that do 5
not participate in JADECARE
Number of DG Sante and CHAFEA representatives 2
9 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Policy dialogues of Policy Board members 3
Output Indicator(s)
Reports including recommendations to next adopter’s sustainability plans 3
Outcome/Impact Indicator(s)
Level of perception that JADECARE will support further building up the capacity of 80%
national and regional authorities to organize and deliver integrated person-centered care
including integration in policies, as expressed by Policy Board members
Specific Objective 3 Target value
To create a community of stakeholders that includes caregivers, healthcare experts,
academia, industry, policy makers and /or general public.
Process Indicator(s)
Number of meetings with stakeholders >20
Number of presentations at scientific and policy discussion events >40
Output Indicator(s)
Estimated audience of JADECARE dissemination channels 1,000
Outcome/Impact Indicator(s)
Level of perception that JADECARE guidelines and results have impact in policy setting, 90%
and scientific, industrial and general debates and fora
Specific Objective 4 Target value
To improve next adopters´ digital transformation
Process Indicator(s)
Analysis of digital situation is performed in next adopters’ sites 23
Establishment of specific objectives regarding digital transformation are set in next adopters
Action Plans 23
Output Indicator(s)
% Sites with Changes in digital services are confirmed (digital health system infrastructure; 80%
data analytics and use of technologies, citizen empowerment tools and patient reported data.
Outcome/Impact Indicator(s)
Perceived improvement of digital services by end users 80%
Specific Objective 5 Target value
To support next adopters in facilitating the sustainability of the practice with plans for actions
at local/regional/national level
Process Indicator(s)
Elements of sustainability are addressed in all individual implementation action plans 23
Establishment of local/regional/national networks among next adopters and stakeholders 23
identified to be important to assure sustainability
Output Indicator(s)
Sustainability strategy and action plan of next adopters’ practices 23
Outcome/Impact Indicator(s)
Perceived probability that the developed practice will be sustainable after end of JADECARE, 80%
as expressed by members of local/regional/national networks among next adopters and
stakeholders identified to be important to assure sustainability
Specific Objective 6 Target value
Perform a systematic appraisal of the quality of the transfer and implementation process,
understanding, evaluating and reporting the experience of adopting oGPs in heterogeneous next
adopter sites.
Process Indicator(s)
Scope definition, situation analysis and PDSA cycle performed on schedule 80%
Output Indicator(s)
CFIR and SQUIRE 2.0 reports on adoption of good practices 23
Outcome/Impact Indicator(s)
Blueprint on learning from good practices 1
10 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Specific Objective 7 Target value
To improve knowledge and skills of transfer methodologies and tools
Process Indicator(s)
Number Study visits 4
Number Thematic workshops 12
Output Indicator(s)
Number of professionals participating in different knowledge exchange actions 200
Satisfaction with knowledge exchange actions 80%
Outcome/Impact Indicator(s)
% of professionals that improve in knowledge and skills 80%
Specific Objective 8 Target value
Quality, compliance and usefulness
Process Indicator(s)
% surveys completed (acceptance rate & perceived usefulness) 80%
Output Indicator(s)
Satisfaction with the project progress 80%
Outcome/Impact Indicator(s)
% stakeholder consider Project useful 90%
(B) At next adopters’ level SMART objectives and key performance indicators will be tailored to each site
according to the local Good Practice and Action Plans defined and implemented. They will be defined in the
transfer Work Packages (WP 5-8). They will consider general dimensions and digital transformation.
Regarding general dimensions, the objectives will cover:
scope and degree of adoption of original Good Practices (oGPs),
specific process, pathway reorganization and change management,
the involvement and commitment of key stakeholders,
the implementation experience,
continuity and sustainability of the practice.
Regarding digital transformation, SMART objectives and KPIs will cover:
digital health system infrastructure,
risk stratification and data analytics,
use of technologies including Electronic Health Record, personal health folder and electronic prescription,
citizen empowerment and use of patient reported data,
innovation initiatives on integrated care reorganization of care pathways, workforce roles and skills
training and research programs.
Next adopters will set SMART objectives (specific, measurable, appropriate, realistic and time-bound)
◦ Specific: A clear description of the aim:
◦ Measurable: Precisely defined and easily quantified
◦ Appropriate: It should fit the local needs, capacities and culture of the target group
◦ Realistic: There must be a reasonable chance that the objective or aim can be reached
◦ Time-bound: It must be related to a certain time period
2.3 STAKEHOLDER - TARGET GROUPS
As described in the Blueprint Digital for transformation of Health and Care for the Ageing Society 28, the “integrated
care” does not evolve naturally and needs a deep transformation of care delivery mechanisms not only from the point
of view of health care providers and professionals but also considering the whole society. Thus, it is critical to reach
all stakeholders to create a long-lasting community where multidisciplinary teams, including patients, formal and
informal caregivers are established and processes for collaboration are set-up. The necessary policies, technology
tools/platforms and skills should be available to assure sustainability and replicability of the innovative models
provided by this Joint Action. The list of stakeholders within and beyond those involved in JADECARE is given in
the following table:
TABLE 1. JADECARE STAKEHOLDERS
28
https://ec.europa.eu/digital-single-market/en/blueprint-digital-transformation-health-and-care-ageing-society
11 146
JADECARE- 951442
Stakeholders Role in JADECARE Methods Associated withgroup
to reach the document Ref. Ares(2020)3808356 - 20/07/2020
Number
Regional / Local Seven regional healthcare systems are National/Regional/local early adopter health 23
Health systems going to participate in JADECARE as systems will involve extended regional teams
Competent Authorities (CAs). In (WP5-8). Local teams will choose the final core
addition, 15 regional healthcare services features of good practice to be transferred. In WP4
are going to be involved in the project a learning community will be created and
as Affiliated Entities (AE). Those CAs supported to promote knowledge
and AEs are going to participate generation/exchange. All health systems will be
actively in all Work Packages (WPs) involved in the tasks indicated in WP4, for
acting as next adopters and also as replicability and sustainability.
owners of the oGPs to be transferred.
National Health The CAs have been nominated by the A Policy Board will be created, led by NIJZ, in 17
systems/ corresponding Ministries of Health of which the corresponding Ministries of Health of all
Ministries- their countries, so they will be informed participating countries will be involved.
Healthcare of the project progress. The institutions
decision makers from national health systems level from
Bosnia and Herzegovina, Czech
Republic, Estonia, Hungary, Italy,
Latvia, Lithuania, Portugal, Serbia and
Slovenia will participate in the project
either as CA or AE.
Health Policy JADECARE will attempt to engage Other European health systems also will be invited 20
makers and them in fora/committees beyond the to participate in the annual stakeholder forum.
experts health systems involved in the project. They will have access to JADECARE deliverables,
EIP-AHA and Horizon Europa including the Blueprint on learning from good
partnership events and meetings will be practices (D4.2) and the Report on sustainability
an essential forum for JADECARE and integration in national policies (D4.3). WP2,
project discussion WP3 and management activities will make a
special effort to participate in European events
(high-level events of the EU Health Program, EU
Health Summit). The project will produce a
roadmap for the changes needed to introduce
integrated care.
Health The Regions participating in Healthcare professionals will actively participate 250
professionals JADECARE will include in their teams’ in all the WP. They will play a key role in the
and other the clinicians, nurses, IT staff and implementation and transfer of the good practices,
operators managers. A real commitment of detecting the barriers, the key factors (next adopter
professionals is critical to achieve an working groups NAWG). The new role and skills
effective change in healthcare services. development will be shared with wider groups of
Creation of teams with the rest of the professionals through planned communication and
stakeholders will be a fundamental part dissemination channels.
of the project.
Patient Patients will be the participants The project website will provide updates on the 23
organizations (regional teams) and potential users of project background, aim and status; articles in the
the designed services in the new models. lay press or publications by the participant Health
They will take part in the meetings Systems will be focused on the impact on the
described in WP5-8, as well as in patients. Specific patient organization will also be
activities included in WP2. contacted during regional meetings.
Social entities NGOs, active civil associations, key Representatives will take part in the regional 23
working on the leaders/associations in the participating meetings, in WP5-8 and in dissemination
field countries and regions will be included in activities. They will actively participate in the local
representing the the local stakeholder networks dissemination activities to guarantee the social
general supporting the changes in integrated impact and acceptance of the new models.
population care and maximizing the impact of the
JA.
Industry: Digital Will take part through the participating JADECARE will invite the key 15
health health systems as ICT developers or industries/developers to the stakeholder forum and
tools/services collaborators in the to the regional events to consider how to enhance
and platforms development/maintenance and the competitiveness of EU industry to create
developers, ICT integration of the necessary economic growth opportunities.
health sector.
12 146
JADECARE- 951442
Stakeholders Role in JADECARE Methods Associated withgroup
to reach the document Ref. Ares(2020)3808356 - 20/07/2020
Number
tools/platforms for the digitally enabled
integrated care.
Scientific Will participate in scientific fora and JADECARE will participate in relevant scientific 20
community meetings. Representatives of some of events at the European and international levels. In
selected relevant projects and initiatives addition, partners from other related projects will
will be invited to join in WP2 activities. be directly invited to participate in the events
organized by JADECARE.
Specialized Will boost the dissemination and impact Press releases on the main progress and results of 10
media of the JA. the project will be produced.
Universities and The next generation of professionals JADECARE will target universities and training 50
training will guarantee real change and the organizations and present the JA achievements and
organizations(ne sustainability of integrated care. A results. Stakeholders read the scientific
xt generation of change in culture can only be achieved publications in international peer-reviewed
healthcare through their education and scientific journals; the new generation
professionals, involvement. professionals will be reached via presentations at
researchers, national and international congresses and
engineers, ICT conferences. They can influence under- and
developer) postgraduate training programs.
Third Party They have an important role in defining Stakeholders will be invited to analyse and 30
Payers, Official the basket of services and consider possible ways of effective preparation to
Audit Bodies, reimbursement schedules, analyzing meet the requirements of payers and
Health efficiency or proposing new procedures, reimbursement authorities. Stakeholder will be
Technology services, drugs or devices. They are key engaged at the local and European level meetings
Assessment stakeholders in designing and and workshops.
Agencies and implementing the sustainable transfer of
other public or good/best practices, as well as in de-
private commissioning the old models.
regulatory or
standards
organizations
2.4 POLITICAL RELEVANCE
Joint Action on implementation of digitally enabled integrated person-centered care (JADECARE) is perfectly
aligned with the objectives of the Third Programme of the Union Action in the field of health, as well as with one
of the main areas included in the Societal challenge 1 of H2020. The challenge tries to generate solutions to the rising
demand for health, social and informal care services in the ageing population with a growing burden of chronic
diseases and reduce health inequalities.
JADECARE will enable the participation of national authorities but also involve, if possible, those from outside the
Consortium, to benefit from efficient solutions in digitally enabled integrated person-centered care developed by the
early adopters. This should reduce duplication of effort and increase value for money, by promoting innovative
solutions in the field of integrated health care. JADECARE will demonstrate the impact of the digitally enabled
integrated person-centered care solution in health systems around Europe. Even more importantly, it will generate
the knowledge necessary for successful design and implementation of digitally enabled person-centered care
solutions, mainly thanks to work done for the transfer (WP5-8) and evaluation (WP3) of the GP. The JA will support
the development of sustainability plans as part of action plans and implementation reports. It will indicate how the
involved Member States could support sustainability and integrate the results in their national policies, including the
visibility of European Union co-funding and institutions outside JADECARE (EIT HEALTH, other Member states,
or International Organizations).
JADECARE is perfectly aligned with three out of four priority areas included in the Work Program for 2019.
It will directly generate and share country-specific and cross-country knowledge by identifying and sharing the
experience of early and next adopters in the design and implementation of integrated care solutions. The project will
also contribute to the structural support of health systems and generate links to the digital single market. This will be
made possible by the participation of 17 different European countries interested in the implementation of new policies
for digitally enabled person-centered care and can align their strategies with the recommendations generated in the
Joint Action. JADECARE will help to promote health and prevent the impact of non-communicable diseases by
providing measures to the health systems around Europe to organize and deliver integrated person-centered care. But
it also will contribute to improve the health of European citizens and reduce health inequalities, encourage innovation
13 146
JADECARE- 951442
in health and increase sustainability of health systems, focus on Associated
themes thatwith document Ref. Ares(2020)3808356 - 20/07/2020
address current health issues across
Europe and support and encourage cooperation between European countries.
CONTRIBUTION TO THE ANNUAL WORK PLAN
JADECARE project will contribute to the objectives of the Thematic priority 3.4. of Annex I to the Third Health
Programme Regulation. It will help to develop innovative, efficient and sustainable health systems, providing
expertise and sharing good practices to assist Member States in undertaking health system reforms. It will set up a
methodology for pooling the expertise of these 17 Members States. The Work Plan divided into eight work packages
deploys the blueprint designed to ensure the desired impact of JADECARE. It will provide evidence-based advice
on effective and efficient investment and innovation in health systems, based on the experience of the four original
Good Practices in digitally enabled integrated person-centered care. The four oGPs have been selected by the Steering
Group on Health Promotion and Prevention and Management of Non-Communicable Diseases (SGPP) as the most
interesting and promising practices to transfer to other countries.
JADECARE is led by Kronikgune as Competent Authority from Spain and the owner or early adopter of the
selected practice Basque Health Strategies in ageing and chronicity. Kronikgune will lead the WP5. IDIBAPS
(affiliated entity to Kronikgune) is the owner of the Catalan open innovation hub on ICT-supported integrated care
services for chronic patients. IDIBAPS will lead the WP6. The owners of the oGP OptiMedis Model-Population-
Based Integrated Care, will be subcontracted by Eurométropole de Strasbourg (France), the leader of WP7. The
procurement procedure without prior advertising or competitive tendering is subject to the articles L.2122-1 and
R.2122-3 of the French public procurement code, in accordance with EU regulations. The Region of South Denmark,
owner of the oGP Digital Road and the leader of WP8 is an affiliated entity of the Danish Competent Authority,
North Denmark Region.
Based on the broad experience of these early adopters (and other partners in the project) in implementing/transferring
practices from setting to another, JADECARE will progress beyond state of the art in transferring good practices.
The methodology to be used allows customizing the transfer and adoption process to the specific needs and context
of the next adopters. This will take into account existing programs and activities and the priorities, strategies, assets
and resources. It allows the transfer of a whole oGPs, parts of an oGP or a mix-match of two or more of the
oGPs. The maturity level of the next adopter will also be considered as will the features to be transferred and the
specific assets needed to do it. This is a more realistic model than the more academic proposals that envision that a
good practice can be transferred as such to an area with a completely different context, means and conditions. A
detailed analysis of needs, scope, situation and implementation plans including sustainability elements will be
performed for each of the next adopter sites to ensure the feasibility, effectiveness and sustainability of the oGP
transfer. This means that although the initial interests have been expressed during the preparation of the JA, the
precise features and interventions to be implemented in each next adopter site will be defined after the first
tasks in WP4, 5, 6, 7, and 8. The progress and impact of this approach will also be evaluated in WP3, and
sustainability-related outputs by WP4.
JADECARE will create and share the knowledge and capacity on how to design and successfully implement
sustainable digitally enabled integrated person-centered care solutions. To this purpose, JADECARE will follow
the implementation strategy developed in the JA CHRODIS Plus 29, adapting it to the particularities of the next
adopters to transfer the four oGPs previously mentioned to 23 next adopters. The implementation strategy contains
methods and techniques used to enhancing the adoption, implementation, monitoring, reporting and sustainability of
an intervention30. It will promote the systematic introduction of evidence-based interventions into practice and policy
and hence improve health31. These interventions cover a wide range of areas such as change management and
reorganization of the existing care models, embedding digital technologies and tools in care services, reorganization
of patient pathways, health workforce roles and skills with digital technologies and data, building the capacity of
individuals and communities to participate in the care process, citizen empowerment, use of patient reported data,
new payment methods, performance assessment of new care models and digital solutions.
JADECARE will deploy activities to prepare the local environment for implementation, customizing them to the
different needs and levels of maturity of the next adopters. Purposely designed “twinning actions” have been
included in the WP5-8. This will facilitate the establishment of local/regional/national networks for the implementing
partners and the stakeholders important for assuring sustainability.
As the following sections will show, JADECARE has been built based on results of earlier work in the EU Health
Programme, the EU Framework Programmes for Research and Innovation as well as EU initiatives such as the
European Innovation Partnership on Active and Health Ageing (EIP AHA) as:
29
JA CHRODIS plus implementation strategy at www.CHRODIS.eu
30
Curran GM, et al. Effectiveness-implementation Hybrid Designs. Med Care. marzo de 2012;50:217-26.
31
Foy R, et al. Implementation science: a reappraisal of our journal mission and scope. Implement Sci IS. 2015;10:51.
14 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Tools for deploying integrated care from EU projects (e.g. ACT@Scale and SCIROCCO), SANTE's Integrated
Care Resource Centre and the work of the EIP AHA. Sirocco Maturity Model will be used in WP5-8, to analyze
among others the core features and context characteristics.
Guidance on the design, implementation and assessment of integrated care, from the work of the EU expert group
on Health Systems Performance Assessment. It has been followed used to design the Evaluation framework. In
addition, the CFIR (Blended Framework for Implementation Research) methodology selected in the project
PROACT (Integrated Technology Systems for ProACTive Patient Centered Care) will be followed in the WP 5-
8.
The guidance on the transfer and scaling-up of GP, developed by the Joint Action CHRODIS PLUS will be used
to design the GP transfer and adoption, as will the Guidance for best practice transfer from the twinning projects
SCIROCCO Exchange and VIGOUR.
The JADECARE leader has participated in the Joint Actions CHRODIS and CHRODIS Plus, the guidance
concerning the management of multi-morbidities produced by these Actions has been followed in the generation
of the oGP of Basque Country and will be taken into account in the final configuration of the GPs to be adopted.
The JADECARE project will:
Support the good practice transfer from the systems of the “early adopters”, Kronikgune, Idibaps, OptiMedis
and Region South Denmark to the “next adopters” from the 17 health systems participating in the JA. The “early
adopters” Spain, Germany and Denmark will include other areas of their countries to be “next adopters” of one
of the four oGPs or their combinations. The project will combine the experience of the “early adopters” and the
“next adopters”. The information generated by all participating entities will develop knowledge that will lead to
the development of the blueprint for digitally enabled integrated care and the creation of best practices transfer
methodology.
Reinforce the capacity of health authorities to successfully address the transition to digitally-enabled,
integrated, person-centered care. JADECARE will generate a network involving for the first time both “next
adopters” with “early adopters” including in all the cases, organizations with direct responsibility for organizing and
delivering care. The results obtained in WP5-8 will show the next adopters to implement the GPs and develop
solutions on how to ensure sustainability (Month 13-36). The implementation will start, and specific interventions
will roll out based on PDSA according to their maturity level, resources available and time frame of the project. WP4
will provide guidance to reinforce the capacity of health authorities to successfully address important aspects of
health system transformation.
ADDED VALUE
Areas – where to achieve
Mechanisms- how to achieve EU-added value
EU added value
Impact on target groups JADECARE will have a direct impact on all the targets groups that have been identified as
stakeholders by helping to change the model of care provision. JADECARE will settle the
basis to implement the integrated scale at large scale at national regional and local health
systems by knowing how to really transfer experiences that are working and to create
innovative/tailored practices based in the oGPs. This will have a direct impact not only in
healthcare professionals but also on patients, carers, general population as well as the
industrial sector.
Long-term effects and JADECARE has been conceived to last beyond the three years of the project. The
potential multiplier effects, methodology used in WP5-8 and the activities included in WP4 will support the sustainability
such as replicable, and replicability of JADECARE. Elements of sustainability will be addressed in the
transferable and sustainable implementation action plans and reports. The methodologies used in JADECARE for GP
activities transfer could be applied in other fields of public health. The long-term effect of JADECARE
will be supported by involving the stakeholders who can provide political support and
commitment to integrated care as members of the consortium or participating in governance
bodies.
Contribution to All CAs and AEs participating in JADECARE are politically committed to the
complementarity, synergy implementation of digitally enabled integrated person-centered care. However, the real
and compatibility with implementation and knowledge of integrated care vary a lot from setting to setting in the 17
relevant EU and EU Member participating countries. The opportunity to tailor and adapt the oGPs selected in other areas of
States policies and programs Europe will facilitate and generate knowledge exchange and strengthen networks. In addition,
several of the participants are involved in other initiatives associated with integrated care: Key
members of EIP-AHA, Health System Performance Assessment Group or other H2020
projects and initiatives.
Workforce education and As the systems of care are transformed, various roles need to be adapted or created and new
training skills developed. With changing demands, competencies, talent and experience must be
retained, and the care systems need to become ‘learning systems’ to improve productivity and
increase success rates. JADECARE will support a redesign of health and social care
15 146
JADECARE- 951442
Areas – where to achieve Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Mechanisms- how to achieve EU-added value
EU added value
professionals’ roles and will identify new roles and new ways of monitoring chronic patients.
Based on early adopters’ experience and the key issues pinpointed by the next adopters, new
pathways and learning networks will be generated.
Collaboration, networking The large number of changes needed to deliver integrated care at a regional or national level
and building trust presents a significant challenge. It requires reorganization of services and care processes and
alignment of purposes across diverse organizations and professions. The participants must
show the willingness to collaborate and put the interest of the overall care system above
individual incentives, as will be demonstrated in JADECARE. The networks for healthcare
providers and other agencies and authorities will improve active cooperation and increase trust
among stakeholders. JADECARE will facilitate the collaboration between the stakeholders,
they will have the chance to participate in the activities included supporting the knowledge
transfer, learning and generating further evidence on integrated care.
PERTINENCE OF GEOGRAPHIC COVERAGE
JADECARE will involve partners from 17 European countries reaching almost 40 different Regions in providing a
comprehensive view of the idiosyncrasies and differences at the European level. JADECARE includes various
countries that have begun their respective journeys toward integrated care at different times. The level of
penetration, adoption and/or maturity of integrated care in a country does not depend solely on time elapsed
since the initiation of the implementation of integrated care policies. Indeed, there are many factors that have to be
considered while designing such integrated care systems if we are to achieve successful implementation. Among
others, the financial design of the system; governance and stewardship of the health system, workforce composition,
roles and numbers of professionals have to be considered. The characteristics of the top-down (policies, strategies)
and bottom-up approaches (programs, projects) have to be analyzed; program governance models; training for
managers and clinical staff, among other factors. To tackle all these elements and account for the existing limitations,
JADECARE includes the health systems from all European countries, covering different funding systems (Beveridge
and Bismarck) and considering the different pace of adoption of Integrated Care32. In addition, JADECARE includes
partners with different Gross National Income (GNI) (11 out of 17 are under the 90% of average GNI) and different
levels of maturity of digitally enabled health care systems.
Some partners such as Estonia, Latvia, Lithuania, Czech Republic, Hungary, Croatia, Serbia, Slovenia, and Bosnia
and Herzegovina show large differences in the application of IC at the national level. Some of them have been
focusing on the integration of social and health services using telemedicine and eHealth solutions and that will benefit
from the implementation of the new oGPs identified and piloted by Spain, Denmark and Germany, where others have
a limited experience in the field of integrated care in health systems.
JADECARE is going to provide a realistic view of the idiosyncrasies at the European level. The project will include
by including not only different health systems, but also present social, organizational, religious, ethical and economic
different points of view. This will guarantee that the analysis of the barriers, key factors, frameworks and indicators
will generate a useful roadmap to guide the change in integrated care is management in Europe.
CONTEXT OF THE PROJECT WORK
Policy-makers and care providers share a key concern with patients: ensuring that the health services deliver the best
possible care and that it is safe, effective and responsive to the needs of patients. Yet, there is a large variation in
healthcare resources both within and across countries, as can be seen in the following table, where the percentage of
gross domestic product devoted to expenditure on health range from 5,9 (Latvia) to 11,2 (France and Germany).33
TABLE 2. HEALTHCARE RESOURCES IN COUNTRIES PARTICIPATING IN JADECARE
Current expenditure on Current
health, per capita, US$ expenditure on Physicians, density
purchasing power health, % of per 1 000 Nurses, density per
parities (current prices, gross domestic population (head 1 000 people (head
HEALTH RESOURCES current PPPs) product count) count)
2018 2018 2017 (or nearest 2017 (or nearest
year) year)
Bosnia i Herzegovina* 957 9.6 2.0 5.0
Czech Republic 3058 7,5 3,7 8,1
Denmark 5299 10,5 4,0 10,0
Estonia 2231 6,4 3,5 6,2
Finland 4228 9,1 3,2 14,3
32
Health system performance assessment- Integrated Care Assessment (20157303 HSPA) 2018
33
Busse R, Klazinga N, Panteli D, Quentin W Improving healthcare quality in Europe: Characteristics, effectiveness and implementation of different strategies
(OECD 2019) https://apps.who.int/iris/bitstream/handle/10665/327356/9789289051750-eng.pdf?sequence=1&isAllowed=y&ua=1
16 146
JADECARE- 951442
Current expenditure on Current Associated with document Ref. Ares(2020)3808356 - 20/07/2020
health, per capita, US$ expenditure on Physicians, density
purchasing power health, % of per 1 000 Nurses, density per
parities (current prices, gross domestic population (head 1 000 people (head
HEALTH RESOURCES current PPPs) product count) count)
2018 2018 2017 (or nearest 2017 (or nearest
year) year)
France 4965 11,2 3,2 10,5
Germany 5986 11,2 4,3 12,9
Greece 2238 7,8 6,1 3,3
Hungary 2047 6,6 3,3 6,5
Italy 3428 8,8 4,0 5,8
Latvia 1749 5,9 3,2 4,6
Lithuania 2416 6,8 4,6 7,7
Portugal 2861 9,1 5,0 6,7
Serbia* 1312 10.4 3.1 4.5
Slovenia 2859 7,9 3,1 9,9
Spain 3323 8,9 3,9 5,7
United Kingdom 4070 9,8 2,8 7,8
OECD AVERAGE 3994 8,8 3 8,8
OECD Health Statistics 2019 http://stats.oecd.org/Index.aspx?DataSetCode=SHA.*WHO https://www.who.int/countries/en/ data from 2014 and 2016
The 2008 economic crisis had a clear impact on the healthcare expenditure in most countries, the recover can be seen
from 2013 onwards.
2009-2013 2013-2017
10
7.6
7.3
8
6.1
5.8
5.5
5.5
5.4
4.9
4.6
4.5
6
3.5
3.4
3.3
3.2
2.7
2.5
4
2.4
2.3
2.3
2.2
2.1
2.1
1.9
1.9
1.8
1.7
1.6
1.6
1.6
1.5
1.4
1.4
1.3
1.1
1.1
1.1
1.1
1.1
1.0
0.8
0.8
0.8
0.8
0.8
0.7
0.7
0.6
0.6
2
0.4
0.4
0.1
0.0
0.0
0
-0.1
-0.4
-0.4
-2
-0.6
-0.7
-0.8
-0.8
-0.9
-1.4
-1.9
-1.9
-4
-3.1
-6
-8
-8.7
-10
Annual average growth rate (real terms) in per capita health spending, 2009 to 2017 (or nearest year) Source: Health at a Glance:
Europe 2018 - © OECD 2018
The data from European countries show that it is possible to improve local services through innovation; however,
more needs to be done to ensure that these improvements benefit the population at large. Increasingly, the innovation
in health services involves the development, introduction and mainstreaming of new technologies, which traditionally
have had a high failure rate in the health care sector.34 Digital health (eHealth) tools have been proposed to improve
access to health care services and enhance care co-ordination and integration. They can enable self-management,
support decision-making and monitoring, perform risk analysis, and facilitate proactive interventions. Digital health
tools have been implemented in all countries, but the levels of maturity differ between the employed programs35 and
JADECARE provides a comprehensive overview of the situation of Europe, as can be seen in the following table.
The table below presents the social, cultural and economic context of the next adopters´ countries associated with
digitalization (several sources)36.
34
Nolte E How do we ensure that innovation in health service delivery and organization is implemented, sustained and spread? WHO Regional Office for Europe
2018 http://www.euro.who.int/__data/assets/pdf_file/0004/380731/pb-tallinn-03-eng.pdf?ua=1
35
Baltaxe E, Czypionka T, Kraus M, Reiss M, Askildsen JE, Grenković R, Lindén TS, Pitter JG, Rutten-van Molken M, Solans O, Stokes J, Struckmann V,
Roca J, Cano I. Digital Health Transformation of Integrated Care in Europe: Overarching Analysis of 17 Integrated Care Programs. J Med Internet Res
2019;21(9):e14956.DOI: 10.2196/14956
36
SmartHealthSystems International comparison of digital strategies. BertemsmannStiftung, https://www.bertelsmann-
stiftung.de/fileadmin/files/Projekte/Der_digitale_Patient/VV_SHS-Studie_EN.pdf eHealth – Future Digital Health in the EU
https://www.espon.eu/sites/default/files/attachments/Final%20report.%202019%2003%2025_final%20version_0.pdf , Country Health Profiles
http://www.euro.who.int/en/about-us/partners/observatory
17 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
TABLE 3. SOCIAL, CULTURAL AND ECONOMIC CONTEXT OF THE NEXT ADOPTERS
Country Social, cultural and economic context
Bosnia and According to the Constitution of Bosnia and Herzegovina, Bosnia and Herzegovina consists of two
Herzegovina entities, the Federation of Bosnia and Herzegovina and the Republic of Srpska. Brčko District BiH
(Bismarck) was established in 2000, through international arbitration, with powers largely similar to those
entities. Organization, provision and financing the health care is under responsibility of the
Federation of Bosnia and Herzegovina, the Republic of Srpska and the Brčko District of BiH. Health
care sector in Bosnia and Herzegovina consists of health care systems organized at entity, cantonal
and Brčko District level. This could be characterized as significant fragmentation given the fact that
the systems are organized differently in the Federation of BiH, Republic of Srpska and Brčko District.
In terms of the organizational structure and management, these systems operate at the level of entities,
cantons and Brčko District, which complicates the way health care services are provided, increases
management and coordination costs and adversely affects the rationality of management of healthcare
When it comes to their financing, the health care systems in Bosnia and Herzegovina have been
encountering serious challenges for a rather long time. Typically, almost every year, expenses exceed
the income of health insurance funds in both Entities and cantons
Croatia Croatia has among the lowest health spending in EU and stagnating last 10 years. This has caused a
(Bismarck) high out-of-pocket spending in the country. Prevention, primary care and long-term care are
undervalued. According to the Europe´s Digital Progress Report (EDPR) 2017, Croatia ranks 24th
out of 28 EU Members States. The report tracks the progress of digitalisation. In this same report,
Croatian citizens are above EU average in the category of Internet users. But, Croatia has no strategy
in place to address its digital skills challenges. In fact, education, activities and initiatives that are
being conducted, are mostly of a private character or ICT business sector
Czech Republic Though health spending in the Czech Republic is under average in EU, the availability of full
(Bismarck) spectrum of health services has been for long compensated by the effort of highly qualified personnel
at healthcare providers. The nationally equal system, with several public insurances providing
however essentially the same services, with large number of various kinds of ownerships of providers
demonstrates apparent reluctance to changes be they in care organization, reforms or just sharing
information, as well as when it comes to cooperation with social care domain. Adjustment to changes
in demand for services evoked esp. by ageing population is therefore becoming issue in some regions
and medical specialties. Electronisation is one of the most fundamental themes in the framework of
discussions on future of the Czech healthcare system. The fact that general society is becoming more
and more digitized, seems to make it all the more obvious that the Czech healthcare system (primarily
as compared to other developed countries) is lagging behind. There are various challenges in
establishing services and tools for effective collaboration and sharing health information between
various healthcare providers mutually, and also with patients. The healthcare in the Czech Republic
needs increase pace in digitalization. Nowadays, all Czech hospitals use hospital information systems
internally (although these vary in quality).
It is necessary that the electronisation of health care be implemented in a comprehensive way. For
this purpose, The National eHealth Strategy (adopted in 2016) formulated set of goals and measures
for the development of electronic healthcare for the period by 2020, which has helped to make
important initial steps in digitalization.
Denmark Denmark organizes its healthcare through a public-health service that is available to the entire
(Beveridge) population and is performed at a regional or municipal level. Up to 2006, the central government and
the Ministry of Health were only permitted to formulate the framework
legislation, the objectives, and the recommendations, and to (co)fund the system. Counties and
municipalities were responsible for establishing a catalogue of services, as well as organizing and
ensuring the healthcare service. The data saved in EHRs may also be used for secondary purposes,
such as for research or quality controls, as long as these purposes do not conflict with the law on the
processing of personal data or general health law. This does not require the clear consent of the
patient. Most universities offer general IT courses, including with respect to health IT, in order to
train current and future professionals in new digital solutions. Some hospitals and other public
institutions also offer similar training measures.
Estonia In March 2015, the National E-health Strategy was launched, establishing several objectives: 1) user-
(Bismarck) centric and science-based precision services; 2) holistic case management and integrated service
network; 3) improved service performance and quality; 4) optimized service access and professional
time use via tele-solutions.
France The French healthcare system is organized as a social-insurance system. With the introduction
(Bismarck) of mandatory insurance in 2000, the statutory health insurance system now compulsorily covers the
entire population. Membership is primarily based on the criterion of
employment and there is no mandatory insurance threshold. Family members who are not in the labor
market are co-insured. Private health insurance provides complementary coverage for services not
18 146
JADECARE- 951442
Country Social, cultural and economic context Associated with document Ref. Ares(2020)3808356 - 20/07/2020
provided by the public system. For historic reasons the health insurance fund landscape is broken
down by profession, however it offers a near uniform catalogue of services.
Germany In Germany, the federal government sets the conditions determining medical care throughout the
(Bismarck) country. The country’s national healthcare system is underpinned by the principles of
decentralization and self-governance, which results in formal responsibility for the provision of
healthcare resting on the shoulders of the individual federal states.
Greece Greece’s health care system is a mixed system comprising elements from both the public and private
(Bismarck) sectors. In the public sector, a national health service type of system coexists with a social health
insurance (SHI) model. In 2011, the National Organization for the Provision of Health Services
(EOPYY) was established. It acts as the sole purchaser of health care services for patients covered
by the publicly financed National Health System (known as ESY). The private sector includes profit-
making hospitals, diagnostic centers and independent practices.
Financing is through a mix of public and private resources, including SHI and tax, which account for
approximately 30% each, with users’ private spending making up the remaining 41%. Health
expenditure in 2015 was 8.4% of GDP (compared with the EU average of 9.5%); however, in the
context of drastically reduced GDP since the onset of the economic crisis, expenditure has fallen
substantially (by one fifth) since 201037.
Hungary Health spending in Hungary is well below the EU average and the gap widened over the past decade.
(Bismarck) In 2015, Hungary spent EUR 428 per capita (7.2% of GDP) on health care, about half the EU average
of EUR 797 (9.9% of GDP). Only two-thirds of health spending comes from public sources. The
high level of out-of-pocket spending contributes to a comparatively high share of households facing
catastrophic health expenditure.
Life expectancy at birth in Hungary increased by nearly four years between 2000 and 2015, to 75.7
years, but still remains almost five years below the EU average of 80.6 years (according to available
data in 2017).
Italy A major healthcare reform in 1978 transformed Italy’s social security system – which at the time had
(Beveridge) around 100 different health insurance funds and a highly varied scope of services – into a centrally
run state healthcare service. Further reforms in the 1990s and early 2000s decentralized this system
once again. Since then the regions have been responsible for local healthcare provision, absorbing a
large share of funding. The Health Ministry, which functions as a point of liaison and orientation, has
the task of defining healthcare principles, framework conditions and a certain level of care for the
regions. This includes guidelines and legislation regarding digital health. The regions are obliged to
adhere to the ministry’s defined guidelines and level of care. However, they are completely
autonomous, free to organize and administer their own regional systems
Latvia The National Health Service (NHS) is the operating direct administrative institution subordinate to
(Beveridge) Ministry of Health. It was established on 1st November 2011. NHS took over the functions formerly
carried out by The Centre of Health Economics and Health Payment Center. The Health Care
Financing Law regulates health care services paid by the state. The persons who are not mentioned,
receive medical services at a charge in accordance with the pricelist of a medical institution or the
pricelist of services which are to be paid for, provided by a medical specialist. It is possible to receive
health care services paid by the State only in the medical institutions (not depending on the form of
ownership or property), which have concluded an agreement with The National Health Service
(NHS).
Lithuania The organization of the health system of Lithuania is modern and characterised by institutional
(Bismarck) stability. The country has been steadily pursuing policies designed to better tackle the burden of
chronic diseases, including for instance the development of primary care. Remarkably, and despite
the fact that Lithuania spends little on health, the population benefits from quasi-universal coverage
and key metrics suggest access to care is broadly adequate.
The main challenge Lithuania continues to face however is that the health of the population is not
improving as fast as it has in comparable countries and many outcome indicators place it among the
poor performers of the OECD. There is scope to improve the efficiency of resources currently
allocated to the sector as well as the quality and outcomes of care. Additional investments in health
are probably also warranted and would not necessarily undermine system’s sustainability but they
need to be systematically geared towards addressing the challenges identified38.
Portugal Portugal has a centralized, state-managed national healthcare service which provides services to all
(Beveridge) citizens. Five regional health authorities were established in the 1990s, although they are only
responsible for financing the area of outpatient care, with state authorities retaining responsibility for
hospitals and their financing. The population has a choice of various healthcare systems, although
some are reserved for certain professional categories (e. g., public servants, military personnel, police
officers, bankers). Around a fifth of the Portuguese population also take out private insurance, for
which premiums may be claimed on tax.
37
Health systems in transition. 2017.
38
https://www.oecd.org/health/health-systems/OECD-Reviews-of-Health-Systems-Lithuania-2018-Assessment-and-Recommendations.pdf
19 146
JADECARE- 951442
Country Social, cultural and economic context Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Serbia Since the beginning of the twenty-first century macroeconomic and political reforms, alongside with
(Bismarck) economy strengthening, led to rapid growth of health spending in Serbia. This trend has reached
essentially a plateau level since the beginning of the global macroeconomic recession, recording
fluctuations in 2008–2016. In Serbia, all the money directly or indirectly is provided by the citizens
through financing the state budget, compulsory health insurance, direct payment “out-of-pocket,”
financing from the community funds, donations, loans, etc. The health care system in Serbia is funded
through a combination of public finances and private contributions. The most important source of
health care financing is the National Health Insurance Fund of the Republic of Serbia.
Due to the essential absence of private health care insurance, private funding is more or less
completely based on out-of-pocket payments
Slovenia Slovenia has a public health care system based on compulsory health insurance provided by ZZZS.
(Bismarck) This insurance includes more than 99% of population.
Specific public-private mix is characteristic for the provision of health care services. Public
healthcare network includes private providers with concession and public providers (especially
hospitals, health care centres). Private providers outside public network represent less than 10% of
the market.
Spain Since the 1980s, Spain has had a universal public healthcare service which from 2002 has been
(Beveridge) entirely planned and executed at the regional level. The 17 regions gained financial autonomy in
2009 and since then have been able to raise their own taxes to finance the system. The central Spanish
state’s function is now limited to coordination between the regions, the creation of a service catalogue
and medication policy. Employees in public service additionally have a supplementary care system
which offers some privileges in medical care.
Financing occurs through fiscally financed allocations from the state to the regions. They, in turn,
use funds from their own various regional tax coffers. There is no earmarked healthcare tax, merely
a few specifications that provide information on the amount of funding the healthcare system should
receive. In 2015, overall health expenditure amounted to 9.2 percent of GDP, slightly below the EU
average.
All partners in this Joint Action strive to establish effective health systems by transition from the traditional hospital-
centric approach to community based and integrated care structures, putting the focus on person-centered care,
improved chronic disease management capacity and, crucially, on prevention measures. There are many different
unmet needs in various countries and socioeconomic income groups. Up to a fifth of health spending in Europe is
inefficient and could be used for other care needs. Unnecessary admissions consume over 37 million hospital bed
days each year.39
The EU Member States are expected to suffer from considerable strain on public spending on health and long-term
care in the coming years and decades due to the fast population ageing and moderate economic growth. Better
coordination in the development of digital health solutions could help improve access and efficiency in health service
delivery. Considerable efforts put into the implementation of eHealth solutions could enhance the efficiency of
processes, increase collaboration and improve integration of care. Targeted investments in these areas offer promising
opportunities to increase the resilience of the health system in the future. Further analysis can be performed using
sources such as the OECD/EC produced Country Health Profiles, a comprehensive resource covering the latest health
policy challenges and responses in each country. 40
39
Health at a glance OECD 2018 https://ec.europa.eu/health/sites/health/files/state/docs/2018_healthatglance_factsheet_en.pdf
40
https://ec.europa.eu/health/sites/health/files/state/docs/2019_companion_en.pdf
20 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
FIGURE 1 JADECARE GEOGRAPHIC COVERAGE
The JADECARE project has been designed to support the digital transformation of healthcare. The local context, the
maturity of integrated care models, legal frameworks, culture/values and relevant leaders are going to be considered
for each of the 23 next adopters in 15 European Countries.
The processes involved in introducing innovation range from adoption, implementation, sustaining, spreading or
diffusion, dissemination and scaling up. These processes overlap in complex ways, which means that service
innovation is almost never straightforward.41 The methodology in JADECARE allow approaching the transfer in
different contexts, taking into account socioeconomic, cultural, legal, the current models and the maturity of health
systems. The analysis of these aspects will be the key tasks of WP5-8 during the first 13 months of JADECARE. The
Next Adopters Working groups (NAWGs) will play the main role in the transfer process. NAWG will be responsible
to lead the process of analyzing, designing, monitoring, evaluation and reporting of the implementation in each
setting. Next adopters are not obliged to fit in a specific GP; they can use a “mix and match” approach where they
can select the parts of each GP best suited to their real circumstances (expectations, necessities….)
In the first phase of the transfer and adoption, the needs and scope will be defined based on the requirements,
expectations, strategic objectives, realistic possibilities and existing local interventions of the next adopters. Study
visits will be organized at oGP sites so the adopters will be able to acquire a deep understanding of the oGP and
establish a robust and durable network with the stakeholders from the oGPs. Thus, both types of adopters should be
able to understand the real conditions of the first implementation and appreciate the differences/similarities,
weaknesses/strengths in both cases. A SWOT analysis of the core features selected from the oGP will be conducted
by each next adopter, where the two perspectives, the original GP-related and implementation-related, will be
analyzed.
One of the key aspects of JADECARE is the interests of the participants in the implementation of the oGP. Although
the implementation may not involve a large number of participants, the process carried out will follow strict ethical
standards. One of these issues is users’ privacy, confidentiality and consent. Kronikgune will provide general rules
and procedures based on their experience of implementing the oGP in the Basque Country and the experience in
previous and current integrated care projects. If necessary, they will help to the generate the informed consent and
follow the procedures included in the directive 2004/27/EC (based on the Directive 95/46/EEC of the European
Parliament and of the Council of 24 October 1995 on the protection of individuals regarding the processing of
personal data). All measures will be taken to ensure the confidentiality of participants in the intervention and,
specifically, to follow the new General Data Protection Regulation (GPDR) (UE) 2016/679 (27th April 2016). In
WP1, the legal and ethical surveillance and management will be the core tasks of the project (Task 1.4 and 1.5).
41 Nolte E How do we ensure that innovation in health service delivery and organization is implemented, sustained and spread? WHO Regional Office for Europe
2018 http://www.euro.who.int/__data/assets/pdf_file/0004/380731/pb-tallinn-03-eng.pdf?ua=1
21 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
2.5 METHODS AND MEANS
ORIGINAL GOOD PRACTICES
JADECARE intends to reinforce the capacity of health
authorities to address the important aspects of health
system transformation successfully, in particular the
transition to digitally-enabled, integrated, person-
centered care. The project will support the best practice
transfer from the early adopter systems to the next
adopters.
JADECARE is concretely focused on the transfer and
adoption of four Good Practices, so-called original GPs
(oGPs): Basque Health strategy in ageing and
chronicity: integrated care (Basque Country, Spain),
Catalan open innovation hub on ICT-supported
integrated care services for chronic patients (Catalonia,
Spain), The OptiMedis Model-Population-based
integrated care (Germany) and Digital roadmap towards
an integrated health care sector (Region of South
Denmark) (Figure 2). FIGURE 2 JADECARE OGPS
The description of the main blocks (B) and core features
(CF) of the four oGPs are presented below:
BASQUE HEALTH STRATEGY IN AGEING AND CHRONICITY: INTEGRATED CARE (BASQUE
COUNTRY)
B1- Risk stratification
The objective of the Risk Stratification (RS) is to classify a population according to their future health needs, and
thus be able to implement Integrated Intervention Programs (IIP) that fit those needs. It predicts the future healthcare
cost during the following 12 months. The future health cost is used as a "proxy" indicator of the need for health care.
The stratification in the Basque Country:
Identifies and classifies the patients according to their risk of developing future problems.
Identifies patients with the greatest need for care
Predicts the consumption of health resources over the next twelve months of the identified population
B1- CF1- Stratification Data extraction process and construction of dashboard
Data are obtained from the Electronic Health Record from all active patients (at least one day) during the calculation
period (1 year). The cost of each patient is estimated with his/her diagnosis and his/her pharmaceutical prescriptions.
The process has moved away from a time-consuming and laborious procedure (3 months to 6 months) using the
requests for extraction of data, coming from multiple, scattered and complicated data sources. The new calculation
process is automated and offers fast data extraction (less than one-hour file extraction using ACG Grouper). Data
sources include Primary Care, Hospital Basic Minimum Set of Data, Diagnosis-Related Groups (DRGs), outpatient
appointments and tests, Emergency Department, day hospital, costs and others. These dynamic calculations can be
easily adapted to include new data sources.
The information is processed using ACG Grouper. A customized version of the Johns Hopkins' Adjusted Clinical
Groups Predictive Model (ACG-PM) is used42,43. The ACG system makes it possible to group ICD diagnostic codes
and drugs (ATC system) into groups of diseases and morbidity variables, which are the variables that are finally
introduced into the model.
The prediction of the patient costs forthe following period is conducted using “R”, obtaining the Predicted Cost in
the Estimated Period (next year) per Patient and the Predictive Index = Predicted Cost / Average Total Cost. The
future healthcare cost is transformed into the so-called predictive index (PI), which corresponds to the quotient
obtained by dividing the expected healthcare cost in each individual by the expected average healthcare cost in the
stratified population. It is a number with a lower limitof zero The higher the number, the greater the risk (probability)
of resource use. The PI can be different for each update depending on the data of the patients in the preceeding year.
The population is grouped in different risk strata.
B1-CF2- Classification of patients
The stratification of the patients uses the population model of the Kaiser Permanente Pyramid44. The population is
classified in four groups according to the presence (or absence) of chronic disease, with a special focus on the top
42
Orueta JF, Nuño-Solinis R, Mateos M, Vergara I, Grandes G, Esnaola S. Predictive risk modelling in the Spanish population: a cross-sectional study. BMC
Health Serv Res. 2013 Jul 9;13:269.
43
Assehs White paper; www.assehs.eu
44
https://www.researchgate.net/publication/259583721_Improving_Chronic_Illness_Care_through_Integrated_Health_Service_Delivery_Networks
22 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
5% high-cost chronic patients associated with to next year’s health costs. The patients are assignedto each stratum
according to their Predictive Index (the risk levels are denoted by different colours: red, orange, yellow or green).
Different interventions are designed for each stratum:
The "Case Management" stratum includes 5% of the chronic population, with a high predictive index of
resource consumption. It is represented by a red triangle. This group corresponds to high-risk users who require
complex interventions or case management.
The "Disease Management" stratum groups constitute 20% of the chronic population, with a predictive index
of intermediate resource consumption represented by an orange triangle. These are the peoplewith chronic
conditions requiring constant medical attention, and those whose lifestyle makes them relatively intensive
users of the system.
The stratum of "Self-management" groups includes 75% of the chronic population, with the lowest predictive
index of resource consumption, represented by a yellow triangle. These are the patients with chronic pathology
but in good health.
The "Promotion and Prevention" stratum, represented by a green triangle, groups the rest of the population
with nochronic pathology .
Integrated Intervention programs are customized according to each citizen stratum. They are meant to be deployed
in emergency room visits, hospital admission and general practitioner visits. In order to facilitate and enable the use
of risk stratification information, and thus perform proactive intervention, the information is transferred to each
citizen's Integrated Electronic Health Record (IEHR), including : (i) a tag with the stratum of the risk pyramid in
which the citizen is found. It relates to the value of the Predictive Index, the numeric value of the IP and the date in
which the stratification is carried out; (ii) an "alerts" section identifying the IIP corresponding to that patient (if any).
B1-CF3- Stratification in the framework contract
Stratification is a very powerful tool to promote the shift of mind frame necessary for switching from financing health
activities to planning and financing health needs. It has been useful for identifying target populations for health care
interventions. The Basque Health system uses a framework Contract to regulate the relation between the Health
Department and the Integrated Healthcare Organizations (IO). It contains criteria of population coverage, services
provided, activities, quality criteria and funding. Risk stratification is used to define actions that favor a population
approach in the context of integrated social and health care and to refine the evaluation of the implementation of
effective interventions with proven impact on health. This is used to adjust the Key Performance Indicators (KPI) of
an IHO and the results. It is also used to adjust the capitation funding model.
B2- Integrated Care in the Basque Country
A clear strategic vision45 towards the challenge of ageing, chronicity and dependency has provided explicit support,
leadership and capacities to transform the health system towards integrated care in the Basque Country. An integrated
care strategy has been deployed, focusing on clinical and functional organizational integration. It deploys an
integrated care model capable of providing continuity of care both at health and social care levels. To this purpose, a
number of processes and tools have been developed and implemented.
Integrated care in the Basque Country is based on three pillars:
Integrated governance: establishes the agents participating in the organization and provision of integrated care
services, including the organization of the care process management.
Population approach: implies coordination with social and public health agents.
Multidimensional assessment and action in people aged 70 or older (Care Plan for the Elderly).
Culture and values: a change from a culture of fragmentation to a culture of integration.
B2- CF1- Creation of Integrated Healthcare Organizations
A plan to achieve structural integration has been developed and the concept of IHO introduced. An IHO blends a
hospital and primary care centers (integrating the governance bodies) in one organization with a defined population
catchment area. The objective is to achieve less fragmented, more coordinated, efficient and higher quality care.
Organization performance measures include security, effectiveness, equity, patient centered care, accessibility and
waiting lists, and efficiency.
B2- CF2- Deployment of integrated communication and information systems
The Basque public healthcare provider, Osakidetza, has invested heavily in digitalization and e-Health by deploying
a variety of services to support integrated care and the interoperability between communication and information
systems. This provides non-face to face care focused on prevention, monitoring and health advice. The ICT platforms
and communication channels align actions, avoid duplication of effort and bridge gaps in patient care. Several
relevant tools are now in use:
One of these is the Integrated Electronic Health Record (IEHR) "Osabide", a unified and shared clinical information
system accessible to all healthcare professionals. It contains all health-related information for each patient, facilitating
service delivery and the provision of new forms of healthcare. It has been also extended to public nursing homes and
residences in the Basque Country. Primary health and social care teams have been established in all the organizations
45
http://www.euskadi.eus/web01-s2osa/es/contenidos/plan_gubernamental/xleg_plangub_13/es_plang_13/index.shtml
23 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
and initiatives, such as "InterRAI CA"46, allowing to share diagnoses and care plans to ensure the interoperability of
health and social information systems.
Osanaia is a tool created for the management of nursing care, to set up and manage personalized nursing care plans.
It integrates information from the primary, specialized care and mental health care.
The electronic Prescription service, Presbide has also been deployed and integrated as a module within the IEHR
systems (Osabide) and is operating in all the pharmacies in the Basque Country.
The Personal Health Folder (PHF) allows the citizens to access to their health data or records securely and enable
communication with professionals. The citizens can enrich their PHF through self-tracking programs or uploading
documents. The Osakidetza App is a digital tool focused on citizen empowerment, it supplies access to their Personal
Health Folder, appointments, eHealth call center, the School of Health, other Apps and give feedback by surveys.
Osarean supports the e-Health call center, run by dedicated nurses on a 24X7 basis and manages e-health services
such as follow-ups of some integrated plans and tele-alarm calls.
Telehealth integrates the information of all telemonitoring devices and sensors that measure patients’ clinical
parameters at home, facilitating patient follow up, care adherence and enhancing patient-professional communication
B2- CF3- Care coordination and communication between health providers
A series of pathways for population groups classified according to their risk and condition have been deployed
including all levels of care, disciplines and actions coordination for multimorbid patients, patients with diabetes
mellitus, heart failure, chronic obstructive pulmonary disease, bronchiolitis, palliative care and oncology patients.
In particular, the Complex Multimorbid Program consists of an integrated pathway that aims to provide complex
patients with several co-morbidities, resulting in coordinated multi-level and multidisciplinary care in all IHOs of the
Basque Country. The Program delivers:
Coordination and communication between professionals
Patient-centered care based on the empowerment of the patient/caregiver, and health status monitoring
ICT tools to enable the implementation of the interventions
It defines WHO is involved in caring for and supporting patients, WHAT functions these actors perform, and HOW
different ICT tools facilitate the delivery of these activities. Thus, the multimorbid patients with complex health and
social care needs at high risk of hospital or care home admission, can achieve a reasonably good quality of life and
improved their clinical outcomes. The process has several different phases: identification of frail elderly patients;
comprehensive baseline assessment; therapeutic plan definition; programmed follow-up; patient stabilization at
home, integrated care during hospitalization; and coordinated hospital discharge.
To support care coordination, new figures and roles have been introduced: a “liaison nurse” in hospitals, “case
manager/advanced skill nurse” in health centers and an e-Health advanced skills nurse. The integrated care pathway
includes amongst others :
Stratification of patients into different levels of interventions
Interdisciplinary working team: nurse care manager, GP, social worker and specialists
Care manager role: case management, coordination with GP, support patients in the hospital, Emergency
Department, the discharge process
Consultant specialist role: support of primary care in decision-making
Follow-up outpatients to facilitate early detection of worsening
Making care transition support a priority: coordination between the primary care and the hospital, contacting
the patient 24-48h after discharge
Using virtual or in-person multidisciplinary case meetings to facilitate communication between care providers
Strengthen the patient self-management techniques, especially through motivational interviews
B3- Patient empowerment
Osakidetza has developed a series of online services and information resources to facilitate citizen access to health
services and improve their capacity to make decisions and manage their illness.
B3- CF1- Deployment of a School of Health
Osakidetza has organized a School of Health, "Osasun Eskola"47, to reinforce self-care skills of patients and
caregivers, develop programs of health education (face-to-face and online), for healthy people and chronic patients,
to train caregivers of dependent patients who request it and advise patient associations.
The aim of the School is to preserve and promote health by teaching people to make responsible decisions that affect
health-disease process.
“Osasun Eskola” is also working on training programs for professionals. The programs should help to acquire
educator competences, both face-to-face and virtually.
B3- CF2- Empowerment programs for chronic and/or multimorbid patients
46
http://www.euskadi.eus/gobierno-vasco/-/noticia/2017/innovando-en-el-modelo-de-atencion-sociosanitaria-en-euskadi-interrai-ca-como-embrion-de-la-h-
sociosanitaria-vasca/
47
http://www.osakidetza.euskadi.eus/osasuneskola/es/
24 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
“Paziente Bizia-Paciente Activo”48 is a self-care education program for people suffering from chronic diseases or
those responsible for chronic patient care. It consists of peer education workshops, run by chronic patients or by their
informal caregivers. The participants are taught how to understand the disease and the habits or behaviors that will
help to improve health, status of the patient, how to take responsibility for their health and to make appropriate
decisions.
The Program demonstrates the tools and skills that make it easier for citizens to be more active and responsible for
the care of their own health. It shows how to face problems, propose objectives for changing habits, communication
and relaxation techniques, emotional management. It also provides information about the diseases, physical exercise,
nutrition and appropriate use of medication.
The KronikOn49 program targets complex chronic patients and their caregivers. It consists of a basic set of four 2-30-
minute sessions at a health center or in the patient’s home. Primary and secondary care nurses provide essential
information to help patients in understanding their condition, to identify areas for improvement and to explore and
agree upon the best methods of self-care. The primary care nurses systematically follow-up the health status of their
patients on a monthly basis by phone calls and use a validated questionnaire.
In addition to KronikON program, Osakidetza offers a battery of empowerment services to complex chronic patients,
such as online Health School, information through the PHF, corporative applications etc. Complex chronic patients
are classified according to their health literacy using the VACS scale50 (“Valoración de Competencia en Salud”) and
then they are provided with the appropriate empowerment services. The empowerment level of these patients is
assessed using the indicators of the Nursing Standard Taxonomy (NANDA, NIC and NOC). This taxonomy is
included within the Osanaia, the tool created for the management of nursing care which is embedded the Integrated
Electronic Health Record. The specific indicators for assessing empowerment are:
Does the patient know the disease signs or symptoms?
Does the patient avoid the behavior that can promote disease progression?
Does the patient follow the recommended treatment?
Does the patient know who to call in case of needs?
By scoring each of these indicators systematically over time, nurses can evaluate the progress in the empowerment
of the patients and try to suggest specific actions if there is room for improvement.
CATALAN OPEN INNOVATION HUB ON ICT-SUPPORTED INTEGRATED CARE SERVICES FOR
CHRONIC PATIENTS (CATALONIA)
B1- Health risk assessment: population-based and enhanced clinical decision making.
A core strategic asset in the Catalan scenario is the regional population-based health risk assessment tool, named
GMA (Adjusted Morbidity Groups), developed and adopted in Catalonia51,52,53 which is fully operational for health
policy purposes and for clinicians in the workstation of primary care. It is updated every six months and used to
elaborate the health risk strata pyramid of the general population of Catalonia with a threefold purpose: i) Support
decisions on healthcare services and policies; ii) Identify subsets of patients with high risk of undesirable events (case
finding strategies) that may require preventive interventions; and, iii) Contribute to enhanced clinical decision support
through multisource predictive modelling.
The GMA tool predicts individual citizen risk based on multi-morbidity information gathered from the Catalan Health
Surveillance System (CHSS). It is a publicly-owned open algorithm (CatSalut and Ministry of Health), not based on
experts opinions, which explains its high flexibility and transferability. The latter has been demonstrated by its
adoption by thirteen out of the seventeen regional healthcare systems in Spain, covering 92% of the overall Spanish
population, approximately 38 million citizens.
The GMA algorithm shows higher performance and applicability for prediction of healthcare resources utilization in
primary care than other well-known indices54. The input for the GMA algorithm is a text file containing information
about the health problems (diagnoses) of the insured. The required fields are: i) identification of the insured; ii)
diagnostic classification used; iii) code of the health problem; iv) date of diagnosis; v) birthdate; and, vi) sex of the
insured. The output fields that the GMA algorithm generates are: i) Identity of the insured; ii) Adjusted Morbidity
Group Code; iii) Number of chronic diseases present; iv) Number of organic systems affected by chronic disease; v)
48
https://www.osakidetza.euskadi.eus/pacienteactivo/
49
https://www.osakidetza.euskadi.eus/kronik-on-programa-paciente-cronico-complejo/ab84-oescon/es/
50
VACS. Modelo desarrollado por el Instituto Albert Jovell de Salud Pública y Pacientes (Universitat Internacional de Catalunya), junto con SEDAP (Sociedad
Española de Directivos de Atención Primaria) y ESTEVE.
51
Dueñas-Espín I, Vela E, Pauws S, Bescos C, Cano I, Cleries M, et al. Proposals for enhanced health risk assessment and stratification in an integrated care
scenario. BMJ Open. 2016 Apr;6:e010301.
52
Monterde D, Vela E, Clèries M, grupo colaborativo GMA. Los grupos de morbilidad ajustados: nuevo agrupador de morbilidad poblacional de utilidad en el
ámbito de la atención primaria. Atención Primaria. 2016;48:674–82.
53
Vela E, Tényi Á, Cano I, Monterde D, Cleries M, Garcia-Altes A, et al. Population-based analysis of patients with COPD in Catalonia: A cohort study with
implications for clinical management. BMJ Open. 2018;8:e017283.
54
Monterde D, E. Vela, M. Clèries, L. Garcia-Eroles, J. Roca and P. Pérez-Sust. Multimorbidity as a predictor of health
service utilization in primary care: a registry-based study of the Catalan population. BMC Family Practice. 2020 (in press). https://doi.org/10.1186/s12875-020-
01104-1
25 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Total relative weight of the insured (complexity); and, vi) Clinical label summary of the set of relevant diseases
identified in the insured.
As described, the use of the GMA grouper provides allocation of each citizen into the regional risk stratification
pyramid. The four main strata usually identified are: i) GMA-1 corresponds to 50% of the population, with a lower
complexity level; ii) GMA-2 or low risk stratum: it corresponds to 30% of the population, which has higher
complexity than the previous risk stratum; iii) GMA-3 or moderate risk stratum: it corresponds to 15% of the
population, which has greater complexity than the previous risk stratum; and, iv) GMA-4 or high-risk stratum: it
corresponds to 5% of the population, which has the highest complexity level.
B1- CF1: Assessment of transferability, and identification of steps for adoption, according to intellectual property
rules, of the Catalan population-based risk stratification tool into the ecosystem of the next adopter.
The experience acquired with the process of transferability of the GMA within Spain will facilitate to define
appropriate strategies customized to the characteristics of the next adopters.
B1- CF2 - Health data management strategies (Catalan Health Surveillance System, CHSS).
The steps followed to build-up the CHSS, its characteristics, as well as the different data management strategies
followed in Catalonia will be transferred to next adopters. The potential of data exploitation within the strategies
defined in the current, 2016-2020 and future, 2021-2025, Catalan Health Plans will be shared with the next adopters.
The CHSS includes updated registries of the region of Catalonia (ES) (7.5M inhabitants) from Primary Care,
Hospital-related events (hospitalizations, emergency room consultations and specialized outpatient visits), Pharmacy,
Mental Health, Socio-sanitary services and other items (home-based respiratory therapies, dialysis, outpatient
rehabilitation and non-urgent healthcare transportation) since 2011. It allows analyses of the use of healthcare
resources, pharmacy consumption, prevalence of key disorders and population-based health risk assessment. It is of
note that although integration of CHSS registry data with electronic medical records is not yet in place, it constitutes
the main strategic goal since January 2017.
B1- CF3: Development of enhanced risk prediction modelling for health policy purposes and/or clinical risk
prediction
On-going activity of the Catalan oGP is to build on the specificities of the GMA, incorporating additional clinical
variables and social determinants, to improve the predictive ability of the GMA, and increase the support of clinical
decision making1,3. Practicalities of enhanced multisource clinical predictive modelling, including: i) clinical
information, ii) GMA scoring, iii) patient’s self-tracking data, and, iv) disease-related biological mechanisms, to
guide decision-making in the clinical arena have shown high potential1 and are curently being worked out and tested.
B2- Promotion of healthy life styles
The design and implementation of proper policies to foster healthy life styles to prevent multimorbidity constitute a
major goal. Likewise, patient empowerment to increase self-efficacy and tertiary prevention of episodes of
exacerbation is a key unmet need to improve health-related quality of life, increase survival and reduce avoidable use
of healthcare resources. These are central aspects to be taken into account in the deloyment of integrated care
strategies. However, accessibility and poor adherence are major limitations for cost-effective interventions
addressing such goals. The approach adopted in Catalonia is to learn from the implementation of preventive
perioperative interventions, specifically from the deployment of prehabilitation in high risk candidates to major
surgical procedures. The strategy has been fostered by two major factors. Firstly, the high burden of periooperative
complications, including deaths, on healthcare systems55. Secondly, the time-limited period (average 4 weeks) of the
intervention facilitates the analysis of the factors modulating adherence and effectiveness of the implementation. The
results have indicated a high potential for healthcare value generation and for transferability to other clinical
scenarios. A three-step approach is proposed to next adopters.
B2- CF1- Transferability of the prehabilitation program
Prehabilitation is a preventive intervention targeting high risk candidates for major surgical procedures carried out
preoperatively, average 4-week duration, aiming at reducing complications and enhancing postoperative recovery. It
combines: (i) exercise training and promotion of physical activity; (ii) nutritional balance; and; iii) psychological
support.
The intervention is currently deployed as a mainstream service56,57 and cross-country transferability at EU level is
being tested through an ongoing EIT-Health project (2019-2021). The outcomes of a recent co-design process provide
robust grounds for lean design of a future personalized perioperative care service at regional level covering three
phases: prehabilitation, in-patient care, and post-discharge rehabilitation. There is solid evidence indicating the
potential
B2- CF2- Perioperative care with a population-health approach
55
Dmitri Nepogodiev D, J Martin, B Biccard, A Makupe and Al Bhangu. Global burden of postoperative deaths. The Lancet. 2019; 393 (10170): 401
56
Barberan-Garcia A, Ubré M, Roca J, Lacy AM, Burgos F, Risco R, et al. Personalised Prehabilitation in High-risk Patients Undergoing Elective Major
Abdominal Surgery : A Randomized Blinded Controlled Trial. Ann Surg. 2018;267:50–6.
57
Barberan-Garcia A, Ubre M, Pascual-Argente N et al. Post-discharge impact and cost-consequence analysis of prehabilitation in high-risk patients undergoing
major abdominal surgery: secondary results from a randomised controlled trial. Br J Anaesth. 2019;123(4):450-456.
26 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Design and testing of digitally-supported, community-based perioperative care services customized according to
patients’ risk levels is underway.
B2- CF3- Rehabilitation of chronic patients
Lessons learnt in the deployment of prehabilitation services are extremely useful for designing and testing cost-
effective rehabilitation programs for chronic patients, including oncology candidates, aiming at achieving high levels
of accessibility and program’s adherence.
B3- Vertical and Horizontal integration experiences adopted in Catalonia
Innovative practices are continuously emerging in the region leading either to testing or, for those that are successful,
to large scale deployment. The current block (B3) includes four initially selected examples successfully assessed in
the EU project ACT@Scale58. Each of the experiences encompasses the different dimensions highlighted in: (i)
change management and reorganization of the existing care models; (ii) embedding digital technologies and tools in
care services, re-organization of patient pathways; (iii) health workforce roles and skills with digital technologies
and data; (iv) building the capacity of individuals and communities to participate in the care process; (v) citizen
empowerment; (vi) use of patient reported data; (vii) new payment methods; (viii) performance assessment of new
care models; and, (ix) digital solutions. Brief description of the four selected experiences indicated belwo, can be
found in8:
B3- CF1- Programme for chronic and frail patients (Badalona Serveis Assistencials, BSA).
B3- CF2- Support for complex case management including home hospitalization, transitonal care and
vertical&horizontal integration supported by digital tools (Health District Barcelona-Esquerra, AISBE)
B3- CF3- Healthcare support programmes for nursing homes (MUTUAM, Barcelona).
B3-CF4- Integrated Care for admission avoidance of subacute and frail patients (PS Pere Virgili, Barcelona).
The analysis of implementation strategies following the CFIR approach and identification of KPIs for long-term
follow-up of the service beyond the initial deployment phase are available for most of the interventions59.
B4- Innovative assessment and regulatory aspects
This block includes three different items of healthcare performance assessment and experiences, as well as ongoing
work, on regulatory issues.
B4- CF1- Catalan Health Plans and Practicalities of healthcare delivery assessment
The Catalan oGP has had a well-blended background for the design and deployment of five-year period Regional
Health Plans over the last thirty years. The last two programs 2011-201560 and 2016-201661 focused on the deployment
of integrated with an emphasis on the digital transformation of the health system. The region is currently actively
designing the 2021-2025 Health Program. Moreover, Catalonia is producing both recommendations and innovative
information on practicalities of healthcare delivery assessment (Nextare) based on the evaluation framework 9 taking
into account: (i) Health outcomes assessment with a Quadruple aim approach; (ii) Evaluation of service
implementation (CFIR); (iii) Assessment of maturity (Sirocco); and; (iv) identification of service specific key
performance indicators.
B4- CF2- Regulatory aspects associated with patient’ self-tracking data
TIC-Salut has generated recommendations/standards for patients’ self-tracking data using Apps and taking into
account interoperability with the regional personal health folder, La Meva Salut62
B4- CF3 - Regulatory aspects of health data management for research purposes and quality assurance purposes.
Health data management across institutions for research purposes in Catalonia is regulated under the umbrella of the
PADRIS program, run by AQuAS63. Regulatory aspects of health data management for quality assurance and service
innovation purposes are currently being addressed in Nextcare under the auspices of TIC-Salut, which plays the role
of regional authority on health data privacy. In 2020 a new Joint Action on Data Protection on how the GDPR will
be applied to health information is planned.
B5- Digital support of integrated care services
Digital support of health services in Catalonia involves regional interoperability among an extensive network of
healthcare providers with highly heterogeneous health information systems. It is of note that a well-developed health
information exchange system is in place. This is the role of the shared regional health record (HC3) which consists
of a series of health information exchange platforms linking publicly-paid heterogeneous healthcare providers at
regional level. Within this mature scenario, in addition to HC3 (B5-CF1), two key tools are fully blended and
implemented across the entire region: i) B5-CF2, Primary Care electronic medical record (eCAP) and the Electronic
58
ACT@Scale (2016-19) – Advancing Care Coordination and Telehealth at Scale [Internet]. Available from: https://www.act-at-scale.eu/
59
Baltaxe E, Cano I, Herranz C, et al. Evaluation of integrated care services in Catalonia: population-based and service-based real-life deployment protocols.
BMC Health Serv Res. 2019;19(1):370
60 Government of Catalonia M of H. Health Plan for Catalonia 2011-2015. 2012. Available from:
http://salutweb.gencat.cat/web/.content/home/el_departament/pla_de_salut/documents/arxius/health_plan_english.pdf.
61 Department of Health. Catalonia Health Plan for 2016-2020 (in Catalan). 2016. Available from:
http://salutweb.gencat.cat/web/.content/home/el_departament/Pla_salut/pla_salut_2016_2020/Documents/Pla_salut_Catalunya_2016_2020.pdf.
62
Modol JR. Navigating Towards Self-Care: The Catalan Public Patient Portal. In: Aanestad M, Grisot M, Hanseth O, Vassilakopoulou P, editors. Information
Infrastructures within European Health Care: Working with the Installed Base. Cham: Springer International Publishing; 2017. p. 173–92.
63
Public Data Analysis for Health Research and Innovation Program (PADRIS) http://aquas.gencat.cat/en/ambits/analitica-dades/padris/
27 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Prescription; and ii) B5-CF3, the Personal Health Folder (La Meva Salut, LMS) also interoperable with HC3. All
these basic tools are governed by the eHealth (eSalut) Office. The steps followed for the development of these three
items, their current status and future evolution will be shared by the practice.
It is of note that the region is currently developing an ambitious ICT plan for the full digital transformation of the
health system with an emphasis on cloud-computing and artificial intelligence (AI). Some of these aspects are
covered by B5-CF4. Within this umbrella will be sharing experiences testing digital tools to support: i) col·laborative
work among stakeholders across health and social care tiers, as well as implementation of adaptive case management
and digital tools for patients’ self-tracking information. Finally, B5-CF5 addresses the ongoing ICT deployment
strategic plans for the period 2020-2023. The characteristic features proposed for the transfer are listed below:
B5-CF1 - Regional information exchange platform (HC3)
B5- CF2- Primary Care electronic Medical Record (eCAP) and Electronic Prescription
B5- CF3- Personal Health Folder (La Meva Salut)
B5- CF4- ICT tools supporting adaptive case management & col·laborative work9
B5- CF5- Cloud-based strategies (SISCAT program)
The first three items, B5-SF1 to B5-SF3, correspond to mature digital support tools already fully adopted at the
regional level. Moreover, the oGP proposes the conceptual approach recently reported in64 to assess the maturity of
digital transformation.
THE OPTIMEDIS MODEL-POPULATION-BASED INTEGRATED CARE (GERMANY)
The model is based on the Triple-Aim approach, according to which three aims are pursued simultaneously: 1.
Improving the patient experience of care (including quality and satisfaction), 2. Improving the health of populations;
and 3. Reducing the per capita cost of health care (Berwick, Nolan, Whittington 2008). The innovative nature of the
program, with its strong reference to theoretical models and up-to-date scientific literature and its rigorous evaluation,
means that the HK model is a useful model for other countries to adapt and expand. The business model of HK has
some distinguishing characteristics: at its core is the value-oriented population-based shared savings contract based
on the Triple Aim Approach. Crucial components of this approach include a) the fact that a specific population,
representative of a typical risk pool and covered by the integrated care system, can be identified—thereby minimizing
the risk of adverse selection, b) the support of an “integrator” who has the know-how and competences to guide the
development and implementation of population health improvement programs and c) that there are economic rewards
from the production of the improved health status instead of a mere increase of services.
B1 - Shared savings contract with reimbursement/commissioning organizations
A key characteristic is the value-oriented population-based shared savings contract. This model maintains existing
reimbursement schemes and financial flows, but the integrator company assumes virtual responsibility for the
development of the so called contribution margin. The contribution margin is the difference between the amount the
purchaser receives from the central health care fund for the expected (risk-adjusted) mean costs of care of all insured
and the costs that were actually incurred by their population, adjusted for baseline differences before the start of the
intervention. A positive contribution margin is then shared between the insurance companies and the integrator to
compensate investment costs. Another key characteristic of the model is that the integrator company is financially
accountable for all people in the population served, not just for those who are registered members or receive care
from physicians that form part of the network, thus reducing the risk of cream-skimming and incentivising prevention
and health promotion.
B1- CF1- identifying current contractual arrangements and assessing possibilities for value-based contracting
B1- CF2- defining data standards and appropriate outcome measures
B1- CF3- designing the valued-based payment framework
B1- CF4- constructing the analytical model to execute the contract
B2 - A model including strong stakeholder engagement
OptiMedis sets up population-based integrated care health system as a regional LTD companies in coordination with
local stakeholders, mostly physician networks and other health care providers. Governance arrangements focus on
strong representation of local user groups and social organizations to ensure sustainability of the network and
alignment with local needs.
B2- CF1- Identifying and liaising with stakeholder groups
B2- CF2- Creating appropriate governance structures
B3 - Electronic integration across providers
64
Baltaxe E, Th Czypionka, M Kraus et al. Digital Health Transformation of Integrated Care in Europe: Overarching Analysis of 17 Integrated Care Programs.
J Med Internet Res 2019; vol. 21: iss. 8. e14956
28 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
A variety of digital tools are designed for specific indications, whether for asthmatics, people with slide-beds or
people suffering from depression. However, it is increasingly recognized that improving health requires measures
that often go beyond the responsibility of a single organization (hospital, practice, rehabilitation etc.). In order to
influence the health of the population, an understanding of the determinants of health in the life cycle is necessary
and, based on this, the derivation of measures for a comprehensive population health management (PHM). PHM
differs from classical support services for the chronically ill in several respects: It includes several chronic diseases
and conditions, considers co-morbidities, includes proactive health promotion management, includes predictive
models for health development and - based on these - strategies for case management of high-risk patients as well as
for personal health management at population level for people with a low risk of disease or morbidity. PHM requires
a constant exchange of data from all health care providers as well as other sources of data on population health.
Moreover, PHM is not only an IT suite, but requires a regional manager who derives relevant decisions for the clinical
and non-clinical management of health potentials from the multitude of data. OptiMedis is IT agnostic and helps
regions procure and deploy the most appropriate IT solution.
B3- CF1- Assessing state of current health IT integration and IT tools in use
B3- CF2- Market assessment on tools adequate to improve IT connectivity of providers
B3- CF3- Training with providers to assess incentives for IT deployment and usability assessment
B3- CF4- Patient access to their data (Open Notes approach)
B4 - Patient involvement and empowerment
The patient-centered care approach is paramount to the success of the OM model and embedded at three levels: at
the structural level, in the planning of interventions, and in the interactions between physicians and patients.
At the structural level, patients are represented in patient advisory boards, which elect their representatives on a
biannual basis and are given the opportunity to contribute to identifying and developing new programmes. At the
level of intervention planning there is a strong focus on shared-decision making and self-management support, which
is embedded in design and development. At the level of individual interactions of patients with health professionals,
patients joining first undergo a comprehensive health-check based on which they may be offered to participate in any
of the health promotion and disease prevention programmes HK. Patients are also given the opportunity to develop
health-related goals, which are discussed with the doctor and then monitored over time, accompanied by individual
support and participation in patient education and self-care programmes as needed. In order to support the patient-
centered care approach, physicians, other health professionals and practice staff are offered training. Underlying all
these efforts is an understanding of the patient as a co-producer of their health (Batalden P et al 2015).
B4- CF1- Patient advisory boards
B4- CF2- Shared-decision making tools and self-management support
B4- CF3- Comprehensive health checks and health-related goals
B4- CF4- Providing training on incentives and tools to implement patient centered care
B5 - Data-driven management
Effective Information and Communication Technology (ICT) is vital to allow data-driven management (Hammersley
et al., 2006), to ensure that the correct information is exchanged in a timely manner and understood, while at the
same time laying the foundation for stable cooperation and changes. Data must be processed in a way that it can
trigger a continuous learning and improvement process65 (). “Business Intelligence” (BI) is often used as generic term
for this: “Business Intelligence is the process of transforming data into information and, through discovery, into
knowledge“66. OptiMedis provides overarching management support, business intelligence and health data analytics,
whereby the data driven health analytics propel both the planning of health programs and guide local practice
improvements via feedback reports to participating physicians. These reports are based on a balanced scorecard
approach, which uses structure, process and outcome indicators and is designed to be interactive in that it allows
users to select indicators to retrieve more detailed information. Some indicators are supported by targeted
improvement activities. For example, the dashboard indicates problematic prescription behavior (e.g. a high
proportion of drug prescription according to the PRISCUS or FORTA D classification models for potentially
hazardous prescriptions for older people) (Holt S et al 2010, Kuhn-Thiel AM et al 2014). This indicator is supported
by two-monthly geronto-pharmaceutical consultation meetings for which physicians prepare a patient case report and
which discusses potential problems jointly with a pharmacologist to optimize medication regimes. The infrastructure
utilized to produce the dashboards has the capacity to integrate and transform multiple data sources (such as claims
data, health records, patient survey), to analyze the potential effectiveness of a program or identify high-risk patients
and provide automated benchmark reports to participating physicians. This business intelligence solution was
awarded with the Best Practice Award Business Intelligence by the German Business Application Research Center
(BARC) The DataWarehouse Approach includes suite of analytical tools that support improvement processes in
integrated health care networks. Diverse data can be integrated via various ETL (extract, transform, load) processes
65
Kupersmith et al., 2007; Vijayaraghavan , 2011
66
Behme, 1996
29 146
JADECARE- 951442
in the Core Data Warehouse (MS SQL Server). Thereby data are Associated with document Ref. Ares(2020)3808356 - 20/07/2020
brought into relational connections, standardized
(and subjected to quality checks, cleansing and normalization. After this stage data are via additional ETL processes
prepared for the analytical database, among others e.g.
insurance selections67 ,
risk adjustment methods like propensity score and exact matching68,
relative time references (i.e. for example what happened a quarter prior or post enrolment on a Disease
Management Program),
model and scenario calculations (e.g. risk structure equalization schemes calculations69, disease-related
expense attribution models) and
predictive modelling approaches
B5- CF1- Potential analysis tool
B5- CF2- Performance dashboards
B5- CF3- FORTA tool to identify over- and underutilization regarding prescriptions
B6 – Prevention, health promotion and public health
In order to reach the Triple Aim, a set of activities and programmes were established, which all draw on a common
set of underlying features: a) individual treatment plans, b) care planning based on the Chronic-Care Modell (Barr
VJ et al 2003), c) patient coaching. The following Prevention and Health Promotion Programmes that have been
developed so far: Strong heart (programme targeting heart failure), Healthy weight (for metabolic syndrome,
including diabetes), Good prospects (care services for children), In balance (blood pressure), Strong muscles – solid
bones (osteoporosis), Staying mobile (treating early stage rheumatism), Strong support - healthy back (chronic back
pain), Better mood (depression), Good counselling (help, advice and support in critical times), Psycho Acute (acute
psychological issues), Disease management programmes, Smoke-free Kinzigtal (including pre-surgery smoking
cessation), Social support (to reduce stress where patients are in critical situations) , Liberating sounds (in tune with
music) and, a self-management training programme (based on the Stanford Chronic Disease Self-Management Pro-
gramme).
B6- CF1- Individual treatment plans and care programmes
B6- CF2- Care planning based on Chronic care model
B6- CF3- Patient coaching
DIGITAL ROADMAP TOWARDS AN INTEGRATED HEALTH CARE SECTOR (REGION OF SOTH
DENMARK)
The Roadmap towards Integrated Care consists of different elements that together make up the foundation for digital
and cross sectorial communication. One of the key success factors is a strong collaboration between the different
organizations in the regional eco-system of academia, knowledge institutions and private companies; a focus on user
involvement of both professionals and end-users in co-designing solutions and implementation processes. Moreover,
a good public-private partnership and preferably an agile one as well as a strong IT infrastructure to make digital
communication possible.
B1-Cross sectorial digital communication: standards and agreements
The objective of electronic standards is to make sure that the various IT systems and organizations can reuse the data
which is exchanged. The messages are the most frequent text-based clinical messages in the Danish health care
system, e.g. discharge letters, referrals, lab test orders, e-prescriptions and reimbursement from public health
insurance and are all in the high 90’s percentile when it comes to usage. The agreements made between the health
sectors ensure that the responsibility is clear, and collaboration is formalized.
B1-CF1: Health Agreements: The main road towards Integrated Care consists of three lanes. First the lane of our
health agreements, which describe the responsibilities and communication between the three sectors (hospitals,
municipalities and GPs) and are revised every 4 years. In these agreements special emphasis is typically made on
the elderly and patients with a chronic or complex condition. Patients with a chronic condition are categorized
into 4 categories according to the complexity of their disease as well as their self-care ability. These categories
have different care pathways where specific responsibility has been divided between the caregivers. Current
mandatory health agreements between municipalities and regions on coordination of care address a number of
topics related to admission and discharge from hospitals, rehabilitation, prevention, psychiatric care, information
technology (IT) support systems, and formal progress targets. Agreements are formalized for municipal and
regional councils at least once per four-year election term, generally take the form of shared standards for action
67
Hauner et al., 2003; Windt et al., 2008
68
Rosenbaum and Rubin, 1983; Austin, 2011; Stuart 2010
69
Pimperl, 2014
30 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
in different phases of a patient’s journey within the system, and must be approved by the Danish Health Authority.
The degree to which the regions and municipalities succeed in reaching the goals is measured by national
indicators published online.
B1-CF2: Messaging Standards: The electronic communication between these three organizations consists mainly
of national standards for electronic messaging, visualized by the second lane. These standards were first developed
in 1995 and are now widely implemented in Denmark and maintained by MedCom. Through the years, MedCom
has developed more than 150 standards, profiles and web services consisting of ‘the good letters’ which are all
being used increasingly. At the same time, new standards are being developed an all of them are implemented
with IT vendors within the healthcare sector. MedCom’s standards secure that the various IT systems and
organizations can reuse the data which is exchanged. The messages cover the most frequent text-based clinical
messages in the Danish health care, e.g. discharge letters, referrals, lab test orders, e-prescriptions and
reimbursement from public health insurance and are all in the high 90’s percentile when it comes to usage. For
example:
All GPs keep electronic health records (EHRs), and 98 per cent exchange records electronically.
GPs receive all laboratory test results from the hospitals electronically.
99 % of all prescriptions are sent electronically to the pharmacies.
97 % of all referrals to hospitals are made electronically.
All referrals to medical specialists and psychologists are made electronically.
B1-CF3: SAM:BO Agreement, which is the third lane, is the agreement that blends the Health Agreement and the
electronic standards. In here a description of which messages are to be sent at which point of the care pathways guides
the sectors in setting up the correct communication procedures. The success of this system has largely been due to
the long haul of organizational collaboration, which is then translated into electronic communication. This
constellation is unique to the Region of Southern Denmark and makes sure that the agreements are clear and
implemented. It was fist implemented in the Region in 2009. Although most communication travels along the main
road there are also cases where more than standard information is needed and where we have some cases of digital
health projects with the focus of even more cross-sectorial communication.
B2- Cross sectorial digital communication: Additional solutions to support complex disease areas
A roadmap approach has been used in explaining the Region of Southern Denmark’s ICT solutions using personas
to exemplify a turn off the main health roadway for specialized health treatment at different health services in their
life course and how the Region’s ICT approach supports integrated care across different healthcare services in the
region. This is an informative visible approach for easier understanding of how ICT can work within complex
healthcare systems. The following projects are all examples of additional solutions for more complex disease areas
that require even more digitally enabled cross-sectorial communication.
B2-CF1: Tele-COPD: At least 200.000 people in Denmark suffer from COPD and the number is on the rise.
COPD is primarily caused by smoking and secondary by conditions in the work field. 20 % of all acute admissions
are caused by COPD and we know that the earlier the disease is diagnosed the easier it is to treat and slow down.
That is why we see telemedicine in the area of COPD as a supplement to the treatment. In our current work with
expanding telemedicine for COPD patients the purpose is to reduce the consultations and admissions as well as
making sure that the patients feel safe at home. The national initiative is focused on patient education, early
detection of symptoms and an increase in quality of life. The aim is to include approximately 2.600 patients with
COPD in telemedicine usage in the Region. In the project 22 municipalities, 4 hospitals and a large number of
GP’s are included in the Region of Southern Denmark. As part of the implementation a large effort to inform the
patients on home-monitoring is being made – including pamphlets and videos with information on what to expect.
The patients will be offered devices to measure oxygen levels, pulse and weight at home. The collection and
distribution of the information will be in line with the national procurement of telemedicine that has just been
finished, with a range of 5 suppliers for the citizens’ view.
B2-CF2: Tele-psychiatry: In 2013 we opened the Tele psychiatric center in the Region with the ambition to
develop and evaluate digital communication and devices for patients with a psychiatric diagnosis. One of the
projects the center has been involved in was the European Union funded MasterMind, which stands for:
MAnagement of mental health diSorders Through advancEd technology and seRvices – telehealth for the MIND.
The project’s focus was telemedicine within the psychiatry – more specifically telemedicine for treatment of
depression. Depression is a disease with high incidence and social costs in Europe, but also an area with proven
clinical effectiveness of ICT (information and communication technology) in its treatment. The aim was to offer
a patient-centered treatment course and ensure that the patient has access to high-quality treatment in their
immediate environment. The MasterMind project implemented cognitive behavioral therapy through digital
services for almost 5,000 depressive adults in eleven European countries and implemented collaborative care
through video conference for patients with depression, who were treated by general practitioners.
31 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Videoconferences were used to create networks between the health professionals in order to make it easier for
them to support each other and to share knowledge. In addition, video conferences could be used for offering
specialist treatment in remote areas. In that way, patients with depression gained access to therapy if they had
internet access. After the end of the project, the tele psychiatric solutions are still in use by most of the partners,
and many have decided to upscale their service for more diseases and users. In Denmark, internet psychiatry is
still an option for patients with panic disorder, social phobia, other phobias and light to moderate depression. The
solution is now national, and it is managed by Tele psychiatric Centre in the Region of Southern Denmark.
B2-CF3: My Patient Journey: “My Patient Journey” is an app developed at Odense University Hospital to
facilitate digital communication between the hospital departments and patients. The app also helps patients find
and keep track of information from the hospital and gives them a better overview and experience in
communicating with the hospital. It also the Region’s selected tool for collection of PRO-data such as filling out
questionnaires and recording experiences which is a strategic focus point for the Region. The solution is used in
44 separate hospital departments in the region, and more than 37,000 patients use it. Some of the functionalities
and content of the solutions are Appointments, Notifications, Questionnaires, Voice-recording of consultations,
Courses, Diary, Medical passport, Messages and My data. The key to the app is the variety and the flexibility to
combine the relevant functionalities for a specific department, pathway and patient type. Another key is the focus
on the importance to co-create the solutions with the users, both the healthcare staff, the patients, the relatives and
truly design the solution for the users and their needs.
B2-CF4: Online physical rehabilitation: Another similar app is the online physical rehabilitation platform that
allows rehabilitation therapists in the hospital or municipality to design a training program from a range of
exercises to fit the patient. The exercises are short videos of trained therapists showing how to do the exercise and
the patients can access these videos on their mobile devices and register their pain level when they have finished.
This gives the care professionals a better feeling of the patients’ progress and when to have a consultation or edit
the training program and it gives the patients the freedom to train at home at their convenience. They can also use
the app to see their own progress, chat with the therapists and fill out questionnaires. The solution is used in a
number of the Regions’ hospitals and municipalities – and has a positive business case as well as satisfied users.
B2-CF5: Digital Health Centre: The main tasks of the municipal health centers are to provide health promotion
and disease prevention aimed at the citizens. This is e.g. done through guidance and counselling on a healthy
lifestyle. The focus is on providing tools, motivation and support for self-managing a change of their lifestyle and
routines. They also create network possibilities for citizens, as well as provide knowledge to health organizations
in the civil society. They also support rehabilitation after interventions at the hospital and offer preventive home
visits to citizens above the age of 75. The health centers have nurses, dieticians, physiotherapists and doctors. The
current challenge for the health centers is the increase in the number of at-risk citizens, difficulties engaging the
citizens in patient education (for geographic, economic, physical or time reasons) and maintaining lifestyle
changes. The Digital Health Centre is a partnership between 5 municipalities, the Diabetes Association, Heart
Association and the Region of Southern Denmark through the Health Innovation Centre and the department of
cross-sectional cooperation. The vision of the Digital Health Centre project is to develop and integrate digital
solutions in the courses of the healthcare centers. Under this vision, several subprojects are unfolded. Patients can
join from home, where they can see pre-recorded information, participate in webinars gain knowledge by reading
short texts, and chat with both health care professionals and other patients. The systematic use of digital solutions
should result in: flexibility, motivation and resource optimization and patient empowerment. Since the smaller
municipalities can join together to produce content to the online-platform and therapists can be used to a wide
range of citizens from different areas resources can be better used. Patients that do not like to be in physical
sessions with others can join and they have the possibility to go back and revisit the information when they are
motivated to implement a change.
B2-CF6: Geri Toolbox: With the aim of reducing acute admissions, the GERI Toolbox contributes to early
detection and timely intervention for elderly citizens with multi-morbidities and loss of functional capabilities.
Home care nurses use in-home clinical equipment (incl. a mini laboratory) and telemedicine technology. This
allows GPs to receive basic objective health information that supports early clinical decision-making and timely
intervention. The acute nurse brings the GERI Toolbox, packed in a small easy-to-bring roller suitcase, and the
measurements are transferred to a common IT platform (Generic Telemedicine Platform) which homecare, the
GP and eventually the hospital can access. The focus in this project is on simplification of communication, the
possibility of early detection and treatment as well as a reduction of acute admissions. The Generic Telemedicine
Platform (GTP) ensures that the demands of the future healthcare sector are met in relation to the increase in
collected data from the citizens’ own homes. Data will be used by clinicians in hospitals, municipalities and GPs.
The GTP can collect home monitoring-, sensor- and PRO data and show the data in a uniform and recognizable
way, so that clinicians can get an overview of the individual citizen and use the collected data in treatment
planning. Through the GTP data collected by the citizens in their own home will be accessible to all healthcare
providers involved in a course of treatment. They can access the same data and knowledge. The data is integrated
32 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
with the electronic patient journal in the Region of Southern Denmark, which is the core system for the clinicians.
This makes it easier to test and offer telemedicine solutions to citizens.
NEXT ADOPTERS IN JADECARE
Digital innovations, if designed purposefully and implemented on the basis of cost-effective criteria, can contribute
to improvements in the effectiveness, accessibility and resilience of health systems. They can provide tools to support
the modernization of health and social care systems and their adaptation to the challenges mentioned above. They
can facilitate the implementation of new care models as part of health systems reforms, together with the related
organizational changes in care delivery, financing modalities or workforce skills.70
eHealth is believed to have great potential to improve integrated care71. A digitalized information infrastructure that
ensures timely and reliable sharing of clinical and other information can improve health outcomes and efficiency,
and also create a repository of valuable data for researchers and system managers.
A recent study72 comparing the digitization of healthcare systems in 14 EU Members States and three OECD
countries, has demonstrated that the countries digitize their healthcare systems at very different speeds. Estonia and
Denmark rank at the top of the index, whereas France and Germany trail behind. The top countries of the Index are
leading in all three areas examined: policy activity and strategy, technical implementation and readiness and the
actual use of data.
Enabling people to access, and interact with, their electronic medical record (EMR) is an important feature that can
help people become more involved in their health and their care.73 Most countries report a unique patient identifier is
used within electronic health records.74 One in eight EU residents (13%) made an appointment with a health care
practitioner on line in 2016, up from one in twelve (8%) in 2012.
Many countries in Europe are already implementing EMRs in all health care settings, including primary care. In
2016, the proportion of primary care practices using an EMR was approximately 80% on average in 15 EU countries,
although there are wide variations. While an EMR was used in all or nearly all primary care practices in Denmark,
Estonia, Finland, Greece, Spain, Sweden and the United Kingdom, its use was much more limited in Croatia and
Poland. In Denmark and the United Kingdom, the proportion of primary care practices using an EMR doubled
between 2012 and 2016.75
Some countries report comprehensive record sharing within one “country-wide” system designed to support each
patient having only one electronic health record. This is the case for example of Estonia, France, Greece, Latvia, and
the United Kingdom (Northern Ireland). In these countries, plans call for patient records to be shared among physician
offices and between physicians and hospitals regarding patient treatment, current medications, and laboratory tests
and medical images. Some have already achieved this functionality, while others are progressing toward it. Other
countries have EHR systems, but within it, some key aspects of record sharing are sub-national only (Spain). Croatia
and Denmark report that some aspects of record sharing are comprehensive at the national level. 76
2012 2016
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
FIGURE 3 Percentage of primary care physician offices using electronic medical records, in 2012 and 2016. health at a glance: europe 2018
70
Blueprint on the transformation of health and care in Europe. https://ec.europa.eu/digital-single-market/en/blueprint-digital-transformation-health-and-care-
ageing-society
71
Struckmann V, Leijten FR, van Ginneken E, Kraus M, Reiss M, Spranger A, SELFIE Consortium. Relevant models and elements of integrated care for multi-
morbidity: results of a scoping review. Health Policy 2018 Jan;122(1):23-35
72
SmartHealthSystems International comparison of digital strategies. BertemsmannStiftung
73
Health at a Glance: Europe 2018 , OECD 2018 https://ec.europa.eu/health/sites/health/files/state/docs/2018_healthatglance_rep_en.pdf
74
Oderkirk, J. (2017), "Readiness of electronic health record systems to contribute to national health information and research", OECD Health Working Papers,
No. 99, OECD Publishing, Paris, https://doi.org/10.1787/9e296bf3-en.
75
Health at a Glance: Europe 2018, OECD 2018 https://ec.europa.eu/health/sites/health/files/state/docs/2018_healthatglance_rep_en.pdf
76
Oderkirk, J. (2017), "Readiness of electronic health record systems to contribute to national health information and research", OECD Health Working Papers,
No. 99, OECD Publishing, Paris, https://doi.org/10.1787/9e296bf3-en.
33 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
In most countries, the patients are able to see the information contained in their electronic record (the only exceptions
being Croatia and the Czech Republic), and in some of these (Denmark, Estonia, France, Greece, Latvia and Spain),
they are also able to interact with their record, for example to add or amend the information.77
The level of use of digital healthcare solutions and services is quite variable in the European Union78. The largest
number of patients making an appointment with a practitioner via a web site can be found in Denmark, Spain and
Finland. In 2016, in these countries, more than 35% of patients used the Internet to book a medical examination with
a practitioner. In Germany, France and Italy, the percentage of patients fixing an appointment online was less than
the EU average (16%), 12%, 11.9% and 10%, respectively as can be seen in the following figure:
FIGURE 4 TREND IN INTERNET USE IN EUROPE: Source: Institute For Competitiveness 2017
The level of preparedness for e-health and digital healthcare in Europe varies79. The figure below refers to an index
based on the dimensions, internet use in the healthcare sector, infrastructure development and security and privacy:
FIGURE 5 PREPAREDNESS FOR eHEALTH IN EUROPE: I-COM INDEX. Source: Institute For Competitiveness 2017
77
Oderkirk, J. (2017), "Readiness of electronic health record systems to contribute to national health information and research", OECD Health Working Papers,
No. 99, OECD Publishing, Paris, https://doi.org/10.1787/9e296bf3-en.
78
EU STUDY 6.117 Digital Health
79
I-com. DIGITAL HEALTH The impact of Big Data & AI on EU healthcare systems https://www.i-com.it/wp-content/uploads/2017/12/Studio-Digital-
Health.pdf
34 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Most countries are transitioning from paper-based prescriptions to ePrescribing, but the implementation of
ePrescribing varies greatly across the EU. In 2018, over 90% of prescriptions were transmitted to community
pharmacies electronically in Estonia, Denmark, Portugal and Spain. However, ePrescribing has not been
implemented in several countries (such as France or Germany), these countries have stated that they plan to start
implementing ePrescribing at the regional or national levels over the next few years.80
FIGURE 6 Percentage OF ePrescriptions in community pharmacies2018. Health At A Glance: Europe 2018 - OECD 2018
According to a survey among the relevant stakeholders in Europe, funding is perceived as the major challenge in
eHealth development. Interoperability and workforce concerns are ranked as the number two and number-three
challenge. Clearly, for health authorities, tackling interoperability is the main challenge. Healthcare providers arealso
concerned about a lack of sufficiently skilled employees and comliance with IT security requirements. eHealth
priorities differ by country/region: EMR implementations are a top priority in Germany (54%) and the United
Kingdom (37%), while they are of lower priority in more EMR-mature countries like Italy (23%) and Spain (12%).
In countries where healthcare providers are typically more digitally mature, the patient is already receiving increasing
attention from eHealth professionals.81
The table below presents a brief description of the situation in the next adopters´ countries (different sources82 )
TABLE 4. DIGITAL HEALTCARE SOLUTIONS IN JADECARE’S NEXT ADOPTERS´
Country Digital healthcare solutions
Bosnia and In 2014, T-Systems Hungary with its partner from the Federation of Bosnia and Herzegovina (FBiH),
Herzegovina Medit was commissioned by the Health Insurance Institutes of three FBiH cantons to implement the second
(Bismarck) phase of the implementation of a uniform integrated healthcare system for all healthcare facilities of three
FBiH cantons: Tuzla; Zenicko-Dobojski and Unsko-Sanski cantons. Within the project, T-Systems
delivers hospital information systems and other related medical software, as well as hardware through its
local partner and supports its maintenance. A further extension of the current licenses in Tuzla, Zenicko-
Dobojski and Unsko-Sanski cantons and Sarajevo is foreseen in the very near future. Based on the services
provided by T-Systems Hungary there is a cloud-based, unified information systems on cantonal level.
This system supports secure access to health data and radiology images for healthcare providers of various
levels and for the patients themselves. The system provides the basis for the local eReceipt, eCard and
eDoctor system. Going beyond the cantonal system, the aim of the project is to create a unified integrated
eHealth system on a federal level. As the interconnection of the deployed information systems are
guaranteed, the new system works as a regional EHR system, open to further developments and creates a
stable base for a country-wide EHR system.
80
Health at a Glance: Europe 2018, OECD 2018 https://ec.europa.eu/health/sites/health/files/state/docs/2018_healthatglance_rep_en.pdf
81
Annual European eHealth Survey 2019 https://europe.himssanalytics.org/sites/himssanalytics_europe/files/eHealth%20TRENDBAROMETER%20-
%20HIMSS%20Analytics%20Annual%20European%20eHealth%20Survey%202019.pdf
82
SmartHealthSystems International comparison of digital strategies. BertemsmannStiftung, https://www.bertelsmann-
stiftung.de/fileadmin/files/Projekte/Der_digitale_Patient/VV_SHS-Studie_EN.pdf eHealth – Future Digital Health in the EU
https://www.espon.eu/sites/default/files/attachments/Final%20report.%202019%2003%2025_final%20version_0.pdf , Country Health Profiles
http://www.euro.who.int/en/about-us/partners/observatory
35 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Country Digital healthcare solutions
The National Health Policy Strategy Plan priorities in the Federation of BiH are:
▪ Strengthening themechanisms to bolster efficient and informed health management
▪ Aligning legislative framework with reform objectives and European Union regulations
▪ Strengthening the protection of patient and provider rights
▪ Improving management of the health system
▪ Strengthening primary health care focusing on health promotion and prevention
▪ Strengthening public health functions
▪ Improving human resources for health
▪ Bolstering the pharmaceutical sector’s ability to ensure access to safe, quality, and cost-effective drugs
▪ Improving health information systems and technology management
▪ Improving health contracting, procurement, and payment
▪ Increasing health insurance coverage
In 2019, Health Insurance Fund of the Republic of Srpska signed a contract with a consortium (MMS Code
Banja Luka, Lanaco Banja Luka, Ericsson Nikola Tesla Zagreb) to develop integrated health care
information system for all health care institutions in Republic of Srpska (55 primary health care centers,
14 general and specialized hospitals and university clinical hospital). The integrated health care system’s
cornerstone is establishment of the central component with electronic medical record and electronic
medical digest for each citizen of Republic of Srpska. Each facility (70+) gets access to information system
assets and data via web applications and web services. The system establishes automated communication
between several data repositories to minimize repeated data entry and prevent errors. E-prescription and
e-receipt are again functional (after initial partial implementation in period 2009 – 2014). Two data centers
were established (primary and backup location) and fully equipped (servers, storage, etc.) in Banja Luka
and Bijeljina; new communication equipment and 3000 workstations are procured for health care
institutions, to replace aging and obsolete equipment. The system development is finished and now is in
testing phase. This system is to replace information systems in primary health care centers that is
operational in all facilities since 2009.
Croatia Development of eHealth solutions is still one of the national priorities
(Bismarck) Central Health Care Information System in Croatia (CEZIH) with more than 17,000 users and a large
number of information systems makes a good basis for informatization of the entire health care
system in Croatia. All participants in the system send data into the central database in real time and receive
advanced reports on operation of the health care system from that database. In fact, there is a:
▪ Well-established nation-wide ePrescription system established in 2011. Complete national coverage
was achieved, and a significant step was made towards “paperless office”. Over 50 million of e-
prescriptions are issued. Over 50 million of e-prescriptions are issued through CEZIH system each
year.
▪ Well-established nation-wide eHealth Records system (EHR) on the level of primary care with
implemented software for: preventive activities for chronic diseases - diabetes mellitus, hypertension,
COPD and obesity; rational therapy prescribing for the elderly – „chronic patient panels“. A large
number of health reports are still produced by manual data processing.
▪ Some secondary health care services included - eLab, eAppointment system
In Croatia, telemedicine service, i.e. medical services provided from a distance through information and
communication technologies, are currently provided at the primary, secondary and tertiary level of health
care.
Czech Republic The government established a National eHealth strategy of the Czech Republic 2016-2020. The main
(Bismarck) objective of the program "Health 2020" is to improve state of health of the population and to reduce the
incidence of illnesses and premature death. Another objective is the stabilization of disease prevention,
starting up effective cooperation mechanisms between the various departments which will work in the
long-term.
As a general summary of the measures, the National Strategy for Health 2020 is further elaborated in
various implementation documents (action plans) established in accordance with sixteen set themes of
protecting and promoting public health and disease prevention, state of health of the population of the
Czech Republic and other topics of public health and health care organizations. One of the themes and at
the same time a separate action plan is the Action Plan no. 11 Computerisation of Health which formulates
four strategic objectives:
1) Increasing citizen involvement in the care of their own health, prevention.
2) Increasing the efficiency of the healthcare system.
3) Increasing the quality and accessibility of health services.
4) Creation and development of information infrastructure and electronic healthcare management.
e-Prescription has already been implemented nationwide (used by oved 90% MDs in March 2020) and
infrastructure for access and viewing of the patient´s medication record is being built so that it should be
possible to use it gradually from June 2020.
36 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Country Digital healthcare solutions
On 1 January 2020, the Ministry of Labour and Social Affairs and the Czech Social Security
Administration (CSSA) launched an electronic sick note system. COVID-19 crises in 2020 has led not
only to introduction of some nation-wide specific services (such as Smart Quarantine) but also catalysed
and speed up preparation of organizational framework and introduction of digital services supporting
distant care and communication between patients and healthcare providers (incl. teleconsultations).
Further steps in digitalization of healthcare in the Czech Republic has been outlined in Strategic
Framework “Health 2030”, endorsed by MoH in 2019.
Denmark With over 20 years of experience in the field of digital health, the Danish company MedCom has been
(Beveridge) responsible for the development and distribution of electronic means of communication in healthcare since
1994. It plays a central role in the intersectoral communication
of individual health services. Another driving force is the National Board of eHealth, which has the
objective of building national ICT infrastructure and continuously developing it.
It also establishes the required standards for the interoperability of the various regional systems that are
used in most physicians’ practices and in many hospitals.
As the hospitals rely mainly on regional or local systems that cannot always communicate with the EHRs
in physicians’ practices, a national medication database was implemented, the Shared Medication Record.
This provides information on patients’ current medication
and their vaccination status.
The final cornerstone of the Danish digital health system is the health information portal sundhed.dk. Since
2004, the Ministry of Health, the regions (in their capacity as major financial stakeholders), and the
municipalities have run this portal, kept it up-to-date, and have used it to bring together the aforementioned
databases. There are also a number of additional services, e.g. a national ePrescription server. This allows
the electronic transfer of prescriptions as well as their cancellation by the treating physician.
The Danish Digital Health Strategy is aligned with two further overarching framework plans: the
digitalization strategy of the Danish public sector (Digital Strategy 2016-2020), and the Citizen and Patient
Involvement Strategy.
Together these form the foundation for the far-reaching, comprehensive digitalization of Danish society,
simplified access to various public services, as well as a cost-efficient, user-friendly and secure healthcare
system. The national Digital Health Strategy, which has been formulated as a guideline for the healthcare
sector, does not mention health IT directly. However, it does refer specifically to the national digitalization
strategy, ensuring that these two strategies are very well coordinated with each other. This probably
indicates that, from a Danish perspective, digitalization is a means rather than an end in itself.
The central access point for all public digital services is NemLog-in, which is integrated with sundhed.dk,
among other services. This was developed in 2007, as part of a joint project involving counties,
municipalities, and the central government, in order to provide the public with access to a wide array of
digital applications. It represents one of the measures that was taken in the course of Denmark’s digital
development and was stipulated in the former digital strategy. All of Denmark’s citizens can be
authenticated with their NemID and receive secure access to their health data. Physicians also have a
healthcare professional ID, which they need to use to access patient data. All care sectors of the Danish
healthcare system are 100 percent digitized and connected to the data network of MedCom
Estonia Estonia is a leader for eHealth solutions in Europe. With its X-Road infrastructure, which enables secure
(Bismarck) data exchange between all actors in the healthcare system (and the entire public sector), Estonia is one of
the most digitally advanced countries in Europe. The Estonian National Health Information System
(ENHIS)20 is the core of Estonian eHealth, being operative since 1 September 2008. It is a national central
electronic database for processing health records of all patients receiving healthcare services from any
Estonian healthcare service provider. All officially recognized healthcare service providers must by law
upload their patients’ EHRs on the ENHIS and patients can view all of their EHRs stored on the ENHIS
on the patient platform “My E-Health”. The identification of the patient takes place by logging in with an
electronic national identification card or through mobile phone-based identification (mobile-ID).
Any Estonian healthcare professional can access ENHIS data for any patient (only for the purpose of
providing healthcare services) if the healthcare service provider that employs the healthcare professional
has a valid Estonian activity license or can be denied access if a particular patient has prohibited access to
his or her ENHIS data.
The e-Prescription model is very advanced in Estonia. https://e-estonia.com/solutions/healthcare/e-
prescription
France In 2004, the French government laid the legislative cornerstone for the development of an electronic health
(Bismarck) record – the Dossier médical personnel (DMP). The goal: unrestricted web access to patient data at any
time, from any location. A government agency, ASIP Santé, led the program and was monitored by
information security authorities. The agency for the modernization of the information system infrastructure
in hospitals coordinated adjustments to individual applications to make them DMP-ready.
France’s first strategy for the digitalization of the healthcare sector was released in 2016 and focused on
selected services for the support of healthcare provision, and above all improvements in cost effectiveness
37 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Country Digital healthcare solutions
and decision-making for physicians using big data and telemedicine services. Digital health is regarded as
an integrated component of general healthcare rather than just an “add-on.” The legislation passed in this
context creates the necessary framework for the regions, who decide for themselves which type of services
and solutions they wish to implement locally.
At the national level, digital health is not driven by political parties or particular individuals. The regions
assume responsibility for incremental piloting and project evaluations. Implementation plans and
corresponding schedules were by the government for the reintroduction of the DMP in 2016, the
introduction of regional ePrescriptions and telemedicine services, and for the expansion of the French
health information portal santé.fr, but not for an interoperability strategy.
While the ASIP Santé is responsible for the establishment and dissemination of the interoperability
framework, it still remains largely incomplete. No standards have yet been completely enforced, and there
is no defined timeframe for mandatory rollout.
While some healthcare facilities have introduced certain guidelines and standards related to documentation
of clinical data, implementation lags a long way behind. Fewer than 25 percent of all physicians in the
outpatient and inpatient care sectors structure their clinical
notes in a standard way using prescribed terminology guidelines
Germany Since 2010 as part of its eHealth initiative, the Federal Ministry of Health has held regular meetings with
(Bismarck) a number of stakeholders to identify and address implementation hurdles to digital applications such as
telemedicine. At these meetings, the government and stakeholders have developed various measures
designed to reduce these barriers. The stakeholders generally include all self-governing bodies involved
with providing standard healthcare as well as the major associations representing companies that provide
ICT and IT solutions for the healthcare sector. The most significant outcomes of these meetings include a
national telemedicine portal, a list of criteria for projects addressing the future of eHealth and a planning
report on interoperability. The key elements of this report are reflected in Germany’s eHealth Act. There
are no comprehensive, binding targets, guidelines or deadlines for a digital healthcare system as a whole.
But the eHealth Act does regulate specific applications individually. Although there are legislative plans
for the National Association of Statutory Health Insurance Funds to take on financial responsibility for the
digitalization of Germany’s healthcare system, the government has not allocated for a digital health budget
or established a dedicated digitalization authority. gematik’s mandate is limited to developing the
telematics infrastructure and the electronic patient card. The German healthcare system features electronic
documentation across all sectors. However, there is no national framework underpinning the exchange of
data; instead, this takes place mostly through separate and individual networks (e.g., KV’s Safenet).
Electronic records and their content remain for the most part stored within a specific institution and are
not shared with third parties. In 2020, the Digital Supply Act (DVG) facilitates a range of innovations to
improve the German health system.
• Extended doctor-on-call service: As of January 2, 2020, the medical on-call service (Ärztliche
Bereitschaftdienst) is now available round the clock, offering callers medical assistance or
emergency doctors’ appointments.
• Apps by prescription: For the first time ever this year, doctors in Germany will be able to prescribe
health-orientated apps to their patients. Any costs incurred will be reimbursed by statutory health
insurance. The Federal Institute for Drugs and Medical Devices will check the quality and safety
of the applications; the developers then have one year to prove that their app improves the quality
of care.
• Online doctor consultations: The DVG promotes the use of online consultations. Doctors will be
allowed to actively promote digital consultations on their websites (before they were only allowed
to discuss them in private conversations).
• Digital prescriptions: In order to reduce paperwork in the healthcare system, the “pink paper
prescription” will be gradually replaced with an electronic variant.
• Digital sick notes: The paper certificate that must be issued in triplicate by doctors whose patients
wish to take sick leave, is set to be replaced by a digital version from 2021.
• Electronic patient records: From 2021, all state-insured patients will be able to receive a digital
copy of their medical records from their insurer, if they wish. The file will include observations,
diagnoses, vaccination histories and doctor’s letters. The patient then has the power to decide
which information should be kept in the file, and what they want to delete.
Greece Healthcare in Greece is provided by the national health system (NHS). It consists of a universal health care
(Bismarck) system provided through national health insurance, and private health care. During the past few years, a
multitude of eHealth services has been introduced, in line with European Union (EU) priorities, to control
costs and improve services in a secure manner. These include ePrescription and eReferral for primary care,
eConfirmation for insurance status verification, eReimbursement, eAppointment for booking doctors’
appointments for primary care, and a business intelligence system (Bi-Health) that automates online
retrieval of operational data for the Hellenic Ministry of Health (MoH).
38 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Country Digital healthcare solutions
Despite the fact that significant progress has been made to effectively link hospitals, regional health
systems, and primary care, still no uniform access to a patient’s EHR is available. This is because
information systems were set up in the public health sector independently of each other and not in a
coordinated way. Notwithstanding the positive effects of the introduction and use of the electronic medical
record (EMR) in medical practices, and the benefits obtained, considerable barriers still exist to EHR
information exchange. Τhe level of digitization of EMRs in the Greek NHS is not recorded in a systematic
manner, and progress made is not reported accurately. This is besides the increasing efforts made in the
recent years to establish new information infrastructures for eHealth in Greece aiming towards improving
healthcare efficiency and overcoming existing communication barriers83.
Hungary The Hungarian national eHealth platform (EESZT) electronically stores information about the patients,
(Bismarck) connects all the Hungarian healthcare providers (such as hospitals, pharmacies, general practitioners)
making it easier for physicians working in different institutions to access all important health information
about the patient. Medical documents, related to all the treatments a patient has received, shall be sent to
the system, building up a complete patient case history. EESZT is integrated with existing systems,
therefore clinicians, GPs and pharmacists can use their own health information systems (HIS). By using
EESZT the physicians can rely on a detailed picture of the patient, which allows for more precise medical
decisions, greatly enhancing patient safety. On the other hand, the availability of previous diagnostic
results greatly reduces the number of repeated diagnostic procedures. On September 1st, 2017 the
possibility to join EESZT was opened for all the Hungarian healthcare providers. By November 1st, 2017
every healthcare provider of the Hungarian public health system was obliged by law to provide the data
they generate about each patient to the EESZT.
The general public can also benefit from the developments through a specific portal: eeszt.gov.hu. Citizens
are able to access all their medical records through the so-called “government gateway” or “Client Gate”,
which is the official central electronic administration web service of the country. The portal allows citizens
to view their medical record, electronic prescriptions, health care encounters etc. In order to protect
sensitive medical data, the portal allows citizens to grant and restrict access to health professionals and to
review the access log to their data.
The development of EESZT is an ongoing process, new services and processes are in process and will be
finished by the end of 2020.
Italy In Italy, a joint committee made up of representatives of the Health Ministry and the individual regions is
(Beveridge) responsible for the introduction and monitoring of electronic healthcare services through the National
Health Information Network (NSIS). The first step in this direction came in 2004 with the inception of a
common digital health policy and corresponding definition of digital health architecture. After a 2008
government evaluation revealed major disparities in regional distribution of appointment booking systems
and electronic health records, by 2012 a number of laws were passed and amended to introduce digital
health services nationwide. Since 2015, for instance, every healthcare organization
has to provide electronic health records that are configured according to certain national guidelines.
Since 2010 the law has regulated the electronic transmission of certificates of incapacity to the National
Institute for Social Security and employers, for instance, as well as the use of ePrescriptions. Here there
are two different infrastructures available: a national
and a regional gateway. One major objective of the Italian digitalization strategy within the healthcare
sector is to reduce paper documentation.
Italy currently has an overall healthcare strategy in which the state of digitalization in the healthcare system
is a key topic. Since 2008, digital health has been a focus for future developments in the country’s
healthcare sector and is listed as one of the priority areas of the national “Strategy for Digital Growth /
Development 2014-2020.” The healthcare system is established at various levels. The Ministry of Health
is responsible for the development and implementation of new national strategies for healthcare, while
direct service provision falls to the various regions. With respect to the differences between the regions,
there is also a range in the scope of digital (health) services that have been made available in recent years.
Of Italy’s 20 regions, only five have not yet introduced centralized regions electronic health records.
While development of Italy’s digital health system is limited at the national level, it is well advanced in
some regions. There are regional EHR systems that collect information on the health of patients – seven
regions have implemented this, a further ten are still in the pilot phase and four regions do not yet have
mature systems (as at 2017). However, these EHRs are subject to regional limitations in terms of data
exchange. Currently there are government efforts to merge the regional databases into one uniform national
EHR.
Latvia One of the main objectives of the NHS is to implement the e-Health program according to the policy
(Beveridge) decided by the State (now carrying several co-funded projects by ERDF (European Regional Development
Fund): electronic health record; e-booking; e-prescription etc.
83
Towards the Development of a National eHealth Interoperability Framework to Address Public Health Challenges in Greece
39 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Country Digital healthcare solutions
E-health is a health program for more efficient use of information and communication technology tools.
The main objectives of e-health development are to: improve health, promote individual control of their
health; reduce wasted time spend on patients contacts with medical institutions; increase the effectiveness
of the health care, providing health care specialists with a quick access to necessary patient health data;
reduce the amount of information that health care specialists need to enter into the documents; increase
the amount and usability of a structured information; increase effectiveness of medical institutions;
increase health care data reliability and security. From 1 January 2018 the sick-leave certificates and
prescriptions for state compensated medicines will be only issued electronically.
E-health in Latvia today: Patients can easily access care records using state e-services' portal (authenticated
with ibank information, electronic signature). These e-services are: "My state paid healthcare services";
"My general practitioner"; "My newborn children data"; "My data within the diabetes mellitus patients'
register".
E-health solution architecture. E-health solution architecture is developed as modular system, which
consists of three layers: The first layer - for business users, who integrate with systems using their business
systems; The second layer - is our system which includes all core models; The third layer - is national e-
governance infrastructure for data exchange with registries.
The recording of the medical information about the resident will start at the moment when the medical
institution or physician visited has started work (data entry) on E-health. Thus, part of the medical
information will be available to the resident only in time, as the medical institutions and doctors become
more active users of the E-health system.
Lithuania In Lithuania national digital health strategy and development is coordinated by the Ministry of Health.
(Bismarck) National health ICT services are funded by state budget and available investment programs. National
Healthcare Insurance Fund finances healthcare services and allows ICT development at regional level.
Lithuanian national digital health platform ESPBI was launched in 2016 after development stage in 2009-
2015. Main objective was to create one national health record for the patient and involve health care
professionals in digital health services. National platform ensures storage and exchange of EHR,
ePrescription and medical images. Simultaneously, during 2009-2015 several other national components
were developed: registers of licenses of health care professionals and health care institutions, register of
medicines and other, online appointment booking system for outpatient consultations and other. Health
care institutions developed hospital information systems which are integrated with national digital health
platform. It resulted in full access and management at national level of these EHR records: referrals,
discharge letters, visit descriptions, prescriptions, birth and death certificates and other. National digital
health service covers 100% of insured patients, 100% pharmacies and almost 100% healthcare institutions.
Access to national digital platform is ensured via electronic identification of health care specialists and
patients.
Further development of Lithuanian digital health system is planned with implementation of country wide
digital health services: mobile application for patients, mobile application for nurses delivering home care,
teleconsultation services, further integration of appointment booking system with patient EHR and
referrals, exchange of digital health records.
Portugal One of the goals of Portugal’s 18th government was that every citizen would have an electronic health
(Beveridge) record (EHR) by 2012, and that it would be accessible in electronic form. In December 2009 the Health
Ministry established the Digital Health Agency (Serviços Partilhados do Ministério da Saúde, or SPMS),
a public body tasked with the provision of “shared” or networked electronic services in all facilities of the
national healthcare service. Its role in Portugal is to drive the distribution and development of digital
healthcare services. The National Commission for Clinical Information Technology (Comissão para a
Informatização Clinica) was established in 2011 to develop and roll out a national health information
platform and a summary document containing clinical data, or clinical patient summary (Resumo Clinico
Único do Utente, or RCU2). These goals were reached in 2012.
Portugal’s national digital health strategy, the 2016 National Strategy for the Health Information
Ecosystem 2020 (ENESIS 2020), aims primarily at improving the cost effectiveness of the entire
healthcare system through digital solutions. A further goal is a combined strategy for meeting overall
health policy objectives with the help of centralized digital solutions. As Portugal is administered centrally,
authority in the healthcare sector is not delegated to the regions.
Although to date there has been no nationwide, unified, legislation with precisely calibrated impact with
a view to the opportunities and risks of big data in the healthcare sector, the rollout of a national network
for exchange of health information is supported strategically and conceptually by the ministry and the
SPMS. It bears responsibility for telemedicine services and applications, mHealth and the Portuguese
Platform for Health Data. Portugal has taken part in international data exchange projects in the past and
has created national framework conditions to enable exchange of patient data with other EU countries,
particularly the patient summary, under the umbrella of epSOS
Serbia Serbia has benefited from several projects aligned towards the development of a national foundation for
(Bismarck) eHealth. A community assistance for reconstruction, development and stabilization project, called
40 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Country Digital healthcare solutions
“Development of HIS for basic health and pharmaceutical services”, initiated the development of
electronic health records for Serbia. This was furthered by the Ministry of Health’s Serbia Health project,
which also developed a database of health resources and classifications and realized HIS in four hospitals.
Next, a hospital information system project focused on standardization and expansion of the infrastructure.
This project integrated data delivery in health care and extended the HIS to another 10 hospitals, covering
the health care needs of 30% of the population and moving towards a national HIS. Serbia has also
established an eHealth Unit in the Ministry of Health and amended the Law on Health Care and Health
Care Insurance Act.
Slovenia The operation and the functions of eHealth solutions are regulated by the special ‘Healthcare Data Records
(Bismarck) Act’ – HDRA since 2000. This act covers the collection, processing, archiving and usage of data and
database management in the entire field of healthcare in Slovenia, including all eHealth services, relevant
stakeholders and beneficiaries. Management of eHealth ICT infrastructure in Slovenia is centralized on
the national level and managed by the two institutions – Health Insurance Institute of Slovenia (ZZZS)
and the National Institute of Public Health (NIJZ).
The primary eHealth platform in Slovenia is z-Vem which serves as the access point for both the electronic
health records (EHR) and patient health records (PHR).
The eHealth architecture is designed around z-Vem platform which connects healthcare providers and
users, incorporates Central Repository of Patient Data (CRPD) with EHR and PHR and allows data
exchange via dedicated network zNet. All healthcare service providers are obliged to send relevant data to
CRPD. In addition to this ‘national’ infrastructure, all hospitals have for their own internal business and
professional needs, their own ICT solutions and related infrastructure, which is not yet fully integrated
into the national eHealth system. Patients can access their own data via digital certificate. Medical
personnel have access to these data via their own professional health eID card restricted according to their
privileges.
The eHealth solution landscape is by large the result of the implementation of the National eHealth Project
launched in 2005 and successfully finalized in 2018. NHP has been focusing on the infrastructure,
solutions and services, consolidating the fragmented digitization efforts developed by individual
institutions, which represent the backbone of the national eHealth information system in Slovenia. All
solutions and services that were developed on a national level, are now available for the whole state and
accessible to all healthcare service providers in the country (of which some, i.e. ePrescriptions, are
mandatory for healthcare providers).
Spain The federal, decentralized structure of Spain’s healthcare system means that any form of national initiative
(Beveridge) requires agreement between the central government and the regions within the forum of the Interterritorial
Council of the Spanish National Health Service (Consejo Inter-territorial del Sistema Nacional de Salud,
CISNS). The need for a minimum electronic dataset of health-related data to be used and exchanged
throughout the regions was recognized as early as 2002. However, this idea was only decided upon in
2010, and even then, it was non-binding.
Since 2015, there has been no uniform national strategy for the digital health sector, which has fallen
victim to ongoing economic and government crises. The Digital Agenda for Europe 2015-2020 has served
as a guideline for further development since that time.
The decentralized system and the number of participating actors has hampered efficient implementation.
While 77 percent of all Spaniards have an electronic medical record, usage is effectively restricted to their
region of residence. This also restricts usage of the electronic health record, which remains unable to share
its information with other regions. Attempts to make the system interoperable date back to 2009.
Spain’s digital healthcare strategy is not chiefly focused on developing and improving the digital
healthcare service in its current state. There have been successful efforts toward digitalization and
implementation of digital services in the healthcare sector at the regional level.
Patient data management services have a high degree of digital functionality with respect to data
protection, security and processing, but under present conditions there is no facility for individual patients
to determine who can and cannot access their personal data.
Spain is currently in the midst of increased national efforts to have the regions assume responsibility for
adopting international standards of health IT in relation to the coding, storage and use of data.
Corresponding standards are applied in all regions, although not to the same extent. Each of the Spanish
regions has an electronic health record from which a legally defined minimum dataset is automatically
extracted in the form of the Historia Clínica Digital Sistema Nacional de Salud, a patient summary that
can be exchanged nationally. The EHR systems can interact with national health registries for the
coordination of healthcare for chronic diseases, for instance. Catalonia, Andalusia, the Basque Country
and Valencia are particular pioneers in this field.
Political leadership in digitization does not imply just the top-down ordering of the measures to be applied. Good
health policy means providing a clear framework that fosters acceptance and drives developments. Centralized forms
of digital health implementation are found only in a few countries. Regionally organized healthcare systems are often
41 146
JADECARE- 951442
most effective in integrating digitization into routine care delivery.Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Digital strategies should be policy oriented to the
needs and imperatives of the individual health systems – such as improving quality of care and services, increasing
patient safety, or facilitating access to care in rural areas. To advance the digital transformation, it is best to focus
first on the individual, well-prioritized services: Countries with a proven record in digitization target specific
treatment pathways – such as diabetes – or focus on “simpler” processes such as introducing ePrescriptions or a
nation-wide electronic emergency data record. In contrast, large-scale, all-encompassing programs tend to fail.
Co-design is an effective means of promoting user acceptance; resistance to the changes inflicted by digitalization is
common in many countries. The physicians, in particular, often oppose such changes strongly. As a result, many
countries have recognized that promoting acceptance is of strategic importance and that it requires using appropriate
resources. JADECARE approach is based on the principle that digital processes and solutions should be tailored to
the needs of users. They should be co-designed by end-users and key stakeholders alike, whose involvement should
be integrated into the development process. This also applies to the formulation of digital strategies (e.g., through the
inclusion of focus groups) and the conceptualization of products. Unnecessary planning failures and costs associated
with a pure digital health technology push should be avoided.
The 23 next adopters in 15 Member States participating in JADECARE have expressed their interest in adopting
specific features of one or more original GP regarding digitally enabled personalized integrated care. The summary
of these interests is shown below (in green):
TABLE 5. NEXT ADOPTERS´ INTEREST IN ORIGINAL GOOD PRACTICES
Digital
Basque Health Catalan open The OptiMedis
Country Next adopter Roadmap – R.
strategy innovation hub model
S. Denmark
Bosnia and Institute for Public Health of
Herzegovina the Federation of BH
Bosnia and Ministry of Health and Social
Herzegovina Welfare -Republic Srpska
Croatian Health Insurance
Croatia
Fund
Czech
Univ. Hosp. Olomouc
Republic
Denmark The North Denmark Region
Estonia Viljandi Hospital
France Eurometropole de Strasbourg
School of Medicine, Aristotle
Greece
University of Thessaloniki
Jahn Ferenc South-Pest
Hungary
Hospital and Clinic
Azienda Sanitaria Locale
Italy
Napoli 2 Nord
Italy Lombardy Region
Tuscany Regional Health
Italy
Agency (ARS)
Italy Azienda USL Umbria 1
Italy Marche Region
Children`s Clinical University
Latvia
Hospital
Lithuania Ministry of Health
Central Administration of the
Portugal
Health System
Ministry of Health of Republic
Serbia
of Serbia
Health Insurance Institute of
Slovenia
Slovenia
Consejería de Salud y Familias
Spain
Junta de Andalucía
Spain Servicio Cántabro de Salud
42 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356
Digital - 20/07/2020
Basque Health Catalan open The OptiMedis
Country Next adopter Roadmap – R.
strategy innovation hub model
S. Denmark
Gerencia Regional de Salud de
Spain
Castilla y León
Spain Servicio Murciano de Salud
There is a possibility of selecting different oGPs results in an scenario where some next adopters will work on
only one oGPs, whereas others will deal with more than one(mix and match approach). Therefore, the
JADECARE transfer strategy needs to consider both scenarios. The logic and the structure of the WPs are defined
accordingly.
FIGURE 7. JADECARE TRANSFER STRATEGY
Next adopters do not only choose different transfer strategies but also present different levels of maturity for
deploying integrated care services and their ambitions and expectations for to the local Practice implementation
in JADECARE. Some next adopters might have not initiated integrated care deployment or only some first steps,
while others might be half-way in the process or appear ready for a scale-up. Consequently next adopters, depending
on their local resources and political support, they might commit to an increase in the implementation capabilities, to
a small-scale or large-scale implementation during JADECARE. Special attention will be paid to the contextual
factors and establishing coherence when the blocks are taken from more than one oGPs.
To evaluate the maturity of the next adopters for deploying digitally enabled integrated care and assess their
ambitions, a survey was launched. The 23 next adopters completed the questionnaire, which allowed to map their
aptitudes and potential for JADECARE project.
They were asked to perform a self-assessment of their maturity for deploying integrated care services (policies,
strategies and guidelines; health system infrastructure; digital transformation including Electronic Health Record,
personal health folder and electronic prescription; and training programs and research and innovation initiatives on
integrated care). As it can be seen in the next figure, most of them had been involved in deploying integrated care:
eleven adopters had taken initial steps, 6 were already in the half-way in the process and 5 were ready for a scale-up.
43 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
FIGURE 8. MATURITY OF NEXT ADOPTERS. INTEGRATED CARE DEPLOYMENT
The respondents showed a remarkably wide variety of areas of interests is remarkable among next adopters and
ranges from change management, re-organization of care pathways and introduction of technologies into care
services to citizen empowerment and new payment methods. Most of the next adopters are willing to work on
various dimensions in JADECARE, having the use of technologies in care services (78%), use of patient reported
data (65%) reorganization of care pathways (61%), workforce roles and skills with technology (52%) and citizen
empowerment (57%) as the most prominent relevance. Fortunately the oGPs deal with these areas and their specific
core features, which are the transferable elements, provide concrete solutions or strategies. Next adopters will select
the core features of one or more oGPs in order to tackle with the challenges that these dimensions entail.
FIGURE 9. AREAS OF INTERESTS OF THE NEXT ADOPTERS
In terms of commitment and ambition for implementation during JADECARE, most of the next adopters aim at
small-scale implementation (15), whereas others (7) are interested in increasing the capacity (knowledge,
management development, plans etc.) of the design and successfully implementation of digitally enabled integrated
person-centered care. Only one next adopter intends to scale-up interventions at the system level.
44 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
FIGURE 10. COMMITMENT AND AMBITION OF THE NEXT ADOPTERS
Thus, the JADECARE next adopters have estimated the size of the implementation on their site (Table 3). Table 3
presents the variety of implementation sizes and target populations, according to the type of approach (increased
capabilities, small-scale or large-scale deployment). These figures must be seen as the first estimate. More than
50.000 people will be directed involved. A large number of professionals and healthcare centers are going to directly
participate in JADECARE in the next adopters’ projects. Moreover, well over five million people in the participating
countries can potentially benefit from JADECARE. The exact numbers will be obtained once the first situation
analysis and action plans in the next adopter regions are approved.
TABLE 6. SIZE OF IMPLEMENTATION OF JADECARE´
Geographical Population
Target population Health professionals Healthcare
Country area of GP directly
after JADECARE involved organizations involved
implementation involved
Bosnia and Bosansko- Around 10% of staff:
Herzegovina Podrinjski MD: 48; Health Centers: 2
canton 2,533 25,336 Primary Care Nurses: Public health
169; institute: 1
Other health workers: 9
Republic of One primary health
Srpska care center directly
involved in piloting
8 GPs from primary
health care center Ministry of Health
16,000 200,000 8 Nurses from primary and Social Welfare in
health care center Government of
Republic of Srpska as
an adopter and lead
for transformational
practice
Croatia Local, Capital CIHF, CIPH, 3-4
30-50 people 20 (2-3 GP’s,2-3
city of Zagreb, 10.000 patients in general practices and
will specialists in
Croatia the region 1-2 hospitals (total=7-
participate pneumology)
10)
Czech Jeseník / Population in
Republic Olomouc Region Jeseník District is 1 Jeseník Hospital -
38 000 (targeted for Jesenická nemocnice
the pilot activity), a.s.
Population is Internal medicine
Olomouc Region department –
100 GPs
has 633 000 in cardiology and
2 000 – 30 cardiologists
habitants (targeted diabetology
patients and 15 diabetologists
for complex local 5 GP´s in Jeseník
other users 60 nurses
Good Practice - district
30 case managers
lGP), 33% of the 3 Primary care health
population has one centres in Olomouc
or more chronic Region
diseases (incl. 1 University Hospital
cancer) and they are Olomouc (UHO)
primary target of the
45 146
JADECARE- 951442
Geographical Population Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Target population Health professionals Healthcare
Country area of GP directly
after JADECARE involved organizations involved
implementation involved
lGP. Czech
Republic has 10,65
million inhabitants
(targeted by
Strategic
Framework “Health
2030”).
Denmark Regional There were 320.000
2 endocrinologists
3,000 cases of diabetes in 1 hospital
2 diabetes nurses
Denmark in 2018.
Estonia Local-Regional Viljandi county
with 47087
inhabitants National
TBD
coordination model, 3 specialist doctors 1 public hospital
the potential target
population is up to 1
328 000 people
France local and will Strasbourg: 1
University Hospital of
cover the rural paramedical coordinator,
Strasbourg
area of Saverne 1GP, 2 nurses, 2
Hospital of Saverne
(North of psychologist, 1 dietician,
Regional Health
Strasbourg) and In the Region: 4 sport instructors
Agency
part of the city of Grand Est = 5,5 specialized in adapted
Local Health
Strasbourg. 1500 million inhabitants physical activity, 1
Insurance
In the Country: 66,5 prevention coordinator.
organization (Caisse
million inhabitants Saverne including 2 GPs,
Primaire
1 patient education
d’Assurances
coordinator, 1 dietician, 1
Maladie)
sport instructor, 1 nurse, 1
sophrologist
Greece The city of Target population is
Thessaloniki. the total number of
The "City habitants of the city
of of about 750.000
Thessaloniki&qu which are using the
ot; consists of six health care services.
Municipalities The total number of
and one habitants in
Municipal Unit northern Greece that Hospital doctors (all 2 Hospitals in the City
(from the could benefit from specialties) 500 of Thessaloniki
Municipality of TBD the GPs 40 2 Health Care Centers
Pylea - adoption of Good Hospital Managers 2 in the City of
Chortiatis), practice in the Nursing personnel 350 Thessaloniki
which region of 4 the
constitute the Health District is of
Thessaloniki 1.500.000
Planning Group habitants and a large
(PCT) number of tourists
mostly from Europe
visiting the area
during summer.
Hungary 20th district of 20th district of
Budapest, Budapest
Budapest, Pest (Pesterzsébet)
County, Central 1 public hospital
Hungary Region TBD 65.611 inhabitants 3 psychiatrists 1 outpatient care
352.157 inhabitants, 4 psychologists center
according to the 32 GPs
participant
hospital’s territorial
supply obligation
Italy-Napoli Local. The population n. 13 primary care
n. 1 Medical Director
group represents centres,
120 people n. 2 manager
14.26% of the total n. 10 specialized
administrative
population. The ambulatory care
46 146
JADECARE- 951442
Geographical Population Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Target population Health professionals Healthcare
Country area of GP directly
after JADECARE involved organizations involved
implementation involved
elderly who are not n. 12 managers reference n. 5 Hospitals
self-sufficient contact
represent 2.6% of n. 4 researchers, technical
the population over staff
65 years, equal to n.
5,923 people
Italy- Regional and About one third of 2-3 specialists, 2-3 case The specialized team
Lombardia Local (Local The pilot Lombardy managers and some GP will come from 1
area not decided, cohort might population will be involved, public hospital
yet) be a specific 10.060.000 citizens coordinated by a regional involved in the
cluster of the of which 2.333.780 board. regional “Taking
300,000 65 and over, of Care” reform. GPs
citizens which 1.810.000 are will be engaged on
affected by affected by long behalf of the local
long term term chronic healthcare authority
chronic conditions (ATS).
conditions
and currently The target
enrolled in population after
the regional JADECARE might
“Taking be around 3.300.000
Care” The target
Reform population during
Program. JADECARE Pilot
will be defined with
the selected
Territorial
Institution.
Italy- Regional -Functional
Toscana (PIanna di Territorial
The whole
LUcaa and Aggregation (FTA):
population of the
Lunigiana) Piana di lucca - 5 FTA
north-west local
Number of the GPS Lunigiana = 2 FTA
health authority =
65 Piana Di Lucca -public hospitals =
3000 1.208.516
39 Lunigiana -Piana di lucca = 1
The whole
Specialists TBD Lunigiana = 2
population of
Ambulatory care
Tuscany region =
services =Piana di
3.496.478
lucca = 61; Lunigiana
= 53
Italy- Regional -Health 1 FTA – Functional
Umbria district “Media Territorial
Valle del Aggregation
Tevere” composed by GPs
who guarantee H24
About 3.600 assistance 7 days/7
people 1 “Casa della salute”,
(estimate: + a territorial services
65 years old structure where are
About 100.000 20 General practitioners
people of located GPs,
people (estimate: 2 nurses case managers
“TFA Integrated home
+65 years people of 1 primary care nurse
Marsciano” assistance service, a
Umbria region with, 1 Medical doctor
into Media residential structure
at least, one chronic specialized in Public
Valle Tevere who guest old chronic
ill ) Health
district with, patients and a
at least, one specialized
chronic ambulatory care
illness) 1 COT – Territorial
Operations Central
which manages the
discharges of
frail/chronic patient
from hospital to home
47 146
JADECARE- 951442
Geographical Population Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Target population Health professionals Healthcare
Country area of GP directly
after JADECARE involved organizations involved
implementation involved
Italy- Regional and For the local area: a
Marche local working group composed
For the local area:
of about 50 professionals
about 25 healthcare
of different disciplines,
Total population of organizations, such as
such as GPs, nurses,
9.000 Marche region = primary care centers,
physicians specialized in
1.531.753 community hospitals,
chronic diseases,
ambulatories, nursing
informatics, clinical
homes)
engineers, social
workers, etc.
Latvia National 359 000 children in
Latvia;70 000
patients annually in
Eblendncy
department
TBD 700 physicians and 600 of Children’s Hospital, 3
(Children’s Hospital
nursing staff in CH regionals hospitals
- CH).
17 000 patients are
being treated in
Inpatient units of
CH;
Lithuania Regional 60 (family physician,
nurses, medical 6 (primary care
specialists, public health centers, specialized
628,748 at national
600 care specialist/life style ambulatory care,
level
medicine specialists, municipal public
kinesitherapists /other health buraus
health professionals).
Portugal Local 1,2 million in the
TBD around 10% of 3 hospitals and 42
TBD Area. 8,2 at national
professionals primary care centers
level
Serbia Local – Belgrade 90 GPs in Primary
Health Center- Novi
Beograd
50 nurses - Primary
Health Center- Novi
Beograd
80 GPs in Primary
Health Center-Zemun
50 nurses - Primary
Primary Healthcare Health Center-
TBD 380,000 patients centers: 2 with 20 Zemun
75,000 over 65 ambulances
2 clinical centers 30 specialists Clinical
Center Bezanijska
Kosa
80 nurses Clinical
Center Bezanijska
Kosa
30 specialists Clinical
Center Zemun
80 nurses Clinical
Center Zemun
Slovenia Regional 10 GPs
15 specialists - doctors
1 hospital
15 nurses at GP
Whole population in 2 primary health care
15 nurses at specialists
the area 10.000. centers (primary care
5 case managers at health
2.000 Between 100.000 and specialized
care providers
directly and whole ambulatory care
10 other health care
involved, population (2 included)
professions at health care
million) 2 private GPs
centers (e.g.
included in public
physiotherapist,
network
kinesiologist,
psychologist)
48 146
JADECARE- 951442
Geographical Population Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Target population Health professionals Healthcare
Country area of GP directly
after JADECARE involved organizations involved
implementation involved
Spain- The region of Of the total
Andalusia Andalusia population, there are
3.106.921 chronic 75 Professionals in
patients in Primary Healthcare Primary healthcare
Andalusia, centers (Family centers: 15
500 patients (1.226.177 patients physicians, pediatricians Hospitals: 5
with 5 or more and nurses) and hospitals Specialized
drugs and 381.952 (specialists from different ambulatory care: 5
are those with 10 or specialties).
more drugs during
at least 6 months).
Spain- Regional Approximately 250
Cantabria health professionals will
participate in the
1,000 adoption of Good Primary care centers:
550,000 potential
Practice with the role of 5
targets
primary care nurse, Hospitals: 3
hospital nurse,
physiotherapist, gp, and
hospital specialist
Spain- Regional TDB around 2% of Around 2% of Health
Castilla y Family doctor: 2,759 Centers: 247
Around 2% of total
Leon TBD Primary Care Nurses : Local Offices: 3,669
population,
2,613 UCA (healthcare
2,319,857
Social health workers: continuity units) in
119 hospitals: 11
Spain- Regional Two of the nine
Murcia Health Areas of the
8 GPs one per Health Murcia Region
Around 50,000 Center (including 8 primary
TBD
users out of total 8 Nurses one per Health care centers and 6
1,400,000 users Center medical officers)
3 Physicians Two Hospitals of
reference one per
Health Area.
JADECARE STRUCTURE
JADECARE consists of 8 work packages, the four core oGPs and other four focused on transversal activities (WP1
Project coordination, WP2 Dissemination and communication, WP3 Evaluation and WP4 Sustainability) (Figure
11).
FIGURE 11 JADECARE PROJECT STRUCTURE
49 146
JADECARE- 951442
JADECARE consortium consists of 17 CAs and 23 AEs. CAs callAssociated with document Ref. Ares(2020)3808356 - 20/07/2020
upon affiliated entities to implement action tasks
described in the Joint Action, according to the Article 8 of the JADECARE Grant Agreement. AEs will implement
actions and tasks according to the JADECARE Joint Action, as described in the Article 11.1 of the JADECARE
Grant Agreement.
Coordination and implementation roles and activities in the Joint Action are performed by CAs (as Leading
Beneficiaries (LB)), and AEs. AEs can act as Leading Executive Organisations (LEO) and Co-Leading Executive
Organisations. CAs and AEs are responsible for Work Packages and/or Tasks and contribute to the Deliverables and
Milestones as described in the JADECARE Joint Action.
JADECARE activities and outputs are consistent with the intended objectives, outputs and the overall impact of the
Project. The structure of JADECARE supports the distinct transfer strategies, having next adopters only selecting
features from one original GP or others being interested in more than one original GP. JADECARE devotes one work
package for each oGP, from WP5 to WP8, which are named transfer WPs (tWP). If a given next adopter decides to
choose features of distinct oGPs, they will participate in the corresponding tWPs. The NAWGs are responsible for
integrating the tasks performed in the different transfer WPs they are involved. They will have only one
coherent Practice and implementation Action Plan, merging/consolidating the outputs of each of the transfer
work Packages they are involved if they have a mixed match approach. The coherent design and implementation
of the final Practice and Action Plan will be supported, ensured and monitored. Transfer WPs are closely
interconnected to tasks in WP4 Sustainability. It will facilitate, support and coordinate: (i) Knowledge exchange
among early adopters and next adopters. (ii) Developing local Practices and Pilot Action Plans. In case of a mix-
match approach, it will support putting together (“blending”) the elements arisen from each of the Transfer work
Packages involved. (iii) Synergies between transfer work packages and (iv) local good practice sustainability. Work
Package 3, T3.2 will provide, support and monitor the implementation methodology.
Next adopters have an initial idea of the oGPs they are interested in (see section 5.1.5). However, it is at the beginning
of the project (M1-M3) that the final selection of the core features of the oGPs to be implemented in each site will
be made.
IMPLEMENTATION OF LOCAL GOOD PRACTICES
In JADECARE, a three-step implementation strategy (designed and tested in JA CHRODIS Plus) will be used by
next adopters. It has been defined to be appropriate from the scientific point of view, applicable considering data
availability and feasible according to project´s timeline and resources.
The three steps are:
Pre-implementation phase: planning and preparation for the implementation (next adopters will deliver
implementation action plans, that will include the vision of their future practice)
Implementation phase: roll-out and operation (next adopters will provide inputs for regular monitoring and
intermediary evaluation (for PDSA cycles) as well as the final evaluation)
Post-implementation: impact assessment and learning (next adopters will deliver final implementation report, that
will include sustainability strategy and action plan)
A set of methods and techniques will be used to enhance the adoption, implementation and sustainability of Practices.
During the pre-implementation phase, three main activities will be carried out: (i) the scope definition, (ii) situation
analysis and (iii) local Good Practice and Pilot Action Plan development. The scope definition implies next adopters
to choose the final core features to implement, depending on their needs, expectations, strategic objectives, real
possibilities and existing local interventions. Then, next adopters will analyze their context by performing a SWOT
analysis related to the selected core feature(s) of the oGP. The SWOT analysis output will provide next adopters with
a clear view of their improvement areas, priorities, scale, extent and strategic actions required for planning the
implementation. Based on the situation analysis next adopters will describe their local Practice, which builds up on
existing interventions plus the selected core features, and produce the Pilot Action Plans, the blueprint that outlines
the implementation of the local GP. Core elements of sustainability will be addressed already in the pre-
implementation phase and sustainability plans outlined.
As explained in the 5.2 section “JADECARE structure”, if next adopters go for a “mix and match” approach, they
will participate in more than one transfer WP. The activities performed within each transfer WP will be coordinated
to avoid duplicities and overlapping. The next adopters will be in charge of ensuring that the work done in the
different transfer WPs is aligned and tWP Leads and co-leaders will support them (Figure 7).
50 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
FIGURE 12 PRE-IMPLEMENTATION PHASE ACTIVITIES.
Implementation will start and specific interventions will roll out based on PDSA (“plan, do, study, act”) cycle,
structured collaborative procedures that intend to facilitate the implementation in real and system-level. PDSA cycles
consist of:
PLAN: Plan the actions defined in the Pilot Action Plan to test the changes. Detail actors (who), functions and
roles (what), timeframe (when) and setting (where).
DO: Test the action and once is finished, data are collected and any problem or unexpected observation is
documented.
STUDY: The data obtained during the DO phase are analyzed. The obtained results are compared to the
predictions. Learning is summarized.
ACT: Based on the lessons learned changes are refined. Modifications are determined. This improved change is
then re-implemented in a new PDSA cycle.
The next adopters will complete at least one PDSA cycle and will commit to the promotion of the implementation
beyond the Joint Action and in line with their sustainability plan. The outputs of the PDSA cycle(s) will include
assets that facilitate, support and boost the adoption of original GPs and the capacity building for implementing
digitally enabled integrated care. These assets can vary from regulatory or strategic documents to guidelines and tools
for planning, implementation, management, evaluation and technology, among others.
Transfer and implementation of digitally supported integrated care solutions require ‘simultaneous innovation’ in
both care service redesign (e.g. care pathway or case management) and the technology tools to enable it. The full
process of their development, production, funding, implementation and evaluation requires careful consideration in
this context.84
A special emphasis will be made on the different dimensions identified in previous implementation experiences such
as the Carewell Project.85 All key stakeholders have to be involved in user centered design activities to ensure their
requirements are elicited, understood and documented. ICT-enabled integrated healthcare projects require the
procurement of eHealth devices (e.g. telemonitoring devices, smartphones, tablets); ICT infrastructure components
(e.g. servers) software; and interoperability middleware. Regulations and guidance, including timelines, in relation
to procurement, will be considered. Education and training have to be considered and provided to the user (workforce,
care recipients and family carers), through either online tutorials, individual or group-based learning sessions.
Incentives have to be aligned to encourage collaboration within and across the care sectors and to address the key
outcomes and key local priorities.
EVALUATION
Progress monitoring will provide a systematic assessment of the quality and compliance of the project to verify its
planned implementation of the project and the achieving of the objectives. A comprehensive approach will be
employed, using quantitative and qualitative methods, to provide key information to the partners, to overcome the
detected limitations and strengthen the development of activities. It has to be taken into account, though, that for
84
Assessing the Impact of Digital Transformation of Health Services Expert Panel on effective ways of investing in Health (EXPH)
https://ec.europa.eu/health/expert_panel/sites/expertpanel/files/docsdir/022_digitaltransformation_en.pdf
85
Lewis L, Goodwin N Guidelines for Implementing Integrated Care in Policy and Practice the Journey to Deploying Scalable Integrated Healthcare Services.
February 2017 http://carewell-project.eu/fileadmin/carewell/deliverables/d8.6_v2.0_carewell_guidelines_for_deployment_printable_version.pdf
51 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
some changes, it may not only take several years to see a clear impact at the health system level, but it may also be
highly difficult to isolate the costs and effects of such changes in a developing health care environment.86 The
evaluation framework is based on previous published work by different authors that try to comprehend the difficulty
of evaluation digital health solutions.87,88,89,90
The impact of the Project will be measured on two levels: a) the overall Joint Action (including impact on external
stakeholders) and b) the next adopter sites. Impact will be described, analyzed and summarized in the deliverable 3.3
Final Evaluation Report.
The former is directly related to WP4, which deeply analyses the impact of the Joint Action at the policy level and
focuses on solutions to ensure oGPs and local GP sustainability. The impact at the overall Joint Action mainly
contributes to reinforce the capacity of care authorities to the transition of health systems to digitally enabled,
integrated, person-centered care.
The latter is related to WP3 and transfer WPs (WP5-8) which provides methodologies and procedures to support the
good practice transfer from early adopters to next adopters. At the Joint Action level, the specific Objectives and
process, output and outcome indicators have been defined in section 2.2. A specific objective (number 6) addresses
the degree of deployment of digitally enabled integrated person-centered care (DEIPCC) in 23 European Regions
with different degrees of maturity. It sets different targets according to the baseline maturity of the regions. There are
process indicators such as the number of oGPs´ features addressed in transfer process, the number of blended next
adopters Good Practices and Action Plans implemented. Output indicators include increased capacity to implement
DEIPCC (including topics such as use of technologies in care services, reorganization of care pathways and building
capacity of individuals and communities) and small-scale and large-scale deployment and/or extended
institutionalization of DEIPCC. The outcome/impact indicator(s) is the estimated involved population of
JADECARE, 50,000 people.
The association between JADECARE expectations, specific objectives, process, output and outcome indicators and
analysis approach have been depicted in the following evaluation framework:
JADECARE Objective Process indicator Output indicator Outcome or impact Analysis
expectation indicator approach
Reinforced To create a Number of meetings Estimated audience of Level of perception Quantitative
capacity community of with caregivers or JADECARE that JADECARE
building of next stakeholders that healthcare experts dissemination guidelines and
adopters and includes caregivers, Number of channels results have impact
health healthcare experts, presentations at events in policy setting,
authorities policy makers and /or (scientific, etc.) and scientific,
general public industrial and
general debates and
fora
To improve Number of study visits Number of % of professionals Quantitative
knowledge, capacity professionals that improve in and
Number of thematic
and use of workhops participating in knowledge and qualitative
JADECARE different knowledge skills
methodologies, tools exchange actions
and practices Satisfaction with
knowledge exchange
actions
To perform a Scope definition, CFIR and SQUIRE Blueprint on Quantitative
systematic appraisal situation analysis and 2.0 reports on learning from good and
of the quality of the PDSA cycle performed adoption of good practices qualitative
transfer and on schedule practices
86
Assessing the Impact of Digital Transformation of Health Services Expert Panel on effective ways of investing in Health (EXPH)
https://ec.europa.eu/health/expert_panel/sites/expertpanel/files/docsdir/022_digitaltransformation_en.pdf
87
Kidholm K, Ekeland AG, Jensen LK, Rasmussen J, Pedersen CD, Bowes A, et al. A model for assessment of telemedicine applications: MAST. International
journal of technology assessment in health care. 2012; 28(1):44-51.
88
Jasehn. Report on A Minimum HTA Inspired Framework to Assess the Value of National eHealth Projects. Jasehn report, 2017.
89
WHO. Monitoring and Evaluating Digital Health Interventions: A practical guide to conducting research and assessment. World Health Organization, 2016.
90
Vis C, Kleiboer A, Prior R, Bønes E, Cavallo M, Clark SA, et al. Implementing and up-scaling evidence-based eMental health in Europe: The study protocol
for the MasterMind project. Internet Interventions. 2015; 2(4):399-409
52 146
JADECARE- 951442
JADECARE Objective Process indicator OutputAssociated
indicatorwith document Ref. Ares(2020)3808356
Outcome - 20/07/2020
or impact Analysis
expectation indicator approach
implementation Number of interviews Number of reports
process, and focus groups including the
understanding, performed implementation
evaluating and experience from
reporting the stakeholders´
experience of perspective
adopting oGPs in
heterogeneous next
adopter sites.
To support next Elements of Sustainability Perceived Quantitative
adopters in ensuring sustainability are strategy and action probability that the and
the sustainability of addressed in Individual plan of next adopters’ developed practice qualitative
the practice with implementation action practices will be sustainable
plans for actions at plans after end of
local/regional/nation Establishment of JADECARE, as
al level local/regional/national expressed by
networks among next members of
adopters and local/regional/natio
stakeholders identified nal networks among
to be important to next adopters and
assure sustainability stakeholders
identified to be
important to assure
sustainability
To present a potential Policy Board meetings Reports including Evidence-based Quantitative
use of results and including MoHs, recommendations to policy making
deliverables of national focal points for next adopter’s Report to assure
JADECARE for Health Programme at sustainability plans further building up
further building up EC and other policy- the capacity of
the capacity of oriented stakeholders national and
national and regional regional authorities
authorities to to organize and
organize and deliver deliver Integrated
integrated person- person-centered
centered care care
including integration
in policies
Good practice To support and Number of oGPs´ Number of next Estimated target Quantitative
transfer reinforce digitally features addressed in adopters with population of
enabled integrated transfer process increased capacity to JADECARE
person-centered care implement DEIPCC
(DEIPCC) in 23 in the future
European settings Number of blended Number of small-
with different degrees next adopters Good scale deployments
of maturity Practices and Action (piloting) of DEIPCC.
Plans
Action plans Number of large-scale
implemented deployments (system
level) of DEIPCC
To improve next Analysis of digital % Sites with Changes Perceived Quantitative
adopters´ digital situation is performed in digital services are improvement of and
transformation in next adopters’ sites. confirmed (digital digital services by qualitative
Establishment of health system end users
specific objectives infrastructure; data
regarding digital analytics and use of
transformation are set technologies, citizen
in next adopters Action empowerment tools
Plans and patient reported
data.
Successful To provide technical, Achievement of Avoidance of JADECARE Quantitative
Joint Action scientific, financial milestones deviations overall deliverables
management and administrative accepted
53 146
JADECARE- 951442
JADECARE Objective Process indicator Associated
Output indicatorwith document Ref. Ares(2020)3808356
Outcome or impact Analysis- 20/07/2020
expectation indicator approach
management and
support
Quality, compliance % surveys completed Satisfaction with the % stakeholder Quantitative
and usefulness a (acceptance rate & project progress consider Project
perceived usefulness useful
At next adopters level, evaluation will be customized in each site according to the SMART objectives and key
performance indicators of the local Good Practice and Action Plans defined in the transfer Work Packages (WP 5-
8). They will include general dimensions and digital transformation.
Regarding general dimensions, the KPIs will include:
scope and degree of adoption of original Good Practices (oGPs),
specific process, pathway reorganization and change management,
the involvement and commitment of key stakeholders,
the implementation experience and
continuity and sustainability of the practice
readiness of the organization to uptake digitalization
Regarding digital transformation, the KPIs will include:
digital health system infrastructure,
risk stratification and data analytics,
use of technologies including Electronic Health Record, personal health folder and electronic prescription;
citizen empowerment and use of patient reported data,
innovation initiatives on integrated care reorganization of care pathways, workforce roles and skills and
training and research programs,
access to health services,
management of change towards digitalization,
ethical aspects of digitalization.
The impact assessment consists of:
Assessment plan definition: the impact indicators (quantitative and qualitative), target levels for the impact
indicators, the information to be collected and the collection methods or sources including a mix of qualitative
and quantitative methods (questionnaires, surveys, semi-structured interviews or focus groups).
Data collection: gathering information according to the assessment plan, data analysis (content analysis for
qualitative data or statistical for quantitative data) and reporting.
The implementation process will be performed based on the Consolidated Framework for Implementation Research
(CFIR), which facilitates and guides the analysis to elucidate the factors that have influenced (positively or
negatively) the implementation process. The CFIR provides a menu of constructs that have been associated with
effective implementation. The CFIR is easily customized to diverse settings and scenarios. Using CFIR will allow
next-adopters’ working group (NAWGs) not only to learn a specific methodology that helps identifying relevant
factors affecting the implementation but also to increase success rate in future implementation experiences.
The whole implementation experience reporting will be done based on the SQUIRE 2.0 guideline. It will be used so
the evidence base and transferability potential are enhanced.
The complexity of the JADECARE objectives and approach requires that the tasks of the four transfer WPs, the
evaluation and the sustainability are closely interconnected (Figure 13). These WPs are interdependent in several
ways, an output from one task can become the input for another task from the same or another WP. This which
implies not only to apply clear and straightforward methodologies but also to establish effective communication and
coordination between WP Leads and co-leaders.
54 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
FIGURE 13. INTERDEPENCY OF TASKS OF WP3-WP8.
2.6 EXPECTED OUTCOMES AND BENEFITS OF THE PROJECT
JADECARE will contribute to innovative, efficient and sustainable digitally enabled integrated person-centered
healthcare systems. It will encourage innovation and increase sustainability of health systems, enabling participating
national authorities but also those beyond the Consortium, to benefit from the uptake of evidence-based interventions
into practice and policy. These will improve their healthcare performance and outcomes. The results and outcomes
of digital transformation of health services will depend on the quality of the process and the involved stakeholders.
This includes end-users of digital health services (be it professionals, care users or citizens), developers of digital
health services, producers of health services and governments.91
The expected results aim to influence:
Increased use of evidence-based practices in Member States
Increased sustainability of health systems
The scope, scale and extent of these outcomes will be different for each of the next adopters depending on their
baseline maturity, their needs and their local strategies and resources. They will include regulatory or strategic norms,
planning and implementation guidelines, management and delivery facilities and tools and digital technologies
covering features such as:
Change management and reorganized care models
Embedded digital technologies and tools in care services
Reorganized care pathways including new funding or payment methods
Developed health workforce roles and skills
Empowered citizens in for active participation in healthcare decision making
Improved performance assessment methods
The evaluation will have a full description of the relevant digital technology, its use and aims, addressing elements
like the intended use, costs and consequences.
JADECARE will enhance the collaboration and trust among stakeholders, support knowledge transfer and learning
and generate further evidence on integrated care. This will yield benefits beyond the timeframe of the JA.
JADECARE will share its main findings and will ensure the sustainability of policies at the local, regional and
national levels.
91
Assessing the Impact of Digital Transformation of Health Services Expert Panel on effective ways of investing in Health (EXPH)
https://ec.europa.eu/health/expert_panel/sites/expertpanel/files/docsdir/022_digitaltransformation_en.pdf
55 146
2.7 GANTT CHART Associated with document Ref. Ares(2020)3808356 - 20/07/2020
The timetable includes the work packages and tasks as well as the different milestones (red) and deliverables (green).
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
57 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
WORK PACKAGES
Leading
Lead
WP WP TITLE Executive WP DESCRIPTION
Beneficiary
organization
WP1 Coordination KG KG The aim is to manage and coordinate the project adequately. To this purpose, the project coordinator team will
provide technical, scientific, financial and administrative management and support. WP1 will monitor the
progress to avoid deviations and will ensure ethical compliance. Moreover, this WP will guarantee smooth
communication with CHAFEA and SANTE.
WP2 Communication SU-HSMTC AEEK WP2 will disseminate high quality information on JADECARE deliverables and progress. This will contribute to
and the development of a sustainable mechanism of advancing/providing high quality services of integrated care in
dissemination Europe. The work starts with initial communication activities to position the JA on the EU landscape, generate
recognition and understanding of the project goals and ambitions. Specific dissemination activities will follow to
enhance and magnify the effect and impact of the common work and support the sustainability of best practice
transfer and replication. WP2 will create and execute the external and internal communication plans as well as
the visual identity and promotional materials. The website will be an essential element for WP2 as well as for the
whole project. In addition, WP2 will have a task devoted to event organization including stakeholder forum.
WP3 Evaluation AUTH 4THYPE This WP will ensure proper functionality of JADECARE components in adopting countries. It will provide a
methodological framework for assessing JADECARE system. It will cover the requirements and expectations for
the different features adopted and will help to understand, evaluate and report in detail the experience of adopting
the project. WP3 will assess the quality and compliance of the project processes and stakeholder views inclusion
and satisfaction. It will also perform a systematic appraisal of the quality of the transfer and implementation
process, evaluating and reporting the experience of adopting oGPs in in heterogeneous next adopter sites.
Moreover, WP3 will assess the reinforcement of the capacity of health authorities to organize and deliver
digitally-enabled, integrated, person-centered care. It will evaluate the transfer of the good practices (or their
significant elements) from the “early adopters” to the “next adopters” by examining performance, acceptance,
satisfaction and sustainability.
WP4 Integration in NIJZ NIJZ This WP will share main findings, assure and cross fertilization and contribute to the sustainability at the national,
National local or regional level. It will set up a plan for future use of results and deliverables to be integrated into policies.
Policies and To this purpose, WP4 will identify general principles and individual characteristics of successful implementation
Sustainability of good practices. This WP will support exchange of knowledge and experiences of implementation by next
adopters including study visits and consolidation of their local GPs and Action Plans. It will generate
recommendations and guidance for incorporation of good practices using new knowledge and understanding,
based on the results of implementation by next adopters. Moreover, the WP will support next adopters in ensuring
the sustainability of the practice with plans for actions at local/regional/national level. WP4 will provide results
and deliverables to reinforce the capacity of national and regional health authorities in transforming health care
systems and delivering integrated person-centered care including integration in policies
WP5 Basque Health KG KG This WP will analyze and settle the bases and implement the GP from Basque Country in the next adopters. The
strategy in next adopters will have the opportunity to learn about the oGP in a dedicated workshop during the Kick off
58 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Leading
Lead
WP WP TITLE Executive WP DESCRIPTION
Beneficiary
organization
ageing and meeting by month 1. They will select the core features of the oGP and work on them. The NAWGs will perform
chronicity: a situation analysis and define the strategic action, define the specific interventions and facilitate implementation.
integrated care Kronikgune will provide a detailed description of the oGP in a dedicated workshop during the Kick off meeting.
good Practice At next adopter´s site, NAWG, depending on their needs, expectations, strategic objectives, real possibilities and
transfer and existing local interventions, will choose the final core features by month 3. Kronikgune will support next adopters
adoption during this process if required. In a second stage, study visits to the oGP site will be organized in order to provide
next adopters with the possibility to acquire deep knowledge on specific aspects of the oGP. Then, development
of future vision of the next adopters’ practice, related to the selected features, implementation plan, monitoring
and intermediary evaluation for PDSAs, final evaluation and elaboration of final implementation report, that will
include sustainability strategy and action plan. specific interventions and actions will be taken in each next adopter
site to allow the implementation.
WP6 Catalan open IDIBAPS KG This WP will analyze and settle the bases and implement the GP from Catalonia in the next adopters. After
innovation hub knowing the oGP in the kick off meeting, next adopters could pre-select the initial core features in which are
on ICT- initially interested and the leader of WP6 will present the general outline of WP6 leadership and management
supported plan at all phases of the implementation including final reporting. After the study visits to analyze the situation,
integrated care a SWOT analysis will be developed to design and implement the specific intervention.
services for In order to efficiently organize transferability to next adopters, WP6 has identified five well-defined blocks with
chronic patients high potential for implementation by next adopters, as well as specific actions within each of them:
good Practice 1. Health risk assessment: population-based and enhanced clinical decision making (Block 1)
transfer and 2. Promotion of healthy lifestyles (Block 2)
adoption 3. Vertical and Horizontal integration experiences adopted in Catalonia (Block 3)
4. Innovative assessment and regulatory aspects of digitally-supported integrated care services (Block 4)
5. Digital support of integrated care services (Block 5)
IDIBAPS will support next adopters during this process if required. In a second stage, study visits to the oGP site
will be organized in order to provide next adopters with the possibility to acquire deep knowledge on specific
aspects of the oGP. Then, development of future vision of the next adopters’ practice, related to the selected
features, implementation plan, monitoring and intermediary evaluation for PDSAs, final evaluation and
elaboration of final implementation report, that will include sustainability strategy and action plan. specific
interventions and actions will be taken in each next adopter site to allow the implementation
WP7 The OptiMedis OPTIMEDIS EUSTRAS WP7 will lead to the selection of the core features of the oGP that next adopter´s will work on and will perform
Model- the situation analysis and define the strategic actions of next adopters. In WP7 the specific interventions and
Population- actions that will be transferred to next adopters will be selected. This WP will facilitate and support the transfer
based of GP features to next adopters´ context. This WP will analyze, settle the bases and implement the GP from
integrated care Optimedis in the next adopters. A dedicated workshop during kick off meeting will provide the opportunity to
good Practice better now the oGP. After this first step, study visits will be organized at oGP site to deep into the knowledge of
transfer and GP. Then, the situation of each next adopter will be analyzed, and the specific interventions and actions will be
adoption designed to implement the GP. OPTIMEDIS will support next adopters during this process if required. In a second
59 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Leading
Lead
WP WP TITLE Executive WP DESCRIPTION
Beneficiary
organization
stage, study visits to the oGP site will be organized in order to provide next adopters with the possibility to acquire
deep knowledge on specific aspects of the oGP. Then, development of future vision of the next adopters’ practice,
related to the selected features, implementation plan, monitoring and intermediary evaluation for PDSAs, final
evaluation and elaboration of final implementation report, that will include sustainability strategy and action plan.
specific interventions and actions will be taken in each next adopter site to allow the implementation
WP8 Digital RSD RND This WP will analyze, settle the bases and implement the GP from South Denmark in the next adopters. After
roadmap identifying the main features of the Danish GP in the dedicated workshop during the kick off meeting, next
towards an adopters NAWGs will have the opportunity to pay a visit to the oGP. As in the rest of transfer WPs, after the
integrated SWOT analysis the specific interventions and actions will be designed and piloted. Next adopters will have the
health care opportunity to know better the oGP in a dedicated workshop during the Kick off meeting by month 1. First,
sector Good Kronikgune will explain the methodology for the scope definition which is mainly delimited by selecting the
Practice features of the intervention that will be finally implemented. Then, following this methodology, the Region of
transfer and Southern Denmark will describe in depth the core features of the oGP, Roadmap towards Integrated Care,
adoption implemented in the Region of Southern Denmark. The Roadmap towards Integrated Care consists of different
elements that together make up the foundation for the digital and cross sectorial communication. Region of South
Denmark will support next adopters during this process if required. In a second stage, study visits to the oGP site
will be organized in order to provide next adopters with the possibility to acquire deep knowledge on specific
aspects of the oGP. Then, development of future vision of the next adopters’ practice, related to the selected
features, implementation plan, monitoring and intermediary evaluation for PDSAs, final evaluation and
elaboration of final implementation report, that will include sustainability strategy and action plan. specific
interventions and actions will be taken in each next adopter site to allow the implementation
The interdependency between WPs and tasks responds to the complexity of the JADECARE objectives, approach and methodology. The four transfer WPs (WP5-8), the
evaluation (WP3) and the sustainability (WP4) are closely interconnected and act in a synergistic manner. Findings and results of one task can feed other tasks of the same
WP or another. To map this cross-fertilization, the main contents of deliverables, contributing tasks and partners are detailed in the table below.
60 146
D.N D. Name Content Associated
Input from with document Ref. Ares(2020)3808356
Leading - 20/07/2020
Main contributors
Executive
Organization
D3.1 Impact Project progress monitoring plan T3.1, T3.2 AUTH AQuAS, KG,
Assessment Evaluation framework (objectives, process, output and outcomes indicators) for the 23 & T3.3 IDIBAPS, Eustras
Plan JADECARE next adopters (Optimedis), RSD,
Analysis plan (quantitative and qualitative) NIJZ, next
Data management procedures, templates, responsibilities and timeline adopters,
Methodology for the implementation quality assurance AGENAS
D3.2 Interim Project progress measurement T3.1, T3.2, AUTH AQuAS, KG,
Evaluation Intermediate evaluation of the KPIs (mainly process indicators) defined in the local T3.3, T5.4, IDIBAPS, Eustras
Report Action Plans T6.4, T7.4, (Optimedis), RSD,
Monitoring of the next adopters’ pilot implementation T8.4 NIJZ, next
Identification of deviations in indicator achievement adopters,
Definition of corrective actions AGENAS
D3.3 Final Assessment of the quality and compliance of the project process and stakeholders’ T3.1, T3.2, AUTH AQuAS, KG,
Evaluation views on inclusion and satisfaction T3.3, T5.4, IDIBAPS, Eustras
Report Analysis and reporting of the implementation process T6.4, T7.4, (Optimedis), RSD,
Impact at next adopters’ level by analyzing process, output and outcome indicators T8.4 NIJZ, next
included in the local Action Plans adopters,
Lessons learned and recommendations for future good practice transfer and AGENAS
implementation
D4.1 Local Good Summary reports of the study visits T4.1, T4.2, AGENAS Next adopters, KG,
Practices and Description of the local Good Practices (pilots) T4.3, T4.5, IDIBAPS, Eustras
Action Plans How the practice to transfer looks like T5.3, T6.3, (Optimedis), RSD,
Set up T7.3 & NIJZ
Locations T8.3
Target groups
Number of citizens/patients covered
Documentation of the local Action Plans
Concrete actions (what) needed for the implementation
Responsible actor (who)
Timeline (when)
Settings (where).
D4.2 Blueprint on Guidelines and standard operation procedures for JADECARE good practice transfer: T4.1, T4.2, AGENAS Next adopters, KG,
how to transfer Methodology and recommendations to support the implementation or the adoption T4.4, T3.3, IDIBAPS, Eustras
the of an identified good practice T_.1, T_.2, (Optimedis), RSD,
JADECARE Definition of core elements to assure scale up T_.3 and NIJZ, BAGSFI,
good practices Process to ensure sustainability after the end of the project T_.4. of AUTH, AQuAS
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
D.N D. Name Content Input from Leading Main contributors
Executive
Organization
WPs 5.6.7
and 8)
D4.3 Characteristics Description of the sustainability strategy, sustainability elements of local Good T4.1, T4.2, NIJZ Next adopters, KG,
of Practices, their integration into health policies and how JADECARE has helped T4.5, T4.6, IDIBAPS, Eustras
JADECARE, Member States to support and reinforce their capacity for digitally enabled patient T3.3 (Optimedis), RSD,
leading to centered integrated care: AGENAS.
sustainability identification of the holder of sustainability planning process BAGSFI, AUTH
and integration what should be sustainable including expected results
into national assessment of the context/situation
policies. planning for support of key stakeholders and community
assessment of long-term stability and flexibility of the holder
strategic partnerships
strategic financial planning
finding and conclusions from the Policy Dialogues
D5.1 The Basque Description of the “Basque integrated care approach” oGP, including main blocks and T4.1, T4.2, KG Next adopters,
integrated care core features, the implementation requirements and process step-by-step, barriers T4.3, T4.5, AGENAS, NIJZ,
approach found and solutions identified, lessons learnt and recommendations and the present T5.1, T5.2, BAGSFI
original Good situation of the oGP. T5.3, T5.4
Practice and Implementation process of the “Basque integrated care approach” in each next
transfer adopter´s site including how it started, who was involved, who was “coached”, how the
process original practice was adapted, which of its elements were chosen, what other elements
were added and from where, resources and capabilities needed, technology required,
barriers and facilitators and how elements needed for local GP sustainability have been
tackled.
D6.1 The Catalan The description of the “Catalan Innovation Hub” oGP, including main blocks and core T4.1, T4.2, IDIBAPS Next adopters,
Innovation features, the implementation requirements and process step-by-step, barriers found and T4.3, T4.5, AGENAS, NIJZ,
Hub original solutions identified, lessons learnt and recommendations and the present situation of T6.1, T6.2, BAGSFI
Good Practice the oGP. T6.3, T6.4
and transfer The implementation process of the “Catalan Innovation Hub” in each next adopter´s
process site will be described: how it started, who was involved, who was “coached”, how the
original practice was adapted, which of its elements were chosen, what other elements
were added and from where, resources and capabilities needed, technology required,
barriers and facilitators and how elements needed for local GP sustainability have been
tackled.
62 146
JADECARE- 951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
D.N D. Name Content Input from Leading Main contributors
Executive
Organization
D7.1 The Optimedis The description of the “Optimedis Model” oGP, including main blocks and core T4.1, T4.2, EUSTRAS Next adopters,
Model original features, the implementation requirements and process step-by-step, barriers found and T4.3, T4.5, (OPTIMEDIS) AGENAS, NIJZ,
Good Practice solutions identified, lessons learnt and recommendations and the present situation of T7.1, T7.2, BAGSFI
and transfer the oGP. T7.3, T7.4
process The implementation process of the “Optimedis Model” in each next adopter´s site will
be described: how it started, who was involved, who was “coached”, how the original
practice was adapted, which of its elements were chosen, what other elements were
added and from where, resources and capabilities needed, technology required, barriers
and facilitators and how elements needed for local GP sustainability have been tackled.
D8.1 The Danish The description of the “Danish roadmap towards integrated care” oGP, including main T4.1, T4.2, RSD Next adopters,
roadmap blocks and core features, the implementation requirements and process step-by-step, T4.3, T4.5, AGENAS, NIJZ,
towards barriers found and solutions identified, lessons learnt and recommendations and the T8.1, T8.2, BAGSFI
Integrated present situation of the oGP. T8.3, T8.4
Care original The implementation process of the “Danish roadmap towards integrated care” in each
Good Practice next adopter´s site will be described: how it started, who was involved, who was
and transfer “coached”, how the original practice was adapted, which of its elements were chosen,
process what other elements were added and from where, resources and capabilities needed,
technology required, barriers and facilitators and how elements needed for local GP
sustainability have been tackled.
63 146
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
DELIVERABLES
Lead Lead Diss. Delivery
DN. Deliverable name WP Nº beneficiary Executive Contributing partners Level Month
organization
D1.1 Project Handbook WP1 KG KG All partners PU 6
D2.1 Leaflet WP2 AEEK SU-HSMTC All partners PU 6
D2.2 Project website WP2 BAGSFI ZTG GMBH All partners PU 6
D2.3 Dissemination and communication strategy and plan WP2 AEEK SU-HSMTC All partners PU 6
D2.4 Final report on Dissemination WP2 AEEK SU-HSMTC All partners PU 36
D2.5 Layman report WP2 AEEK SU-HSMTC All partners PU 36
D3.1 Impact Assessment Plan WP3 4THYPE AUTH AQuAS, KG, IDIBAPS, Eustras (Optimedis), PU 9
RSD, NIJZ, next adopters, AGENAS
AQuAS, KG, IDIBAPS, Eustras (Optimedis),
D3.2 Interim Evaluation Report WP3 4THYPE AUTH RSD, NIJZ, next adopters, AGENAS PU 18
AQuAS, KG, IDIBAPS, Eustras (Optimedis),
D3.3 Final Evaluation Report WP3 4THYPE AUTH RSD, NIJZ, next adopters, AGENAS PU 36
D4.1 Local Good Practices and Action Plans WP4 AGENAS AGENAS Next adopters, KG, IDIBAPS, Eustras PU 15
(Optimedis), RSD, NIJZ
D4.2 Blueprint on learning from good practices WP4 AGENAS AGENAS Next adopters, KG, IDIBAPS, Eustras PU 35
(Optimedis), RSD, NIJZ, BAGSFI
D4.3 Characteristics of JADECARE, leading to WP4 NIJZ NIJZ Next adopters, KG, IDIBAPS, Eustras PU 36
sustainability and integration into national policies. (Optimedis), RSD, AGENAS, BAGSFI
The Basque integrated care approach original Good
D5.1 Practice and transfer process WP5 KG KG Next adopters, AGENAS PU 30
D6.1 The Catalan Innovation Hub original Good Practice WP6 KG IDIBAPS Next adopters, AGENAS PU 30
and transfer process
D7.1 The Optimedis Model original Good Practice and WP7 EUSTRAS OPTIMEDIS Next adopters, AGENAS PU 30
transfer process
D8.1 The “Danish roadmap towards Integrated Care WP8 RND RSD Next adopters, AGENAS PU 30
original Good Practice and transfer process
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
2.8 PROJECT MANAGEMENT STRUCTURE
METHODS
The management approach of the JA is based on the PM2 methodology of the European Commission, tailored to the
context of JADECARE. It is also based on the broad experience of KRONIKGUNE in the coordination of cooperative
project at international level in H2020 and previous Framework Programmes, but also in the area of Public Health.
The management structure of JA has been designed to respond to the needs of a large-scale consortium. It involves
a broad range of stakeholders (CAs and AEs) at pan-European level in the implementation and sustainability of good
practices. Specifically, it intends to reinforce the capacity of health authorities to successfully address the transition
of health systems to digitally-enabled integrated person-centered care, as well as to support the best practice transfer,
while respecting traditional and accepted project management standards and principles.
Coordination and implementation roles and activities in the Joint Action are performed by CAs (as Leading
Beneficiaries (LB)), and AEs. AEs can act as Leading Executive Organisations (LEO) and Co-Leading Executive
Organisations. CAs and AEs are responsible for Work Packages and/or Tasks and contribute to the Deliverables and
Milestones as described in the JADECARE Joint Action.
Many tasks have a somewhat tight, though thoroughly evaluated, time schedule. This will require a close monitoring
and emphasis on internal communication between consortium members, to allow close progress assessment and
interaction between all the actors involved in the JA. The management structure aims to ensure efficiency and, at the
same time, to avoid imposing an exaggerated overhead on the project that could hamper its real implementation and
development.
The described management activities are focused on the executing phase of the JA, as well as on assuring that after
the closing phase of the project, a real change has been achieved and the sustainability of the new models is
guaranteed. The structure for the JA is based on a multi-level organization that ensures:
The fulfilment of the project work plan.
The management of trade-offs affecting scope, quality, time, and cost.
The due attention needed on critical activities that aim to ensure the achievement of milestones and that contribute
to strategic objectives.
The relationships among partners, including conflict resolution.
The quality and efficiency with which the project activities are carried out.
The proper follow-up and fulfilment of the Grant Agreement with CHAFEA, including administrative and
financial issues, the Consortium Agreement and any other legal arrangements with external parties.
GOVERNANCE, ROLES, RESPONSIBILITIES
FIGURE 10 JADECARE MANAGEMENT STRUCTURE
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
The management structure in JADECARE is composed by the General Assembly (GA), the Steering Committee
(SC), the Coordination Team (WP1 Leader), the Work Package Leads (WPL), the Next Adopters Working Groups
(NAWG) and the Policy Board (PB). This management structure will promote smooth and dynamic collaboration
between the project participants.
General Assembly (GA): A general assembly of all entities with decision-making responsibility in matters affecting
the overall project strategy, major work plan updates, composition of the Consortium, effort and budget re-
assignment.
The GA will be chaired by the Joint Action Coordinator and contain representatives from each of the Competent
Authorities. This plenary assembly will be the ultimate decision-making body in JADECARE. It will deal with
critical issues affecting the joint action as a whole, such as overall strategy and all other matters that the Steering
Committee opts to refer to a higher level. GA members will be required to have the authority to take corrective
actions and make decisions as necessary within their respective organizations or clarify the relevant line management.
The GA will approve (via the Consortium Agreement) the management structure, and the decision-making principles
and responsibilities of all management bodies as described in this section before the start of JADECARE. Typically,
the GA will deal with major amendments to the work plan, changes in the composition of the Consortium, and
changes in effort/budget allocation between work packages. The GA will also monitor and review progress, ensure
that objectives are met and approve deliverables, supervise management and coordination and the performance in the
different work packages, as periodically reported by the SC.
The GA will thus meet at least once a year face-to-face, so that the project evolution and governance are visible and
transparent to all participants, and contributions are gathered and discussed in a timely fashion. GA members might
be assisted by technical or managerial staff from their organizations for these meetings. For decision purposes, each
member of the GA will be allocated one vote. Two thirds of the members attending a meeting of the GA will
constitute a quorum. Simple majority of the attending members will be enough for decision adoption. In the event of
a tied vote, the JA Coordinator (as Chair) will have an additional vote. DG SANTE and CHAFEA’s representatives
will participate as observers in the meetings.
Steering Committee (SC): A An operational body comprising the Coordination Team and the WP Leads (Lead
Beneficiary, Leading and Co-Leading Executive Organisations) as a decision making on daily running of the project,
with prerogatives regarding minor updates, and effort/budget re-assignment as well as conflict resolution.
SC will be an operational body in charge of daily coordination of the project work, following up progress in each of
the critical areas and the planning of tasks and activities. The SC will be responsible of monitoring the technical
quality of the work and coordination between WP Leads, and of conflict resolution as well as the establishment of
mitigation plans to reduce impact of potential risks. These include in particular the resolution of disputes and matters
relating to allocation of efforts, as well as situations in which the project efficiency might be endangered. At the
initiative of any of its members, the SC will also be able to constitute committees for matters that require specific
attention (such as security, new technological issues, gender equality, etc.), and to establish working procedures for
such committees. The SC will meet at least once a month via tele- or web-conferencing, and at least once a year face-
to-face. Consensus will be needed for decision adoption. DG SANTE and CHAFEA’s representatives will participate
as observers in the meetings.
Coordination Team (CT): KRONIKGUNE will assume the role of JA Coordinator, being the organization
representing the JADECARE Consortium. It will be responsible for the achievement of the JA goals and the
contractual obligations towards the European Commission, and will provide global scientific and technical
leadership, quality assurance policy and overall coordination of the joint action. The Coordinator Team will be
formed by the JA Coordinator supported by the Scientific Coordinator, the Project Manager and the Financial
Manager
The JA Coordinator (JAC) will lead the Coordinator team, assuming the overall leadership of the JA; will provide
strategic guidance, devise changes in scope and focus of the different tasks, coordinate all efforts of the SC and
manage dependencies between tasks, linking components towards a successful completion of the JA. The JAC will
be a central figure for conflict resolution, decision-making enabling and consensus building. The JAC will also deal
with partnership management (accession of new partners, withdrawal, formal relationships with external
collaborators), as well as supervise relationships with related external initiatives, managing the stakeholder
expectations.
Scientific Coordination (SCO) will be responsible for the delivery of high-quality results within the identified
objectives and constrains; will be in charge of establishing a common overall methodological approach, defining
high quality standards and directing the efforts towards implementation, assessment and scientific publications. The
Scientific coordinator will provide ethical oversight, guaranteeing that data collection and analysis are performed
according to current legislation at European and national level.
66 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Project Management (PM) will be in charge of the day-to-day management of the JA; will support the coordinator’s
activities and monitor compliance with the work plan, planned resources, time schedule and liaison with CHAFEA.
The PM will support WP Leads, promoting synergy and efficiency, facilitating communication among partners,
ensuring timely submission of the project deliverables and tracking milestones. The PM will drive risk and issue
management (identification, assessment of threats and opportunities, mitigation and contingency plans), manage
quality control procedures, support meetings organization and production of minutes. The PM will also promote the
application of the management methodology and the use of the PM2 methodology’s artefacts, information systems,
governance and logistics.
Financial Management (FM) will support the adequate use of resources of the project as well as to
analyze/review/support issues that could arise in the participation of Affiliated Entities through their Competent
Authorities. FM will be responsible for overall financial management (periodic reporting, budget management,
payments control), supporting the SC and GA in budget arrangements, allocation of funds, coordinating and
supporting partners in financial and administrative tasks. The FM will be also responsible of Grant Agreement and
Consortium Agreement management (amendments) and other legal issues.
Other roles may be added to the Coordinator Team according to the needs of the project.
Work Package Lead (WPL) will be performed by the Lead Beneficiary (LB), the Leading Executive Organization
(LEO) and the co-Leading Executive Organisation.
LEO and co-Leading Executive Organisation have the responsibility for day-to-day management and coordination
of the activities included in their respective work packages as defined in the work plan, implement solutions for
problems, supervise Task Leaders, produce the corresponding deliverables, identify risks as early as possible and
follow them up, and report to the PM about the progress achieved against that planned. They will be able to raise
proposals to the SC regarding effort and budget redistribution, and re-assignment of roles and responsibilities within
their respective WPs. WP participants will meet at least once a month via tele- or web-conferencing.
Next Adopters Working Groups (NAWG) including local stakeholders in all the participating countries.
A Next Adopters Working Group (NAWG) will be created in each of the next adopter sites for the implementation
of the Local Good Practices, led by the representative of the corresponding Competent Authority or Affiliated Entity.
NAWGs will be supported by the responsible of the oGPs as described in the transfer WPs (WP5-8). The NAWG
will include representative of health systems, healthcare professionals, community members, third sector. All
members of each next adopter team will meet regularly in order to share their experiences and learn from them,
suggest improvements, receive and provide support, plan different measures, review objectives, and collect and
deliver good practices. During these meetings, the Competent Authority or affiliated Entity representative will inform
the members of the team about the progress of the intervention in the other areas, highlighting any problematic
situation or any issues raised.
Policy Board (PB) An external board composed by representatives of Ministries of Health (MoH) of all the
participating countries.
The policy board will be formed by all Competent Authorities involved in JADECARE that are MoHs, national focal
points for Health Programme at the European Commission (or other representatives of MSs identified by them) from
other Member States from EU and EEA, and all other policy-oriented stakeholders that implementers will identify
as important based on their sustainability-related analyses. The role of the Policy Board will be to give input to
sustainability plans from the focus of policy, and the definition of core messages to support evidence-based policy
making with respect to sustainability of JADECARE results. The PB will have a key role in guaranteeing the
sustainability of the Joint Action and the impact after the end of the project. The Policy board will be stablished and
coordinated by WP4 Leader and co-leader with support of the Coordination Team.
Regarding communication, a Consortium Communication Policy will be established by the Coordination Team,
making extensive use of electronic resources and described in the project handbook. Regarding conflict resolution,
the project organization is planned to support a bottom-up approach. Issues amongst participants in any given activity
will be solved at the work package level with the help of the respective WPL, who, with assistance of the Coordination
Team, will use mediation and expert and referent powers to objectively solve the issue. If still unresolved the issue
will in turn be referred to the SC and ultimately to the GA, where voting mechanisms take place. DG SANTE and
CHAFEA’s representatives will participate as observers in the meetings.
PROCESSES & ARTEFACTS
The JADECARE consortium has put great care in defining the most appropriate management structure according to
its complexity. The scale of the project requires putting great care in defining the most appropriate and efficient
organizational structure and decision-making mechanisms:
General Management Procedures: Entities are responsible for:
Effective economic management and conduct of operational work in accordance with the program guidelines
and with ethical and legal standards.
67 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Complying with general terms and conditions governing the grant and any terms and conditions established
by the CHAFEA.
Managing and supervising operational personnel.
Meeting reporting requirements specific to CHAFEA.
Acknowledging, whenever possible, the financial support for the operational work.
Quality assurance Management: a Project Handbook will be elaborated at the beginning of the project (M6)
defining high quality criteria and deliverables acceptance procedures. The quality of the transfer and
implementation process will be assessed through internal evaluation procedures and the project progress will be
monitored to systematically assess the quality and compliance of the project process through an internal evaluation
plan.
Project change management: changes with a significant impact in any of the project dimensions (i.e. scope, time,
cost, quality or risk) will be properly assessed, agreed on and approved by the appropriate level of authority. It
will be will brought transparency, accountability and traceability to all project changes implemented after the
initial scope and plan have been baselined.
Communication management: JADECARE is a Joint Action involving 17 CA and 23 AE that must interact.
There will be at least annual meetings of the GA and monthly meetings of the SC. The Coordinator Team will
carry out a full supervision and logistic support on these matters and on the synchronization of all tasks, defining
control procedures to follow the evolution of work, solving potential conflicts between entities, defining
communication and dissemination policies for results and planning the exploitation strategy (if any). In the annual
GA meetings, technical progress will be transmitted through presentation of results and peer review, for a coherent
coordination and project planning. Consensus in decision-making is highly desirable, both for quality assurance
and to ensure that the goals and interests of the partners are respected. After each meeting, minutes will be
compiled.
The primary forms of communication and exchange of documents among JADECARE partners will be
teleconferences, email, FTP and web exchange.
FIGURE 14 SHOWS THE COMMUNICATION WILL FLOW BETWEEN THE CAS, AES, THE JA COORDINATOR AND CHAFEA.
Risk management process: will identify and monitor, during project implementation, internal and external risks
as well as any other issues that might affect the project progress. A Risk Log will be used to document and
communicate the risks and their response actions. Project risks have been identified at the preparation step and a
risk assessment has been developed as detailed in the section 9.6. Risks will be updated and re-evaluated during
the duration of the project. Each partner has the responsibility to report immediately to their respective WP Lead
and to the Coordinator Team any situation that may arise and may affect the project objectives or their successful
completion. Any change in time schedule of deliverables or in the allocated budget must be reported to the
corresponding WP Lead and to the Coordinator Team. In case of problems or delays, the Steering Committee will
be consulted, and it will establish mitigation plans to reduce the impact of risk occurring.
Conflict Resolution: Conflicts will be solved at the lowest level possible, and preferably amicably. If an agreement
cannot be reached at the task or WP level, then the JA Coordinator will mediate. If that is not satisfactory, then
the GA will decide and, if necessary, will ask for the authorization of the EC for any envisaged changes.
The main artefacts that will be generated during project management will be:
Project Handbook: will summarize the project objectives and document the selected approach for achieving the
project goals. It will document the Critical Success Factors (CSFs), define the key controlling processes, the
68 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
conflict resolution and escalation procedure, policies and rules, and the project mindsets. The Project Handbook
will document the project governance roles and their responsibilities and define the plans necessary for managing
the project as well as any methodology-tailoring decisions. The project goals and scope (found in the Initiating
Phase documents) are key inputs to this artefact. The Project Handbook is an important reference document for
all project members and stakeholders, and along with the Project Work Plan, is the basis on which the project is
managed and executed.
Project work plan: will be used as the basis to monitor the progress and control the project. It will document all
project activities needed to achieve the project goals along with their detailed effort/cost estimates, their schedule
and resulting project duration and resource requirements. The project work plan will be developed and maintained
by the Coordinator team.
Project stakeholder matrix: The Project Stakeholder Matrix lists all (key) project stakeholders and their contact
details and clearly states their role(s) in the project. It may also include a classification or categorization of each
stakeholder.
QUALITY & CAPACITY OF THE PARTNERSHIP
As previously described the JADECARE consortium is composed by 17 competent authorities covering a
representation of 17 of the actual 28 members of the European Union, one candidate country as Serbia and a potential
candidate like Bosnia and Herzegovina. The owners of the oGP are involved in the project as applicants: Competent
Authorities like KG or Affiliated Entities like IDIBAPS or RSD or as subcontractor like Optimedis (under Ville et
Eurométropole de Strasbourg). The presence of the owners of the oGP is crucial to guarantee the real implementation
of the four oGP that have been selected by the Steering Group on Health Promotion, Disease Prevention and
Management of Non-Communicable Diseases (SGPP). Optimedis is a private company that has developed the oGP
selected by the SGPP and included in WP7 and will participate as a subcontractor following H2020 rules for
subcontracting activities, considering that cannot act as a partner in the Joint Action. As it has been described before
table included in section 5.1.5 and the 23 next adopters have declared the interest in the implementation of oGP or
mix-matches of the four selected GP by the SGPP. To guarantee a broad impact and future application of the oGP
included in the Joint Action, observer regions have been included in JADECARE. United Kingdom will participate
by the means of HSCB as an observer in JADECARE. HSCB doesn´t aim to be a next adopter during JADECARE
duration but will actively participate to identify other potential barriers and solutions in their area of influence so the
coverage of different health systems could even be broader. In addition, experts in dissemination and
communication activities as AEEK and BAGSFI are going to lead WP2 where the organization of events including
stakeholder forum will be a key element for the project involving all communication departments from the different
regions participating in JADECARE. Without a large amount of robust data and indicators the future impact of
JADECARE will be highly limited, so evaluation will be led by an international expert in evaluation as
AUTH/4THYPE in close collaboration with other international experts like KG or AQUAS. Sustainability and
integration in national policies is a must for JADECARE so apart from including a broad representation of health
systems in Europe, the measures and pathways for this sustainability will be coordinate by NIJZ and AGENAS to
generate the necessary plans for next adopters not only for the implementation but also for sustainability of the
change. Both entities have a broad experience in the field and the work will be perfectly coordinated and aligned
with activities included in WP 5-8.
KG is the designated CA for Spain and will be the coordinator of JADECARE. KG is experienced in the
coordination and management of European projects and Joint Actions mainly related to research and implementation
of innovative health care delivery integration systems. KG has coordinated Carewell (CIP)92 , also ASSEHS (2HP)
and is now coordinating UPRIGHT (H2020). In addition, has been recently awarded by H2020 program, to
coordinate an Innovation action in the field of integrated care. Other European projects of interest are C3Cloud, Fi-
STAR, Mastermind, SCIROCCO, ACT, ACT@Scale, Advantage, CHRODIS-Plus, EIP on AHA (B3 Action Group
on Integrated Care) where they have collaborated with other participating entities like:
JA CHRODIS Plus where CIPH (Croatia), AUTH (Greece), SU (Hungary); AGENAS, Ministry of Health Italy,
NIJZ, AQUAS and CSJA have also been involved,
EIP on AHA where all the participants in the project have selected regions in the map of Reference Sites and
have included innovative practices in the repository of EIP-AHA. In addition, several partners are part of the
Action Group B3 (Integrated care),
SCIROCCO and SCIROCCO Exchange where KG has collaborated with the University Hospital Olomouc
(Czech Republic), NIJZ, OPTIMEDIS, and Italian partners in the development of identified methodologies in
collaboration developing at first time the concept of B3 Maturity model.
92
https://ec.europa.eu/digital-single-market/en/news/top-25-influential-ict-active-and-healthy-ageing-projects
69 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Greece partners as well as region of Sothern Denmark, AQuAs and KG have been also working in ACT Scale
whose aim was to identify, transfer and scale up existing and operational Care Coordination and Telehealth good
practices with the target of reaching a total of 100,000 care recipients across regions and programmes in multiple
European countries.
In CareWell coordinator, Italian and Denmark partners have worked in the delivery of integrated healthcare to
frail elderly patients through comprehensive multidisciplinary programmes. ICTs facilitate the coordination and
communication of healthcare professionals and support patient centered delivery of care at home. The project
supported the integration of care in six European Regions.
It is important to highlight that most of the partners as described in section 11 have been involved in other JA that
are also linked to management of chronic diseases, frailty, e-health such as:
Joint Action to support the eHealth Network [JAseHN]: AEEK, SE, NVD (Latvia) AEEK and CIPH
eHAction: CHIF was responsible for preparing legal interoperability in cross-border context where NIZJZ and
AEEK are also partners.
ADVANTAGE: KG, CSJA, CIPH, AGENAS, ACSS, NIJZ and DOH have worked together in the JA related to
frailty
infAct: InfAct (Information for Action): MCA, NIJZ, MSAE, ACSS are participating in this JA.
iPAAC JA: NIJZ coordinates this JA, where CIPH and ACSS participate.
JAHEE - The Joint Action Health Equity Europe: MCA, CIPH, NIJZ and ACSS are working together in this JA.
SHARP: MCA, NIJZ, CIPH, MSAE are collaborating in this JA.
In addition, several of the participants have worked in the preparation of the Health system performance
assessment – Integrated Care Assessment (20157303 HSPA) document as participants in the co-design of the
performance assessment framework and maturity assessment of health systems.
CAPACITY OF THE STAFF TO CARRY OUT THE PROJECT
COORDINATOR: KRONIKGUNE
Kronikgune (KG) is an Institute for Health Services Research that promotes and carries out management and
organization research on health and socio-health services. Its scientific research programme is aligned with the
policies of the Basque Department of Health, that pursue the continuous adaptation and transformation of the health
system by keeping people at the centre of the system and addressing the challenges derived from aging, chronicity
and dependency.
Kronikgune will advance in health policies and services evaluation, intervention models development, dissemination
and the analysis of health services’ change and implementation. Its expertise lies in the analyses for health promotion
strategies; study of stratification models and their usefulness to predict patients’ needs and adequacy of resources;
design of personalized care; best models and management services for integrated care; strategies and advanced
methods of decision making, organizational transformation and innovation, including research in developing new
products and technologies for e-health (diagnosis, support, monitoring, coordination).
Kronikgune is experienced in the coordination and management of European projects and Joint Actions mainly
related to research and implementation of innovative health care delivery integration systems.
Kronikgune’s area of expertise comprises the development and implementation ICT enabled solutions for the
management of chronic disease, evaluation of health services and identification of determinants in the management
of chronicity, with a common framework that integrates both social and health aspects.
Overall, Kronikgune analyses strategies for health promotion, including individual and structural actions and action
models in community health; studies stratification models and their usefulness to predict needs and adequacy of
resources for chronic patients; the design of personalized care (care management for high-risk patients, chronic
patient integrated, multidisciplinary collaborative care programs); best models and management services for
chronicity, including funding, contracting services, integrated care systems, technologies or new professional roles;
strategies and advanced methods of decision making, organizational transformation and innovation, including
research
Since 2016, the Basque Country is considered a 4-star Reference Site, which is the highest rating awarded by the
European Commission to demonstrate excellence in the development, implementation and scaling-up of innovative
practices, in line with the strategic aims of EIP on AHA. This recognition is also due to the commitment undertaken
regarding an integral approach to active and healthy ageing and including new policies which place the person at the
centre of all actions.
The Basque Government Health Department, through Kronikgune, Osakidetza and other organizations and
institutions, has been part of the European EIP on AHA Association since 2012.
Kronikgune participated in the 6th EIP on AHA Partner Conference hold under the slogan: “Digital transformation
of health and care for Active and Healthy Ageing in Europe”. The event has focused on reviewing the action plans
70 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
defined within the Action Groups which come under the framework of the EIP on AHA strategy. The alignment of
the plans and commitments undertaken by the partners in relation to the European Commission policies have been
analysed, and in particular, regarding the “Transformation of Health” and “Care in the context of the Digital Single
Market”. Kronikgune, representing the Basque Country, took part in.
KEY STAFF:
MD. Esteban de Manuel Keenoy obtained MD University of Navarra holds a Master degree in Community Health,
University of London (LSHTM) and a Specialist degree in Family Medicine, Autonomous University of Madrid.
Has a career in management in health and scientific institutions. From 1983 to 2002 he was in Andalucía, first as
Regional Director of Primary Health Care and Health Promotion and later, as Academic Director of the
Andalusian School of Public Health. From 2003 to 2011 he has been CEO of the Institute of Health Sciences of
Aragón, responsible for Health R&D and knowledge management in the Region of Aragon, in Northeast Spain.
Since July 2011 he is in charge of the Institute for Health Services Research Kronikgune, set up by the Basque
Government within the R&D strategy to confront ageing, chronic diseases and healthy living. He has been
involved in national and international projects advising public health and health systems development. His main
expertise is on strategic management, human resources development and knowledge management in health
services and research.
Dr Ane Fullaondo obtained an MD in Biology at the Autonomous University of Madrid (2005) and PhD in
Genetics and Molecular Biology at the University of the Basque Country (2009). Currently, she obtained a
Masters in research methods and evaluation of health services health economics of the National Distance
Education University (UNED). In 2015 she obtained the LEAD – The certificate of Specialization in Leadership
and Transformation in Organizations and Health Systems from Deusto Business School. Since the end of 2012,
she has been a researcher in Kronikgune and from November 2015 until now, she has been coordinator of research
projects in Kronikgune.
Jon Txarramendieta holds an Engineering in Industrial Organization at the University of Deusto (2010) and a
Master degree in Health Management at Deusto Business School (2015). In 2017, he obtained the Expert Course
in Health Services and Chronic Diseases Research. He has experience in the implementation of health services in
national and European project context. Since 2016 he works as Project Manager at Kronikgune, where he has
been involved in several EUfunded projects including Mastermind, ACT@Scale, SCIROCCO, SCIROCCO
Exchange and the JA CHRODIS Plus.
Jose Maria Aguirre holds a bachelor in Business Administration at Deusto Business School (1990). In 2018, he
obtained the Senior Management Programme for Research, Innovation and Technology Transfer Institutions at
IESE Business School. He has experience working as Auditor and Chief Financial officer. Since 2012, he works
as Financial and Administrative Manager at Kronikgune. He is responsible for the financial and administrative
management of several European Projects in DG SANTE, H2020, CIP and FP7 programmes. He has been the
financial coordinator of ASSEHS, CAREWELL and UPRIGHT project.
AFFILIATED ENTITIES
CSJA: The Regional Ministry of Health of Andalusia (CSJA) is responsible for public health, health policy,
planning and regulation, healthcare management and provision in Andalusia, as well as the leadership of the
Andalusian Public Healthcare System (APHS). CSJA develops different initiatives in the field of frailty
prevention following the IV Andalusian Health Plan, the general framework of health policies in Andalusia to
improve the health of the population, through Health in All Policies strategy. Two other comprehensive plans
tackle specifically this issue: the Andalusian Plan of integrated care for patients with chronic diseases, and the
Andalusian Comprehensive Care Strategy. Andalusia is a 4-star Reference Site within the European Innovative
Partnership on Active and Healthy Ageing. SAS Andalusian Health Service- Public agency depending on the
Regional Ministry of Health of Andalusia which main aim is to provide healthcare services to the population in
the region. It is a wide network based on a high-quality, patient-centered, accessible care, with two levels of care:
primary healthcare, the backbone, with 1,500 primary centers and 30 public hospitals. SAS counts with key
professionals and departments whose participation becomes essential for this Joint Action. Fundación Pública
Andaluza Progreso y Salud (FPS) is a non-for-profit organization which belongs to the Andalusian Regional
Ministry of Health. FPS provides services to the Andalusian Public Health System through three lines of activity.
SCS: The Cantabrian Health Service (SCS) is an autonomous administrative body attached to the Ministry of
Health of the Government of Cantabria. The SCS has implemented a strategy for the managmenet of the
Chronicity of Cantabria, as a guide and the driving force for change, the instrument to improve knowledge and
the network of social services in a position to face an enormous challenge of the population's health conditions
and to place the health system in a better position. The principles of user participation, of their families, and of
patient associations; of training and co-responsibility; of continuity of care and coordination between levels and
systems permeate the entire Plan and give meaning to the concept of placing at the centre of the plan. IDIVAL
71 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
manages the RTD developed by the health system in the region. IDIVAL has a strong commitment to research
and innovation, ingredients that have been key in its success story and have reverted to the high quality of care
provided daily
SACYL: The Chronic Patient Care Strategy in Castilla y León (SACYL) aims to adapt the functioning of the
Castilla y León healthcare system to the new reality of the growing demand for care derived from patients with
chronic diseases. It focuses on five fundamental aspects: Organize and adapt hospital resources to the conditions
and needs of these patients; Strengthen the role of primary care and improve its conditions to facilitate effective
care; To ensure coordination between the professionals of the different levels of care that intervene to guarantee
the continuity of care; To advance towards healthcare integration through the effective coordination of the health
and social systems; To promote the active participation of patients and caregivers in the maintenance of health.
SMS: The Murcian Health Service (SMS) is the responsible for health care in the Region of Murcia, integrating
a total of 11 hospitals, with 3,651 beds and 508 outpatient appointments of primary care, and providing healthcare
to 1.47 million inhabitants (about 3.09% of the whole Spanish population). The SMS provide services and develop
the following actions: Health Promotion, Prevention of the disease, Comprehensive Primary Care health,
Specialized Healthcare. It is noteworthy that the Region of Murcia is considered by firms specialized in the
implementation and evaluation of health-related technologies. The Foundation for Health Training and Research
of the Region of Murcia (FFIS), is a foundation dependent on the Health of Regional Department of Murcia, and
with the Health Service of Murcia (SMS) are the main actors in the development and promotion of the innovation
in the Health Sector in The Region of Murcia. The main objective of the Foundation for Training and Health
Research in the Region of Murcia (FFIS) is to organize, coordinate, promote and manage health research training
and generating effective innovation and useful knowledge to the healthcare system of the Region of Murcia. The
team will include: Pedro Perez Lopez as member of the Member of the Institutional Committee of the Chronic
Attention Strategy: Luis G Contreras Deputy Director General of projects and Innovation among others.
IDIBAPS: The Consorci Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS) is a public research
centre dedicated to translational research in the field of biomedicine. IDIBAPS is formed by the Government of
Catalonia, the University of Barcelona's Faculty of Medicine (UB), the Hospital Clínic de Barcelona (HCB) and
the Institut d'Investigacions Biomèdiques de Barcelona of the Spanish Council for Scientific Research (IIBB-
CSIC). Since 2006, IDIBAPS and HCB have pioneered a profound transformation of health services towards
integrated care in the district of Barcelona-Esquerra (AISBE 540 k inhabitants) and are contributing to scale-up
integrated care in the region of Catalonia (ES). Within the IDIBAPS-HCB frame, the Integrated Care and
System’s Medicine (InCaSyM) group, will collaborate in JADECARE under the leadership of Prof. Josep Roca
MD, PhD. Key collaborators will be: Isaac Cano, PhD (computer scientist); Carme Hernandez, PhD (nurse
coordinator of the home hospitalization program at HCB); Anael Barberan, PhD (physiotherapist coordinator of
the healthy lifestyles program); and, Ines Mila (operations manager). IDIBAPS, WP6 leader, plays an umbrella
role coordinating, jointly with AQuAS, all local stakeholders in Catalonia.
AQUAS Agència de Qualitat i Avaluació Sanitàries de Catalunya has the mission of generating relevant
knowledge to contribute to the improvement of the quality, safety and sustainability of the Catalan Health Care
System and thus easing the decision-making process for citizens and health care managers and professionals.
AQuAS combines different study methodologies in its assessments. Primary data, secondary data, and data
synthesis may be included in the process. The activities of the AQuAS – at request and by own initiative – take
place within the public Catalan healthcare system, industry, insurance companies, research units, and users in
Catalonia, Spain, and abroad. AQuAS is also a collaborating center of the World Health Organization (WHO),
developing various support tasks on HTA and promoting use of proper health technologies. AQuAS has also an
active participation in making and coordinating groups for developing evidence-based clinical practice guidelines.
BOSNIA AND HERZEGOVINA
COMPETENT AUTHORITY
The Ministry of Civil Affairs of Bosnia and Herzegovina (MCA) is state-level institution responsible for carrying
out tasks and discharging duties, which are within the competence of Bosnia and Herzegovina and relate to defining
basic principles, coordinating activities and harmonizing plans of the Entity authorities and defining a strategy at the
international level in the field of health care. Within the Ministry, there is the Department of Health with its two
sections: Section for Statistical Analytical Work and Reporting and the Section for European Integration and
International Cooperation.
Health system in Federation of Bosnia and Herzegovina is decentralised. There is one Federal ministry of health and
10 cantonal ministries of health. Federal ministry of health is roof institution for Federal health insurance fund, Public
health institute and Institute for transfuziology. Each of cantonal ministries has its own cantonal health insurance
72 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
fund, and its own cantonal institute for public health. Every canton has clinical centres, cantonal hospitals, general
hospitals, health centres and ambulates.
KEY STAFF:
Prim.dr Draženka Malićbegović, Project Coordinator, holds an university degree in medicine, with over 25 years
of professional experience in managing and coordination of the various international healthcare Projects which
were/are implemented in Bosnia and Herzegovina and funded by World Bank, UN agencies, EU and bilateral
donors.
AFFILIATED ENTITIES
The main duty of the Ministry of Health and Social Welfare of the Republic of Srpska is the creation of a modern,
rational, efficient and effective health care and social welfare systems, dedicated to the policy of the improvement of
the population health and conditions which affects the health and social welfare.
The Ministry of Health and Social Welfare of Republic of Srpska performs administrative and other professional
tasks related to the promotion, improvement, control and protection of public health, public health, health care, health
system, pharmacy, social, family and child care in Republic of Srpska, Bosnia and Herzegovina
KEY STAFF:
Mr Zdravko Grubač is experienced project manager and project coordinator with key expertise in development
and deployment of information systems in health care. His previous engagements in last 15 years include
preparation of project documentation (operational manuals, budget, procedures and results frameworks, terms of
reference) within specific framework; coordination and oversight of development of various information systems
for health system of Republic of Srpska and information management; development of study/research
methodologies, survey design and implementation.
The Institute for Public Health of the Federation of Bosnia and Herzegovina operates in two organizational
units, in Sarajevo and Mostar, which form a single functional unit. The Institute performs professional tasks within
the legally defined activities, through its services / centers, which are structured into departments.
Through a diverse range of public health functions, the Institute seeks to fulfil its mission as a professional referral
and scientific institution in the field of public health, which through monitoring, scientific research and education, as
well as health promotion, actively influences the improvement of the health status of the population of Federation of
BiH and a vision that emphasizes the role of the Public Health Institute of the Federation of BiH. With its function,
the Institute significantly influences the improvement of the health status of the population and the creation of sound
public policies in cooperation with all public health institutions, other sectors and with the full support of the
community.
KEY STAFF:
Prim.dr Davor Pehar, Director of the Institute, is a primarius doctor, and has great experience in the field of
primary health care. For many years, He has been working as a health care manager, and this brings great value
to one such project. This experience can be of great help for prediction and planning of future moves in this field
of what is needed in practice. He owns great knowledge on practical medicine and information flow which is
crucial for the proper perceiving and solution of the problem.
MSc Tanja Mićić worked on all projects regarding information systems in public health sector from 2013 and
has a great knowledge of how things work and how to organise activities properly. She worked on survey design
and data analysis, data mapping and data mining, statistical analysis, design of information system, user support
and implementation of systems on the actual field.
CROATIA
COMPETENT AUTHORITY
CIPH is a central public health institute in the Republic of Croatia. CIPH deals with public health, health promotion
and education, disease prevention, microbiology, environmental health, school medicine, mental health care and
addiction prevention. CIPH’s main tasks are to plan, promote and implement measures for the enhancement of
population health and reduction of health problems. The Institute functions as a statistical authority which maintains
national public health registries, supervises data storage and coordinates the work of other health registers. It
coordinates the network of regional public health institutes, actively participates in the creation of health policy and
public health regulations and engages in international co-operation for the purposes of improving public health and
welfare.
CIPH’s Division of Occupational Health has been recently incorporated to CIPH but their field of expertise includes
integrated care for workers and their health and healthy aging at work not only in order to improve job satisfaction
but also to provide our workers longer work ability and healthier aging and retirements as well as improving
employability of persons with disabilities.
73 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
KEY STAFF:
CIPH's team will include key roles as the Assistant Director-General of Occupational Health and Head of Division
of Occupational health and Head of Department of Work Ability Preservation and Heath at Work in Croatian Institute
of Public Health (CIPH).
Marija Bubaš, MD, PhD, is an occupational and sports medicine specialist, Assistant Director-General of
Occupational Health and Head of Division of Occupational health and Head of Department of Work Ability
Preservation and Heath at Work in Croatian Institute of Public Health (CIPH). Dr. Bubaš is also Chair of ICOH
Scientific Committee Education and Training in Occupational Health and Board member of European Association
of Schools of Occupational Medicine.
Ana Bogadi Šare, MD, PhD is an occupational medicine specialist, Head of Department of occupational diseases.
Primarius Bogadi Šare has extend knowledge in occupational diseases and health and safety at work. In 2006 she
has participated as a principal investigator in the project led by Croatia and the Netherlands, on implementing best
practices in health coverage of worker and implementation of best practices in occupational health.
AFFILIATED ENTITIES
CIPH’s affiliated entity, CHIF has a main role in implementation and deployment of eHealth in Croatia and together
with Ministry of Health a significant role as policy maker concerning health in general. Croatian Health Insurance
Fund is state institution financing health protection and covering mandatory health insurance in the country. Thus,
CHIF manages prevention at all levels and also health protection. Meaning that CHIF is nationally responsible for
managing all the primary health care, secondary and tertiary health care, organizing digitalization of health services
and introducing good practices, upgrading the system for the better. CHIF collaborates with Croatian Institute of
Public Health when introducing and delivering national prevention programs and best practices in prevention.
Croatian Institute of Public Health is funded by the government in all areas of managing public health. Without the
support of the Croatian Health Insurance Fund it will be much harder to introduce best practice examples into daily
practice at national level as the CHIF has direct contact (through contract agreements) with healthcare workers and
institutions at all three levels of health care. Meaning, the network that CHIF has will help introduce best practices
into every day provision of healthcare.
KEY STAFF:
Sanja Gusić, graduated in Faculty of Electrical Engineering and Computing (University of Zagreb), attended HKS
Executive Education (Digitazing Public Services). She is an experienced software engineer, with an advanced
knowledge of software methods and processes, and requirements engineering.
She has been involved in development and implementation information strategy in national projects ( CEZIH,
ePrescriptions, National Prevention Program, etc) and she was team leader on JAseHN project. She is participating
eHAction and she is coordinator for EESSI project.
Tomislav König, prof. spec. ing. logist. graduated at the University of Applied Sciences Velika Gorica,
professional study of Management of Logistic Systems and Processes. He has 15 years experince in IT sector in
Croatian health insurance fund and actively planed and worked at several National eHealth projects such as the
ePrescriptions, eRefferal and eResult , eOrdering and eWaiting lists. He is participating eHAction project.
CHIF’s team will include a team with experienced software engineer, advanced knowledge of software methods and
processes, and requirements engineering.
CZECH REPUBLIC
Ministry of Health of the Czech Republic (MZCR) is the central authority responsible for health care in the country.
Due to existing health (and care) system development over long decades no consistent model of integrated care is
implemented. Care integration term is usually used in two contexts in the CR: 1. Perspective integration of health
and social care that should resolve accumulated issues on so called “health and social care border” with services
provided to citizens and patients that typically require both health or social care but the conditions for such services
provisioning are still not well aligned, and 2. Partial solutions of coordinated care established by either specific health
service according to law (so called “dispensary care” used in specific diseases), or coordination managed on the bases
of cooperation of medical professionals sometimes formalised in programs jointly agreed by pertinent national
medical societies, and/or agreed institutional relations or agreements between various healthcare providers in the
country. None or just marginally some of these cases sufficiently herald by attributes of integrated care as understood
in the context of healthcare reforms by EIP on AHA, DG SANTE or WHO, particularly if it comes to relation with
electronic sharing of health information and other eHealth services, though such services as such are being
implemented in the last period in line with modern trends in EU countries. Endorsement of the Strategic Framework
“Health 2030” by MoH in 2019 has opened new space for development and implementation of concepts of integrated
care models and further digitalization of healthcare in the Czech Republic.
KEY STAFF:
74 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Doctor Alena Steflova, MD was appointed Deputy Minister of Health of the Czech Republic in December 2017.
From 2003 to 2017 she has been as Director of the National Office of the World Health Organization (WHO) in the
Czech Republic. In 1991-2003 she was invited to the Ministry of Health, where she held various positions, including
an advisor to the Chief Hygienist of the Czech Republic, the head of the outpatient and primary care department and
the director of the department for science and research. She is the author and co-author of a number of articles focused
primarily on prevention, health promotion, public health, WHO policies and strategies and their implementation into
the Czech Republic. As of 2019, Mrs. A. Steflova also coordinates implementation plans in the Strategic Framework
“Health 2030”.
Zdenek Gütter, PhD has his expertise in healthcare innovations based on information and communication
technologies. He focuses on new health and care models using digital technologies and assessment of innovative
services and their impacts. He is particularly involved in deployment and scaling up of digitally-enabled care
solutions for chronic diseases. He is an expert of the Ministry of Health of the Czech Republic for telemedicine,
artificial intelligence and innovations supporting integrated and person centered care in its National eHealth Centre
(NCEZ). He has a track of experience with international projects of the Czech National eHealth Center (NTMC) of
the University Hospital Olomouc (UHO) and with coordination of membership in EIP on AHA and activities of AHA
Reference Site.
Martin Zeman currently works at National eHealth Centre (NCEZ) as its director. NCEZ is the national e-Health
authority under the Ministry of Health. He was formerly the Chief Information Officer (CIO) of the North Bohemia
Regional Hospital Trust. He is a Chairman of the Czech Society of Medical Informatics and Scientific Information.
Martin is responsible for nationwide strategy and implementation of the digital health services in the Czech Republic.
AFFILIATED ENTITIES
Systematic use of eHealth services in healthcare and development of integrated care models is one of the targets of
Affiliated member – University Hospital Olomouc (UHO) with its Czech national eHealth Center (NTMC). UHO is
one of the largest and oldest state-owned teaching hospitals in the CR, with 4,200 employees providing complex
health care services, UHO reports to MoH and effectively acts as Regional Hospital in Olomouc Region with approx.
640 000 inhabitants. UHO is the driver of innovations in healthcare in the Region, develops and scales up eHealth
infrastructure, services and applications. During COVID-19 crises in 2020, it launched several innovative digital
solutions transferable also to other regions. UHO has been acting also as Competence Centre for Telemedicine of
MZCR since 9.2019.
UHO is a member of EIP on AHA since 2012, actively working in AG B3 on Integrated care, with commitments and
submitted own good practices. It is also an AHA Reference site nominated in 2013, 2016 and 2019. UHO has
participated in several EU projects and Twinnings with scopes relevant to JADECARE; last Twinning focused on
healthcare reforms and digital solutions in Catalonia, attended also by MZCR representatives, was concluded in
January 2020.
KEY STAFF:
▪ Antonin Hlavinka is Deputy director of ICT of UHO. He is responsible for the development and operation of
ICT in UHO and for the concept and implementation of Regional e-Health platform, as well as digital security.
▪ Cenek Merta, MBA is Deputy director of UHO responsible for the strategy and processes of purchasing medical
devices and innovations.
▪ David Kula,MBA belongs to the NTMC department of UHO and works as a project manager with expertise in
the economics of innovation implementation. He is involved in the management of projects focused on the
development of telemedicine, eHealth and assistive technologies, innovation of teaching using ICT tools,
responsibility for the development of the Czech National eHealth Center.
Petr Struk, MD. Senior consultant. Professional orientation - pediatric medicine, psychology, eHealth, public health,
health policy, health literacy, primary and community care, research management, education.
DENMARK
COMPETENT AUTHORITY
The Steno Diabetes Center North Denmark is an relative new organization. In December 2017, the Novo Nordisk
Foundation approved a grant of DKK795 million to the North Denmark Region for establishing and operating Steno
Diabetes Center North Denmark
The vision for Steno Diabetes Center North Denmark is that it will improve the longevity and quality of life of
everyone with diabetes and create coherent treatment near people’s homes and halt the growth of people developing
diabetes.
The Hallmark of the “Steno Diabetes Center” is “Digital Health” and the center has recruited highly skill employees
in the field, who have worked many years with digital transformation.
75 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
The Digital Health team is a team of one manager and two project managers. All with 15+ years expires in the field
of digitalisation and with academic background. The Team is part of the Steno Diabetes Center Norddenmark, which
have these other departments, which will be involve in the project:
Department of Patient-centered and evidence-based treatment of diabetes: Doctors, nurse and other caregivers
who are treating the patients
Department of Clinical research: Diabetes research unit with Professor, senior researchers and Ph.D. students
Department of Developing competencies and education: Educators and manager of user counsil
Department of Intersectoral collaboration: Projectmanagers and health care professionals, who collaborate with
GP and municipalities.
https://aalborguh.rn.dk/for-sundhedsfaglige/steno-diabetes-center
KEY STAFF:
Chief Officer Tina Archard Heide holds a Master of Arts in Information Science and Cross-cultural
Communication and a Master in Management and Organizational Psychology. As digitization manager, Tina
Archard Heide is head of Digital Health and Diabetes in Steno Diabetes Center North Jutland. The Digital Health
unit is working across SDCN's various areas with health professionals, researchers and private companies to
develop new digital opportunities and healthcare for citizens with diabetes. Before Steno Tina Archard Heide
comes from a position as head of TeleCare Nord, which on behalf of the Northern Jutland municipalities and the
Region of Northern Jutland has been behind large-scale projects around home monitoring for COPD and heart
failure patients.
Project Manager - Ulrik Appel has a Master of Science in Public Administration from Aalborg University and a
later diploma of management from Technical University of Denmark. Ulrik is working in Steno with focus on
diabetes technologies, data and networking. Prior to Steno, Ulrik Appel worked with welfare and innovation in a
variety of public sectors. Primary as chief consultant for a municipal innovation unit in the country third largest
municipality (Municipality of Aalborg)
AFFILIATED ENTITIES
The Region of Southern Denmark is one of five administrative public units in Denmark. The Region of Southern
Denmark has a large focus on innovation in health and social care and is a four-star excellence reference site in the
European Partnership on Active and Healthy Ageing (EIP on AHA). The health Innovation Centre is the central unit
of innovation within the Region of Southern Denmark.
Through a strong focus on cross-disciplinary collaboration, user involvement and design-thinking the Health
Innovation Centre of Southern Denmark develops innovative solutions that contribute to high quality healthcare for
citizens and efficient services and procedures for healthcare professionals. The innovation field explores new ways
of designing hospitals, improving telehealth and telecare solutions, and supporting daily operations in and around the
Region’s hospital units, e.g. using emerging technologies such as AI and robotics.
The centre employs coproduction and co-creation as a method to involve users as co-creators of solutions. Involving
users – patients, citizens, and employees – is at the core of the Health Innovation Centre of Southern Denmark, e.g.
through a specialisation in needs analyses, user qualification/testing of new technologies and services as well as
implementation. At its core is close collaboration with public health and care organizations and private companies as
well as knowledge- and educational institutes such as the University of Southern Denmark. The main aims are to
bring integrated care to the citizens of the Region as well as being a meeting point and an accelerator for public and
private innovation partnerships.
The Region of Southern Denmark is known as an international front-runner in health innovation, telemedicine,
integrated care, and assisted living. This is partly due to the long tradition of participating in international activities
relating to the core activities of the region. In the JADECARE project, the role of the Region of Southern Denmark,
represented by the Health Innovation Centre, is as Best Practice case with the Digital Roadmap towards Integrated
Care. This concept consists of our SAM:BO agreement connecting the sectors digitally supplemented by a number
of projects in the area of digitally enabled integrated care.
KEY STAFF:
Christian Mercado is the manager of the department for Telemedicine and Ambient-Assisted Living Technologies
at the Health Innovation Centre of Southern Denmark. He has a Master’s degree in IT and has been involved in a
variety of IT-projects both within and beyond the Health Care sector. He has extended experience with EHR
systems, where he has been the project manager of several projects in OUH and responsible for a team of project
managers. He works specifically in the fields of Integrated Care, Digitalization of the Health Care sector and
Implementation of national and regional IT-strategies.
Iben Kromann has a Master’s degree in political science with a special focus on combining New Public
Management with ICT innovation. She has been politically active with four years as member of the Regional
76 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Council. She also has experience as a consultant in the Health Innovation Centre of Southern Denmark, where
she has been working within Public and Private Innovation and as a project manager for a wide range of IT projects
including Nordic PPI. She is currently Team Coordinator for the Team of Telemedicine.
ESTONIA
COMPETENT AUTHORITY
Estonian Ministry of Social Affairs (MSAE) is responsible for the following areas of activity: health care, public
health, e-health, labour, social security benefits, social services, children and families, gender equality and equal
treatment. This means that most authorities responsible for integrated care, including digitally enabled integrated
care, operate in the administrative field of MSAE. The key role of MSAE is to plan the policies in previously
mentioned fields, including bringing together different stakeholders for achieving more integrated care. Improving
integrated care has been one of the priorities for MSAE, being included in the Estonian eHealth Strategic
Development Plan 202093, Welfare Development Plan 2016–202394 and other strategic documents. To achieve the
strategic goals set, a variety of initiatives and projects have been launched.
MSAE is currently working towards building a broader integrated care strategy. The overall aim of this project is to
contribute to a more integrated and person-centered provision of social, medical and vocational support services to
people with disabilities and elderly with high support needs. One ambitious initiative is the enhanced care
management programme carried out together with the World Bank, with implementation being coordinated and
financed by the Health Insurance Fund. The focus of the programme is on high-risk patients and an algorithm has
been developed to assist the family physician and the family nurse in identifying the patients who need more
coordinated support. Coordination of the issues of social assistance is also encouraged, but not mandatory in the
current phase of the programme. In the future, the algorithm could potentially be integrated in the wider coordination
model, being developed in parallel, enabling a more systematic linkage between primary level healthcare and primary
level social welfare. Also, preparatory work for creating an assessment instrument repository is ongoing. The aim is
to create an assessment instrument repository that would enable sharing assessment (such as the interRAI
assessments) between relevant stakeholders (such as patients, GPs, social workers, health and welfare service
providers etc) and enabling carrying out joint assessments across disciplines and organizations. The goal is to enable
more smooth service pathways, easier communication between different stakeholders and reduction of bureaucracy
both for patients, service providers and funders.
To improve the integration of policies and services, MSAE is working closely together with variety of actors such as
the Estonian Social Insurance Board, the Estonian Health Insurance Fund, the Estonian Unemployment Insurance
Fund, unions representing patients and other interest groups, hospitals, GP-s, social service providers and other
stakeholders.
KEY STAFF:
Gerli Aavik-Märtmaa is an adviser for the Social Welfare Department in the Estonian Ministry of Social Affairs,
focusing on the development person-centered services. She is currently responsible for several projects and
initiatives aiming to improve integration between healthcare, social welfare and vocational services and policies.
In addition to her work in the ministry, she is currently doing a PhD in innovation and governance, looking into
new ways of public service delivery. New ways of service delivery, such as better use of data and co-creation
between citizens, service providers and other stakeholders has been an important element of both her academic
research and practical work in the ministry
Rauno Mäekivi serves as an adviser in the Smart Development Department at the Ministry of Social Affairs,
where he is responsible for digital transformations in primary health care and supports innovative initiatives in
social care. He has previously coordinated a task force on long term care at the Estonian Government Office,
developed primary health care services at the Estonian Health Insurance Fund and conducted research at Tallinn
University of Technology (TalTech). Rauno is also a PhD candidate at TalTech, focusing on policies for spurring
innovation.
Liis Sildnik is a chief specialist in the Health System Development Department in the Ministry of Social Affairs,
where she is responsible for the development of the primary health care system. She has also been involved in the
development of the primary level care coordination system development and in other initiatives aiming to improve
coordination and integration within healthcare system and across health and welfare systems. Her educational
background is in sociology, social politics and public health.
AFFILIATED ENTITIES
Viljandi Hospital, that is the Affiliated entity in this project is currently running one of strategic integrated care
projects that is aiming to develop and test a regional model for integrated care (together with digital tools to support
93
https://www.sm.ee/sites/default/files/content-editors/sisekomm/e-tervise_strateegia_2020_15_en1.pdf
94
https://www.sm.ee/sites/default/files/content-editors/eesmargid_ja_tegevused/welfare_development_plan_2016-2023.pdf
77 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
the implementation of such model) in the region of Viljandi. The initial development of the model was funded by
MSAE and the current work is funded by the innovation fund of the Estonian Health Insurance Board. While the
work done in Viljandi mainly concentrates on improving the integrated care in the context of Viljandi region, the
expectation is that the regional integration model could also be implemented in other regions of Estonia. Through
this JA, some of the best practice elements could be transferred into the regional model of Viljandi and after
successful pilot activities be scaled up into the national coordination and integration models.
FRANCE
The Eurométropole de Strasbourg has recently won a national call for proposals on local innovation with great
ambition; its project includes developing an initiative of integrated care locally. The Eurometropole coordinates a
consortium including the key local actors (hospital, physicians, health agency, health insurance, local authorities…).
Eurometropole of Strasbourg covers the City of Strasbourg and 32 surrounding municipalities. The population grows
moderately (+5% by 2040) and ages significantly, therefore increasing the needs for chronic diseases and elderly
care.
The Eurométropole of Strasbourg is part of a bigger administrative medical territory of circa 1 million inhabitants
with one main university hospital in Strasbourg, some private ones and more than a 1000 mostly private general
practitioners. The population of the practitioners is ageing, mainly in the most rural areas of the territory.
KEY STAFF:
Fanny Loux. Project manager senior- Fanny has started in march 2019 to work on a project aiming at accelerating
innovation in the health sector in the area of Strasbourg. Her missions entail reinforcing collaborations between
health actors for the benefit of the local population. Her involvement in JADECARE is complimentary with her
current core missions. She has extensive experience of managing European funding (ERDF) and has participated
in some European projects (URBACT). She has a master in European studies (College of Europe of Natolin,
Poland) (
Rémy Bañuls, Project director. Rémy has worked as Director for Economic development for 4 years and his
missions entail fostering innovation in the health sector, encouraging local and international cooperation between
healthcare actors, universities, clusters and entrepreneurs. He has successfully directed an application for a
national call for projects on local innovation « with great ambition » (total budget for Strasbourg = 115 M €); the
project includes developing an initiative of integrated care locally. In coordination with a consortium of key local
actors (hospital, physicians, health agency, health insurance, local authorities…). Remy has graduated at a
Business School (ESCP Europe, Paris, France).
SUBCONTRACTOR: OPTIMEDIS
The OptiMedis AG is a management company that designs, implements and evaluates accountable care systems in
order to improve health, care experience, and lower costs. It manages a group of regional Integrated Care Delivery
Systems that are located in different parts of Germany and serves as a research and performance management institute
to these regional delivery systems. OptiMedis is well connected in Germany with health insurances, ministries,
medical associations and public services in the regions it is operating in. OptiMedis AG has an internal department
for research projects and data analytics, analysing complex social health insurance data for the regions it serves.
KEY STAFF
Dr Oliver Groene is Vice Chairman of the Board at OptiMedis AG, where he oversees the programmes for research,
health data analytics and development of population health management programs. Previous positions include Senior
Lecturer in Health Services Research at London School of Hygiene and Tropical Medicine and Manager of the
Quality of Health Systems Programme at the World Health Organization Regional Office for Europe. He holds an
MSc and PhD in Public Health and an MA in medical sociology and organizational sciences. Oliver Groene served
as principle investigator (PI) or co-PI on various large scale grants, with total research funding over 9 million EUROs.
He publishes widely in leading clinical, quality-of-care and health policy journals (H-Index=36) and served as Deputy
Editor of the International Journal for Quality in Health Care (impact factor 2.6) from 2015 - 2019.
Dr Janika Blömecke is Manager Health Services Research at OptiMedis. She obtained her PhD at the Medical Faculty
at the University Clinic Hamburg, and has a background in Health Science and Physiotherapy. He worked centers on
the assessment of quality of life outcomes and the implementation of new models of care.
GERMANY
COMPETENT AUTHORITY
BAGSFI
Hamburg is a country in the German federal system, with limited legislative power in the health sector. Germany
with it’s classically Bismarckian social system, has a quite fragmented health system. The big frame in the German
78 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
health policy is set on the federal level, and the definition of the concrete services – to be financed by statutory health
insurance based on federal law - is set by a committee of the umbrella organizations of self-government institutions
(statutory health insurances, physician associations, German Hospital Federation). The BAGSFI is since 2013
member of the EIP-AHA and hosted the D4 meeting in 2017.
The cooperation of the BAGSFI with the LGL and the ZTG was build up, after the initiative of the German federal
health ministry, in the working group for telematics in the health sector (federal and all country ministries). Bavaria
is the leading country of this working group. The cooperation between Bavaria, Hamburg and North-Rhine
Westphalia ensure the dissemination of the JA results and increase the cooperation of active players in the field of
integrated care in Germany.
Germany is currently in the role out phase of the telematics infrastructure, which will connect the health care
providers, which is the basis for the use of electronic health records. In this phase it is very interesting to learn in the
JA, and to elaborate which elements of the good practice can be implement in the German system.
KEY STAFF:
Kai Schnackenberg works for the Ministry of Health and Consumer Protection of the Free and Hanseatic City of
Hamburg, as member of the Division of Health Care Industry, International Affairs and Shareholdings. Since 2012,
he is in charge of project development and management, and he is supervising projects' legal, administrative and
financial framework. He is specialized in the promotion of innovation and digitalization in the health sector. As
graduated nurse and with a degree in Health Science, he has a solid background around health systems; in addition,
he has a Master degree in European Public Administration.
AFFILIATED ENTITIES
LGL: The Bavarian Health and Food Safety Authority (LGL) is the central authority of the Free State of Bavaria for
food safety, health, veterinary affairs and occupational safety/product safety. The JA is attended by the subdivision
GE6, which has extensive experience in the handling of funding programmes. This includes, for example, the
“GesundheitsregionenPlus” (Health Regions Plus). The primary objective of Health Regions Plus is to improve the
state of health of the population, particularly with regard to equal health opportunities, through sectoral networking
and to improve the health-related quality of life. As an interdisciplinary and competent network of regional actors in
the health care sector, the Health Regions Plus take care of the optimization of regional health care in Bavaria.
Consisting of a health forum with management and steering tasks, topic-related working groups and a coordinating
office, the Health Regions Plus focus primarily on the fields of health promotion and prevention via an
interdisciplinary approach.
The funding agency "Innovative Medizinische Versorgungskonzepte" (Innovative Medical Care Concepts, IMV) in
the subdivision GE6 promotes the implementation of innovative concepts for the preservation and improvement of
medical care and/or for the promotion of cross-sector care. An evaluation process also accompanies these concepts.
The funding focuses in particular on projects to maintain and improve care in rural areas, on interdisciplinary/sectoral
cooperation between doctors, hospitals and other medical professionals and on high-quality patient care using digital
media. The funding agency promotes, evaluates and supports these projects, which aim to be integrated into standard
care.
KEY STAFF:
Thomas Ewert, PhD:Bavarian Health and Food Safety Authority – Team leader Bavarian Health Agency, health
services. From 2002 to 2012, Head of Rehabilitation Sciences and Rehabilitation Economics at the university hospital
of Munich. Theses subject “Validation of the Stroke Specific Quality of Life Scale -Validity of the SS-QOL in
Germany and in Survivors of Hemorrhagic or Ischemic Stroke and Validity of the Stroke-Specific Quality of Life
Scale for patients following traumatic brain injury”. Since 2012 team leader at the Bavarian Health and Food Safety
Authority.
Julia Eichelsdörfer: Bavarian Health and Food Safety Authority – Coordination Office eHealth.Julia Eichelsdörfer
is a graduate in business administration and a law assessor, with professional experience in both fields. Having
worked in the private sector (including Consorsbank, Siemens and as an independent management consultant), she
moved to the Bavarian Health and Food Safety Authority at the beginning of 2019, contributing her legal expertise
to the Coordination Office
ZTG GmbH: Centre for Telematics and Telemedicine (ZTG GmbH) is a public-private partnership bringing together
all stakeholders (also in the role of shareholders of the GmbH capital and hence as advisory board) in healthcare of
the Federal State North Rhine Westphalia (NRW). Roughly stakeholders can be characterised as health provider,
health professionals and statutory insurance organizations; third sector and patient’s representatives and industry. It
has been founded with the support of the State Government in 1999 to implement the digital health elements of the
state’s agreed high-level strategy for healthcare. ZTG GmbH receives meanwhile institutional funding from the State
government and generates as well income from project activities. The objective of ZTG-GmbH is to introduce and
79 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
to spread modern information and communication technologies into the healthcare system. The main goal is to
strengthen the quality of care along the increasing demands. A consequent orientation to the interests of patients and
health care providers based on the dialogue with all involved are central building blocks of our work. Besides
consulting services, expert opinions and projects ZTG-GmbH focuses on creating networks between market players.
Kay virtues are independence and highly specialized expertise. In order to secure long-term investment, interoperable
interfaces are just as natural for us as viable privacy concepts and fair financing models. Given it’s long standing
advisory role to the Ministry for Labour, Health and Social Affairs of North Rhine-Westphalia ZTG is and has been
involved in establishing policies and policies for digital health in the state NRW and also in national level activities
like supporting a joint federal and states working group on eHealth reporting to the conference of German state health
ministers and being representing in nation-wide activities like the advisory board of Gematik (German eHealth
Agency) and various working groups supporting collaboration within Europe.
KEY STAFF:
Karinna Dittrich, MA works as a Project Consultant at ZTG GmbH since 2018. She is involved in a variety of
telemedicine related projects. She started to work at ZTG-GmbH as a student assistant in 2015. Master of Arts degree
in Social Sciences with a minor in Health Economy and Health Systems from the Ruhr-University in Bochum. In
addition, she is a 2014 European Public Administration (Bachelor of Arts) graduate from the University of Twente.
GREECE
COMPETENT AUTHORITY
4th THYPE (the 4th Health District of Macedonia and Thrace) is one of the two main health administration and policy
organisations if Nothern Greece. It offers web applications such as employee management, store management,
appointment management, External medicine secretariat, H/W & S/W support, VPN communication through Cisco
Meraki equipment between Central Offices and 56 Health Centers. 4th RHA possesses the infrastructure and
technique equipment:
Dell R620 servers holding virtual infrastructure, Netapp Storage (approximately 10Tb of Data), various virtual
servers, such as Primary & Secondary AD server, Antivirus server, mail server, DB Server, Web Application Servers
etc., Fortinet firewalls in HA mode for internal use and Cisco Meraki Firewalls located in 21 Health Centers and
Central Offices.
KEY STAFF:
Emily Makrialea (female), University Degree on Βusiness Administration and two Master Degrees on Bussiness
administation with expertise field IT systems she is currently working in the 4th Health District of Macedonia and
Thrace, Ministry of Health as Head of the Programming and Development Department. She is project manager in
EC Interreg projects where 4th DYPE is lead partner.
Chrysa Girtzimani (female), University Degree on Department of Statistics and Actuarial Science of the
University of Piraeus she is currently working in the 4th Health District of Macedonia and Thrace, Ministry of
Health as Head of the Research and Development Department. She has a long experience in the implementation
of EC Interreg projects where 4th DYPE is lead partner
Theodosios Lozos (male) Chief Information Officer: Theodosios holds a BSc in Computer Science from Rutgers
the State University of New Jersey (USA) and a Msc in Health Management from HOU (ΕΑΠ). He worked for
more than 10 years in various companies such as Logismos S.A., Hellenic Steel S.A., and Intrasoft S.A. Since
1997 is in the Public Health Sector. Currently is in the 4th YPE of Makedonia & Thrace (4th Regional Health
Authority of Makedonia and Thrace.) in the Dept. of Information System, managing and developing the
information services. The main task is the implementation of the strategy for the utilization of the information
technology in the health sector in the region (15 Hospitals, 51 Health Centers, 232 Peripheral Infirmary etc). Since
2001 he was engaged in several European Programs such as Prohealth, BeHealth, RESHEN (IST 2000/5th
framework), Υγείας Πρότυπον (ΓΓΕΤ-ΕΠΑΝ), pEHR (eTEN), ), IMPRESS Project (http://fp7-impress.eu/,
Information Society SA, ΠΕΠ etc
AFFILIATED ENTITIES
The Aristotle University of Thessaloniki (AUTH) is the largest University in Greece. The School of Medicine
accommodates >340 academic staff and >3500 active students. The Lab of Medical Physics is a major research and
development centre in assistive technologies, applied neurosciences, medical education, affective computing,
semantic web, medical robotics and brain computer interfaces, radiodiagnosis and non-ionizing radiation. It is
composed of 10 research groups, leaders in their respective specialties, which pursue innovative research projects.
They have been recognized internationally for their research excellence and have been funded by a wide spectrum of
sources.
The Lab of Medical Physics is a major research and development centre in assistive technologies, applied
neurosciences, medical education, affective computing, semantic web, medical robotics and brain computer
interfaces, radiodiagnosis and non-ionizing radiation. It is composed of >10 research groups, leaders in their
80 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
respective specialties, which pursue innovative research projects. They have been recognized internationally for their
research excellence and have been funded by a wide spectrum of sources. Several groups and cliniques from the
School are involved under the leadership of the Lab of Medical Physics (MedPhys).
KEY STAFF
Professor Panagiotis Bamidis is aProf. of Medical Physics, Medical Informatics and Medical Education in
MedPhys, School of Medicine the Aristotle University of Thessaloniki, Greece. He has founded and has been
leading four research groups, namely, in Medical Education Informatics, in Assistive Technologies and Silver
Science, in Applied and Affective Neuroscience, and in Health Services Research. In the last 10 years, he has
been the co-ordinator of seven large European projects (Lifechamos.eu, captain-eu.org, SmokeFreeBrain.org;
www.meducator.net; www.longlastingmemories.eu, www.epblnet.eu, www.childrenhealth.eu) as well as the
principal investigator for a number of national and international funded projects. His publication record consists
of more than 120 international refereed journal papers, and over 530 international peer reviewed conference
papers, as well as several book chapters / edited conference proceedings volumes and over some 4200 citations
(h-index>28
Dr. Christina Plomariti graduated from the Physics department of Aristotle University of Thessaloniki in 2015.
She has a master’s in medical informatics. Since January 2018 she is a research associate in the Lab of Medical
Physics in Aristotle University of Thessaloniki in "Smoke free Brain", "Anapneo", “INADVANCE” and
“CoviRR” project. Also, she participates in a research that aims to examine the effect of microgravity in the
quality of sleep, held in Medical Physics.
HUNGARY
COMPETENT AUTHORITY
AEEK is an umbrella agency of several authorities and the leading organization for health provision. "Its tasks range
from hospital planning, care coordination, licensing of medical professionals and management of external funding to
implementation of national strategies and communication with international research organizations" [OECD]. The
mission of AEEK is to ensure the implementation of the strategy for the healthcare sector “Healthy Hungary 2014-
2020”. In addition, AEEK acts on behalf of the controlled entities in centralized public procurement processes, and/or
assists them preparing and implementing procurement themselves.
AEEK owns, operates and controls public 100 hospitals (local, regional and national level) and provides public
procurement activities and methodological support for them, as well as operates and develops the Electronic Health
Cooperation Service Space (EESZT) nation-wide Health Informatics / eHealth system supporting care coordination
between different providers and offering services to citizens (e.g. ePrescription). AEEK coordinates the work of the
professional branches of the advisory body to the health minister to define clear care protocols and guidelines, as
well as to streamline the pathway for patients with complex needs, both the quality of care and efficiency of care
delivery may be improved.
Since 2011 AEEK has taken part in preparing and monitoring more than 120 ESIF and Swiss Contribution Fund
(SCF) projects of health sector (exceeding 1 billion EURO total) and as lead partner implementing 30 ones (exceeding
140 million EURO total). These ESIF projects aim to execute development in prevention, primary care, outpatient
and inpatient services. Development activities covered methodology, HR, ICT (complex national eHealth system),
infrastructure (building and equipment) and national patient pathway reorganization.
In November 2017 AEEK launched the Electronic Health Cooperation Service Space (EESZT) transforming paper-
based or locally working national healthcare system to a modern, service-focused nation-wide Health Informatics /
eHealth system (“National EHR System”) which meets all the latest demands and requirements related to data
security, information technologies and healthcare
KEY STAFF:
AEEK is responsible for national data management and analysis, supports the dissemination of professional results,
manages, and coordinates EU and other international projects related to the health sector. The personnel of the
organization are highly-qualified experts, with professional knowledge, who also have skills and competences, and
relevant experience in managing and participating in international projects. The organization may perform economic
activity on the market e.g.: IT and health professional services.
Mr. István CSIZMADIA, MSc in Economics and Health Care Management (male): István leads international
programmes and projects at National Healthcare Service Centre (AEEK), Hungary. He has extensive (29 years’)
experience in a) Preparing, planning and managing EU funded programmes, b) Strategic planning, c) Preparing
and submitting applications for EU grant, d) Implementing and coordinating EU projects, e) Evaluating
applications and monitoring projects, f) Generating and providing support to innovation, cluster, logistic,
transport, energy, environment and health programmes and projects, g) Working with international organizations
e.g. EU COM, EU Council, UN organizations, h) Preparing and implementing bilateral and multilateral
81 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
international agreements. Since June 2018 he has been the Work Package leader of WP5 ‘Innovative use of health
data’ in the Joint Action supporting the eHealth Network (eHAction).
Mr. Robert LANG, MBA, CFA (male): Senior advisor and consultant at National Healthcare Service Centre
(AEEK), Hungary. He has extensive experience a.) in strategic and financial planning, b.) product and solution
development in digital and online services, c.) e-learning solutions, d.) preparing and submitting applications for
EU grants in Healthcare, e.) implementing EU projects. Robert worked as founder and top level executive at
several market oriented ICT firms and has deep entrepreneurial background with international scope.
Dr. Béla MUZSIK MD (male): Béla is Director for Management, Data Analysis and Data Supply at National
Healthcare Service Center (AEEK), Hungary. He has extensive 16 years’ experience in a) Primary care,
occupational medicine and occupational rehabilitation, b) Healthcare quality management and audit, c) Patient
safety, d) Training and education e) Providing support to formal and informal care providers, f) Strategic planning,
g) Preparing and submitting applications for EU grant, h) Implementing EU projects and coordinating work
packages, i) System performance assessment.
AFFILIATED ENTITIES
Semmelweis University (SU): SU will be involved to provide capacities, knowledge and experiences in leading
communication and dissemination, as well as to contribute to developing the plan for future use of results and
deliverables to be integrated in policies. The Health Services Management Training Centre (HSMTC) at Semmelweis
University was established 25 years ago with the aim to become a leading health policy and management education,
research and knowledge centre for Hungary and in the broader region. The Centre has three main profiles: education,
research and participation in organizational and system level development activities. It plays active role both in
Hungarian and in international health policy and management affairs.
KEY STAFF:
Mr. Márton KIS (male) joined the team of HSMTC in the fall of 2014 as financial economist. He is participating
in finding of, application for and execution of different national and international projects. As the member of the
Dissemination Knowledge Centre he is coordinating a number of Hungarian and international projects (JAseHN,
EIT Health Innostars, HTA Joint Action, CHRODIS+ JA, IMI2 CSA, Helium, Erasmus+, Ecoquip), and active
member of the eHealth team of HSMTC. Márton graduated in 1996 as financial economist, and in the last 25
years he has been working in all ranks of a bank, from a clerk till management positions.
Ms. Anna KOZÁK (female) obtained her degree in Sociology in 2009. She studied health care policy, planning,
financing and health economics at Eötvös Loránt University. She studied psychology at St. Andrew’s University,
UK. She worked at the National Health Care Services Centre between 2012 and 2015, when she joined Health
Services Management Training Centre as a junior expert.
Ms. Anna FEJÉR-SZÉKELY (female) obtained her degree in Artist Designer (MA) in 2009 at Moholy- Nagy
University of Art and Design, and than as Design Manager in 2010. From 2008 to 2018 she worked as graphic
designer and layout editor at local government of Perbál, when she joined Health Services Management Training
Centre as graphic designer.
Jahn Ferenc Dél-pesti Kórház és Rendelőintézet (JFDPK)
JFDPK is a public hospital. It runs one of the health promotion offices (HPO) throughout Hungary. The HPO will be
one of the key pillars to implement the knowledge transfer in Hungary. The HPO performs integrated healthcare and
prevention functions of JFDPK. The HPO lacks digital characteristics, however, offers friendly conditions to make
use of the learnings from the good practices of the JA. Therefore, the main idea of involving the hospital is to ensure
expertise and capacities for preparing and executing the pilot through its HPO. The other key pillar to implement the
knowledge transfer will be the Centre for Psychiatry and Addiction Medicine in JFDPK (CPAM).
KEY STAFF:
Mr. Zsolt MOLNÁR-GALLATZ dr. jur. (male) is the Strategic Director of Jahn Ferenc Kórház és Rendelőintézet.
He has masters degree in law and state and in healthcare management, and bachelore degree in public
administration. He is managing projects and development programs since 2001. As a strategic director, he is
responsible for the EU and other funded projects of the hospital, and for the Pesterzsébet Health Promotion Office.
Mr. Gábor GAZDAG (male). He is Doctor of Medicine (MD), Master in Science in Biomedical Engineering,
Doctor in Philosophy (PhD) in Clinical Psychiatry and Master of Business Administration (MBA). He has
professional qualifications as a Specialist in psychiatry, psychotherapy, in addiction medicine, in geriatrics, in
health insurance and in psychiatric rehabilitation. He is the head of the Centre for Psychiatry and Addiction
Medicine in JFDPK.
Ms. Henriett JUHASZNE LACSNI (female) is a Health Promotion Office Manager and Mental Health Specialist
at Pesterzsébet Health Promotion Office. She has previous work experience in the fields of health- and social care,
and while working she acquired several degrees – Geriatric Nurse, Health Teacher, Mental Hygiene Specialist,
Social Worker and Competence Developer Trainer. She is currently studying in a Grief Counselling programme.
82 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
In her current position the main focus is to help the Health Promotion Office become an essential part of the
district and spread professional network between agents of local health- and social care. While not at meetings or
organising screenings for the people, she also helps our clients directly in various trainings to overcome struggles
and in their life.
ITALY
COMPETENT AUTHORITY-AGENAS
The institutional role of AGENAS (national agency for regional healthcare services, public sector entity under the
supervision of the ministry of health) can be illustrated by the different tasks it has been assigned with regard to
integrated care:
• the national chronicity plan (NCP), approved in 2016, aims at improving the quality of life of people suffering
from chronic diseases, making assistance more effective and efficient and ensuring equity in access to citizens.
• the pact for health 2014-2016 focusses on humanization of healthcare and the centrality of the patient
including not only the physical aspects of the disease, but also the psychological, relational and social aspects that
affect health status. The pact aims at implementing a multi-professional and interdisciplinary model of territorial
assistance, characterized by the integration between specialized medicine and general medicine.
• AGENAS coordinates a technical task-force to define/update guidelines and recommendations on integrated
care networks. 6 organizational guidelines have been approved on cardiology, neonatology, stroke, severe trauma,
oncology, community services and hospital-community integration. Other 6 networks are currently being
developed.
• since September 2017, Agenas is partner of the CHRODIS-plus joint action (ja), whose goal is to support
member states in identifying efficient means to foster an effective management of chronic diseases and
multimorbidity.
• AGENAS supports the Ministry of health in the implementation of the national operating programme
“chronicity” financed by EU structural funds, particularly for the implementation of line no. 1 “promoting the
eblendnce, the collection and the knowledge of good practices”.
KEY STAFF:
Alessandro Ghirardini: Dr Ghirardini, MD and PhD in Hematology General Clinic and Laboratory at the University
of Rome and Master in Infective Disease at La Sapienza, Italy, is the Director of the Revision and monitoring of
clinical networks and organizational development office. Before his AGENAS appointment, was a Medical Director
of the Quality of activities and services Department within the Directorate of the Health Care Planning of the Italian
Ministry of Health. From 2001 until 2003, during his work at the General Directorate for International Relations of
the MoH, he was the Governmen representative to OECD and Council of Europe. Paolo Michelutti. Project manager
in EU projects on health care management and health workforce planning. 20 years of experience in health care sector
as expert and consultant in health workforce management and planning and health care organization improvement
for local health care providers, regional competent authorities and national public institutions. Senior Lecturer at
University in Organization Theory and Design. Lecturer in management training courses.
Federica Vitello. Project officer in EU projects on health care management, with several years of experience in
international cooperation, organizational and financial management of national and international research activity.
Experienced in public health administration with a Master in European Projects planning and management, and in
European public management and economic policy.
AFFILIATED ENTITIES
ASL NA2:
Local Health Agency Naples 2 (ASL NA2) is part of Campania regional health system, coordinated by the Health
Directorate. In this proposal, ASL NA 2 will ensure the interaction with the Regional Health Directorate, as well as
the engagement of the other stakeholders of the Regional Health System through Campania ProMIS network. With
13 Districts and 5 Hospitals, this ASL is one of Campania largest service providers, and include the large island of
Ischia.
KEY STAFF: Maria Femiano, ProMIS referent for ASL NA2.
Alessandro Ferrari. Analyst Manager - ASL Napoli 2 Nord at the UOC Information Technology and Clinical
Engineering since October 2016. Degree in Electronic Engineering with a Computer Science address. 2nd level
University Master in "Management of Companies and Health Organizations (DAOSan). From 2 May 2005 to 15
October 2019 "Director of Computer Integration Specialist Instructor" at Campania Region Directorate General 10
for University, Research and Innovation. Excellent technical skills and competences.
LOMBARDIA: The Lombardy Region DG Welfare regional authority has been recently awarded as a 4-stars
Reference Site of EIP-AHA. Started with the approval of the regional law n. 23 of 2015 "Evolution of the Healthcare
System", the Lombardy welfare reform has designed a new way of “Taking care” of the chronic and fragile patient
based on the development of innovative technical-organizational models that act in an integrated way for all the
83 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
professional skills involved - hospital and territorial - through networks of care and health care support, also through
telemedicine networks. The key concepts around which the new model is based is that of innovation and the definition
of an individual assistance plan document for each enrolled citizen. Within the regional “Taking Care” program,
Lombardy Region recognized the importance of continuous improvement and incremental local model adaptation as
a mean to tackle the complexity of a changing healthcare environment. Lombardy Region is interested in deepening
knowledge and skills on how to support hospitals in communication & education activities towards complex chronic
patients, integrating patient empowerment & patient perceived quality of life in current care management programs.
KEY STAFF: Dr. Alessandra Piatti (female). Medical Doctor and PhD, specialised in Hygiene and Prevention
Medicine (University of Milan and London School of Hygiene). Manager, Head of the Unit “Clinical Network and
Research”, under the General Directorate “Welfare”, Regione Lombardia, with mandate on the definition and
assessment Health & Social Support Plans, the promotion of the creation of Network of Pathologies (chronicity,
frailty, rare diseases, transplant networks), to guarantee homogeneity over the territory and the compliance with
National / International Guidelines in particular for high complexity pathologies, the management of International
projects on Health.
Dr. Marcello Melgara (male) Reviewer of several EC projects on eHealth and Semantic Interoperability. epSOS
skills: WP manager for Implementation and Testing, semantic interoperability, sustainability, testing and piloting,
system architecture. epSOS responsible for Implementation, testing, Semantic Services and National Pilot. Italian e-
SENS eHealth pilot responsible. Trillium Bridge: WP Specification leader. EXPAND responsible for epSOS asset
maintenance and relation with Institutions. H2020 PHC 34 eStandards, openMedicine, ASSESS-CT,
VALUeHEALTH WP leader and contributor. He is the appointed Italian member of the eHMSEG – Semantic Task
Force and WP Organization Leader within that Task Force. He is leading tasks in the CEF eHealth Italy Preparation
and Implementation.
ARS TOSCANA: The Tuscany Regional Health Agency (ARS) is a public scientific entity of the Tuscany Region.
ARS supports the Regional Government and the Council in their activities regarding health and healthcare policies,
providing evidence-based knowledge. The staff is formed by medical scientists, epidemiologists, public health
researchers, statisticians, data scientists, economists, sociologists, computer technicians and project managers.
Among other activities, the entity assesses the quality of the implemented healthcare policies, the outcomes of clinical
interventions and the quality of care in community health services, hospitals and nursing homes. We monitor whether
the healthcare services organization and performance correspond to the real needs of citizens and if there are health
inequalities. The scientific and technical support to the regional health system covers the entire course of policy
development, up to the verification and assessment of results.
KEY STAFF: Lorenzo Roti. MD, medical director, Faculty of Medicine and Surgery, Specialized inHygiene and
Preventive Medicine. Expert in organizational management and clinical governance. Chief medical officer at
Svaldo Sensi. Nurses. Master Degree in Nursing and Obsterical Sciences. Specialized in coordination of nursery
activities. Responsible for the territorial nursing care in North-west Tuscany Health Authority (Lucca district).
USL UMBRIA 1: Azienda USL Umbria 1 is a public Local Health Authority assisting the largest and most populous
area of the Umbria region, the green heart of Italy. The high quality of services certified each year by the Ministry of
Health, the ageing population index higher than the national average, the rural and dispersed population and the
presence of innovative organizational forms of primary care such as TFA make Umbria an optimal territory for
implementing innovative projects of management of chronic diseases using eHealth.
The Usl Umbria 1 Company in the last two years, thanks to the regional programming that has established the
Territorial Functional Aggregations and territorial operations centers, has implemented an important innovation of
territorial assistance that has improved the quality of services and integration between hospital and territory. In this
context, the patient's domicile, residential and closeness of care play an increasingly privileged role, and for this
reason the need for digital health, thanks to which it is possible to share data, carry out and install telemonitoring
devices to improve care for the chronically ill.
KEY STAFF: Manuela Pioppo. Head of Quality development and communication USL Umbria 1. She has activated
the Territorial Operations Centre - COT, unique in Umbria, for the management of assisted discharge. She followed
the computerization project of the Electronic Clinical Folder and assisted discharges in all 6 hospitals and 6 business
districts. She was the Health Director of the University Hospital of Perugia, committing to a strong innovation in the
organization of services to achieve high standards of appropriateness and safety of care such as the widespread
institutional accreditation in 52 complex structures; activation of beds of Short Observation of First Aid, Surgical,
Urological, Pediatric and Internalistic; the Rooms of Lucina for the management of physiological childbirth by
midwives; 12 Nursing Hospital PL, among the first national experiences.
MARCHE: The regional authority Marche Region, through its Health Service, has been recently awarded as a 3-
stars Reference Site of EIP-AHA. The Marche Region and the Regional Agency for Health (ARS), its operative arm,
are highly committed to the organization and delivery of integrated person-centered care, with particular care for
older people, and to incentivizing health reforms and digital transformation of healthcare. The Region, besides other
84 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
strategic, economic and monitoring roles, is involved in strategic actions, such as the definition and implementation
of the Social-Health Regional Plan, the development of a strategy to support and valorize marginal or disadvantaged
territories, and the execution of the Regional law on active ageing. One of the current focus is to make sure that the
existing care models are re-shaped to better address and respond effectively to the current needs of the health systems,
at a time where major economic and demographic change is taking place. Therefore, Marche Region-ARS is very
interested in learning and transferring innovative practices in the field of integrated care, which could produce impact
in the management of chronic diseases and quality and continuity of care. Marche Region-ARS has a wide network
of collaborations with local, national and international institutions and is part of ProMis, an institutionalized Italian
Network led by Aulss4-Veneto Region including all regions, aimed to the collaboration and internationalization of
the research in the public health field.
KEY STAFF: Eng. Giancarlo Conti has over 15 years’ experience as clinical engineer in different healthcare
authorities. Since 2017 he is Responsible for the Center of HTA and biomedical technologies of ARS, that is in
charge of developing and implementing technology innovations on information systems, digital solutions, and
telemedicine systems in the region. Managers (Regional Health manager)
Dr Lucia Di Furia, MD PHD, has over 15 years’ experience in research and has worked in various centres in Italy.
She has been the Italian Scientific Manager in various EU projects aiming at improving knowledge around active
and healthy ageing. Since 2013 Dr Di Furia has been a Medical Manager at ARS, responsible for Hospital Care,
eblendncy and urgency in acute settings, research and training. Since 2016 she is the Director of Health Department
of Marche Region. Moreover, she is the representative of ProMis for Marche Region.
MhH Italy: The MhH has been institutionally performing activities concerning the monitoring of the National health
service delivery for people with complex needs either frail, with chronic conditions, disable and dependent.
In cooperation with the Regions and in line with the international recommendations, the Moh adopts regulations on
the project topics and issues and tries to reduce gap between the Regions in their implementation. In this project Mho
will participate in the international comparison to enhance awareness, experience and managerial efficiency of its
integrated health care bodies. The Moh will support the integration of different policies regulations and resolutions
from a European/international perspective into Italian ones where they resulted effective. The Mho will be proactive
in the dissemination of the results of the work packages in which is involved (and the overall project results itselves)
and will promote the transfer of the results into national policies, Guidelines and Agreements with the Regions.
KEY STAFF: Mariadonata Bellentani. She has been working in the Public Health Care sector since 1987, with main
charges in healthcare regulation, organization and planning. Since 2016 she is the Director of Office II "National
Health Plan and Sector Plans" of the Directorate General for Health Planning in the MoH. She was the Chief of
Healthcare Organization Department at Agenas from 2002 to 2016. She is member of several Round tables and
Scientific Committees hold by the Ministry of Health concerning community care services, accreditation system and
cross-boarder care. Her main field of research is Primary Health Care management, monitoring and regulation; She
is author of many scientific publications both national and international and of several national dossier on specific
health topics such as dependency, palliative care, primary care, dependency, prevention.
Modesta Visca, Since 2016 she is in charge of healthcare regulation, organization and planning in the office II DG
health planning MoH and in the past in the Healthcare Organization Department at Agenas. Since 2006, she has been
working in project management of research activities of national projects and her main field of research is Primary
Health Care and Long Term Care services management, monitoring and planning and recently cross-boarder care.
She has been involved in several European projects and Joint Action (managed by DGSANCO as project manager
assistant and health economist and by DGEMP as health policy expert). She participates also spreading health
research results in international networks and associations such European Public Health Association EUPHA,
European health Management Association EHMA, European Forum for Primary Care EFPC.
Paola Francesca Benvenuto, received the Laura Degree in Law from University “La Sapienza” in Rome, a second
level Master of science in Labor, Trade Union and social security disciplines, University of Tor Vergata, in Rome
and Specialization Diploma in "Law and Economics of the European Communities", University "La Sapienza”. She
has up to 20 years of experience in administration and financial issues. She is the Director of General Affairs and
National System for the Verification and Control of Healthcare - Office I , Directorate General for Healthcare
Planning of the MoH. She directed in the past years the Human Resources Office of the Italian Medicines Agency-
AIFA.
LATVIA
COMPETENT AUTHORITY
The National Health Service of the Republic of Latvia is the operating direct administrative institution subordinate
to Ministry of Health. The aim of the National Health Service is to: implement State policy for availability of health
care services; administrate the State budgetary funds prescribed for health care; implement State policy in the
85 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
planning of health care services; ensure rational and the most effective use of State budget; implement the e-Health
programme according to the policy decided by the State.
The Ministry of Health supports the participation in Joint Action on implementation of digitally enabled integrated
person-centered care, by nominating National Health Service as Competent authority and Children’s Clinical
University Hospital as Affiliated entity.
There are and/or has been implemented several projects in Latvia with National Health Service:
Development of e-health integrated information system (NVD, The National Health Service)
Development of Electronic Health Card and Integration Platform Information System (NVD, The National Health
Service) - to create an environment in which information could be exchanged between different health information
systems;
Electronic booking of visits (e-booking), electronification of healthcare workflows
Development of electronic prescription information system (NVD, The National Health Service)
Cross-Border Healthcare Contact point - an information centre, providing information regarding our Latvian
national health care system and procedure for obtaining cross-border health care services (The National Health
Service)
KEY STAFF:
Edgards Labsvirs is the Director of National Health Service (NHS). He had a broad experience in Medical
Technology and IT/Electronics with a demonstrated history of working in the hospital & health care industry, as
well as consumer electronics and telecom retail networks. Skilled in Sales & Marketing Management, Negotiation
& Customer Relations, People Management. Holding Master degree in Health Management and developing in
area of healthcare management, public health and related business areas. Best performing in dynamic international
environments.
AFFILIATED ENTITIES
State owned company “Children's Clinical University Hospital” is the largest specialised multi-profile medical
institution for children in Latvia. Every year more than 30,000 patients are treated on an in-patient basis and more
than 160,000 receive out-patient medical care services. The hospital’s vision is to ensure high quality and safe health
care services for children, developing multi-profile and eblendncy as well as child-friendly medical care, medical
education and research implementing 6 Sigma (LEAN) principles for patient flow and better human resources
planning.
KEY STAFF
Mr Valts Ābols for 20 years, has held national and international senior positions in the pharmaceutical company
GSK as a board member and director of external relations. He has also served as a member of the board of directors
of the Foreign Investors Council and chaired the Health Task Force, and was a lecturer in health management at
Riga Stradins University. Having excellent skills of healthcare management, team management, strategical
planning and management of business processes. He is the Head of Children´s Hospital since 2016.
Ieva Lejniece is the National Coordinator of Latvia at HOPE (the European Hospital and Healthcare Federation);
International Medical Training Manager at Riga Stradins University (RSU); Managing Director at Children’s
Hospital Foundation. She is an Experienced Manager with a demonstrated history of working in the management
consulting industry. Specialized in healthcare sector for last 5 years. Having good skills in Project Management,
Strategic Planning, Development Programs, Business Process, Process Improvement, Strategy, Quality
Management, and Internal Audit. Have participated in one month-long experience, skills and knowledge-sharing
programme for healthcare professionals in Spain. Currently national coordinator of European Hospital and
Healthcare Federation for Latvia
LITHUANIA
Lithuania is focusing on quality, affordability and efficiency in primary health care system. Integrated care service
development also is one of the key points of county health care development prioritiesThe integrated services in
outpatient primary health care is supported by a team of personal and public health care specialists and social workers.
Presently outpatient primary health care services consist of: Family Physician (FP) services, Primary mental health
care services and Primary dental health care (PDHC) services, public health bureaus of municipalities. In 2019 FP
team has been supplemented by: life style medicine specialist, nurse assistant, social worker, kinesitherapist. PDHC
team supplemented by oral hygienist.
One of the main priorities in our country is to strengthen public health services at local level, including disease
prevention and healthy lifestyle promotion, raising of health literacy in general population, implementing integrated
health services. In order to achieve threes objectives, we strongly believe, that establishment of public health bureaus
at municipalities is a makes a significant impact to the results. First municipality public health bureaus were
established in 2006 and up to now we have a network of 47 bureaus out of 60 municipalities. Municipalities without
86 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
local established public health bureaus have to ensure the provision of public health services through collaboration
agreements between bureaus in other municipalities.
This organizational structure ensures better provision and development of integrated services.
Year 2018 remote primary health care services started to take place. Primary outpatient healthcare institutions have
been empowered to provide remote services by using information and communication technologies. Presently the
family doctor has possibility to: remotely issue referrals for diagnostic procedures, remotely prescribe medicine and
medicinal products. However, the development of remote consultations between FP and Medical specialists are
planned as well as further development and enhancement of services are required in areas such as rehabilitation and
kinesitherapy.
Integrated health care services, digitalisation and remote services possibilities are making big impact to better
organization of treatment of multimorbid patients.
KEY STAFF:
Gitana Ratkiene - Ministry of Health of the Republic of Lithuania, Personal Health care Department, Primary
health care and nursing Division. Adviser. Responsible for restructuring and further development of primary
health care.
Ramune Andriusaitiene – Ministry of Health of the Republic of Lithuania, Personal Health care Department,
Primary health care and nursing Division. Chef specialist, working in further development and digitalization of
Primary health care and nursing area.
Elita Radkevic - Ministry of Health of the Republic of Lithuania, Personal Health care Department, Primary health
care and nursing Division. Chef specialist, working in medical rehabilitation- kinesitherapy, geriatrics and
internists area.
Edita Laurinaviciene – Ministry of Health of the Republic of Lithuania, EU fund support division. Head of the
Division. Responsible for the planning, development and implementation of the specific measures (projects)
aimed at improving quality, accessibility, effectiveness and performance of health care services.
PORTUGAL
COMPETENT AUTHORITY
The Central Administration of the Health System (ACSS) coordinates Networks of the Primary Health Care,
hospital care and long term care at a national level, sets funding models for contracting health care and monitors the
implementation of those contracts. It is also in charge of providing NHS with appropriate information and
communication systems in coordination with the Shared Services of the Ministry of Health (SPMS). In this context
ACSS has been working on models of care that promote integration and people centered care. The main challenges
for ACSS are contribution to the efficiency and sustainability of the NHS; improvement of the governance of the
health system; ensuring equitable and consistent funding policies in line with the health policy; development of
human capital and improve the performance of healthcare professional and increasing the transparency in the NHS.
KEY STAFF:
Adelaide Belo is a medical doctor, with a specialist degree in internal medicine, by the Faculty of Medicine, Lisbon
(1984). She has a career both as a MD and as a Manager of healthcare organizations. Since 2013, she is the
coordinator of the “Consulta a tempo e horas” - Access Management Unit at the Administration of the Health System.
Since 2017 she coordinates a case management project in a Local Health Unit (Unidade Local de Saúde do Litoral
Alentejano) and she is also the president of the Portuguese Association for Integrated Care (2018).
Fátima Fonseca is a medical doctor, specialist in family medicine, by ICBAS (University of Porto), since 2002. She
has also experience in management of health units, namely a Local Health Unit (Unidade Local de Saúde do Alto
Minho). In her career she has been in charge of several projects related to integration of care such as patient pathways,
patient centered care and health governance. She is also the vice-president of a patients association for respiratory
diseases.
Vanessa Ribeiro is graduated in nursing, by the Lisbon School of Nursing. She holds a Master degree in Health
Management and a PhD in Public Health, both by the NOVA University of Lisbon – National School of Public
Health. She as experience as a nurse from 2004 to 2011 and after that working with the Directorate-General of Health
and the Administration of the Portuguese Health System, namely with projects related to integration of care.
AFFILIATED ENTITIES
The NOVA National School of Public Health (ENSP/NOVA), a pioneer institution in public health teaching in
Europe, as well as the research centre it hosted, the Public Health Research Centre (CISP/NOVA), is a producer of
nationally and internationally recognized research oriented to the resolution of problems in the fields of health and
health care. ENSP/NOVA counts with renowned experts in diverse fields, including health promotion, management
and economics, and belongs to the NOVAhealth Integrated Care which is committed to innovation and research in
care integration. Since its foundation, in 1966, the ENSP/NOVA is a reference university institution in the design,
development and evaluation of the Portuguese health system that has closely collaborated with the Portuguese
87 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Ministry of Health and its institutions, including ACSS. The role of ENSP/NOVA in the Joint Action will be to
support ACSS in the three phases of JADECARE (pre-implementation, implementation and post-implementation
phases).
KEY STAFF:
Rui Santana is Professor at the Department of Health Systems Policies’ and Management and Deputy Director of
NOVA National School of Public Health and. He holds a Phd in Public Health, a Post-Graduation in Hospital
Administration and he is graduated in Corporate Management. Research interest includes the study of Integrated
Care, Ambulatory Care Sensitive Conditions, Healthcare Financing and Cost Methods in Health Organizations. He
was member of several Technical Groups of the Ministry of Health and consultant of the World Bank for Public
Expenditure Reviews and Public Expenditure Tracking Surveys. He is Associate Editor of the Portuguese Journal of
Public Health and reviewer of scientific journals.
SHARED SERVICES OF THE MINISTRY OF HEALTH (SPMS)
Shared Services of the Ministry of Health (SPMS) is the Portuguese Health Ministry Central Purchasing entity, the
National Authority for information communication and technology (ICT) and for international cooperation matters
on eHealth. Conceived in 2010 as a State-Owned Enterprise (SOE) by the Ministries of Health and Finance, SPMS
purpose is to provide shared services, in the areas of purchasing and logistics, financial services, human resources
and ICT to entities who operate specifically on health and care, in order to “centralise, optimise and rationalise” the
procurement of goods and services within the Portuguese National Health System (NHS).
With regard to the provision of shared services for the transition to digital-enabled systems from “early” to “next
adopter”, the following two information systems design by SPMS represent the latest contributions for enhancing the
Portuguese NHS:
SClínico Hospitalar - Conceived to standardize electronic clinical records, SClínico aims to normalize the clinical
information collected throughout health institutions in order to allow access and systematization of patients'
clinical information. This system is common to all NHS caregivers and incorporates in itself - screening, discharge
letters, e-Bulletin for vaccination, Health Data Platform, Electronic Medical Prescription, Home Respiratory Care
Prescription, Patient Tracking Information System with HIV / AIDS (SI-LIFE) and VCI. VCI is a module in
SCLINICO that allow Healthcare Professional from a hospital to see in an integrated view all the health data from
hospital and primary care units about a patient.
S3 - Developed to promote interoperability among healthcare information systems, S3 represents a SONHO's
(Integrated Hospital Information System) upgrade by incorporating within itself: a 360-vision component, cross-
sectional scheduling, document management, multi-channel communication with citizens and different partners
involved in the administrative and clinical processes.
Thus, by cooperating nationally and internationally for the advancement and development of state-of-the-art
healthcare services, SPMS strives to achieve a public, integrate, inclusive, efficient and citizen-centered NHS
where information effectively interoperates whilst promoting preventive and self-care actions by being instantly
accessible to both citizens and healthcare providers.
KEY STAFF
Henrique Martins – President of SPMS’ Board of Directors, MD, PhD. He studied Medicine and is an Internal
Medicine Specialist. Prof. Henrique obtained his PhD degree in Management from the Judge Business School,
University of Cambridge, and has several publications in the area of management and informatics in healthcare. He
was formerly the Chief Medical Information Officer (CMIO) of the Hospital Prof. Dr Fernando Fonseca and later
Adjunct for Health IT to the Health Secretary of State. Moreover, he is responsible for nationwide efforts on complete
electronic prescription and new Health Information Platform Sharing for Electronic Health Records. At EU level,
Prof. Henrique Martins Co-chairs the eHealth Network and steers the 3rd Joint Action supporting the eHealth
Network.
Arlete Monteiro – Head of the National Telehealth Centre and SPMS’ Director for Information System, , PMP®
graduated in Mathematics (Computing and Operations Research) and Mathematics (Teaching) with post-graduations
in Project Management and Evaluation from Universidade Católica Portuguesa and in Advanced Management for
Healthcare Organizations from AESE Business School. Since 2011 she works in SPMS, and at the present is an IT
director, responsible for several areas, including Mobile and Citizens Services, Hospital Systems and ePrescription.
SERBIA
Serbia health system has been facing up a profound change during the last twenty years because of the previous
political context. Serbia received multiple international support, mainly earmarked for capacity building
(improvement of buildings, medical equipment and education) and to reform the way of health system functioning.
For instance, European Union supported health care in Serbia since the year 2000. As Serbia continues its
negotiations with the EU over accession by 2020, modernising the country’s healthcare system will become
increasingly important. Healthcare will be covered under Chapter 28 (consumer and health protection) in the
88 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
accession negotiations. Serbia recently joined the Third EU Health Programme 2014-20, highlighting the country’s
commitment to improving its healthcare system in line with EU standards. Integrated care is a key element in the
policy of health for the country in fact palliative care has been introduced in Serbia, the Ministry of Health established
the Palliative Care Task Force and adopted the National Strategy for Palliative Care to guide the development of
palliative care across Serbia as a first step of this strategy.
KEY STAFF:
Branko Marović received BS, MS and PhD degrees in computer engineering and computer science from University
of Belgrade in 1993, 1998 and 2001, where he is currently the deputy director of the University of Belgrade Computer
Centre. He also worked at the UCLA Radiology Science Department. His current areas of work and interests include
health informatics, IT and research infrastructures, software governance and architecture and management and
improvement of IT services. Branko participated in several FP and H2020 projects, often as activity or task leader,
and was a project manager of the EU funded IPA project EU-IHIS (2012-2015) that implemented hospital
information systems in 19 hospitals throughout Serbia and developed a cross-institutional EHR platform. He is also
teaching in postgraduate courses on medical informatics and virtual reality at the University of Belgrade School of
Electrical Engineering.
Nikola Radoman, BS degrees in economics and MS degree in computer science, Belgrade Univesity.I work as an IT
Consultant Second Serbian Health Project for Ministry of Health Republic of Serbia since august 2017. It is a World
Bank Project. I am responsible for the implementation of all eHealth projects for Ministry of Health. Now we are in
the implementation of eRadiology on a national level and implementation of electronic health record (EHR). Before
that I was in National Health insurance fund, person in charge for information about drugs. He will be the project
manager.
SLOVENIA
COMPETENT AUTHORITY
NIJZ as National Institute of Public Health hold the authority and leadership position in development, implementation
and research in all aspects of public health. It is one of the core institutions in the healthcare system to develop and
implement national strategic documents, such as National Health Resolution, National resolution on healthy food
and physical activity, National cancer plan, National diabetes plan etc. NIJZ is leading and supporting the
implementation of nationwide project to integrate health promotion and disease prevention/early diagnosis activities
at primary care that is based on community approach. In JA CHRODIS PLUS, NIJZ is developing a model for
integration of care across primary and secondary levels of care, as an implementation of the National Health
Resolution.
NIJZ has also taken on the role of coordinator in four prominent EU-funded Joint Actions: EPAAC – European
Partnership for Action Against Cancer, PARENT – Cross-border Patients’ Registries Initiative, CANCON –
Development of a European Guide on Quality Improvement in Comprehensive Cancer Control and iPAAC –
Roadmap on Implementation and Sustainability of Cancer Control Actions.
KEY STAFF:
Jelka Zaletel, MD, PhD, research associate, senior diabetes and policy expert, co-leader of work package on
diabetes in JA-CHRODIS, co-leader of work package on quality of care in prevention and care of chronic diseases
in JA CHRODIS PLUS, co-chair of National diabetes programme coordination group at Ministry of Health
Slovenia, senior expert in several WHO-MoH Slovenia national projects and a member of working group on
Optimizing service delivery, leading the Task on Diabetes – a case study as a part of the project Analysis of the
health system in Slovenia at MoH, and expert in several other national and EU projects.
Denis Opresnik, MA in cultural anthropology, with experience in JA CHRODIS PLUS as the coordinator of
Slovenian pilot action, leading and/or working in several diabetes-related national projects, and in national
projects addressing health inequalities and vulnerable groups by developing community approach involving social
research and interventions.
Claudia Adamič, project officer with a university degree in economics. She has over 25 years of professional
experience, having a high command in English. For the last 10 years she has been working as financial and
administrative officer for European projects at the Research and Project Management Centre at NIJZ. Involved in
more than 50 European funded projects including JA-CHRODIS and JA CHRODIS PLUS.
AFFILIATED ENTITY
The affiliated entity, Health Insurance Institute of Slovenia (ZZZS), represents the national payer in our single-payer
healthcare system, and the development/refining of payment models to support integration of care is one of their
priorities according to their strategic plan.
The Health Insurance Institute of Slovenia (HIIS; i.e. Zavod za zdravstveno zavarovanje Slovenije,
http://www.zzzs.si ) conducts its business as a public institute, bound by statute to provide compulsory health
insurance. HIIS is the sole mandatory health insurance provider in Slovenia.
89 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
It's principal task is to provide effective collection and distribution of public funds, in order to ensure the insured
persons quality rights arising from the said funds. The benefits basket arising from compulsory health insurance,
comprise the rights to health care services and rights to several financial benefits.
Regarding the law, HIIS is responsible for payment models, which are the basis for payment of health services,
provided by the public health care providers. Therefore, HIIS has a lot of experiences in this field. Additionally, HIIS
is constantly searching for new ideas and new methods of payment to achieve better treatment outcomes and more
efficient use of limited resources – generally to achieve triple aim: improving the patient experience of care (including
quality and satisfaction); improving the health of populations; and reducing the per capita cost of health care. The
upgrade of current payment models is included in the HIIS strategic program for the period 2020 – 2025, including
the piloting of a new model, which could be the model of integrated care.
KEY STAFF
Anka Bolka, manager of analytics and development department at ZZZS. She has many years of experiences in
various areas of HIIS activities: she cooperated or led many internal projects (i.e. introduction of health insurance
card, digitalisation of data exchange with health care providers), as well as national and international projects (i.e.
SUSTAINS, DRG cost analysis).
Karmen Janša, , medical doctor, specialization in internal medicine. Karmen has many years of experiences in
clinical work with diabetic patients. She works partially at the ZZZS at the analysis and development department
and partially at the Jesenice General Hospital. Her favourite areas are quality management, patient’s
empowerment and new forms and possibilities of integration between the different levels of health care. She has
participated in the preparation and implementation of various projects.
Karmen Grom Kenk, Msc. Karmen is a consultant at ZZZSwith more than 20 years of experiences in negotiations
and contracting health care providers, system of healthcare financing, payment models (healthcare services
reimbursement), data analysis about health service performance, digitalisation and introduction of new methods.
She is an expert in development of new models of healthcare services payment, especially on primary health care
and hospital care.
UNITED KINGDOM (NORTHERN IRELAND)
The Health & Social Care Board (HSCB) is an executive body s of the DoH In Northern Ireland
The DoH leads a major programme of cross-government action to improve the health and well-being of the
population and reduce health inequalities through an Integrated Care approach. Northern Ireland is recognised for its
work in developing innovative solutions for medicines management and adherence - this was one of the areas of
“good practice” for which we were awarded 4* Reference Site status. A number of networks have been developed
focusing on this area and spanning several European countries. This includes a Medicines Optimisation Working
Group which has members from 9 countries. A key objective is the WHO global challenge on medicines safety.
A strategy for NI health and social care was launched in 2016 - Health and Wellbeing 2026: Delivering Together. It
aims to reform the way services are delivered, focusing on integrated person-centered care. As part of this, a
programme of hospital services reform is in progress which is targeted at reducing waiting lists and redesigning
services in areas such as pathology and stroke. 17 Integrated Care Partnerships (ICPs), each covering a population
cohort of approximately 100,000 have been in place n NI since 2013.
The work of ICPs is also helping inform work on a prototype for an Integrated Care System in NI. A new way of
working in the planning and delivery of integrated health and social care services.
Within primary care implementation has begun of a multi-disciplinary team (MDT) approach. These programmes
are underpinned by digital transformation as set out in the eHealth and Care Strategy, and in particular by the
implementation of the Encompass electronic health and care record which will support further integration and
connectivity across NI’s care model.
KEY STAFF:
Sloan Harper, the Director of Integrated Care at the Regional Health and Social Care Board. A qualified and
experienced General Practitioner with extensive experience in primary care management within the Northern
Health Board; and Deputy Chief Medical Officer at the Department of Health, Social Services and Public Safety.
The Director currently leads on the delivery of GP, Community Pharmacy, Dental and Ophthalmic Services for
HSC Board as well as initiatives to improve integrated working across health and social care, and is Chair of the
International Foundation for Integrated Care (Ireland).
The Director is supported by the Programme Director for Integrated Care at the Regional Health and Social Care
Board. With 29 years’ experience in Health and Social Care management. The Programme Director currently
leads on a number of integrated programmes including ICPs and Project ECHO©.
FINANCIAL MANAGEMENT
Financial management will be key for the adequate progress of JADECARE. As previously described a financial
manager will be included in the coordinator team. This manager will support the adequate use of resources of the
90 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
project as well as to analyse/review/support issues that could arise in the participation of Affiliated Entities through
their Competent Authorities. Financial responsible have been identified in each of the participating CA and a specific
communication group will be created with all the financial responsible to share the documents, review the process
and analyse any potential issue that could arise. In the handbook the general rules and quality norms for keeping and
reporting the financial data will be provided and webinars, teleconferences or other necessary means will be used to
keep all the participating entities updated.
91 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
2.9 BUDGET
CONTENT DESCRIPTION AND JUSTIFICATION
JADECARE budget distribution favours the success of the selected oGPs transfer devoting a large part of the budget
to prepare the local environment for implementation, including twinning actions, such as study visits, thematic
workshops, webinars and mentoring from experts. All next adopters have been provided with a specific budget for
study visits (framed into WP4) allowing deeper understanding of the oGPs and thematic workshops (within the
transfer WPs) to share learning and experience during the implementation. In particular, more than 380.45 (47.11%)
person months have been allocated to the transfer WPs which aims to ensure that next adopters have the required
resources to adopt the features of selected oGPs. WP4 (20.11%) includes a considerable effort from Competent
Authorities and next adopters as well so the sustainability of digitally enabled integrated care becomes a key issue in
policy level debates.
The direct costs, in addition to travel costs (attendance to Kick off meeting, Consortium Meetings, Policy level
meetings, final conference, study visits, thematic workshops and invitation of collaborating partners to JADECARE
meetings) include dissemination material (15.000€ for US), website (25.000€ for ZTG-GmbH), scientific
publications (7.000€ for US), translation (2.000€ for each CA) and audit (8.000€ for KG, 8.000€ for AGENAS, 4,000
for NIJZ and 4,000 for EUSTRAS). The material to be translated includes: newsletters, leaflets, evaluation protocols
and outputs (for example guidelines for qualitative analysis and summaries of interviews and focus groups),
guidelines for sustainability targeting policy makers etc.
SUMMARY OF EFFORT
Total Person-
Participant
WP1 WP2 WP3 WP4 WP5 WP6 WP7 WP8 Months Per
short name
Participant
1. KG 67,00 7,00 32,75 15,25 19,00 19,00 0,00 35,25 195,25
2. MCA 2,00 3,00 4,00 7,00 7,00 0,00 21,00 0,00 44,00
3. CIPH 2,00 1,00 2,00 1,40 4,80 0,00 0,00 6,40 17,60
4. MZCR 2,00 2,00 2,00 6,00 5,34 5,33 0,00 5,33 28,00
5. RND 2,00 2,00 2,00 7,00 7,50 0,00 7,50 13,00 41,00
6. MSAE 2,00 2,00 2,00 5,00 4,60 4,70 4,70 0,00 25,00
7. EUSTRAS 2,00 1,00 2,00 3,00 0,00 0,00 6,00 0,00 14,00
8. BAGSFI 2,00 11,00 2,00 10,25 0,00 0,00 0,00 0,00 25,25
9. 4THYPE 2,00 2,00 20,00 4,00 18,00 0,00 0,00 0,00 46,00
10. AEEK 2,00 21,00 2,00 7,00 0,00 25,00 0,00 0,00 57,00
11. AGENAS 2,00 8,00 10,00 31,25 31,00 31,00 3,00 17,00 133,25
12. NVD 2,00 2,00 2,00 4,00 0,00 0,00 0,00 21,00 31,00
13. LR SAM 2,00 1,00 2,00 4,00 7,50 0,00 0,00 7,50 24,00
14. ACSS 2,00 2,00 5,00 5,50 18,00 0,00 0,00 0,00 32,50
15. MoHRS 2,00 1,00 2,00 4,00 15,00 0,00 0,00 0,00 24,00
16. NIJZ 2,00 2,00 2,00 45,00 0,00 0,00 10,00 0,00 61,00
17. HSCB 2,00 1,00 0,00 3,00 0,00 0,00 0,00 0,00 6,00
Total Person 99,00 69,00 93,75 162,65 137,74 85,03 52,20 105,48 804,85
Months
92 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Country Organization WP1 WP2 WP3 WP4 WP5 WP6 WP7 WP8 Total
Spain KRONIKGUNE 67 1 10 3 13 0 0 0 94
Spain CSFJA 0 0,25 0,75 1 1 1 0 0 4
Spain FPS 0 0,75 2 2 5 5 14,75
Spain SCS 0 0,25 1 1 0 0 0 4 6,25
Spain IDIVAL 0 0,75 2 2,25 0 0 0 7 12
Spain SACYL 0 1 2 2 0 0 0 14 19
Spain SMS 0 0,75 1 1 0 0 0 7 9,75
Spain FFIS 0 0,25 1 1 0 0 0 3,25 5,5
Spain AQUAS 0 1 13 0 0 0 0 0 14
Spain IDIBAPS 0 1 0 2 0 13 0 0 16
Bosnia and MCA 2 1 0 3 0 0 0 0 6
Herzegovina
Bosnia and MHSwRS 0 1 2 2 0 0 14 0 19
Herzegovina
Bosnia and ZZJZFBIH 0 1 2 2 7 0 7 0 19
Herzegovina
Croatia CIPH 2 1 2 1,4 2,8 0 0 3 12,2
Croatia CHIF 0 0 0 0 2 0 0 3,4 5,4
Czech Republic MZCR 2 1 0 4 0 0 0 0 7
Czech Republic UHO 0 1 2 2 5,34 5,33 0 5,33 21
Denmark RND 2 1 2 4 7,5 0 7,5 0 24
Denmark RSD 0 1 0 3 0 0 0 13 17
Estonia MSAE 2 1 0 3 0 0 0 0 6
Estonia VH 0 1 2 2 4,6 4,7 4,7 0 19
France EUSTRAS 2 1 2 3 0 0 6 0 14
Germany BAGSFI 2 1 2 5,25 0 0 0 0 10,25
Germany LGL 0 5 0 2,25 0 0 0 0 7,25
Germany ZTG 0 5 0 2,75 0 0 0 0 7,75
Greece 4THYPE 2 1 0 4 15 0 0 0 22
Greece AUTH 0 1 20 0 3 0 0 0 24
Hungary AEEK 2 1 0 5 0 9 0 0 17
Hungary SUHSMTC 0 19 0 0 0 0 0 0 19
Hungary JFDPK 0 1 2 2 0 16 0 0 21
Italy AGENAS 2 1 0 18,25 3 3 3 3 33,25
Italy MhH 0 1 0 3 0 0 0 0 4
Italy ASL NA2 0 1 2 2 0 14 0 0 19
Italy LOMBARDIA 0 1 2 2 0 0 0 14 19
Italy ARSTOSCANA 0 1 2 2 14 0 0 0 19
Italy MARCHE 0 1 2 2 0 14 0 0 19
Italy USL UMBRIA 0 1 2 2 14 0 0 0 19
Italy PROMIS 0 1 0 0 0 0 0 0 1
Latvia NVD 0 1 0 0 0 0 0 6 7
Latvia CCUH 2 1 2 4 0 0 0 15 24
Lithuania LR SAM 2 1 2 4 7,5 0 0 7,5 24
Portugal ACSS 2 1 2 2,75 8 0 0 0 15,75
Portugal ENSP/NOVA 0 1 2 1,75 6 0 0 0 10,75
Portugal SPMS 1 1 4 0 0 0 6
Serbia MoHRS 2 1 2 4 15 0 0 0 24
Slovenia NIJZ 2 1 0 43 0 0 0 0 46
Slovenia ZZZS 0 1 2 2 0 0 10 0 15
United Kingdom HSCB 2 1 0 3 0 0 0 0 6
Total Person Months 99 69 93,75 162,6 137,7 85,03 52,2 105,48 804,85
FIGURE 15 SUMMARY OF EFFORT PER CA AND AE
93 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
DETAILED BUDGET
ª
Applicant No. & Short Name 1.KG
(If affiliated entity: Affiliated to
which Applicant number/Short
name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Director 7.000,00 12,00 84.000,00
R+D Coordinator 6.000,00 18,00 108.000,00
Project Manager Senior 4.000,00 36,00 144.000,00
Project Manager 3.500,00 28,00 98.000,00
Total person Total Costs (€) for (A)
month
94,00 434000,00
Justification
Coordination of the JA, owners of oGP leader of WP5, support to all
applicants
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
0 Kick off meeting will be held in Bilbao
16200 3 Consortium Meetings (5 persons) Coordinator
5400 Final Conference (5 persons) Coordinator
8857,46 3 Policy level meetings (1 person per MS)
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
20000 KoM Organization (room Rental, Wifi, Catering, )
2000 Translation
8000 Audit
4000 WP4 study visits organizers
4000 Thematic workshops: oGP
Total Costs (€) of (C) 68.457,46
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 35.172,02
Total estimated eligible costs 537.629,48
94 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 1.1 CSFJA
(If AE: Affiliated to which 1.KG
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Coordinator_Project Leader 6.000,00 2,25 13.500,00
Project Manager 4.000,00 1,75 7.000,00
Total person Total Costs (€) for (A)
month
4,00 20.500,00
Justification
Personnel involved implementation of GP as next adopters.
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
NA
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
NA
Total Costs (€) of (C)
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 1.435,00
Total estimated eligible costs 21.935,00
95 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 1.2 SCS
(If AE: Affiliated to which 1.KG
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Coordinator_Project Leader 6.000,00 1,50 9.000,00
Implementation expert 3.500,00 4,75 16.625,00
Total person Total Costs (€) for (A)
month
6,25 25.625,00
Justification
Personnel involved implementation of GP as next adopters.
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
NA
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
NA
Total Costs (€) of (C)
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 1.793,75
Total estimated eligible costs 27.418,75
96 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 1.3 SACYL
(If AE: Affiliated to which 1.KG
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Senior Researcher 7.000,00 1,00 7.000,00
Coordinator_Project Leader 6.000,00 2,00 12.000,00
Project Manager 4.000,00 12,00 48.000,00
Implementation expert 3.500,00 4,00 14.000,00
Total person Total Costs (€) for (A)
month
19,00 81.000,00
Justification
Personnel involved implementation of GP as next adopters.
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
6480 WP4: Study Visit Implementation sites
6480 Thematic workshops: implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
Total Costs (€) of (C) 23.760,00
(D) Indirect Costs Total Costs
(€)
(Max. 7% on A, B and C) 7.333,20
Total estimated eligible costs 112.093,20
97 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 1.4SMS
(If AE: Affiliated to which 1.KG
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Coordinator of implementation in 7.136,00 3,25 23.192,00
Murcia
Responsible of innovation in SMS 8.665,00 0,50 4.332,50
Researchers 7.033,00 3,50 24.615,50
Implementation expert 5.580,00 2,50 13.950,00
Total person Total Costs (€) for (A)
month
9,75 66.090,00
Justification
Personnel involved implementation of GP as next adopters. Participation
of the responsible of innovation is critical to guarantee the real
implementation of the innovative GP proposed in JADECARE. And also
the coordinator of implementation, who is the responsible of Strategy for
chronic patients management in Murcia.
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
1080 Kick off Meeting (1 person)
3240 3 Consortium Meetings (1 person)
1080 Final Conference (1 person)
3240 WP4: Study Visit Implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
Total Costs (€) of (C) 8.640,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 5.231,10
Total estimated eligible costs 79.961,10
98 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 1.5 AQUAS
(If AE: Affiliated to which 1.KG
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Senior Researcher 7.000,00 2,00 14.000,00
Coordinator_Project Leader 6.000,00 2,00 12.000,00
Project Manager 4.500,00 10,00 45.000,00
Total person Total Costs (€) for (A)
month
14 71000
Justification
Personnel involved in evaluation, sustainability. Co-leader WP3.
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
NA
Total Costs (€) of (C) 10.800,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 5.726,00
Total estimated eligible costs 87.526,00
99 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 1.6 IDIBAPS
(If AE: Affiliated to which 1.KG
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Senior Researchers 8.500,00 4,00 34,000
Project Manager 6.500,00 12,00 78,000
Total person Total Costs (€) for (A)
month
16,00 112.000,00
Justification
Leading WP6 as oGP owner, support to transfer to next adopters
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
4000 WP4 study visits organizers
4000 Thematic workshops: original oGP
Total Costs (€) of (C) 18.800,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 9.156,00
Total estimated eligible costs 139.956,00
100 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 1.7 FPS
(If AE: Affiliated to which 1.KG
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Coordinator_Project Leader 6.000,00 1,00 6.000,00
Project Manager 4.000,00 9,75 39.000,00
Implementation expert 3.500,00 4,00 14.000,00
Total person Total Costs (€) for (A)
month
14,75 59.000,00
Justification
Personnel involved implementation of GP as next adopters
(B) Direct costs of sub-contracting Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
6480 WP4: Study Visit Implementation sites
3240 Thematic workshops: implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
4000 Thematic workshops: original oGP
Total Costs (€) of (C) 24.520,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 5.846,40
Total estimated eligible costs 89.366,40
101 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 1.8 IDIVAL
(If AE: Affiliated to which 1.KG
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Project Manager 4.000,00 12,00 48.000,00
Total person Total Costs (€) for (A)
month
12,00 48.000,00
Justification
Personnel involved implementation of GP as next adopters
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
6480 WP4: Study Visit Implementation sites
6480 Thematic workshops: implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
NA
Total Costs (€) of (C) 23.760,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 5.023,20
Total estimated eligible costs 76.783,20
102 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 1.9 FFIS
(If AE: Affiliated to which 1.KG
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Responsible of JADECARE in FFIS 4.663,50 3,50 16.322,25
Project manager technician 3.208,50 2,00 6.417,00
Total person Total Costs (€) for (A)
month
5,50 22.739,25
Justification
Personnel involved implementation of GP as next adopters
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
1080 Kick off Meeting (1 person)
3240 3 Consortium Meetings (1 person)
1080 Final Conference (1 person)
3240 WP4: Study Visit Implementation sites
3240 Thematic workshops: implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
4000 Thematic workshops: organizers
Total Costs (€) of (C) 15.880,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 2.703,35
Total estimated eligible costs 41.322,60
103 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 2 MCA
(If AE: Affiliated to which
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Project Coordinator 2.900,00 3,00 8.700,00
Senior experts 3.900,00 3,00 11.700,00
Total person Total Costs (€) for (A)
month
6,00 20.400,00
Justification
Team will be involved in WP1-4 and supporting the implementation of
GP.
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
1080 Kick off Meeting (1 person)
3240 3 Consortium Meetings (1 person)
1080 Final Conference (1 person)
3240 Policy level meetings (1 person)
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
2000 Translation of oGP and dissemination materials
Total Costs (€) of (C) 10.640,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 2.172,80
Total estimated eligible costs 33.212,80
104 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 2.1 MHSw-RS
(If AE: Affiliated to which 2.MCA
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Project Coordinator 2.500,00 6,00 15.000,00
Implementation expert (service 2.500,00 12,00 30.000,00
manager)
Implementation expert (quality and 2.750,00 1,00 2.750,00
measures)
Total person Total Costs (€) for (A)
month
19,00 47.750,00
Justification
Team will be involved in WP1-4 as appropriate and in the implementation
of GP.
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
6480 WP4: Study Visit Implementation sites
6480 Thematic workshops: implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
NA
Total Costs (€) of (C) 23.760,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 5.005,70
Total estimated eligible costs 76.515,70
105 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 2.2 ZZJZFBIH
(If AE: Affiliated to which 2.MCA
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Project Coordinator 2.500,00 6,00 15.000,00
Implementation expert (service 2.500,00 12,00 30.000,00
manager)
Implementation expert (quality and 2.750,00 1,00 2.750,00
measures)
Total person Total Costs (€) for (A)
month
19,00 47.750,00
Justification
Team will be involved in WP1-4 as appropriate and in the implementation
of GP.
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
6480 WP4: Study Visit Implementation sites
6480 Thematic workshops: implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
NA
Total Costs (€) of (C) 23.760,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 5.005,70
Total estimated eligible costs 76.515,70
106 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 3. CIPH
(If AE: Affiliated to which
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Project manager/financial officer 1.487,87 1,10 1.636,66
Project Coordinator 3.992,92 1,80 7.187,25
Senior experts 2.444,29 9,30 22.731,90
Total person Total Costs (€) for (A)
month
12,20 31.555,80
Justification
Team will be involved in WP1-4 as appropriate and in the implementation
of GP.
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
3240 Policy level meetings (1 person)
WP4: Study Visit Implementation sites
6480
Thematic workshops: implementation sites
3240
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
2000 Translation JADECARE materials
4000 Thematic workshops organizers
Total Costs (€) of (C) 29760
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 4.292,11
Total estimated eligible costs 65.607,91
107 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 3.1 CHIF
(If AE: Affiliated to which 3. CIPH
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Implementation expert (service 2.291,85 2,70 6.188,00
manager)
Implementation expert (quality and 1.804,69 2,70 4.872,66
measures)
Total person Total Costs (€) for (A)
month
5,40 11.060,66
Justification
Team will be involved in WP1-4 as appropriate and supporting the
implementation of GP.
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
1080 Kick off Meeting (1 person)
3240 3 Consortium Meetings (1 person)
1080 Final Conference (1 person)
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
NA
Total Costs (€) of (C) 5.400,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 1.152,25
Total estimated eligible costs 17.612,90
108 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 4 MZCR
(If AE: Affiliated to which
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Managers 5.050,00 2,00 10.100,00
Researchers 5.050,00 4,00 20.200,00
Administrator 2.867,00 1,00 2.867,00
Total person Total Costs (€) for (A)
month
7,00 33.167,00
Justification
Team will be involved in WP1-4 as appropriate and supporting the
implementation of GP.
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
1080 Kick off Meeting (1 person)
3240 3 Consortium Meetings (1 person)
1080 Final Conference (1 person)
3240 Policy level meetings (1 person)
4320 WP4 Study visit implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
2000 Translation of JADECARE materials.
Total Costs (€) of (C) 14.960,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 3.368,89
Total estimated eligible costs 51.495,89
109 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 4.1 UHO
(If AE: Affiliated to which 4 MZCR
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Clinician 5.050,00 2,00 10.100,00
Nurses 2.867,00 1,00 2.867,00
Managers 5.050,00 4,00 20.200,00
Researchers 5.050,00 6,50 32.825,00
Administrator 2.867,00 7,50 21.502,50
Total person Total Costs (€) for (A)
month
21,00 87.494,50
Justification
Team will be involved in WP1-4 as appropriate and in the implementation
of GP. Co-leader WP8.
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
4320 WP4: Study Visit Implementation sites
3240 Thematic workshops: implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
4000 Thematic workshops organizers
Total Costs (€) of (C) 22.360,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 7.689,82
Total estimated eligible costs 117.544,32
110 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 5. RND
(If AE: Affiliated to which
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Clinician 12.000,00 6,00 72.000,00
Nurses 5.500,00 6,75 37.125,00
Managers 7.000,00 11,25 78.750,00
Total person Total Costs (€) for (A)
month
24,00 187.875,00
Justification
Team will be involved in WP1-4 as appropriate. Leader of WP8 owner of
oGP.
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
3240 Policy level meetings (1 people)
6480 WP4: Study Visit Implementation sites
3240 Thematic workshops: implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
2000 Translation of JADECARE materials
4000 Thematic workshops organizers
Total Costs (€) of (C) 29.760,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 15.234,45
Total estimated eligible costs 232.869,45
111 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 5.1 RSD
(If AE: Affiliated to which 5. RND
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Project leader 7.830,00 12,75 99.832,50
Project assistant 2.685,00 4,25 11.411,25
Total person Total Costs (€) for (A)
month
17,00 111.243,75
Justification
Team will be involved in WP1-4 as appropriate and in the implementation
of GP. Owner of oGP
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
3240 Policy level meetings (1 person)
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
4000 WP4 Study visits: organizers
4000 Thematic workshops: oGP
Total Costs (€) of (C) 22.040,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 9.329,86
Total estimated eligible costs 142.613,61
112 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 6. MSAE
(If AE: Affiliated to which
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Project Coordinator (MSAE) and 3.300,00 4,00 13.200,00
policy expert (social welfare and
integrated care)
Policy expert (health) 3.300,00 1,00 3.300,00
Policy expert (digital development) 3.300,00 1,00 3.300,00
Total person Total Costs (€) for (A)
month
6,00 19.800,00
Justification
Team will be involved in WP1-4 as appropriate.
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
1080 Kick off Meeting (2 people)
3240 3 Consortium Meetings (2 people)
1080 Final Conference (2 people)
3240 Policy level meetings (1 person)
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
2000 Translation JADECARE materials
Total Costs (€) of (C) 10.640,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 2.130,80
Total estimated eligible costs 32.570,80
113 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 6.1 VH
(If AE: Affiliated to which 6. MSAE
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Project Coordinator (Viljandi
2.500,00 4,00 5.000,00
Hospital)
Implementation expert (service
2.500,00 3,00 5.000,00
manager)
Implementation expert (quality and
2.750,00 3,00 5.500,00
measures)
Implementation expert (IT) 2.300,00 3,00 8.250,00
Implementation expert (specialist
6.200,00 3,00 18.600,00
doctor)
Implementation expert (management) 6.800,00 3,00 20.400,00
Total person Total Costs (€) for (A)
month
19,00 62.750,00
Justification
Team will be involved in WP1-4 as appropriate and implementation of GP.
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
6480 WP4: Study Visit Implementation sites
3240 Thematic workshops: implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
4000 Thematic workshops organizers
Total Costs (€) of (C) 24.520,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 6.108,90
Total estimated eligible costs 93.378,90
114 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 7. EUSTRAS
(If AE: Affiliated to which
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Director 7.000,00 3,00 21.000,00
Project Manager Senior 4.000,00 11,00 44.000,00
Total person Total Costs (€) for (A)
month
14,00 65.000,00
Justification
Team will be involved in WP1-4 as appropriate and in WP 7 with
Optimedis
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
Optimedis: subcontracting oGP 179000 The owners of the oGP OptiMedis Model-Population-Based
Optimedis Integrated Care, will be subcontracted by Eurométropole de
Strasbourg (France), leader of WP7. It is necessary to
subcontract Optimedis to guarantee the presence of the all
the owners of oGPs selected by the SGPP.
Total Costs (€) of (B) 179000
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
3240 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
3240 Policy level meetings (1 person)
3240 WP4: Study Visit Implementation sites
3240 Thematic workshops: implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
2000 Translation of JADECARE materials
3240 Thematic workshops: organizers
4000 Audit
Total Costs (€) of (C) 26.520,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 18.936,40
Total estimated eligible costs 289.456,40
115 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 8. BAGSFI
(If AE: Affiliated to which
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Managers (Project management, 7.611,52 5,25 39.960,48
communication, first level
controlling)
Researchers (Preparation and 7.611,52 5,00 38.057,60
execution of tasks 4.1 and 4.2)
Total person Total Costs (€) for (A)
month
10,25 78.018,08
Justification
Team will be involved in WP1-4 as appropriate and in implementation of
GP, next adopters
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
3240 Policy level meetings (1 person)
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
2000 Translation of JADECARE materials
Total Costs (€) of (C) 16.040,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 6.584,07
Total estimated eligible costs 100.642,15
116 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 8.1 LGL
(If AE: Affiliated to which 8. BAGSFI
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Researchers (Preparation and
7.004,92 4,25 29.770,91
execution of tasks 2.4. )
Researchers (Preparation and
7.004,92 3,00 21.014,76
execution of tasks 4.2.)
Total person Total Costs (€) for (A)
month
7,25 50.785,67
Justification
Team will be involved in WP1-4 as appropriate and implementation of GP.
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
1080 Kick off Meeting (1 person)
3240 3 Consortium Meetings (1 person)
1080 Final Conference (1 person)
12000 External speakers - SH forum (CM)
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
NA
Total Costs (€) of (C) 17.400,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 4.773,00
Total estimated eligible costs 72.958,67
117 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 8.2 ZTG- GmbH
(If AE: Affiliated to which 8. BAGSFI
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Managers (Project Management
Liaison; Contributions to Task 4.1
(core characteristics of oGPs and
7.291,68 3,75 27.343,80
general principles) and Task 4.2
(Knowledge exchange and
generation)
Researchers (Liaison to WP2
Dissemination; Support for Task 2.3 7.291,68 4,00 29.166,72
(Website) )
Total person Total Costs (€) for (A)
month
7,75 56.510,52
Justification
Team will be involved in WP1-3 as appropriate, key role in WP4 in WP2
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
1080 Kick off Meeting (1 person)
3240 3 Consortium Meetings (1 person)
1080 Final Conference (1 person)
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
25000 Website development and maintenance
Total Costs (€) of (C) 30.400,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 6.083,74
Total estimated eligible costs 92.994,26
118 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 9. 4THYPE
(If AE: Affiliated to which
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Senior Researcher 4.500,00 1,00 4.500,00
Coordinator_Project Leader 4.000,00 6,00 24.000,00
Project Manager 3.500,00 12,00 42.000,00
Junior Researcher 3.000,00 3,00 9.000,00
Total person Total Costs (€) for (A)
month
22,00 79.500,00
Justification
Team will be involved in WP1-4 as appropriate, and in implementation of
GP, next adopters.
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
3240 Policy level meetings (1 person)
6480 WP4: Study Visit Implementation sites
6480 Thematic workshops: implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
2000 Translation of JADECARE materials
Total Costs (€) of (C) 29.000,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 7.595,00
Total estimated eligible costs 116.095,00
119 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 9.1 AUTH
(If AE: Affiliated to which 9. 4THYPE
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Senior Researcher 5.000,00 3,00 15.000,00
Coordinator_Project Leader 5.000,00 4,00 20.000,00
Project Manager 3.500,00 14,00 49.000,00
Junior Researcher 3.000,00 3,00 9.000,00
Total person Total Costs (€) for (A)
month
24,00 93.000,00
Justification
Team will be involved in WP1-4 as appropriate and implementation of GP.
Leader WP3
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2360 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2360 Final Conference (2 people)
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
NA
Total Costs (€) of (C) 11.200,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 7.294,00
Total estimated eligible costs 111.494,00
120 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 10. AEEK
(If AE: Affiliated to which
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Senior Researcher 3.950,00 1,00 3.950,00
Coordinator_Project Leader 3.500,00 4,00 14.000,00
Project Manager 3.150,00 10,00 31.500,00
Junior Researcher 2.800,00 2,00 5.600,00
Total person Total Costs (€) for (A)
month
17,00 55.050,00
Justification
Team will be involved in WP1-4 as appropriate and in implementation of
GP, next adopters
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
3240 Policy level meetings (1 person)
2160 WP4: Study Visit Implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
2000 Translation of JADECARE materials
Total Costs (€) of (C) 18.200,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 5.127,50
Total estimated eligible costs 78.377,50
121 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 10.1 SU-HSMTC
(If AE: Affiliated to which 10. AEEK
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Senior Researcher 4.500,00 1,00 4.500,00
Coordinator_Project Leader 4.000,00 3,00 12.000,00
Project Manager 3.500,00 12,00 42.000,00
Junior Researcher 3.000,00 3,00 9.000,00
Total person Total Costs (€) for (A)
month
19,00 67.500,00
Justification
Team will be involved in WP1-4 as appropriate and lead WP2.
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
20000 Final conference organization
15000 Dissemination material: Audio-visual material (3-5
videos) 4,000.00; Communication package (visual
ID, templates, leaflet (i.e. 3000), flyer (i.e 3000 –
5000); Layman report (3000-5000) and poster
template, roll-ups, infographics)11,000.00
Scientific publications
7000
Total Costs (€) of (C) 52.800,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 8.421,00
Total estimated eligible costs 128.721,00
122 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 10.2 JFDPK
(If AE: Affiliated to which 10. AEEK
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Senior Researcher 4.500,00 1,00 4.500,00
Coordinator_Project Leader 4.000,00 4,00 16.000,00
Project Manager 3.500,00 6,00 21.000,00
Junior Researcher 3.000,00 2,00 6.000,00
Implementation expert 3.000,00 8,00 24.000,00
Total person Total Costs (€) for (A)
month
21,00 71.500,00
Justification
Team will be involved in WP1-4 as appropriate, next adopters
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
4320 WP4: Study Visit Implementation sites
3240 Thematic workshops: implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
4000 Thematic workshops: organizers
Total Costs (€) of (C) 22.360,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 6.570,20
Total estimated eligible costs 100.430,20
123 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 11 AGENAS
(If AE: Affiliated to which
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Clinician (Scientific legal 1,00 11.869,24
11.869,24
responsible)
Project Manager senior 5.194,33 25,00 129.858,25
Project Manager Junior 2.645,72 3,25 8.598,59
Researchers (expert epidemiologist) 8.532,00 3,00 25.596,00
Researchers (expert statistician) 4.274,23 1,00 4.274,23
Total person Total Costs (€) for (A)
month
33,25 180.196.31
Justification
Team will be involved in WP1-4 as appropriate and in implementation of
GP, next adopters. Co-lead WP4
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
2000 Translation JADECARE materials
8000 Audit
Total Costs (€) of (C) 20800
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 14.069,74
Total estimated eligible costs 215.066,05
124 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 11.1 ASL NA2
(If AE: Affiliated to which 11 AGENAS
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Clinician (Medical director) 9.000,00 1,00 9.000,00
Managers (Administrative) 2.500,00 2,00 5.000,00
Managers (Reference contact) 6.500,00 12,00 78.000,00
Researchers (Technical staff) 2.700,00 4,00 10.800,00
Total person Total Costs (€) for (A)
month
19,00 102.800,00
Justification
Team will be involved in WP1-4 as appropriate, implementation GP, next
adopter
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
6480 WP4: Study Visit Implementation sites
6480 Thematic workshops: implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
NA
Total Costs (€) of (C) 23.760,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 8.859,20
Total estimated eligible costs 135.419,20
125 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 11.2 LOMBARDIA
(If AE: Affiliated to which 11 AGENAS
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Senior Researcher 7.000,00 1,50 10.500,00
Coordinator_Project Leader 5.500,00 3,00 16.500,00
Project Manager 4.375,00 13,00 56.875,00
Junior Researcher 4.500,00 1,50 6.750,00
Total person Total Costs (€) for (A)
month
19,00 90.625,00
Justification
Team will be involved in WP1-4 as appropriate, implementation GP, next
adopter
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
6480 WP4: Study Visit Implementation sites
6480 Thematic workshops: implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
NA
Total Costs (€) of (C) 23760
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 8.006,95
Total estimated eligible costs 122.391,95
126 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 11.3 ARS TOSCANA
(If AE: Affiliated to which 11 AGENAS
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Clinician (Medical director) 8.643,00 1,00 8.643,00
Nurses (Qualified healthcare
3.984,00 2,00 7.968,00
professional)
Managers (Adminsitrative) 2.163,00 1,00 2.163,00
Managers (Reference cotnact) 6.545,00 12,00 78.540,00
Researchers (Technical staff) 3.121,00 3,00 9.363,00
Total person Total Costs (€) for (A)
month
19,00 106.677,00
Justification
Team will be involved in WP1-4 as appropriate, implementation GP, next
adopter
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
6480 WP4: Study Visit Implementation sites
3240 Thematic workshops: implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
4000 Thematic workshops organizers
Total Costs (€) of (C) 24.520,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 9.183,79
Total estimated eligible costs 140.380,79
127 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 11.4 USL UMBRIA
(If AE: Affiliated to which 11 AGENAS
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Clinician (Medical director) 6.500,00 1,00 6.500,00
Nurses (Qualified healthcare
3.583,00 3,00 10.749,00
professional)
Managers (IT Staff) 3.500,00 8,00 28.000,00
Managers (Adminsitrative) 3.583,00 7,00 25.081,00
Total person Total Costs (€) for (A)
month
19,00 70.330,00
Justification
Team will be involved in WP1-4 as appropriate, implementation GP, next
adopter
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
6480 WP4: Study Visit Implementation sites
6480 Thematic workshops: implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
NA
Total Costs (€) of (C) 23760
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 6.586,30
Total estimated eligible costs 100.676,30
128 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 11.5 MARCHE
(If AE: Affiliated to which 11 AGENAS
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Physician (Qualified professional
7.100,00 12,00 85.200,00
leading integrated care team)
Nurses (Qualified healthcare
3.200,00 2,00 6.400,00
professional)
Managers (Administrative) 3.980,00 1,00 3.980,00
Managers (Director) 13.200,00 1,00 13.200,00
Managers (Regional Health manager) 10.020,00 3,00 30.060,00
Total person Total Costs (€) for (A)
month
19,00 138.840,00
Justification
Team will be involved in WP1-4 as appropriate, implementation GP, next
adopter
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
6480 WP4: Study Visit Implementation sites
6480 Thematic workshops: implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
NA
Total Costs (€) of (C) 23.760,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 11.382,00
Total estimated eligible costs 173.982,00
129 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 11.6 PROMIS
(If AE: Affiliated to which 11 AGENAS
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Project Manager 4.677,00 0,50 2.338,50
Managers (Administrative contact) 3.121,00 0,50 1.560,50
Total person Total Costs (€) for (A)
month
1,00 3.899,00
Justification
Team will be involved in WP1-4 as appropriate, implementation GP, next
adopter
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
9363 Activities of dissemination and communication
Total Costs (€) of (B) 9363
(C) Other direct costs
(C.1) Travel Costs (€) Justification
1080 Kick off Meeting (1 person)
3240 3 Consortium Meetings (1 person)
1080 Final Conference (1 person)
(C.2) Equipment Costs (€) Justification
(C.3) Other goods and services Costs (€) Justification
Total Costs (€) of (C) 5.400,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 1.306,34
Total estimated eligible costs 19.968,34
130 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 11.7 MhH
(If AE: Affiliated to which 11 AGENAS
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Managers (Reference contact) 12.703,00 1,00 12.703,00
Researchers (Technical staff) 4.861,00 3,00 14.583,00
Total person Total Costs (€) for (A)
month
4,00 27.286,00
Justification
Team will be involved in WP1-4 as appropriate, implementation GP, next
adopter
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
1080 Kick off Meeting (1 person)
3240 3 Consortium Meetings (1 person)
1080 Final Conference (1 person)
3240 3 Policy level meetings (1 person)
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
NA
Total Costs (€) of (C) 8640
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 2.514,82
Total estimated eligible costs 38.440,82
131 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 12. NVD
(If AE: Affiliated to which
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Managers 1.190,00 7,00 8.330,00
Total person Total Costs (€) for (A)
month
7,00 8.330,00
Justification
Team will be involved in WP1-4 as appropriate, implementation
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
1080 Kick off Meeting (1 person)
3240 3 Consortium Meetings (1 person)
1080 Final Conference (1 person)
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
NA
Total Costs (€) of (C) 5400
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 961,10
Total estimated eligible costs 14.691,10
132 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 12.1 CCUH
(If AE: Affiliated to which 12. NVD
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Managers 2.742,00 14,00 38.388,00
Clinician 1.350,00 10,00 13.500,00
Total person Total Costs (€) for (A)
month
24,00 51.888,00
Justification
Team will be involved in WP1-4 as appropriate, and in implementation of
GP, next adopters
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
3240 Policy level meetings (1 person)
6480 WP4: Study Visit Implementation sites
6480 Thematic workshops: implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
2000 Translation JADECARE materials
Total Costs (€) of (C) 29.000,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 5.662,16
Total estimated eligible costs 86.550,16
133 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 13 LR SAM
(If AE: Affiliated to which
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Site Administrator 2.530,00 6,00 15.180,00
Assistant responsible Primary Health
1.516,00 6,00 9.096,00
care
Assistant, rehabilitation, Sanatorium
(anti-relapse) treatment 1.605,00 6,00 9.630,00
implementation
Assistant, planning, development and
2.383,00 6,00 14.298,00
implementation
Total person Total Costs (€) for (A)
month
24,00 48.204,00
Justification
Team will be involved in WP1-4 as appropriate, and in implementation of
GP, next adopters
(B) Direct costs of sub-contracting Costs (€) justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
3240 Policy level meetings (1 person)
6480 WP4: Study Visit Implementation sites
3240 Thematic workshops: implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
2000 Translation
4000 Thematic workshops: organizers
Total Costs (€) of (C) 29760
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 5.457,48
Total estimated eligible costs 83.421,48
134 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 14. ACSS
(If AE: Affiliated to which
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Manager 1.624,00 8,00 12.992,00
Clinician 8.772,00 3,00 26.316,00
Nurse 1.908,00 4,75 9.063,00
Total person Total Costs (€) for (A)
month
15,75 48.371,00
Justification
Team will be involved in WP1-4 as appropriate, and in implementation of
GP, next adopters
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
1080 Kick off Meeting (1 person)
3240 3 Consortium Meetings (1 person)
1080 Final Conference (1 person)
3240 Policy level meetings (1 person)
6480 WP4: Study Visit Implementation sites
6480 Thematic workshops: implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
2000 Translation JADECARE materials
Total Costs (€) of (C) 23600
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 5.037,97
Total estimated eligible costs 77.008,97
135 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 14.1 NOVA
(If AE: Affiliated to which 14. ACSS
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Researchers (two people) 1.800,00 10,75 19.350,00
Total person Total Costs (€) for (A)
month
10,75 19.350,00
Justification
Team will be involved in WP1-4 as appropriate, implementation
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
1080 Kick off Meeting (1 person)
3240 3 Consortium Meetings (1 person)
1080 Final Conference (1 person)
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
NA
Total Costs (€) of (C) 5400
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 1.732,50
Total estimated eligible costs 26.482,50
136 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 14.2 SPMS
(If AE: Affiliated to which 14. ACSS
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
ICT and Communication Director 5.519,00 2,00 11.038,00
Chief of Unit/Office or Coordinator 4.552,21 2,00 9.104,42
Technical experts 2.474,28 2,00 4.948,56
Total person Total Costs (€) for (A)
month
6,00 25.090,98
Justification
Team will be involved in WP1-4 as appropriate, implementation
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
1080 Kick off Meeting (1 person)
3240 3 Consortium Meetings (1 person)
1080 Final Conference (1 person)
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
NA
Total Costs (€) of (C) 5400
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 2.134,37
Total estimated eligible costs 32.625,35
137 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 15. MoHRS
(If AE: Affiliated to which
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Senior Researcher 750,00 1,00 750,00
Project Manager 1.440,00 11,00 15.840,00
Junior Researcher 1.000,00 1,00 1.000,00
Implementation expert 2.250,00 11,00 24.750,00
Total person Total Costs (€) for (A)
month
24,00 42.340,00
Justification
Team will be involved in WP1-4 as appropriate, and in implementation of
GP, next adopters
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
2160 Kick off Meeting (2 people)
6480 3 Consortium Meetings (2 people)
2160 Final Conference (2 people)
3240 Policy level meetings (1 person)
6480 WP4: Study Visit Implementation sites
6480 Thematic workshops: implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
2000 Translation JADECARE materials
Total Costs (€) of (C) 29.000,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 4.993,80
Total estimated eligible costs 76.333,80
138 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 16. NIJZ
(If AE: Affiliated to which
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Senior experts 4.750,00 6,00 28.500,00
Manager 5.000,00 28,00 140.000,00
Financial Manager & admin.support 3.750,00 4,00 15.000,00
Junior Researchers 2.500,00 8,00 20.000,00
Total person Total Costs (€) for (A)
month
46,00 203.500,00
Justification
Team will be involved in WP1-4 as appropriate, leader of WP4
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
3240 Kick off Meeting (3 people)
9720 3 Consortium Meetings (3 people)
3240 Final Conference (3 people)
3240 Policy level meetings (1 person)
16000 Collaborating SH travel
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
18000 3 policy level meetings organization
2000 Translation JADECARE materials
4000 Audit
Total Costs (€) of (C) 59.440,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 18.405,80
Total estimated eligible costs 281.345,80
139 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 16.1 ZZZS
(If AE: Affiliated to which 16. NIJZ
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Clinician 3.300,00 4,00 13.200,00
Managers 5.375,00 9,00 48.375,00
Senior researchers 4.700,00 1,00 4.700,00
Junior researchers 2.665,00 1,00 2.665,00
Total person Total Costs (€) for (A)
month
15,00 68.940,00
Justification
Team will be involved in WP1-4 as appropriate, and in implementation of
GP, next adopters
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
1080 Kick off Meeting (1 person)
3240 3 Consortium Meetings (1 person)
1080 Final Conference (1 person)
6480 WP4: Study Visit Implementation sites
3240 Thematic workshops: implementation sites
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
4000 Thematic workshops organizers
Total Costs (€) of (C) 19.120,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 6.164,20
Total estimated eligible costs 94.224,20
140 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Applicant No. & Short Name 17. HSCB
(If AE: Affiliated to which
Applicant number/Short name)
(A) Direct personnel costs
Staff function Monthly Cost Estimated Sum Cost (€)
Person-month
Project manager 4000 6 24000
Total person Total Costs (€) for (A)
month
6 24000
Justification
Observer for future implementation
(B) Direct costs of sub-contracting Costs (€) Task(s)/Justification
NA
Total Costs (€) of (B)
(C) Other direct costs
(C.1) Travel Costs (€) Justification
1080 Kick off Meeting (1 person)
3240 3 Consortium Meetings (1 person)
1080 Final Conference (1 person)
3240 Policy level meetings (1 person)
(C.2) Equipment Costs (€) Justification
NA
(C.3) Other goods and services Costs (€) Justification
NA
Total Costs (€) of (C) 8.640,00
(D) Indirect Costs Total Costs (€)
(Max. 7% on A, B and C) 2.284,80
Total estimated eligible costs 34.924,80
141 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
PREVIOUS AND CURRENT GRANTS RELEVANT TO THE PROGRAMME
CALLS Current and previous grants
JOINT CHRODIS PLUS: KG, AQUAS, CSJA, NIJZ, MoH-Italy, SU, AUTH, AGENAS, and CIPH
ACTIONS are participating in the JA that will contribute to the reduction of this burden by promoting the
(CHAFEA) implementation of policies and practices that have been demonstrated to be successful
Joint Action to support the eHealth Network [JAseHN]: AEEK, SE, MoH it, NVD (Latvia)
AEEK and CIPH have been working develop political recommendations and instruments for
cooperation in the four specific priority areas that are specified in the eHN’s Multi annual Work
Programme (MWP) and that were adopted by the eHN in May 2014: (1) interoperability and
standardisation, (2) monitoring and assessment of implementation, (3) exchange of knowledge
and (4) global cooperation and positioning.
eHAction: CHIF was responsible for preparing legal interoperability in cross-border context
as a base for Legal Agreement for eHeath projects and implementation of eHealth guidelines
as work package leader where NIZJZ and AEEK are also partners.
ADVANTAGE: KG, CSJA, CIPH, AGENAS, ACSS, NIJZ and DOH have worked together
in the JA related to frailty that has summarised the current state of the art of the different
components of frailty and its management, both at a personal and population level
infAct: InfAct (Information for Action) is a JA on health information (HI): MCA, NIJZ,
MSAE, ACSS are participating in this JA.
iPAAC JA the general objective of the Joint Action – Innovative Partnership for Action
Against Cancer is to develop innovative approaches to advances in cancer control. NIJZ
coordinates this JA, where CIPH and ACSS participate.
JAHEE - The Joint Action Health Equity Europe will represent an important opportunity for
MS to work jointly to address health inequalities and underlying social determinants of health.
MCA, CIPH, NIJZ and ACSS are working together in this JA.
SHARP: The SHARP Joint Action will strengthen implementation of Decision
1082/2013/EU, supporting the EU level preparedness and responses to health threats and the
implementation of the International Health Regulations. MCA, NIJZ, CIPH, MSAE are
collaborating in this JA.
PROJECTS OF SCIROCCO and SCIROCCO Exchange projects build upon the preliminary achievements of
THE EU the B3 Action Group on Integrated Care of the European Innovation Partnership on Active and
HELTH Healthy Ageing (EIP on AHA) that first developed the concept of the B3 Maturity Model. KG,
PROGRAMME OPTIMEDIS, ITALY, MoH (Czech Republic) and NIZJZ among other partners of this project
that have been involved in SCIROCCO or SCIROCCO Exchange.
VIGOUR: will effectively support care authorities in progressing the transformation of their
health and care systems to provide sustainable models for integrated care which will facilitate
identification of good practice and scaling-up. PROMIS, CSJA and DOH participate in this
project.
EUROPEAN All applicants are highly active in the development of collaborative projects:
COLLABOR. KG: C3-CLOUD: aims to develop personalised care plans for complex multimorbid patients,
PROJECTS supported by ICT tools and managed by a coordinated multidisciplinary team, that promotes
(H2020/ integrated care and the involvement of the patient and/or caregiver; UPRIGHT general
INTERREG) objective is to promote mental wellbeing and prevent mental disorders by enhancing resilience
capacities in youths, through a holistic approach addressing early adolescents, families and
education professionals.
CIPH/CHIF: INCA Inclusive Introduction of Integrated Care (INCA) – the aim is to
coordinate the socio-sanitary services of the different administrations, aiming to reduce costs,
improve patient experience and achieve greater efficiency and value from health delivery
systems. EXPAND - Expanding Health Data Interoperability Services (EXPAND). To convey
the results of EXPAND, creating critical mass among the different Stakeholders in preparation
of deployment of CEF cross-border eHealth services.
MoH (Czech Republic): Interreg CE project NiceLife (aiming among others to scale up
relevant good practice from Italy) and SHAPES (innovation action –IA - that aims to develop
and deploy a pan-European Integrated Care Platform).
142 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
CALLS Current and previous grants
4THYPE/AUTH:: «SMiLe, Strenghtening primary Medical care in IsoLated and deprived
cross-border arEas>>. INTERREG V-A Partnership Program “Greece - Bulgaria 2014-2020”
The Lab co-ordinates the H2020 SmokeFreeBrain (www.smokefreebrain.eu) project in line
with a call from the Global Alliance of Chronic Diseases (GACD). The Lab co-ordinates the
H2020 project CAPTAIN (https://www.captain-eu.org/), which develops coaching
technologies for the elderly. The lab participates in H2020 INADVANCE
(http://medphys.med.auth.gr/project/inadvance) project, focused on palliative care. The lab
participates with the role of partner in many European projects promoting active and healthy
ageing through new technologies, like H2020 project UNCAP (Ubiquitous iNteroperable Care
for Ageing People; http://www.uncap.eu/) and H2020 iPrognosis (Intelligent Parkinson early
detection guiding novel supportive interventions; http://www.i-prognosis.eu/) which aims at
the early diagnosis of the Parkinson’s disease.
AEEK: HELIUM -Health Innovation Experimental Landscape through Policy Improvement,
INTERREG EUROPE, The aim of the project is to support experience exchange as well as
sharing good practices concerning health innovation in order to promote the effective execution
of projects especially funded by the Structural Fund. ECHO - Establishing and operating a pilot
for a Cybersecurity Competence Network to develop and implement a common Cybersecurity
Research & Innovation Roadmap. ECHO delivers an organized and coordinated approach to
strengthen proactive cyber defense of the European Union, through effective and efficient
multi-sector collaboration. InterReg Europe - Delivery of Innovative solutions for Home Care
by strengthening quadruple-helix cooperation in regional innovation chains (HoCare).
Objective of HoCare project is to boost delivery of home care innovative solutions in regional
innovation chains by strengthening of cooperation of actors in regional innovation system
using Quadruple-helix approach.
AGENAS: In September 2017 AGENAS signed a joint tender Contract with the Semmelweis
University, the University of Leuven (Katholieke Universiteit Leuven), the Italian Ministry of
Health (Ministero della Salute), and the Standing Committee of European Doctors (CPME),
for the action titled “Support for the health workforce planning and forecasting expert network”
in the field of European health workforce planning.
NVD-CCUH: Children's Clinical University Hospital Riga is full member in 2 ERNs and
affiliated partner in several European Reference Networks (ERNs) approved by the ERN Board
of Member States. The ERNs are co-funded by the European Commission (EUCERD Joint
Action). ERNs will develop new innovative care models, eHealth tools, medical solutions and
devices; "Integrated hospital units for patient and staff-centered oriented deep renovation IN-
PATIENT"(within H2020);
DOH: Through Structural Funds such as the INTERREG VA programme, there has been
significant investment to underpin cooperation between the health and social care sector in NI
and the border counties of the Republic of Ireland (RoI). The health theme of the INTERREG
VA Programme 2014-20 is delivering cross-border projects across a range of areas including
older people’s services and health research. Projects are encouraged to incorporate integrated
and innovative approaches, eHealth applications and interoperable solutions - an example is
mPower which is enabling older people to live independently in their own homes, supported
by a modernised infrastructure for healthy ageing. The Programme is expected to demonstrate
the workability of a range of innovative transnational service delivery models capable of wider
application. DOH collaborates also with Basque Country in the project MIDAS that intends to
have a real impact on these problems, and to release some of the potential of Big Data to
improve health, and health care delivery.
NATIONAL/ MoH (Czech Republic): A national project supervised by Technological agency of the CR in
REGIONAL/ programme Omega has focused on the use of EIP on AHA tools for scaling up of AHA good
INTERNAL practices. NTMC also participates in three relevant Twinning in 2017 and newly in a Twinning
PROJECTS organized by RSCN, together with Catalonia. MOH has accepted a new “Strategic Framework
for Health Care Development in the Czech Republic by 2030” in 2019, where there are -
besides all the focus on healthcare transformation and modernization - 3 most relevant specific
goals: Primary care reform, Implementation of integrated care models and Digitalization of
143 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
CALLS Current and previous grants
healthcare. Implementation plans for these goals will be developed and pertinent projects
supporting them will follow. It is expected that the knowledge and other findings from
RND: Telecare North: TeleCare North is an ambitious, large-scale telemedicine project, where
the region of North Denmark offer telemedicine to all COPD patients in North Jutland who
could benefit from it; Strategic Digital management in Region of North Denmark, where a
strategy for digital transformation of the entire organization with over 12.000 Employees
(Doctors, nurse, scientists etc.) was develop; Innovation unit in the Municipality of Aalborg.
The Innovation Unit was the project office for many different innovation projects. Projects like
innovative procurement of medical medical equipment financed by the European Regional
Development Fund. The Digital health unit has a project portfolio current with over 40 active
projects.
MSAE: Developing and piloting integrated care model to better support people recovering
their first psychosis; Piloting the model of care co-ordination with a focus on people with
complex care needs (with a special focus on frail elderly). The purpose of the project was to
create a person-centered coordination system for people with complex needs on the primary
level. For that, new roles of care-coordinators were developed in test municipalities, that aimed
to better connect primary healthcare and the social welfare system. interRAI contact
assessment tool was used, cross-sectoral service plans were created, and in-risk people were
monitored regularly. The model was tested in 6 groups of municipalities (in some cases within
a single municipality and in other cases up to three different municipalities).
EUSTRAS: The Eurométropole of Strasbourg has managed European structural funds (ERDF
et ESF) and has taken part in an URBACT project on social innovation. It has signed with the
regional health agency a contract to set up a local health observatory, to take health into account
in all its policies (town planning, mobility…).
BAGSFI: has different on-going projects related with integrated healthcare as e-healthy ship,
Telwunde, I/E-Health NRW (eHealth in cross-sectorial Health Services); Solimed
ePflegebericht (digital nursing documentation); ELSA-APP (EHR in palliative, pediatric care);
GerNe Digital! (Cross-sectorial Health Services in Geriatrics); HeLP (Independent living with
impairments with support in the neighbourhood; NephroTeTe (Cross-sectorial Health Services
/ Case Management for people with kidney disease); SMITH – Smart Medical Information
Technology for Healthcare (German Medical Informatics Initiative);Upcoming e.g.
Telemedizin@NRW– Permanent Implementation Platform for Telemedicine in Routine care;
4THYPE:Health Education and Prevention Network Program (national project).
AEEK: “Development of Social Human Resources” project. The overall objective of the
project is to improve the quality resources in human public services through professional
tetraining in order to meet professional challenges and expectations as well as service standards
to be further developed. "Professional methodological development of health care system"
project This project delivers solutions to improve patient safety by creating and developing
organizational culture and approach that enables workers to identify sources of danger in
carrying out activities and make suggestions for their protection. The National eHealth
Infrastructure (EESZT) is an integrated platform, developed for end-users and healthcare
personnel, available 24 hours a day. Its central services can be accessed anytime through the
users’ own IT systems and equipment. VEKOP-7.2.2-17-2017-00010. “Establishment of a
health promotion office (HPO) and implementation of a comprehensive set of health promotion
programs in Pesterzsébet”
AGENAS: The National project “Proposal for the definition of organizational models that
favour work carried out in multisciplinary and multiprofessional teams within network care
pathways” was carried out for 12 months, in the context of the research projects for the years
2017-2018, and foresaw the involvement of four regions (Campania, Lombardia, Toscana,
Piemonte) in relation to their geographical representativeness, as well as the participation of
the National Institute of Health (ISS). The Ministry of Health has asked Agenas to provide
support to the Project Management in the implementation of the National Operating
Programme “Chronicity” (PON GOV Cronicità) financed by EU structural funds, for all lines
of activity and particularly for the implementation of Line no. 1 “Promoting the emergency,
the collection and the knowledge of good practices”.
144 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
CALLS Current and previous grants
NVD-CCUH: Development and Implementation of Health Network Development Guidelines
and Quality Assurance System in Priority Health Areas»; «Role of Team in Ensuring Patient
Safety and Quality of Treatment Processes; Implementation of a widely used recognized
"Planetree" patient experience systems, competencies at the Children's Clinical University
Hospital; Development of Patient experience system in collaboration with the MeS Lab
research lab at Sant'Anna University (Pisa, Italy) (EC project no. SRSS / S2017 / 019
"Establishment of a health system performance evaluation system in Slovenia and Latvia");
Implementation of a monitoring system of patient experience in the Children's hospital in
collaboration with Meyer Children's hospital, Italy.
LR SAM: Improvement of primary health-care infrastructure (funded by European Structural
funds for addressing health inequalities in Lithuania) Target group - 200 primary health care
institutions in Lithuania. Prescription- Drug interaction database Electronic sale of medicines
and delivery to patient, other automatic checks and reminders. (Implemented in 2019)
(National budget and EU funds). Online Doctor Appointment Booking System; System
deployment at national level for all health care institutions and integration with other eHealth
processes. system will be integrated with Lithuanian e- health system and enable Waiting for
appointment time management, decrease waiting times. Presently, Innovative models of care
of multimorbid patients using Methodological recommendations issued by CHRODIS are
under development. In order to ensure quality and sustainability of primary health care services
in Lithuania is extremely important to have science-based methodological recommendations
for treatment of patients with multimorbidity. European structural funds, will provide an
opportunity to test other possible since based multimorbidity treatment models, select the most
effective model for adoption of it on the national level. The Pilot project for testing innovative
effective care models for multimorbid patients is planned in the nearest future.
ACSS: ACSS was involved in a national strategy to scale up integration of care (SNS +
proximidade). ACSS has also opened a national call with a 35M€ budget to finance integrated
care projects at a local level with the goal of boosting integration of care. ACSS in partnership
with SPMS is improving the health information systems in order to allow following the patient
through the health system (SIGA). Several other initiatives are being developed to improve
integration of care and people centered care such as hospital at home, family nurse in primary
care, teleconsultation, telescreening, telemonitoring of chronic disease patients, decentralized
specialists’ consultations, monitoring of avoidable hospital admissions. ACSS is also
improving care financing models to support integration.
CURRENT APPLICATIONS RELEVANT TO THE PROGRAMME
Some of the partners have current applications relevant to the programme apart from the continuous working in
improving the delivery of integrated care:
Partner Current applications relevant to the programme
KG KG has just been recently awarded by the EC as a coordinator in the topic SC1-DTH-11-2019
— Large Scale pilots of personalised & outcome based integrated care which main objective is
to improve the quality of life of senior people with Advanced Chronic Diseases by providing
innovative integrated intelligent personalized care. ADLIFE will deploy a large-scale
implementation of digitally enabled holistic and integrated supportive care. Denmark will be
one the piloting region in the project and South Denmark will be the area where the pilot will
be implemented in Denmark.
NIJZ Has been invited to participate JA-01-2019 Joint Action on implementation of validated best
practices and JA-02-2019 Joint Action to strengthen health preparedness and response to
biological and chemical terror attacks
145 · 146
JADECARE-951442
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
EXCEPTIONAL UTILITY
JADECARE fulfils the requirements to be considered of exceptional utility:
The 62% of the total budget of JADECARE has been allocated in Member States whose GNI per inhabitant is
less than 90% of the EU average. The total costs for these countries are 3,086247,71 € where the global amount
is 4,999,032€.
In addition, JADECARE joints 17 European countries where 11 of them (Spain, Croatia, Czech Republic,
Estonia, Greece, Hungary, Latvia, Lithuania, Portugal, Serbia and Slovenia) have a GNI per inhabitant lower than
the 90% of the EU average, according to the data provided by CHAFEA.
COLLABORATING STAKEHOLDERS
Institution Contact Person (full name) Country & City
International Foundation for Albert Alonso MD PhD, Past President United Kingdom
Integrated Care (IFIC)
The European Institute for Dipak Kalra, President Belgium
Innovation through Health Data
(i~HD)
EIT Health Spain Cristina Bescos, PhD. Managing Director Spain
European Health Telematics Marc Lange. Director. Belgium
Association (EHTEL)
Technology Enabled Care and Donna Henderson. Head of International United Kingdom
Digital Healthcare Innovation Engagement
Scotland
EMPIRICA Veli Stroetman, Head of eHealth Research & Germany
Policy
Medical University of Regina Roller-Wirnsberger, Professor of Austria
Graz/Austrian Society of Geriatric Medicine. President of Austrian
Geriatric Medicine and Society of Geriatric Medicine and Gerontology
Gerontology
Gesundheitswirtschaft Hamburg Jan Quast, director Germany
GmbH
MedCom Lars Hulbæk, Managing Director Denmark
146 · 146
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
ESTIMATED BUDGET FOR THE ACTION Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Estimated eligible1 costs (per budget category) EU contribution Action's estimated receipts
Financial
B. Direct D. Indirect Reimbursement Maximum EU Maximum Income contributions
A. Direct C. Other Action’s
costs of Total costs generated given by third
personnel costs direct costs costs2 rate %3 contribution4 grant amount5 total receipts
subcontracting by the action parties to the
beneficiaries
A.1 Employees C.1 Travel
(or equivalent)
C.2 Equipment
A.2 Natural
persons under C.3 Other goods
direct contract and services
and seconded
persons
Cost form6 Actual Actual Actual Flat-rate7 7%
d=
a b c e = a+b+c+d f g=e*f h i j k=i+j
0.07 * (a+b+c)
1. KG 434 000.00 0.00 68 457.46 35 172.02 537 629.48 80.00 430 103.58 430 103.56 0.00 0.00 0.00
- CSFJA 20 500.00 0.00 0.00 1 435.00 21 935.00 80.00 17 548.00 17 548.00 0.00 0.00 0.00
- SCS 25 625.00 0.00 0.00 1 793.75 27 418.75 80.00 21 935.00 21 935.00 0.00 0.00 0.00
- SACYL 81 000.00 0.00 23 760.00 7 333.20 112 093.20 80.00 89 674.56 89 674.56 0.00 0.00 0.00
- AQUAS 71 000.00 0.00 10 800.00 5 726.00 87 526.00 80.00 70 020.80 70 020.80 0.00 0.00 0.00
- IDIBAPS 112 000.00 0.00 18 800.00 9 156.00 139 956.00 80.00 111 964.80 111 964.80 0.00 0.00 0.00
- FPS 59 000.00 0.00 24 520.00 5 846.40 89 366.40 80.00 71 493.12 71 493.12 0.00 0.00 0.00
- IDIVAL 48 000.00 0.00 23 760.00 5 023.20 76 783.20 80.00 61 426.56 61 426.56 0.00 0.00 0.00
- SMS 66 090.00 0.00 8 640.00 5 231.10 79 961.10 80.00 63 968.88 63 968.88 0.00 0.00 0.00
- FFIS 22 739.25 0.00 15 880.00 2 703.35 41 322.60 80.00 33 058.08 33 058.08 0.00 0.00 0.00
Σ beneficiary 939 954.25 0.00 194 617.46 79 420.02 1 213 991.73 971 193.38 971 193.36 0.00 0.00 0.00
2. MCA 20 400.00 0.00 10 640.00 2 172.80 33 212.80 80.00 26 570.24 26 570.24 0.00 0.00 0.00
- ZZJZFBIH 47 750.00 0.00 23 760.00 5 005.70 76 515.70 80.00 61 212.56 61 212.56 0.00 0.00 0.00
- MHSw-RS 47 750.00 0.00 23 760.00 5 005.70 76 515.70 80.00 61 212.56 61 212.56 0.00 0.00 0.00
Σ beneficiary 115 900.00 0.00 58 160.00 12 184.20 186 244.20 148 995.36 148 995.36 0.00 0.00 0.00
3. CIPH 31 555.80 0.00 29 760.00 4 292.11 65 607.91 80.00 52 486.33 52 486.33 0.00 0.00 0.00
Page 1 of 5
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
ESTIMATED BUDGET FOR THE ACTION Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Estimated eligible1 costs (per budget category) EU contribution Action's estimated receipts
Financial
B. Direct D. Indirect Reimbursement Maximum EU Maximum Income contributions
A. Direct C. Other Action’s
costs of Total costs generated given by third
personnel costs direct costs costs2 rate %3 contribution4 grant amount5 total receipts
subcontracting by the action parties to the
beneficiaries
A.1 Employees C.1 Travel
(or equivalent)
C.2 Equipment
A.2 Natural
persons under C.3 Other goods
direct contract and services
and seconded
persons
Cost form6 Actual Actual Actual Flat-rate7 7%
d=
a b c e = a+b+c+d f g=e*f h i j k=i+j
0.07 * (a+b+c)
- CHIF 11 060.66 0.00 5 400.00 1 152.25 17 612.91 80.00 14 090.33 14 090.33 0.00 0.00 0.00
Σ beneficiary 42 616.46 0.00 35 160.00 5 444.36 83 220.82 66 576.66 66 576.66 0.00 0.00 0.00
4. MZCR 33 167.00 0.00 14 960.00 3 368.89 51 495.89 80.00 41 196.71 41 196.71 0.00 0.00 0.00
- UHO 87 494.50 0.00 22 360.00 7 689.82 117 544.32 80.00 94 035.46 94 035.46 0.00 0.00 0.00
Σ beneficiary 120 661.50 0.00 37 320.00 11 058.71 169 040.21 135 232.17 135 232.17 0.00 0.00 0.00
5. RND 187 875.00 0.00 29 760.00 15 234.45 232 869.45 80.00 186 295.56 186 295.56 0.00 0.00 0.00
- RSD 111 243.75 0.00 22 040.00 9 329.86 142 613.61 80.00 114 090.89 114 090.89 0.00 0.00 0.00
Σ beneficiary 299 118.75 0.00 51 800.00 24 564.31 375 483.06 300 386.45 300 386.45 0.00 0.00 0.00
6. MSAE 19 800.00 0.00 10 640.00 2 130.80 32 570.80 80.00 26 056.64 26 056.64 0.00 0.00 0.00
- VH 62 750.00 0.00 24 520.00 6 108.90 93 378.90 80.00 74 703.12 74 703.12 0.00 0.00 0.00
Σ beneficiary 82 550.00 0.00 35 160.00 8 239.70 125 949.70 100 759.76 100 759.76 0.00 0.00 0.00
7. EUSTRAS 65 000.00 179 000.00 26 520.00 18 936.40 289 456.40 80.00 231 565.12 231 565.12 0.00 0.00 0.00
8. BAGSFI 78 018.08 0.00 16 040.00 6 584.07 100 642.15 80.00 80 513.72 80 513.72 0.00 0.00 0.00
- ZTG-GmBH 56 510.52 0.00 30 400.00 6 083.74 92 994.26 80.00 74 395.41 74 395.41 0.00 0.00 0.00
- LGL 50 785.67 0.00 17 400.00 4 773.00 72 958.67 80.00 58 366.94 58 366.94 0.00 0.00 0.00
Σ beneficiary 185 314.27 0.00 63 840.00 17 440.81 266 595.08 213 276.07 213 276.07 0.00 0.00 0.00
9. 4THYPE 79 500.00 0.00 29 000.00 7 595.00 116 095.00 80.00 92 876.00 92 876.00 0.00 0.00 0.00
Page 2 of 5
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
ESTIMATED BUDGET FOR THE ACTION Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Estimated eligible1 costs (per budget category) EU contribution Action's estimated receipts
Financial
B. Direct D. Indirect Reimbursement Maximum EU Maximum Income contributions
A. Direct C. Other Action’s
costs of Total costs generated given by third
personnel costs direct costs costs2 rate %3 contribution4 grant amount5 total receipts
subcontracting by the action parties to the
beneficiaries
A.1 Employees C.1 Travel
(or equivalent)
C.2 Equipment
A.2 Natural
persons under C.3 Other goods
direct contract and services
and seconded
persons
Cost form6 Actual Actual Actual Flat-rate7 7%
d=
a b c e = a+b+c+d f g=e*f h i j k=i+j
0.07 * (a+b+c)
- AUTH 93 000.00 0.00 11 200.00 7 294.00 111 494.00 80.00 89 195.20 89 195.20 0.00 0.00 0.00
Σ beneficiary 172 500.00 0.00 40 200.00 14 889.00 227 589.00 182 071.20 182 071.20 0.00 0.00 0.00
10. AEEK 55 050.00 0.00 18 200.00 5 127.50 78 377.50 80.00 62 702.00 62 702.00 0.00 0.00 0.00
- SU-HSMTC 67 500.00 0.00 52 800.00 8 421.00 128 721.00 80.00 102 976.80 102 976.80 0.00 0.00 0.00
- JFDPK 71 500.00 0.00 22 360.00 6 570.20 100 430.20 80.00 80 344.16 80 344.16 0.00 0.00 0.00
Σ beneficiary 194 050.00 0.00 93 360.00 20 118.70 307 528.70 246 022.96 246 022.96 0.00 0.00 0.00
11. AGENAS 180 196.31 0.00 20 800.00 14 069.74 215 066.05 80.00 172 052.84 172 052.84 0.00 0.00 0.00
- LOMBARDIA 90 625.00 0.00 23 760.00 8 006.95 122 391.95 80.00 97 913.56 97 913.56 0.00 0.00 0.00
- UMBRIA 70 330.00 0.00 23 760.00 6 586.30 100 676.30 80.00 80 541.04 80 541.04 0.00 0.00 0.00
- MARCHE 138 840.00 0.00 23 760.00 11 382.00 173 982.00 80.00 139 185.60 139 185.60 0.00 0.00 0.00
- PROMIS 3 899.00 9 363.00 5 400.00 1 306.34 19 968.34 80.00 15 974.67 15 974.67 0.00 0.00 0.00
- MhH 27 286.00 0.00 8 640.00 2 514.82 38 440.82 80.00 30 752.66 30 752.66 0.00 0.00 0.00
- TOSCANA 106 677.00 0.00 24 520.00 9 183.79 140 380.79 80.00 112 304.63 112 304.63 0.00 0.00 0.00
- ASL NA2 102 800.00 0.00 23 760.00 8 859.20 135 419.20 80.00 108 335.36 108 335.36 0.00 0.00 0.00
Σ beneficiary 720 653.31 9 363.00 154 400.00 61 909.14 946 325.45 757 060.36 757 060.36 0.00 0.00 0.00
12. NVD 8 330.00 0.00 5 400.00 961.10 14 691.10 80.00 11 752.88 11 752.88 0.00 0.00 0.00
- CCUH 51 888.00 0.00 29 000.00 5 662.16 86 550.16 80.00 69 240.13 69 240.13 0.00 0.00 0.00
Page 3 of 5
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
ESTIMATED BUDGET FOR THE ACTION Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Estimated eligible1 costs (per budget category) EU contribution Action's estimated receipts
Financial
B. Direct D. Indirect Reimbursement Maximum EU Maximum Income contributions
A. Direct C. Other Action’s
costs of Total costs generated given by third
personnel costs direct costs costs2 rate %3 contribution4 grant amount5 total receipts
subcontracting by the action parties to the
beneficiaries
A.1 Employees C.1 Travel
(or equivalent)
C.2 Equipment
A.2 Natural
persons under C.3 Other goods
direct contract and services
and seconded
persons
Cost form6 Actual Actual Actual Flat-rate7 7%
d=
a b c e = a+b+c+d f g=e*f h i j k=i+j
0.07 * (a+b+c)
Σ beneficiary 60 218.00 0.00 34 400.00 6 623.26 101 241.26 80 993.01 80 993.01 0.00 0.00 0.00
13. LR SAM 48 204.00 0.00 29 760.00 5 457.48 83 421.48 80.00 66 737.18 66 737.18 0.00 0.00 0.00
14. ACSS 48 371.00 0.00 23 600.00 5 037.97 77 008.97 80.00 61 607.18 61 607.18 0.00 0.00 0.00
- SPMS 25 090.98 0.00 5 400.00 2 134.37 32 625.35 80.00 26 100.28 26 100.28 0.00 0.00 0.00
- ENSP/NOVA 19 350.00 0.00 5 400.00 1 732.50 26 482.50 80.00 21 186.00 21 186.00 0.00 0.00 0.00
Σ beneficiary 92 811.98 0.00 34 400.00 8 904.84 136 116.82 108 893.46 108 893.46 0.00 0.00 0.00
15. MoHRS 42 340.00 0.00 29 000.00 4 993.80 76 333.80 80.00 61 067.04 61 067.04 0.00 0.00 0.00
16. NIJZ 203 500.00 0.00 59 440.00 18 405.80 281 345.80 80.00 225 076.64 225 076.64 0.00 0.00 0.00
- ZZZS 68 940.00 0.00 19 120.00 6 164.20 94 224.20 80.00 75 379.36 75 379.36 0.00 0.00 0.00
Σ beneficiary 272 440.00 0.00 78 560.00 24 570.00 375 570.00 300 456.00 300 456.00 0.00 0.00 0.00
17. HSCB 24 000.00 0.00 8 640.00 2 284.80 34 924.80 80.00 27 939.84 27 939.84 0.00 0.00 0.00
Σ consortium 3 478 332.52 188 363.00 1 005 297.46 327 039.53 4 999 032.51 80.007 3 999 226.02 3 999 226.00 0.00 0.00 0.00
1 See Article 6 for the eligibility conditions.
2 The indirect costs claimed must be free of any amounts covered by an operating grant (received under any EU or Euratom funding programme). A beneficiary that receives an operating grant during the action's duration
cannot claim any indirect costs for the year(s)/reporting period(s) covered by the operating grant (see Article 6.2.D).
3 See Article 5.2 for the reimbursement rate.
4 This is the theoretical amount of the EU contribution, if the reimbursement rate is applied to all the budgeted costs. This theoretical amount is capped by the 'maximum grant amount'.
Page 4 of 5
Grant Agreement number: 951442 — JADECARE — HP-JA-2019
ESTIMATED BUDGET FOR THE ACTION Associated with document Ref. Ares(2020)3808356 - 20/07/2020
5 The 'maximum grant amount' is the maximum grant amount decided by the Agency. It normally corresponds to the requested grant, but may be lower.
6 See Article 5 for the cost forms.
7 Flat rate : 7% of eligible direct costs.
Page 5 of 5
Grant Agreement number: 951442 — JADECARE
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
MINISTRY OF CIVIL AFFAIRS (MCA), established in Trg Bosne i Hercegovine 1, SARAJEVO
71000, Bosnia and Herzegovina, (‘the beneficiary’), represented for the purpose of signing this
Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘2’)
in Grant Agreement No 951442 (‘the Grant Agreement’)
between ASOCIACIÓN INSTITUTO DE INVESTIGACIÓN EN SERVICIOS DE SALUD-
KRONIKGUNE and the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)
('the Agency'), under the powers delegated by the European Commission ('the Commission'),
for the action entitled Joint Action on implementation of digitally enabled integrated person-centred
care (JADECARE).
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 39.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary/new beneficiary/new coordinator
[--TGSMark#signature-998728588_75_210--]
Mirna Pavlović with ECAS id n003dye7 signed in the Participant
Portal on 07/08/2020 at 12:33:39 (transaction id SigId-49545-
YH3OGJZtyrDkd3ECzqirv9xxxUCVQJszUc4x62riIzcQu3uOcSt
XD3Kw8EMktkJzGzQbU3pEAkCnzujKTCWPGkrG-
jpJZscgsw0KGD3CAcLrniC-
crQr2EvBzxTqfy1P0nc0DYfztcJyzaPngXaJkEsNynzcIehXzhWu
r54MBYwjeCIlzyEjIIg6RuTbs6oTVeev4i3W). Timestamp by third
party at
Fri Aug 07 13:33:52 CEST 2020
1
Grant Agreement number: 951442 — JADECARE
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO (CIPH), established in ROCKEFELLEROVA 7,
ZAGREB 10000, Croatia, VAT number: HR75297532041, (‘the beneficiary’), represented for the
purpose of signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘3’)
in Grant Agreement No 951442 (‘the Grant Agreement’)
between ASOCIACIÓN INSTITUTO DE INVESTIGACIÓN EN SERVICIOS DE SALUD-
KRONIKGUNE and the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)
('the Agency'), under the powers delegated by the European Commission ('the Commission'),
for the action entitled Joint Action on implementation of digitally enabled integrated person-centred
care (JADECARE).
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 39.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary/new beneficiary/new coordinator
[--TGSMark#signature-998128255_75_210--]
Krunoslav Capak with ECAS id n003ph9b signed in the Participant
Portal on 10/08/2020 at 08:16:31 (transaction id SigId-55360-
2UdF7kC6TVdzSzxMP0hgExMnQWtttqK3EgFRY7zwrOGqY6FRK
DgBgsSEtCKMEceftAoBuYJsCge3gnIBKgaLTdG-
jpJZscgsw0KGD3CAcLrniC-
PMpTPHzN9uSiYZ0q10rhoUvItx9U6DrwvOojFiJsTwsJnn6afc55V2
PeWalgziLiOq4TeVr2lKJwLhnuP2ruI8). Timestamp by third party
at
Mon Aug 10 09:16:36 CEST 2020
2
Grant Agreement number: 951442 — JADECARE
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
MINISTERSTVO ZDRAVOTNICTVI CESKE REPUBLIKY (MZCR), established in
PALACKEHO NAMESTI 375/4, PRAHA 12801, Czech Republic, (‘the beneficiary’), represented
for the purpose of signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘4’)
in Grant Agreement No 951442 (‘the Grant Agreement’)
between ASOCIACIÓN INSTITUTO DE INVESTIGACIÓN EN SERVICIOS DE SALUD-
KRONIKGUNE and the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)
('the Agency'), under the powers delegated by the European Commission ('the Commission'),
for the action entitled Joint Action on implementation of digitally enabled integrated person-centred
care (JADECARE).
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 39.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary/new beneficiary/new coordinator
[--TGSMark#signature-924144512_75_210--]
Adam Vojtěch with ECAS id n003f2zf signed in the Participant
Portal on 17/08/2020 at 12:10:59 (transaction id SigId-104392-
lvWZad1ozzagjhd25Zzn2oo7PasPhSASh5RWpjZSgq0ORoujD
gYzaKkOlhG26DoDheZZf0JNgdca2C4tt0YYbta-
jpJZscgsw0KGD3CAcLrniC-
CSaj1c1bL6zWD3zNCNzwzIzaNZygc0BrsnQeZVtCykqGtxzzM
Q8FxIL13oiMrJaoGb4O1nBk2ezUBEJM9p1zxh65m).
Timestamp by third party at
Mon Aug 17 13:11:09 CEST 2020
3
Grant Agreement number: 951442 — JADECARE
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
REGION NORDJYLLAND (NORTH DENMARK REGION) (RND), established in Niels Bohrs
Vej 30, AALBORG 9220, Denmark, VAT number: DK29190941, (‘the beneficiary’), represented for
the purpose of signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘5’)
in Grant Agreement No 951442 (‘the Grant Agreement’)
between ASOCIACIÓN INSTITUTO DE INVESTIGACIÓN EN SERVICIOS DE SALUD-
KRONIKGUNE and the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)
('the Agency'), under the powers delegated by the European Commission ('the Commission'),
for the action entitled Joint Action on implementation of digitally enabled integrated person-centred
care (JADECARE).
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 39.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary/new beneficiary/new coordinator
[--TGSMark#signature-997381064_75_210--]
Tina Archard Heide with ECAS id n002y04n signed in the
Participant Portal on 03/08/2020 at 10:53:31 (transaction id SigId-
8323-
8bVPzxyxGCraiJJY1cmCN8na5JHINDwYh6XJqHmdvnfav7nha0D
fiAfEuIQzXhTzxuD9uUACwbzQyXs4gczlc9R-
jpJZscgsw0KGD3CAcLrniC-
GHVCUy1SsP2FpfTzcdt5lfbNQxDzeh2CiKP8dLelbCgTeHGmzsR
Fszt5QEwEHZf71Z8iUgm1AGK5LwhtTSbTRIi). Timestamp by
third party at
Mon Aug 03 11:53:43 CEST 2020
4
Grant Agreement number: 951442 — JADECARE
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
SOTSIAALMINISTEERIUM (MSAE), established in Suur-Ameerika 1, TALLINN 10122,
Estonia, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the
undersigned,
hereby agrees
to become beneficiary No (‘6’)
in Grant Agreement No 951442 (‘the Grant Agreement’)
between ASOCIACIÓN INSTITUTO DE INVESTIGACIÓN EN SERVICIOS DE SALUD-
KRONIKGUNE and the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)
('the Agency'), under the powers delegated by the European Commission ('the Commission'),
for the action entitled Joint Action on implementation of digitally enabled integrated person-centred
care (JADECARE).
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 39.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary/new beneficiary/new coordinator
[--TGSMark#signature-998429731_75_210--]
Marika PRISKE with ECAS id nprmaika signed in the Participant
Portal on 07/08/2020 at 06:50:41 (transaction id SigId-45099-
AzJKZHWKBgkjteWfBo4S9MGDf6N853cs2HOjzr0zGNMs0AXV
lp6xAlozYEkMaziNBdohxzyzzmpjdagJ5vPFBrjb-
jpJZscgsw0KGD3CAcLrniC-
zULk8jfzeWJtfsJQc9ozyNVT5HKanuwo9n6VuMMXv2SW9VlfZ
WgCqdoGbFhw4gX11tOkizMSNarT82cfMurczzfW). Timestamp
by third party at
Fri Aug 07 07:50:54 CEST 2020
5
Grant Agreement number: 951442 — JADECARE
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
EUROMETROPOLE DE STRASBOURG (EUSTRAS), established in 1 PARC DE L'ETOILE,
STRASBOURG CEDEX 67076, France, (‘the beneficiary’), represented for the purpose of signing
this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘7’)
in Grant Agreement No 951442 (‘the Grant Agreement’)
between ASOCIACIÓN INSTITUTO DE INVESTIGACIÓN EN SERVICIOS DE SALUD-
KRONIKGUNE and the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)
('the Agency'), under the powers delegated by the European Commission ('the Commission'),
for the action entitled Joint Action on implementation of digitally enabled integrated person-centred
care (JADECARE).
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 39.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary/new beneficiary/new coordinator
[--TGSMark#signature-995380051_75_210--]
Rémy Banuls with ECAS id n002txha signed in the Participant
Portal on 31/07/2020 at 11:33:46 (transaction id SigId-9825-
EGt4ozR61yJPHL9hoSIF7LWXJAiwSgOYfhfDADUwyDLtVk
Qnzu9m3MGhZRxJsW5U2JT5F0cQWILUqDxy6V0yzeW-
rS0vSrmBGYCoND65K3fS5K-
TQszYIaFAYjQlZTCy2dzY4t5oUF9g2kzHAKfBdUP17oTcSO
UupHq8Cput9sfD4qFcK09g8J0YtjlHUlizHgiwQ8). Timestamp
by third party at
Fri Jul 31 12:34:05 CEST 2020
6
Grant Agreement number: 951442 — JADECARE
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
BEHOERDE FUER ARBEIT, GESUNDHEIT, SOZIALES, FAMILIE UND INTEGRATION
HAMBURG (BAGSFI), established in Billstrasse 80, Hamburg 20539, Germany, VAT number:
DE118509725, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the
undersigned,
hereby agrees
to become beneficiary No (‘8’)
in Grant Agreement No 951442 (‘the Grant Agreement’)
between ASOCIACIÓN INSTITUTO DE INVESTIGACIÓN EN SERVICIOS DE SALUD-
KRONIKGUNE and the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)
('the Agency'), under the powers delegated by the European Commission ('the Commission'),
for the action entitled Joint Action on implementation of digitally enabled integrated person-centred
care (JADECARE).
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 39.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary/new beneficiary/new coordinator
[--TGSMark#signature-938070026_75_210--]
Anke Schwerin with ECAS id n0037hxq signed in the Participant
Portal on 20/07/2020 at 14:43:55 (transaction id SigId-1871-
3rOzeQzRXWYPf5Xumdr01ZZDM2IBiX1XhYkTRCPe33Q2TqL
A5Dog69QuCAiQE2Ug9SEk14VIIlEvCKnXlwFA0V-
rS0vSrmBGYCAvZK87YqHD0-
3Q9whRRYwJZgQp8lVslhxuc3zb54rVm3pmISiNJrGhpuHZL3E
dOl4sirmcMAEksBsaD3ftCwhwY3j08bzzwznaW). Timestamp by
third party at
Mon Jul 20 16:56:16 CEST 2020
7
Grant Agreement number: 951442 — JADECARE
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
4I DIOIKISI YGEIONOMIKIS PERIFEREIAS MAKEDONIAS KAI THRAKIS (4THYPE),
established in 16 ARISTOTELOUS STR, THESSALONIKI 54623, Greece, VAT number:
EL999122126, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the
undersigned,
hereby agrees
to become beneficiary No (‘9’)
in Grant Agreement No 951442 (‘the Grant Agreement’)
between ASOCIACIÓN INSTITUTO DE INVESTIGACIÓN EN SERVICIOS DE SALUD-
KRONIKGUNE and the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)
('the Agency'), under the powers delegated by the European Commission ('the Commission'),
for the action entitled Joint Action on implementation of digitally enabled integrated person-centred
care (JADECARE).
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 39.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary/new beneficiary/new coordinator
[--TGSMark#signature-929046601_75_210--]
TSALIKAKIS DIMITRIOS with ECAS id ndimtsal signed in the
Participant Portal on 11/08/2020 at 12:15:15 (transaction id SigId-
68813-
zYrrDHtWafAnzPGzlTVfJiUnkppIFKZH112iRiAHgUbyhL92zobU2w
TCvzpw8U0uyedj6Co94MmfzGttxMnvhzfe-
jpJZscgsw0KGD3CAcLrniC-
Jo2Z18XBKmuTrVi105tnXDn5sbM8GgTedOXOK4sThRakqrBR4K
LEo4zIuzUM38t9J0H5chexwaXu888txBUKQ4). Timestamp by
third party at
Tue Aug 11 13:15:27 CEST 2020
8
Grant Agreement number: 951442 — JADECARE
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
ALLAMI EGESZSEGUGYI ELLATO KOZPONT (AEEK), established in DIOS AROK 3,
BUDAPEST 1125, Hungary, VAT number: HU15324683, (‘the beneficiary’), represented for the
purpose of signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘10’)
in Grant Agreement No 951442 (‘the Grant Agreement’)
between ASOCIACIÓN INSTITUTO DE INVESTIGACIÓN EN SERVICIOS DE SALUD-
KRONIKGUNE and the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)
('the Agency'), under the powers delegated by the European Commission ('the Commission'),
for the action entitled Joint Action on implementation of digitally enabled integrated person-centred
care (JADECARE).
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 39.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary/new beneficiary/new coordinator
[--TGSMark#signature-955290242_75_210--]
Miklós GONDOS DR. with ECAS id n00298lv signed in the
Participant Portal on 14/08/2020 at 08:07:30 (transaction id SigId-
93382-
Y3RzvLXHx0UAcU5XKqZ7vKGddvGC9MIWuBc9LHjwh8IhOmQzz
lWQuCTEwMEO6CjheneVTsJy3NnJHBK2VfpSBkG-
jpJZscgsw0KGD3CAcLrniC-
levOZcwisqY6afVtzgCB6VKzoifzzLBYsdjMYDbxLZwLupWjnJ46H
mKnHZGzmuunm5xcmiCUAPSvWHk7ezOze6V8). Timestamp by
third party at
Fri Aug 14 09:07:37 CEST 2020
9
Grant Agreement number: 951442 — JADECARE
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
AGENZIA NAZIONALE PER I SERVIZI SANITARI REGIONALI (AGENAS), established in
VIA PUGLIE 23, ROMA 00187, Italy, (‘the beneficiary’), represented for the purpose of signing this
Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘11’)
in Grant Agreement No 951442 (‘the Grant Agreement’)
between ASOCIACIÓN INSTITUTO DE INVESTIGACIÓN EN SERVICIOS DE SALUD-
KRONIKGUNE and the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)
('the Agency'), under the powers delegated by the European Commission ('the Commission'),
for the action entitled Joint Action on implementation of digitally enabled integrated person-centred
care (JADECARE).
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 39.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary/new beneficiary/new coordinator
[--TGSMark#signature-959886490_75_210--]
Alessandro Ghirardini with ECAS id n003l5uh signed in the
Participant Portal on 20/07/2020 at 14:19:58 (transaction id SigId-
1403-
puGcyoLkoUIxhMIj2NpW6Ysde5EjLRkhCtwma4lO1ABgt85LHzae
A6LhkqdgK9jLu3j92KE22q1mEvHd7cxea0-
rS0vSrmBGYCAvZK87YqHD0-
x3zpFwzUhIkwMfACb3IYqcLfpUULGJzmerazKxkBaUYOqLuJAw4
HP5D4K19R0gjUnLmp8fzLPBy8TcgTjjmiho8). Timestamp by third
party at
Wed Jul 22 10:17:16 CEST 2020
10
Grant Agreement number: 951442 — JADECARE
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
NACIONALAIS VESELIBAS DIENESTS (NVD), established in 31 Cēsu str., k-3, 6.entrance,
Riga LV-1012, Latvia, VAT number: 90009649337, (‘the beneficiary’), represented for the purpose
of signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘12’)
in Grant Agreement No 951442 (‘the Grant Agreement’)
between ASOCIACIÓN INSTITUTO DE INVESTIGACIÓN EN SERVICIOS DE SALUD-
KRONIKGUNE and the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)
('the Agency'), under the powers delegated by the European Commission ('the Commission'),
for the action entitled Joint Action on implementation of digitally enabled integrated person-centred
care (JADECARE).
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 39.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary/new beneficiary/new coordinator
[--TGSMark#signature-952594224_75_210--]
Inga MILAŠEVIČA with ECAS id nmilasin signed in the Participant
Portal on 06/08/2020 at 15:03:39 (transaction id SigId-42510-
PBYTG3MTPMqeu1Cecsztne0OjSGwdsiRmc5ZzrfnH2TLwQZPF0
nvi5gMGoCGGLnQsUlzzwODWAnIlQejsHkzxM4-
jpJZscgsw0KGD3CAcLrniC-
qrxzy5FyNX4enUAROaVRUrgvlebuZ2zfuOzbnJpzOdzGbKNH4gpi
EH774LMFqq7KmCg2zhQShMpuTUWZPw5x0fy0). Timestamp by
third party at
Thu Aug 06 16:03:52 CEST 2020
11
Grant Agreement number: 951442 — JADECARE
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
LIETUVOS RESPUBLIKOS SVEIKATOS APSAUGOS MINISTERIJA (LR SAM),
established in VILNIAUS G 33, VILNIUS LT 01506, Lithuania, (‘the beneficiary’), represented for
the purpose of signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘13’)
in Grant Agreement No 951442 (‘the Grant Agreement’)
between ASOCIACIÓN INSTITUTO DE INVESTIGACIÓN EN SERVICIOS DE SALUD-
KRONIKGUNE and the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)
('the Agency'), under the powers delegated by the European Commission ('the Commission'),
for the action entitled Joint Action on implementation of digitally enabled integrated person-centred
care (JADECARE).
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 39.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary/new beneficiary/new coordinator
[--TGSMark#signature-933839468_75_210--]
Gitana Ratkienė with ECAS id n002f8h2 signed in the Participant
Portal on 20/07/2020 at 13:06:58 (transaction id SigId-200-
aWXGjXJQETcoNhiUhxNU5Ou0wys1U1ZUXJEHMfWMRSLpqK
iKma80v5aNf650bAZssUZTcMxaiBcYUZ71YEXTvW-
rS0vSrmBGYCAvZK87YqHD0-
7Om9TVIV54VzszVfECOENvf3GKKbOU9prBDit7hQfHjebFIm41
AeaY4VMLXmbMjeL5FfAIfKgEBsudrph3la8a). Timestamp by
third party at
Mon Jul 20 14:07:06 CEST 2020
12
Grant Agreement number: 951442 — JADECARE
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
ADMINISTRACAO CENTRAL DO SISTEMA DESAUDE IP (ACSS), established in AVENIDA
DO BRASIL 53, PARQUE DE SAUDE DE LISBOA EDIFICIO 16, Lisboa 1700-063, Portugal,
VAT number: PT508188423, (‘the beneficiary’), represented for the purpose of signing this Accession
Form by the undersigned,
hereby agrees
to become beneficiary No (‘14’)
in Grant Agreement No 951442 (‘the Grant Agreement’)
between ASOCIACIÓN INSTITUTO DE INVESTIGACIÓN EN SERVICIOS DE SALUD-
KRONIKGUNE and the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)
('the Agency'), under the powers delegated by the European Commission ('the Commission'),
for the action entitled Joint Action on implementation of digitally enabled integrated person-centred
care (JADECARE).
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 39.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary/new beneficiary/new coordinator
[--TGSMark#signature-997349539_75_210--]
Márcia Roque with ECAS id n00348n5 signed in the Participant
Portal on 31/07/2020 at 11:39:24 (transaction id SigId-9884-
jU8p9hlIukAzmAuchWG8MXvC5JBzkECtqaLNiTZvfHmbf3PK7
T4CvpcVzXVuPV7iiD58rToPGKLWFAPYzfU8RES-
rS0vSrmBGYCoND65K3fS5K-
TybthPKswvFza5CLCLSM2k4ykkzSb4yXPO29x525o2eOGmU
TbungWlfaIZuGJgZzu4pMfixzzsLuQXHkrobJR9n). Timestamp
by third party at
Fri Jul 31 12:39:36 CEST 2020
13
Grant Agreement number: 951442 — JADECARE
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
MINISTARSTVO ZDRAVLJE (MoHRS), established in NEMANJINA 22-26, BELGRADE
11000, Serbia, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the
undersigned,
hereby agrees
to become beneficiary No (‘15’)
in Grant Agreement No 951442 (‘the Grant Agreement’)
between ASOCIACIÓN INSTITUTO DE INVESTIGACIÓN EN SERVICIOS DE SALUD-
KRONIKGUNE and the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)
('the Agency'), under the powers delegated by the European Commission ('the Commission'),
for the action entitled Joint Action on implementation of digitally enabled integrated person-centred
care (JADECARE).
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 39.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary/new beneficiary/new coordinator
[--TGSMark#signature-896833192_75_210--]
Zlatibor Loncar with ECAS id n00388hc signed in the Participant
Portal on 03/08/2020 at 12:14:41 (transaction id SigId-9372-
jhyF2vuULAWlJQltb9TgXzx8rzRom4zineFmf6s86oKlprPOV2tPll
9MTBS8ZTGXGwQ6OVmazisRFWRi63E0YBK-
jpJZscgsw0KGD3CAcLrniC-
Z5ti3sRPQzoxikaT6UxlMFpDceYbirrC6AO8yRJuWzLEYofzLNv
sA71H7qGr8QFlSVlzkwj3r0UpsX0Zf8qCU9y). Timestamp by
third party at
Mon Aug 03 13:14:49 CEST 2020
14
Grant Agreement number: 951442 — JADECARE
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
NACIONALNI INSTITUT ZA JAVNO ZDRAVJE (NIJZ), established in TRUBARJEVA CESTA
2, LJUBLJANA 1000, Slovenia, VAT number: SI44724535, (‘the beneficiary’), represented for the
purpose of signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘16’)
in Grant Agreement No 951442 (‘the Grant Agreement’)
between ASOCIACIÓN INSTITUTO DE INVESTIGACIÓN EN SERVICIOS DE SALUD-
KRONIKGUNE and the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)
('the Agency'), under the powers delegated by the European Commission ('the Commission'),
for the action entitled Joint Action on implementation of digitally enabled integrated person-centred
care (JADECARE).
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 39.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary/new beneficiary/new coordinator
[--TGSMark#signature-948891346_75_210--]
Milan Krek with ECAS id n003bif0 signed in the Participant
Portal on 03/08/2020 at 16:37:20 (transaction id SigId-13215-
VtpRDIrJPTEYeMWnHVeTEim8IzaALyUszb9ocKaIAcVOwK
nR1b6mZhQ6K4R3zynLLorB10fhsbbzo53aYBRFMRu-
jpJZscgsw0KGD3CAcLrniC-
R4WzmX9NH6lamGdcx3dk7x3QJPqFzHYBuHX6l4zzStzXeI
hV9ysqFNn09CdHcJBE4QUFnRhTEKabgFbER5PMlcZ).
Timestamp by third party at
Mon Aug 03 17:37:27 CEST 2020
15
Grant Agreement number: 951442 — JADECARE
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
ANNEX 3
ACCESSION FORM FOR BENEFICIARIES
REGIONAL HEALTH AND SOCIAL CARE BOARD (HSCB), established in LINENHALL
STREET 12-22, BELFAST BT2 8BS, United Kingdom, VAT number: GB888808059, (‘the
beneficiary’), represented for the purpose of signing this Accession Form by the undersigned,
hereby agrees
to become beneficiary No (‘17’)
in Grant Agreement No 951442 (‘the Grant Agreement’)
between ASOCIACIÓN INSTITUTO DE INVESTIGACIÓN EN SERVICIOS DE SALUD-
KRONIKGUNE and the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)
('the Agency'), under the powers delegated by the European Commission ('the Commission'),
for the action entitled Joint Action on implementation of digitally enabled integrated person-centred
care (JADECARE).
and mandates
the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement,
in accordance with Article 39.
By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in
accordance with the Agreement, with all the obligations and conditions it sets out.
SIGNATURE
For the beneficiary/new beneficiary/new coordinator
[--TGSMark#signature-952921890_75_210--]
Sloan HARPER with ECAS id nharpesl signed in the Participant
Portal on 23/07/2020 at 09:31:10 (transaction id SigId-7729-
f6BC8w01hPMOvQRmcmQT0LH4yCAliNsvkI52WBzg7eY4ustp
xNmKocAbN2c5bSHxrcjvk8zYw1qPXkrx1TXc8f-
jpJZscgsw0KpCPo0JF2kjq-
4HjzrKemqFwVzvqbIcklUzOcK759VRJUoh8T1FzPQH1okuRUw
6PbQ4Rwqut0JSo87nN7jzNLzPPUElnZqGI3mUqW).
Timestamp by third party at
Thu Jul 23 10:31:22 CEST 2020
16
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
i print format A4
MODEL ANNEX 4 CHAFEA MGA — MULTI
landscape
FINANCIAL STATEMENT FOR [BENEFICIARY [name]/AFFILIATED ENTITY [name]] FOR REPORTING PERIOD [reporting period]
1 Receipts EU contribution
Eligible costs (per budget category)
Financial
contributions Reimburseme Maximum EU
A. Direct personnel B. Direct costs of C. Other direct 2 Income generated Requested EU
D. Indirect costs Total costs given by third Total receipts 3 4
costs subcontracting costs by the action nt rate % constribution contribution
parties to the
beneficiaries
A.1 Employees (or
C.1 Travel
equivalent)
A.2 Natural persons
C.2 Equipment
under direct contract
and seconded persons
C.3 Other goods and
services
6
5 Actual Actual Actual Flat-rate
Cost form
7%
d= e=
a b c f g h= f + g i j k
0,07 * (a + b + c) a+ b + c + d
[short name beneficiary
/ affiliated entity]
The beneficiary/affiliated entity hereby confirms that:
The information provided is complete, reliable and true.
The costs declared are eligible (see Article 6).
The costs can be substantiated by adequate records and supporting documentation that will be produced upon request or in the context of checks, reviews, audits and investigations (see Articles 12, 13 and 17).
For the last reporting period: that all the receipts have been declared (see Article 5.3.3).
i Please declare all eligible costs, even if they exceed the amounts indicated in the estimated budget (see Annex 2). Only amounts that were declared in your individual financial
statements can be taken into account lateron, in order to replace other costs that are found to be ineligible.
1
See Article 6 for the eligibility conditions.
2
The indirect costs claimed must be free of any amounts covered by an operating grant (received under any EU or Euratom funding programme). A beneficiary that receives an operating grant during the duration of the action cannot
claim any indirect costs for the year(s) covered by the operating grant (see Article 6.2.D).
3
See Article 5.2 for the reimbursement rate
4
This is the theoretical amount of EU contribution that the system calculates automatically (by multiplying the reimbursement rate by the total costs declared). The amount you request (in the column 'requested EU contribution') may
have to be less.
5
See Article 5 for the cost forms.
6
Flat rate : 7% of eligible direct costs.
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
ANNEX 5
MODEL FOR THE CERTIFICATE ON THE FINANCIAL STATEMENT (CFS)
This document sets out:
- the objectives and scope of the independent report of factual findings on costs declared
under a EU grant agreement financed under the Health Programme (2014-2020) or
Consumer Programme (2014-2020) and
- a model for the certificate on the financial statement (CFS).
1. Background and subject matter
[OPTION 1 for actions with one RP and NO interim payments: Within 60 days of the end of
the reporting period, the coordinator must submit to the Commission a final report, which
should include (among other documents and unless otherwise specified in Article 15 of the
Grant Agreement) a certified financial statement (CFS; see proposed model below) for each
beneficiary and (if applicable) each affiliated entity, if:
- it requests an EU contribution of EUR 150 000 or more as reimbursement of actual
costs and
- the maximum EU contribution indicated for that beneficiary/affiliated entity in the
estimated budget (see Annex 2) as reimbursement of actual costs is EUR 200 000 or
more.]
[OPTION 2 for actions with several RPs and interim payments: Within 60 days of the end
of each reporting period, the coordinator must submit to the Commission a periodic report,
which should include (among other documents and unless otherwise specified in Article 15 of
the Grant Agreement) a certified financial statement (CFS; see proposed model below) for
each beneficiary and (if applicable) each affiliated entity, if:
- the cumulative amount of EU contribution the beneficiary/affiliated entity requests as
reimbursement of actual costs is EUR 150 000 or more and
- the maximum EU contribution indicated for that beneficiary/affiliated entity in the
estimated budget (see Annex 2) as reimbursement of actual costs is EUR 200 000 or
more.
The CFS must be submitted every time the cumulative amount of payments requested (i.e.
including in previous financial statements) reaches the threshold (i.e. a first certificate once
the cumulative amount reaches 150 000, a second certificate once it reaches 300 000, a third
certificate once it reaches 450 000, etc.).
Once the threshold is reached, the CFS must cover all reporting periods for which no
certificate has yet been submitted.]
1
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
The beneficiary must provide the CFS for itself and, if applicable, for its affiliated entity(ies).
The purpose of the audit on which the CFS is based is to give the Agency ‘reasonable
assurance’1 that costs declared as eligible costs under the grant (and, if relevant, receipts
generated in the course of the action) are being claimed by the beneficiary in accordance with
the relevant legal and financial provisions of the Grant Agreement.
The scope of the audit is limited to the verification of eligible costs included in the CFS. The
audit must be conducted in line with point 3 below.
Certifying auditors must carry out the audits in compliance with generally accepted audit
standards and indicate which standards they have applied. They must bear in mind that, to
establish a CFS, they must carry out a compliance audit and not a normal statutory audit. The
eligibility criteria in the Grant Agreement always override normal accounting practices.
The beneficiary and the auditor are expected to address any questions on factual data or
detailed calculations before the financial statement and the accompanying certificate are
submitted. It is also recommended that the beneficiary take into account the auditor’s
preliminary comments and suggestions in order to avoid a qualified opinion or reduce the
scope of the qualifications.
Since the certificate is the main source of assurance for cost claims and payments, it will be
easier to consider amounts as eligible if a non-qualified certificate is provided.
The submission of a certificate does not affect the Agency’s right to carry out its own
assessment or audits. Neither does the reimbursement of costs covered by a certificate
preclude the Agency or the Commission, the European Anti-Fraud Office or the European
Court of Auditors from carrying out checks, reviews, audits and investigations in accordance
with Article 17 of the Grant Agreement.
The Agency expects the certificates to be issued by auditors according to the highest
professional standards.
2. Auditors who may deliver a certificate
The beneficiary is free to choose a qualified external auditor, including its usual external
auditor, provided that:
- the external auditor is independent from the beneficiary and
- the provisions of Directive 2006/43/EC2 are complied with.
1
This means a high degree of confidence.
2
Directive 2006/43/EC of the European Parliament and of the Council of 17 May 2006 on statutory audits of
annual accounts and consolidated accounts or similar national regulations (OJ L 157, 9.6.2006, p. 87).
2
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Independence is one of the qualities that permit the auditor to apply unbiased judgement and
objective consideration to established facts to arrive at an opinion or a decision. It also means
that the auditor works without direction or interference of any kind from the beneficiary.
Auditors are considered as providing services to the beneficiary/affiliated entity under a
purchase contract within the meaning of Article 9 of the Grant Agreement. This means that
the costs of the CFS may normally be declared as costs incurred for the action, if the cost
eligibility rules set out in Articles 6 and 9.1.1 of the Grant Agreement are fulfilled (especially:
best value for money and no conflict of interests; see also below eligibility of costs of other
goods and services). Where the beneficiary/affiliated entity uses its usual external auditor, it is
presumed that they already have an agreement that complies with these provisions and there is
no obligation to find new bids. Where the beneficiary/affiliated entity uses an external auditor
who is not their usual external auditor, it must select an auditor following the rules set out in
Article 9.1.1.
Public bodies can choose an external auditor or a competent public officer. In the latter case,
the auditor’s independence is usually defined as independence from the audited beneficiary
‘in fact and in appearance’. A preliminary condition is that this officer was not involved in
any way in drawing up the financial statements. Relevant national authorities establish the
legal capacity of the officer to carry out audits of that specific public body. The certificate
should refer to this appointment.
3. Audit methodology and expected results
3.1 Verification of eligibility of the costs declared
The auditor must conduct its verification on the basis of inquiry and analysis,
(re)computation, comparison, other accuracy checks, observation, inspection of records and
documents and by interviewing the beneficiary (and the persons working for it).
The auditor must examine the following documentation:
the Grant Agreement and any amendments to it;
the periodical and/or final report(s);
for personnel costs
o salary slips;
o time sheets;
o contracts of employment;
o other documents (e.g. personnel accounts, social security legislation, invoices,
receipts, etc.);
o proofs of payment;
for subcontracting
o the call for tender;
o tenders (if applicable);
o justification for the choice of subcontractor;
o contracts with subcontractors;
o invoices;
o declarations by the beneficiary;
o proofs of payment;
3
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
o other documents: e.g. national rules on public tendering if applicable, EU
Directives, etc.;
for travel and subsistence costs
o the beneficiary’s internal rules on travel;
o transport invoices and tickets (if applicable);
o declarations by the beneficiary;
o other documents (proofs of attendance such as minutes of meetings, reports,
etc.);
o proofs of payment;
for equipment costs
o invoices;
o delivery slips / certificates of first use;
o proofs of payment;
o depreciation method of calculation;
for costs of other goods and services
o invoices;
o proofs of payment; and
o other relevant accounting documents.
General eligibility rules
The auditor must verify that the costs declared comply with the general eligibility rules set out
in Article 6.1 of the Grant Agreement.
In particular, the costs must:
be actually incurred;
be linked to the subject of the Grant Agreement and indicated in the beneficiary's
estimated budget (i.e. the latest version of Annex 2);
be necessary to implement the action which is the subject of the grant;
be reasonable and justified, and comply with the requirements of sound financial
management, in particular as regards economy and efficiency;3
have been incurred during the action, as defined in Article 3 of the Grant Agreement
(with the exception of the invoice for the audit certificate and costs relating to the
submission of the final report);
not be covered by another EU or Euratom grant (see below ineligible costs);
be identifiable, verifiable and, in particular, recorded in the beneficiary's accounting
records and determined according to the applicable accounting standards of the
country where it is established and its usual cost-accounting practices;
comply with the requirements of applicable national laws on taxes, labour and social
security;
be in accordance with the provisions of the Grant Agreement (see, in particular,
Articles 6 and 9-11a) and
have been converted to euro at the rate laid down in Article 15.6 of the Grant
Agreement:
3
To be assessed in particular on the basis of the procurement and selection procedures for service providers.
4
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
o for beneficiaries with accounts established in a currency other than the euro:
Costs incurred in another currency must be converted into euros at the average
of the daily exchange rates published in the C series of the EU Official Journal
determined over the corresponding reporting period.
If no daily euro exchange rate is published in the EU Official Journal for the
currency in question, the rate used must be the average of the monthly
accounting rate established by the Commission and published on its website;
o for beneficiaries with accounts established in euro:
Costs incurred in another currency should be converted into euros applying the
beneficiary’s usual accounting practice.
The auditor must verify whether expenditure includes VAT and, if so, verify that the
beneficiary:
- cannot recover the VAT (this must be supported by a statement from the competent
body) and
- is not a public body acting as a public authority.
The auditor should base his/her audit approach on the confidence level following a review of
the beneficiary's internal control system. When using sampling, the auditor should indicate
and justify the sampling size.
Specific eligibility rules
In addition, the auditor must verify that the costs declared comply with the specific cost
eligibility rules set out in Article 6.2 and Articles 9.1.1, 10.1.1, 11.1.1, 11a.1.1 and 11a.2.1 of
the Grant Agreement.
Personnel costs
The auditor must verify that:
personnel costs have been charged and paid in respect of the actual time devoted by
the beneficiary’s personnel to implementing the action (justified on the basis of time
sheets or other relevant time-recording system);
personnel costs were calculated on the basis of annual gross salary, wages or fees (plus
obligatory social charges, but excluding any other costs) specified in an employment
or other type of contract, not exceeding the average rates corresponding to the
beneficiary’s usual policy on remuneration;
the work was carried out during the period of implementation of the action, as defined
in Article 3 the Grant Agreement and
the personnel costs are not covered by another EU or Euratom grant (see below
ineligible costs);
for additional remunerations: the 2 conditions set out in Article 6.2.A.1 are met (i.e.
that it is part of the beneficiary’s usual remuneration practices and is paid in a
consistent manner whenever the same kind of work or expertise is required and that
the criteria used to calculate the supplementary payments are objective and generally
applied by the beneficiary, regardless of the source of funding used);
for in-house consultants: the 3 conditions set out in Article 6.2.A.2 of the Grant
Agreement are met (i.e. that the in-house consultant works under the beneficiary’s
5
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
instructions, that the result of the work carried out belongs to the beneficiary, and that
the costs are not significantly different from those for personnel performing similar
tasks under an employment contract).
The auditor should have assurance that the management and accounting system ensures
proper allocation of the personnel costs to various activities carried out by the beneficiary and
funded by various donors.
Subcontracting costs
The auditor must verify that:
the subcontracting complies with best value for money (or lowest price) and that there
was no conflict of interests;
the subcontracting was necessary to implement the action for which the grant is
requested;
the subcontracting was provided for in Annex 1 and Annex 2 or agreed to by the
Agency at a later stage;
the subcontracting is supported by accounting documents in accordance with national
accounting law
public bodies have complied with the national rules on public procurement.
Travel and subsistence costs
The auditor must verify that travel and subsistence costs:
have been charged and paid in accordance with the beneficiary's internal rules or usual
practices;
are not covered by another EU or Euratom grant (see below ineligible costs);
were incurred for travels linked to action tasks set out in Annex 1 of the Grant
Agreement.
Equipment costs
The auditor must verify that:
the equipment is purchased, rented or leased at normal market prices;
public bodies have complied with the national rules on public procurement;
the equipment is written off, depreciation has been calculated according to the tax and
accounting rules applicable to the beneficiary and only the portion of the depreciation
corresponding to the duration of the action has been declared and
the costs are not covered by another EU or Euratom grant (see below ineligible costs).
Costs of other goods and services
The auditor must verify that:
the purchase complies with best value for money (or lowest price) and that there was
no conflict of interests;
public bodies have complied with the national rules on public procurement;
the costs are not covered by another EU or Euratom grant (see below ineligible costs).
6
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Ineligible costs
The auditor must verify that the beneficiary has not declared any costs that are ineligible
under Article 6.4 of the Grant Agreement:
costs relating to return on capital;
debt and debt service charges;
provisions for future losses or debts;
interest owed;
doubtful debts;
currency exchange losses;
bank costs charged by the beneficiary’s bank for transfers from the Agency;
excessive or reckless expenditure;
deductible VAT;
VAT incurred by a public body acting as a public authority;
costs incurred during suspension of the implementation of the action;
in-kind contributions from third parties;
costs declared under other EU or Euratom grants (including those awarded by a
Member State and financed by the EU or Euratom budget or awarded by bodies other
than the Agency for the purpose of implementing the EU or Euratom budget); in
particular, indirect costs if the beneficiary is already receiving an operating grant
financed by the EU or Euratom budget in the same period;
costs incurred for permanent staff of a national administration for activities that are
part of its normal activities (i.e. not undertaken only because of the grant);
costs incurred for staff or representatives of EU institutions, bodies or agencies.
3.2 Verification of receipts
The auditor must verify that the beneficiary has declared receipts within the meaning of
Article 5.3.3 of the Grant Agreement, i.e.:
income generated by the action (e.g. from the sale of products, services and
publications, conference fees) and
financial contributions given by third parties, specifically to be used for costs that are
eligible under the action.
3.3 Verification of the beneficiary’s accounting system
The auditor must verify that:
the accounting system (analytical or other suitable internal system) makes it possible
to identify sources of financing for the action and related expenses incurred during
the contractual period and
expenses/income under the grant have been recorded systematically using a
numbering system that distinguishes them from expenses/income for other projects.
7
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
Certificate on the financial statement (CFS)
To
[Beneficiary/affiliated entity’s full name
address]
We, [full name of the audit firm/organisation], established in [full address/city/country],
represented for signature of this audit certificate by [name and function of an authorised
representative],
hereby certify
that:
1. We have conducted an audit relating to the costs declared in the financial statement of
[name of beneficiary/affiliated entity] (the [‘beneficiary’][‘affiliated entity’]), to which
this audit certificate is attached and which is to be presented to the Consumers, Health,
Agriculture and Food Executive Agency under Grant Agreement No [insert number] —
[insert acronym], covering costs for the following reporting period(s): [insert reporting
period(s)].
2. We confirm that our audit was carried out in accordance with generally accepted
auditing standards in compliance with ethical rules and on the basis of the provisions of
the Grant Agreement and its Annexes (and in particular the audit methodology
described in Annex 5).
3. The financial statement was examined and all necessary tests of [all][[X]%] of the
supporting documentation and accounting records were carried out in order to obtain
reasonable assurance that, in our opinion and on the basis of our audit
total costs of EUR [insert number] ([insert amount in words]) are eligible, i.e.:
actual;
determined in accordance with the [beneficiary’s][affiliated entity’s]
accounting principles;
incurred during the period referred to in Article 3 of the Grant Agreement;
recorded in the [beneficiary’s][affiliated entity’s] accounts (at the date of this
audit certificate);
comply with the specific eligibility rules in Article 6.2 of the Grant Agreement;
do not contain costs that are ineligible under Article 6.4 of the Grant
Agreement, in particular:
costs relating to return on capital;
debt and debt service charges;
provisions for future losses or debts;
interest owed;
doubtful debts;
currency exchange losses;
8
Associated with document Ref. Ares(2020)3808356 - 20/07/2020
bank costs charged by the [beneficiary’s][affiliated entity’s] bank for
transfers from the Agency;
excessive or reckless expenditure;
deductible VAT;
VAT incurred by a public body acting as a public authority;
costs incurred during suspension of the implementation of the action;
in-kind contributions provided by third parties;
costs declared under other EU or Euratom grants (including those
awarded by a Member State and financed by the EU or Euratom budget
or awarded by bodies other than the Agency for the purpose of
implementing the EU or Euratom budget); in particular, indirect costs if
the [beneficiary][affiliated entity] is already receiving an operating
grant financed by the EU or Euratom budget in the same period;
costs incurred for permanent staff of a national administration, for
activities that are part of its normal activities (i.e. not undertaken only
because of the grant);
costs incurred for staff or representatives of EU institutions, bodies or
agencies;
[are claimed according to the euro conversion rate referred to in Article 15.6 of
the Grant Agreement;]
total receipts of EUR [insert number] ([insert amount in words]) have been declared
under Article 5.3.3 of the Grant Agreement and
the [beneficiary’s][affiliated entity’s] accounting procedures are in compliance with
the accounting rules of the state in which it is established and permit direct
reconciliation of the costs incurred for the implementation of the action covered by the
EU grant with the overall statement of accounts relating to its overall activity.
[However, our audit opinion is qualified for:
costs of EUR [insert number]
receipts of EUR [insert number]
which in our opinion do not comply with the applicable rules.]
4. We are qualified/authorised to deliver this audit certificate [(for additional information,
see appendix to this certificate)].
5. The [beneficiary][affiliated entity] paid a price of EUR [insert number]) (including VAT
of EUR [insert number]) for this audit certificate. [OPTION 1: These costs are eligible
(i.e. incurred within 60 days of the end of the action referred to in Article 3 of the Grant
Agreement) and included in the financial statement.][OPTION 2: These costs were not
included in the financial statement.]
Date, signature and stamp
9
Digitally sealed by the European Commission
Date: 2020.07.20 08:40:17 CEST
This document is digitally sealed. The digital sealing mechanism uniquely binds the
document to the modules of the Funding & Tenders Portal of the European
Commission, to the transaction for which it was generated and ensures its integrity and
authenticity.
Any attempt to modify the content will lead to a breach of the electronic seal, which can
be verified at any time by clicking on the digital seal validation symbol.
Commission européenne/Europese Commissie, 1049 Bruxelles/Brussel, BELGIQUE/BELGIË - Tel. +32 22991111
KOOSTÖÖKOKKULEPE NR 2-2.1/1485-1
Eesti Vabariik, Sotsiaalministeeriumi kaudu, registrikood 70001952, asukoht Suur-Ameerika 1,
10122 Tallinn, mida esindab põhimääruse alusel kantsler Marika Priske (edaspidi „Ministeerium“) ja
Sihtasutus Viljandi Haigla, registrikood 90004585, asukoht Pärna tee 3, Jämejala küla, Viljandi vald,
71024 Viljandi, mida esindab juhatuse esimees Priit Tampere (edaspidi „Haigla“), edaspidi koos
nimetatud „pooled“ ja eraldi „pool“,
LÄHTUDES poolte ühisest huvist tagada Euroopa Komisjoni Tarbija-, Tervise-, Põllumajandus- ja
Toiduküsimuste Rakendusameti (Chafea, edaspidi Amet), ASOCIACIÓN INSTITUTO DE
INVESTIGACIÓN EN SERVICIOS DE SALUDKRONIKGUNE (edaspidi Koordinaator) ning
Ministeeriumi vahel sõlmitud toetuslepingu nr 951442-Jadecare (edaspidi toetusleping) ning
Koordinaatori ja Ministeeriumi vahel 20.11.2020 sõlmitud konsortsiumilepingu (edaspidi
konsortsiumileping) elluviimine perioodil 1. oktoobrist 2020. a kuni 30. septembrini 2023. a,
sõlmisid käesoleva koostöökokkuleppe (edaspidi “koostöölepe”) alljärgnevas:
1. Koostööleppe eesmärk ja objekt
1.1. Koostööleppe eesmärgiks on arendada digitaalselt toetatud, integreeritud ja inimesekeskset
hoolduse süsteemi.
1.2. Koostööleppe objektiks on toetuslepingu lisas 1 kirjeldatud tegevustes osalemine sh Euroopa Liidu
liikmesriikide poolt välja valitud parima(te) praktika(te) katsetamiseks ja rakendamiseks
tegevuskava väljatöötamine ning elluviimine.
2. Poolte õigused ja kohustused
2.1. Ministeeriumi õigused ja kohustused:
2.1.1. Jagab koostööleppe täitmiseks teisele poolele vajalikku informatsiooni.
2.1.2. Moodustab punktides 2.2.2. ja 2.2.3. loetletud tegevuste toetamiseks parima praktika
kasutuselevõtmise töörühma.
2.1.3. Osaleb punktis 2.2.3. nimetatud tegevustes.
2.1.4. Tagab toetuslepingus ja konsortsiumilepingus ettenähtud andmete esitamise Koordinaatorile
ning Ametile ja koordineerib infovahetust Haigla ning Koordinaatori vahel.
2.2. Haigla õigused ja kohustused:
2.2.1. Tagab toetuslepingu ja konsortsiumilepingu sätete järgimise.
2.2.2. Osaleb toetuslepingu lisas 1 kirjeldatud tegevustes, mis on suunatud tegevuskava
koostamisele, elluviimisele ja hindamisele.
2.2.3. Koostab koostöös punktis 2.1.2 nimetatud töörühmaga tegevuskava Euroopa Liidu
liikmesriikide poolt välja valitud parima(te) praktika(te) katsetamiseks ja rakendamiseks ning viib
tegevuskava ellu.
2.2.4. Tagab punktis 6.1.1. nimetatud volitatud isiku viivituseta teavitamise, kui:
2.2.4.1. ilmnevad asjaolud, mis takistavad või ei võimalda punktides 2.2.2. ja 2.2.3. nimetatud
kohustusi (sh õigeaegselt) täita;
2.2.4.2. muutub Haigla omandivorm, nimi või aadress.
2.2.5. Esitab toetuslepingu punktides 15.2 ja 15.3 ettenähtud tähtajal ning tingimustel punktis 6.1.1.
nimetatud Ministeeriumi volitatud esindajale Haigla kulude vormikohase koondaruande
(koostööleppe Lisa 5).
2.2.6. Esitab Ministeeriumile järgneva eelarveaasta koostööleppe elluviimisega seotud kulude
prognoosi ning jooksva eelarveaasta prognoosi täpsustused või muudatusettepanekud, mitte
hiljem kui jooksva aasta 31. oktoobriks.
2.2.7. Eristab koostööleppe elluviimise raames tehtud kulud (nii otsesed kui kaudsed kulud)
raamatupidamises ning esitab Ministeeriumi, Euroopa Komisjoni, Ameti, Euroopa Kontrollikoja
(ECA) või Euroopa Pettusevastase Ameti (OLAF) nõudmisel kõik vajalikud dokumendid, sh
raamatupidamisväljavõtteid, mis on vajalikud kulude abikõlblikkuse tõestamiseks.
2.2.8. Tagab igakülgse koostöö ja infovahetuse Ministeeriumi ning punktis 2.2.7. nimetatud
asutustega ja Koordinaatoriga, sh vastused Ministeeriumi volitatud isikute päringutele mõistliku
aja jooksul, kuid mitte hiljem kui viie tööpäeva jooksul.
2.2.9. Tagab koostööleppe elluviimisega dokumentide säilitamise toetuslepingus ettenähtud
tingimustel ja tähtajal.
2.3. Kui koostööleppega tehtavate tegevuste raames töödeldakse isikuandmeid, kohustuvad pooled
töötlema isikuandmeid vastavalt õigusaktides kehtestatud nõuetele. Isikuandmete töötlemise
täpsem kord ja eesmärk lepitakse vajadusel poolte vahel kokku eraldi koostööleppe lisaga.
2.4. Koostööleppe pool kohustub teist poolt informeerima kõikidest olulistest asjaoludest, mis võivad
mõjutada või takistada kokkuleppes sätestatud kohustuste täitmist või õiguste realiseerimist.
3. Kulude hüvitamine
3.1. Ministeerium hüvitab Haiglale toetuslepingu eelarves ettenähtud koostööleppe elluviimisega
seotud kulud, mis on vastavalt toetuslepingule abikõlbulikud (maksimaalselt 74 703,12 €).
3.2. Kulude hüvitamiseks esitab Haigla punktis 6.1.1. nimetatud Ministeeriumi volitatud isikule
koostööleppe täitmisega seotud tegelike kulude vormikohase aruande (koostööleppe Lisa 5) ja
kuludokumendid sh tööaja tabeli (koostööleppe Lisa 4) kulude tekkimisele järgneva kuu 20.
kuupäevaks.
3.3. Ministeerium kinnitab punktis 3.2 nimetatud aruande 15 tööpäeva jooksul ning hüvitab Haiglale
abikõlbulikud kulud 5 tööpäeva jooksul aruande kinnitamisest.
4. Poolte vastutus
4.1. Koostööleppest tulenevate kohustuste täitmata jätmise või mittekohase täitmisega teisele poolele
tekitatud otsese varalise kahju eest kannavad pooled täielikku vastutust selle kahju ulatuses.
4.1.1. Kui Haigla rikub toetuslepingust või konsortsiumilepingust tulenevat kohustust, mille tagajärjel
tuleb Ministeeriumil osaliselt või täielikult tagasi maksta Ametilt saadud rahalised vahendid, on
Ministeeriumil õigus nõuda Haiglalt tagasi vastav summa.
4.1.2. Kui Haigla rikub koostööleppest tulenevat kohustust, on Ministeeriumil õigus jätta
koostööleppes kokkulepitud kulud hüvitamata või vähendada hüvitamisele kuuluvat summat.
4.2. Pooled ei vastuta käesoleva koostööleppe täitmata jätmise või mittekohase täitmise eest, kui see
on tingitud tema tahtest sõltumatutest asjaoludest ehk vääramatu jõu asjaoludest. Asjaolud peavad
olema tõendatavad ja pooled kohustuvad võtma tarvitusele vastavad abinõud tekkida võivate
kahjude vähendamiseks. Pool, kelle tegevus koostööleppe järgsete kohustuste täitmisel on
takistatud vääramatu jõu asjaolude tõttu, on kohustatud sellest koheselt kirjalikku taasesitamist
võimaldavas vormis teatama teisele poolele.
4.2.1. Vääramatu jõuna ei käsitata koostööleppe sõlmimise aja seisuga koroonaviiruse leviku
tõkestamiseks õigusaktidega kehtestatud piiranguid. Vääramatu jõu kohaldumise üheks
eelduseks on asjaolu ettenägematus. Koostööleppe sõlmimise ajal kehtivad piirangud olid
pooltele teada ning kõik tegevused planeeritakse, arvestades leppe sõlmimise ajal kehtivat
olukorda. Kui viiruse leviku tõkestamiseks kehtestatakse lisapiiranguid, mis takistavad
koostööleppe täitmist, on pooltel õigus tugineda vääramatule jõule.
5. Koostööleppe kehtivus
5.1. Koostöölepe jõustub selle sõlmimisel. Koostöölepe loetakse sõlmituks hilisemalt allakirjutamise
kuupäevast ja kehtib kuni toetuslepingu lisas 1 kirjeldatud tegevuste lõppemiseni kuid mitte kauem
kui 30.09.2023. Lepingu lõppemine ei mõjuta selliste kohustuste täitmist, mis oma olemuse tõttu
kehtivad ka pärast lepingu lõppemist sh kohustus säilitada toetuslepingu täitmisega seotud
andmeid ning kohustus teha koostööd punktis 2.2.7 nimetatud asutustega.
5.2. Pool võib kokkuleppe ennetähtaegselt lõpetada teatades sellest teisele poolele ette vähemalt 60
kalendripäeva.
5.3. Koostööleppe tingimuste täitmata jätmisel või mittenõuetekohasel täitmisel on mõlemal poolel
õigus kokkulepe lõpetada.
6. Volitatud esindajad ja teadete edastamine
6.1. Ministeeriumi volitatud esindajaks on:
6.1.1. sisulistes küsimustes Ministeeriumi hoolekande osakonna nõunik Ene Rebane, telefon 626
9818,
[email protected], või teda asendav isik;
6.1.2. finantsküsimustes Ministeeriumi finantsosakonna finantsnõunik Pille Erm, telefon 626 9166,
[email protected], või teda asendav isik
6.2. Haigla volitatud esindajaks koostööleppe täitmisega seotud küsimustes on Mart Kull, tel 434 3043,
e-post
[email protected], või teda asendav isik.
6.3. Poole volitatud esindajal on õigus esindada poolt kõikides koostööleppe täitmisega seotud
küsimustes, v.a koostööleppe muutmine, koostööleppe erakorraline ühepoolne lõpetamine ning
kahjude hüvitamise nõude esitamine.
6.4. Teadete edastamine toimub üldjuhul telefoni või e-posti teel. Juhul kui teate edastamisel on olulised
õiguslikud tagajärjed, peavad teisele poolele edastatavad teated olema edastatud kirjalikus vormis.
Kirjaliku vormiga on võrdsustatud digitaalselt allkirjastatud vorm.
7. Koostööleppe lisad
Koostööleppe juurde kuuluvad allkirjastamise hetkel lisadena alljärgnevad dokumendid:
7.1. Lisa 1 – toetusleping;
7.2. Lisa 2 – konsortsiumileping;
7.3. Lisa 3 – eelarve;
7.4. Lisa 4 – tööajatabel;
7.5. Lisa 5 – aruanne.
8. Lõppsätted
8.1. Koostööleppe täitmisel tõusetuvad vaidlused püüavad pooled lahendada läbirääkimiste teel,
kokkuleppe mittesaavutamisel lahendatakse erimeelsused Eesti Vabariigi seadusega ettenähtud
korras.
8.2. Koostöölepe on allkirjastatud digitaalselt.
Marika Priske Priit Tampere
/allkirjastatud digitaalselt/ /allkirjastatud digitaalselt/
Tel: 626 9301 Tel: 434 3043
E-post:
[email protected] E-post:
[email protected]
LISA 5 KOOSTÖÖKOKKULEPPELE NR 2-2.1/1485-1
LISA 4 KOOSTÖÖKOKKULEPPELE NR {viit}
TIME RECORDING FOR CHAFEA GRANTS Month: Year:
Title of the action / work programme (acronym): Grant Agreement No:
Beneficiary´s / partner's/ afiliated entity's name:
Name and function of the person assigned to the
Type of personnel
action/work programme:
DAY 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
Related activities Total
Reference
(e.g. work package)
0
0
0
0
0
Other EU projects
Sub-total: 0
and activities
0
0
Other activities Sub-total: 0
0
Total Hours 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Short description of the activities carried out in the month:
Signed (name of the person assigned to the action/work programme):
Signed (name of the supervisor):
Date: Date: .
Signature: Signature:
LISA 3 KOOSTÖÖKOKKULEPPELE NR 2-2.1/1485-1